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Abstract 
The science of chemical biology is the ability to answer biological questions by 
analyzing living systems at the chemical level. Two entirely different approaches to 
reach this goal are presented in this thesis. The work is divided in three experimental 
chapters and each one highlights the combination of modern synthetic chemistry with 
biological applications. Experimental data, spectroscopic analysis and appendices can 
be found at the end of this thesis. 
Chapter 1 starts with a general introduction on important natural products that 
contributed to the progress of drug development in an historical perspective. The 
second part of this chapter presents the basic principle of combining multiple 
bioactive natural products to a single hybrid molecule and its potential application 
field. 
Chapter 2 gives a broader introduction into the chemical communication used in 
the bacterial world. The communication pathways of Gram-positive and Gram–
negative bacteria are discussed with a special focus on the latter. The concept of 
quorum sensing and its importance in pathogenesis and biofilm formation are 
described in detail. The progress of synthetic signaling molecules that can modulate 
quorum sensing are discussed in chronological order. 
The combination of molecular anchors to quorum sensing modulators is reported in 
Chapter 3. Inspired by the surface adherent properties of catechols, quorum sensing 
modulators were functionalized on metal oxide surfaces thereby maintaining their 
activity. The immobilized natural product hybrids were recognized by bacterial 
reporter strains as quorum sensing modulators. The mode of action was determined to 
be via slow release of the bioactive hybrid compounds.  
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The recognition pattern for quorum sensing receptors was further developed in 
Chapter 4 by the attachment of fluorescent dyes. First generation fluorescent labeling 
agents for quorum sensing (FLAQS) was successfully applied for the selective 
labeling of the CepR receptor used by Burkholderia cenocepacia. Further 
improvement of the fluorescent moiety allowed the first labeling of quorum sensing 
receptors in wild-type bacteria. 
 
 
 
Second generation FLAQS bearing 3-oxo functionality in the acyl side chain were 
applied for the labeling of LasR, one of the quorum sensing receptors used by 
Pseudomonas aeruginosa.  
A variety of natural products from Illicium species have been shown to possess 
exceptional neuritogenic properties. The synthesis of majucin-type sesquiterpenes and 
the preparation of 10-deoxy-jiadifenolide is the topic of Chapter 5. The synthetic key 
features include a cascade three-component reductive alkylation, a diastereoselective 
intramolecular Nozaki-Hiyama-Kishi coupling with a ketone, and an unprecedented 
cyanide addition to an aldehyde with subsequent lactonization under neutral 
conditions. The synthesis was accomplished in 25 linear steps with an overall yield of 
3.7% for the first 24 steps.  
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Zusammenfassung 
Die Wissenschaft der chemischen Biologie ist die Fähigkeit, biologische 
Fragestellungen durch die Analyse von lebenden Systemen auf chemischer Ebene zu 
beantworten. Zwei völlig verschiedene Ansätze um dies zu tun werden in dieser 
Arbeit präsentiert. Die Arbeit ist in drei experimentelle Kapitel unterteilt und jedes 
hebt die Kombination von moderner synthetischer Chemie mit biologischen 
Anwendungen hervor. Experimentelle Daten und spektroskopische Analysen sind am 
Ende dieser Arbeit zu finden. 
Kapitel 1 beginnt mit einer allgemeinen Einführung über bedeutende Naturstoffe, 
die für den Fortschritt der Arzneimittelentwicklung beigetragen haben. Der zweite 
Teil dieses Kapitels befasst sich mit dem Grundprinzip der Kombination mehrerer 
bioaktiver Naturstoffe zu einem einzigen Hybrid-Molekül und seine möglichen 
Anwendungsfelder. 
Kapitel 2 bietet eine breitere Einführung in die chemische Kommunikation der 
bakteriellen Welt. Die Kommunikationswege von Gram-positiven und 
Gram-negativen Bakterien werden mit einem speziellen Fokus auf letztere diskutiert. 
Das Konzept des Quorum Sensing und seine Bedeutung in der Pathogenese und 
Biofilmbildung sind ausführlich beschrieben. Die Fortschritte der synthetischen 
Signalmoleküle, die Quorum Sensing modulieren können, sind in chronologischer 
Reihenfolge besprochen. 
Die Kombination von molekularen Ankern und Quorum Sensing Modulatoren 
wird in Kapitel 3 beschrieben. Inspiriert von den Hafteigenschaften von Catecholen, 
wurden Quorum Sensing-Modulatoren auf Metalloberflächen funktionalisiert unter 
Erhaltung ihrer Aktivität. Die immobilisierten Naturprodukthybride wurden durch 
bakterielle Reporter Stämme als Quorum Sensing-Modulatoren erkannt. Der 
Wirkungsmechanismus wurde als langsame Freisetzung der biologisch aktiven 
Hybrid-Verbindungen festgestellt. 
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Das Erkennungsmuster für Quorum Sensing-Rezeptoren wurde in Kapitel 4 durch 
die Anlage von Fluoreszenzfarbstoffen ausgebaut. Die erste Generation von 
Fluoreszenzmarkierungsmittel für Quorum Sensing (FLAQS) wurde erfolgreich für 
die selektive Markierung des von Burkholderia cenocepacia verwendeten CepR 
Rezeptors benutzt. Eine weitere Verbesserung der fluoreszierenden Gruppe 
ermöglichte die erste Markierung von Quorum Sensing-Rezeptoren in Wildtyp-
Bakterien. 
 
 
 
Zweite Generation FLAQS mit 3-Oxo-Funktionalität in der Acyl-Seitenkette wurden 
für die Kennzeichnung von LasR, einer der Quorum Sensing-Rezeptoren durch 
Pseudomonas aeruginosa verwendet, entwickelt. 
Eine Vielzahl von natürlichen Produkten aus Illicium Spezies besitzen 
aussergewöhnliche neuritogene Eigenschaften. Die Synthese von Majucin-Sesquiterpenen 
und die Fertigstellung von 10-Deoxy-Jiadifenolid ist das Thema von Kapitel 5. Die 
synthetischen Hauptmerkmale sind ein Kaskadendreikomponenten reduktive Alkylierung, 
eine diastereoselektive intramolekulare Nozaki-Hiyama-Kishi-Kopplung mit einem 
Keton, eine beispiellose Cyanid Addition an einen Aldehyd und anschliessende 
Lactonisierung unter neutralen Bedingungen. Die Synthese wurde in 25 linearen Stufen 
mit einer Gesamtausbeute von 3.7% für die ersten 24 Stufen erreicht. 
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1 INTRODUCTION 
1.1 Natural Products in Drug Discovery 
Natural products have served as the most successful source of potential drug 
leads. 1  Due to their unique structural diversity in comparison to standard 
combinatorial chemistry and the fact that less than 10% of the world’s biodiversity 
has been evaluated for potential biological activity, natural products remain to offer 
excellent opportunities for discovering novel low molecular weight lead compounds. 
Thus, pharmaceuticals of natural origin and derivatives contribute to about 50% of all 
drugs on the market.2 Natural products can be found everywhere and the major 
sources of new secondary metabolites are fungi, plants, marine environment, algae, 
sponges and microorganisms.3 
  The earliest pharmaceutical record, which documents over 700 plant-based drugs, 
originates from Egypt dated 2900 B.C. and is known as the Ebers Papyrus. Further 
findings from Mesopotamia (2600 B.C.) documented oils from Cupressus 
sempervirens (cypress) and Commiphora species (myrrh), which are still used today 
to treat inflammation, colds and coughs.1c Ever since, the use of natural products as 
medicines has persisted throughout history in the form of traditional medicines, 
potions, remedies and oils. Some selected findings are discussed (Figure 1). 
The basis of early medicine was the use of traditional therapies followed by 
subsequent clinical, pharmacological and chemical studies.1e The most famous 
example to date would be the synthesis of the anti-inflammatory agent acetylsalicylic 
acid (I, aspirin). This substance is derived from the natural product salicin, which was 
isolated from the bark of the willow tree Salix alba L. by Edward Stone in 1763.4 The 
synthesis of I was accomplished more then a century later by the chemist Felix 
Hoffmann and was commercialized by Bayer.5 Acetylsalicylic acid (I) is still one of 
                                                
1  (a) B. B. Mishra, V. K. Tiwari, Eur. J. Med. Chem. 2011, 46, 4769; (b) J. Rey-Ladino, A. G. Ross, 
A. W.  Cripps, D. P. McManus, R. Quinn, Vaccine 2011, 29, 6464; (c) G. M. Cragg, D. J. Newman, 
Pure Appl. Chem. 2005, 77, 7; (d) B. Haefner, Drug Discov. Today 2003, 8, 536; (e) M. S. Butler, 
J. Nat. Prod. 2004, 67, 2141; (f) I. Paterson, E. A. Anderson, Science 2005, 310, 451. 
2  D. J. Newman, G. M.  Cragg, J. Nat. Prod. 2007, 70, 461.  
3  D. A. Dias, S. Urban, U. Roessner, Metabolites 2012, 2, 303, 
4  A. Der Marderosian, J. A. Beutler, The Review of Natural Products, 2nd ed.; Facts and 
Comparisons; Seattle, WA, USA, 2002; p. 13.  
5  W. Sneader, BMJ 2000, 321, 1591. 
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the most widely used drugs worldwide with an estimated 40’000 tones being 
produced every year.6 
In 1805, investigations of Papaver somniferum L. (opium poppy) led to the 
isolation of the analgesic drug morphine (II), which was the first active ingredient 
purified from a plant source. The chemical company Merck began its marketing in 
1827. Later, in the 1870s, crude II was boiled in acetic anhydride to yield 
diacetylmorphine (heroin), which was found to be readily converted to the painkiller 
codeine. The first total synthesis of II was reported by Gates in 1952.7 The authors 
accomplished this masterpiece in 31 steps with an overall yield of 0.06%. Even if 
more efficient approaches have been published to date, this achievement remains a 
classic example of total synthesis.  
Quinine (III), isolated from the bark of Cinchona succirubra, had been used for 
centuries for the treatment of malaria, indigestion, fever, mouth and throat diseases 
and cancer. The curative properties of III were originally discovered by the Quechua 
in South America and the plant was later brought to Europe by the Jesuits. In the 17th 
century, chemotherapy using III was the first effective treatment for malaria caused 
by Plasmodium falciparum. It was just in the mid 1800s that the British started 
cultivating the plant worldwide in order to overcome the colonization-associated 
malaria problem.4 The first total synthesis of III by Woodward and Doering in 1944 
can be considered as a milestone in organic chemistry.8  
Artemisinin (IV) was isolated for the first time from the plant Artemisia annua and 
has been approved as another antimalarial drug.2 This compound allows the most 
efficient treatment of all current drugs against Plasmodium falciparum.9 Originally, 
the plant was used in traditional Chinese medicine as a remedy for chills and fevers. 
The first total synthesis of artemisinin was reported by Schmid and Hofheinz in 1983 
from the natural (–)-isopulegol.10 Derivatives of IV are currently in various stages of 
clinical development as antimalarial drugs.1c,11 
                                                
6  T. D. Warner, J. A. Mitchell, Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 13371. 
7  M. Gates, G. Tschudi, J. Am. Chem. Soc. 1952, 74, 1109. 
8  R. B. Woodward, W. E. Doering, J. Am. Chem. Soc. 1944, 66, 849. 
9  N. J. White, Antimicrob. Agents Chemother. 1997, 41, 1413. 
10  G. Schmid, W. Hofheinz, J. Am. Chem. Soc. 1983, 105, 624. 
11 P. M. Dewick, Medicinal Natural Products: A Biosynthentic Approach, 2nd ed.; John Wiley and 
Son: West Sussex, UK, 2002; p. 520. 
INTRODUCTION   
 
3 
Another prominent natural product is penicillin (V). A serendipitous discovery by 
Fleming in 192912 and later isolation and characterization from the fungus Penicillium 
notatum by Chain and Florey led to the 1945 Nobel prize in Physiology and 
Medicine.13 Their results saved countless lives and revolutionized drug discovery 
research.14 Sheehan reported on the first chemical synthesis of penicillin in 1957 after 
nine years of intensive research.15 Even if the developed synthesis was not suitable for 
mass production of V, one of the intermediates (6-aminopenicillanic acid) allowed the 
creation of new forms of penicillin. 
Paclitaxel (VI, Taxol®) was isolated from the bark of Taxus brevifolia in 1967 and 
is now the most widely used breast cancer drug. Isolation from the bark of the 
American yew requires three mature 100 year old trees to provide 1 gram of VI. 
However, the current demand for VI is about 100-200 kg per year and can therefore 
hardly be obtained by isolation procedures.11 Thus, huge efforts have been devoted to 
in the total synthesis of paclitaxel (VI). The synthetic accomplishment of VI is called 
one of the most contested ones with around 30 competing research groups by 1992.16 
The first accepted article for publication was submitted by the Holton group in 1994.17  
Another important natural product is pilocarpine (VII), an L-histidine-derived 
alkaloid found in Pilocarpus jaborandi. This compound has been used as a 
therapeutic in the treatment of chronic and acute open-angle glaucoma for over 100 
years. Interestingly the FDA approved oral formulation of VII in 1994 to treat 
xerostomia (dry mouth), which is a side effect of radiation therapy for head and neck 
cancer.18 In addition, oral preparation of VII was approved for the management of 
Sjogren’s syndrome, an autoimmune disease that damages the salivary and lacrimal 
glands in 1998. 
                                                
12  J. Mann, Murder, Magic, and Medicine; Oxford University Press: New York, NY, USA, 1994; 
 p. 164.  
13  E. P. Abraham, E. Chain, C. M. Fletcher, Lancet 1941, 16,  177.  
14  (a) A. L. Alder, The History of Penicillin Production; American Institute of Chemical 
Engineers: New York, NY, USA, 1970.; (b) E. Lax, The Mold in Dr. Florey’s Coat: The Story of 
the Penicillian Miracle; John Macrae/Henry Hol: New York, NY, USA, 2004; p. 308.  
15  J. C. Sheehan, K. R. Henery-Logan, J. Am. Chem. Soc. 1957, 79, 1262. 
16  N. Hall, Chem. Commun. 2003, 661. 
17  R. A. Holton, C. Somoza, H.-B. Kim, F. Liang, R. J. Biediger, P. D. Boatman, M. Shindo, C. C. 
Smith, S. Kim, H. Nadizadeh, Y. Susuki, C. Tao, P. Vu, S. Tang, P. Zhang, K. K. Murthi, L. N. 
Gentile, J. H. Liu, J. Am. Chem. Soc. 1994, 116, 1597. 
18  T. Aniszewski, Alkaloids - Secrets of Life. In Alkaloid Chemistry, Biological Significance, 
Applications and Ecological Role; Elsevier Science: Amsterdam, The Netherlands, 2007; p. 334.  
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In 1953, Edmund Kornfeld isolated a glycopeptide antibiotic produced in cultures 
of Amycolatopis orientalis from soil samples collected from the jungles of Borneo by 
a missionary in the Eli Lilly Company laboratories and termed it vancomycin (VIII). 
Even though synthetically accessible, 19  industrial production of VIII is mostly 
conducted by fermentation. Activity was shown against Gram-negative bacteria, 
mycobacteria and fungi and it was used for the treatment of severe infection and 
against susceptible organisms in patients hypersensitive to penicillin (V).1e 
 
  
Figure 1: Examples of important bioactive drugs. 
 
Natural product discovery programs driven by pharmaceutical companies provided 
lead compounds for the treatment of cancer, microbial infections, hypercholesteremia 
and tissue rejection in organ transplantation. 20  However, major pharmaceutical 
                                                
19  (a) D. A. Evans, M. R. Wood, B. W. Trotter, T. I. Richardson, J. C. Barrow, J. L. Katz, Angew. 
Chem. Int. Ed. 1998, 37, 2700; (b) K. C. Nicolaou, H. J. Mitchell, N. F. Jain, N. Winssinger, R. 
Hughes, T. Bando, Angew. Chem. Int. Ed. 1999, 38, 240. 
20  (a) D. D. Baker, M. Chu, U. Oza, V. Rajgarhia, Nat. Prod. Rep. 2007, 24, 1225; (b) I. Ojima, J. 
Med. Chem. 2008, 51, 2587.  
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companies decommissioned their programs in the 90s and 2000s due to continuous 
re-discovery of previously isolated compounds and the structural complexity of 
natural products. The later requires total synthesis and derivatization, which is both 
economically and synthetically challenging. Thus, combinatorial chemistry was 
thought to be the future source of novel drug leads or new chemical entities. However, 
only one combinatorial new chemical entity has been approved by the FDA to date, 
namely the kinase inhibitor sorafenib (IX). 21  The innate disadvantage of large 
libraries of compounds produced by combinatorial chemistry is the lack of complexity 
compared to the intricate natural products synthesized by nature.  
Therefore, the development of drug candidates is strictly linked to the progress in 
total synthesis and structure-activity relationship (SAR) studies of complex natural 
products. Furthermore, it enables biological investigations towards target 
understanding, metabolism and mode of action of the selected compounds. The 
second part of this thesis focuses on the synthesis of complex natural products bearing 
important biological activities. 
 
1.2 Natural Product Hybrids in Drug Discovery 
The combination of two or more natural products to form hybrids has been 
proposed as the next stage to profit from natural products.22 This concept is not 
completely new and some examples can be found in Nature, for example, vitamin E 
(X, Figure 2). The terpenoid phytyl chain interacts with the cell membrane, while the 
phenol moiety derived from shikimic acid forms a radical trap. Another interesting 
natural hybrid is the antimicrobial antibiotic thiomarinol (XI), isolated from the 
marine bacterium Alteromonas rava sp. nov. SANK 73390.23 This compound was 
shown to be a hybrid of a pseudomonic acid C analogue and holothin and shows 
characteristics of both parent moieties, namely activity against Gram-positive and 
Gram-negative bacteria. Moreover, the effects of XI are more pronounced than those 
of either parent compound. 
                                                
21  D. J. Newman, J. Med. Chem. 2008, 51, 2589.  
22  Reviews: (a) L. F. Tietze, H. P. Bell, S. Chandrasekhar, Angew. Chem. Int. Ed. 2003, 42, 3996; 
(b) K. Gademann, CHIMIA 2006, 60, 841. 
23  H. Shiozawa, T. Kagasaki, T. Kinoshita, H. Haruyama, H. Domon, Y. Utsui, K. Kodama, S. 
Takahashi, J. Antibiot. 1993, 46, 1834 .  
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Figure 2: Natural product hybrids found in Nature. 
 
Chemists have adapted this basic principle of combining two bioactive moieties to 
form a single hybrid bearing both or improved properties. Compound XII is an 
example of a synthetic hybrid molecule tested against expression of different tumor-
relevant proteins in MCF7 breast cancer cells (Figure 3).24 The western part of the 
molecule is derived from the sex hormone estradiol. The eastern moiety originates 
from geldanamycin, an antibiotic first isolated from Streptomyces hygroscopius. This 
natural product has been shown to bind to the Hsp90 chaperone protein and causes 
degradation of several important signaling proteins. The combination of both entities 
offers the ability to induce a selective degradation of the estrogen receptor. Biological 
tests showed that XII reduces the expression of HER2, ER and Raf-1 in MCF7 breast 
cancer cells. 
 
 
Figure 3: Structure of the anti-cancer natural product hybrid XII. 
 
The advantage of this approach over a combinatorial chemistry concept is its high 
diversity and the inherent biological activity of the hybrids. The hybridization concept 
was applied to the field of quorum sensing in the first part of this thesis by combining 
natural agonists to molecular surface anchors and fluorescent moieties. 
 
 
                                                
24  S. D. Kuduk, F. F. Zheng, L. Sepp-Lorenzino, N. Rosen, S. J. Danishefsky, Bioorg. Med. Chem. 
Lett. 1999, 9, 1233.  
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2 COMMUNICATION IN THE BACTERIAL WORLD 
2.1 Introduction 
Communication is one of the most precious tools developed by living organisms in 
order to enable the living together in communities. Humans have evolved a very 
sophisticated language in order to communicate with each other and therewith enable 
a fruitful and constructive cohabitation. This basic and fundamental tool has not only 
been developed by mankind, but is widely spread throughout the living world. 
Animals use a similar acoustic communication, for instance to warn their conspecifics 
in case of danger or in need for reproduction. However, such a communication 
pathway has not only been developed by higher organisms. Also the simplest life 
forms have evolved a method to improve cohabitation in large communities. This 
chapter will focus on bacterial communication by exchange of chemical signaling 
molecules and their biological importance. 
Our special interest belongs to the oldest living species on earth, namely bacteria. 
These unicellular prokaryotic living organisms are broadly distributed in water, soil, 
air, and on tissue of plants and animals. They play crucial roles in many biological 
processes, such as nitrogen fixation and decomposition of biomass and dead 
organisms. For historical reasons, bacterial can be divided into two main classes 
according to their cell walls’s reaction to Gram staining.25 In 1884, the Danish 
scientist Hans Christian Gram developed a staining solution and observed that some 
bacteria turned blue or violet, while others remained red or pink. Gram termed the 
labeled ones positive and the not labeled ones negative. The difference in staining 
between these two groups relies in thicker peptidoglycan wall that Gram-negative 
cells possess, which provides them with an increased protection and robustness and 
prevents the strain from entering the cell. Gram staining remained an extremely 
valuable analytical tool in both clinical and research settings. The following section 
will describe the different modes of communication used by Gram-positive and 
Gram-negative bacteria. 
 
 
                                                
25  H. C. Gram Fortschr. Med. 1884, 2, 185. 
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2.2 Quorum Sensing – The Bacterial Language 
Communication used by bacteria is not only based on direct contact between single 
cells. In fact, bacteria have developed a complex cell-to-cell communication pathway 
based on the exchange of chemical signaling molecules. This system is used by a 
wide variety of bacteria to synchronize their activities in sizeable groups in order to 
act as multicellular organisms.26 In this way, bacteria have the ability to coordinate 
activities, such as swarming motility, surface attachment, sporulation, antibiotic 
resistance, biofilm maturation or virulence.27 Such pathogenic traits are seemingly 
futile if performed by a single bacterium acting alone and therefore, only expressed 
when the bacterial population density is high enough to overwhelm the host defense 
mechanism. To control the size of the population bacteria produce and release small 
signaling molecules, so-called autoinducers (AI), which then accumulate in the direct 
surroundings. When a certain concentration of AIs is reached, bacteria switch from a 
low-cell-density (LCD) into a high-cell-density (HCD) mode.28 Once HCD is reached, 
a signal transduction cascade is triggered, which culminates in a population-wide 
alternation in gene expression. This synchronous response of bacterial populations 
gives multicellular ability to these unicellular organisms and is referred to as quorum 
sensing (QS).27 Such QS controlled pathways are only beneficial when carried out by 
the entire group. If it is induced before a minimal threshold concentration is reached, 
bacteria are usually not adequate to survive. QS is used by both Gram-negative and 
Gram-positive bacteria but is not crucial for their viability. 
Much attention has been attributed to the phenomenon of QS in the recent years. 
However, the first report of bacterial communication using chemical signaling 
molecules goes back to the year 1965. Tomasz published a paper concerning 
Pneumococcus (today known as Streptococcus pneumoniae) strains and their growth 
behavior and genetic competence.29 In this publication, the author described an 
extracellular factor produced by Streptococcus, which triggered the competence state. 
This factor was termed “hormone-like activator” and enables the synchronization 
                                                
26  C. M. Waters, B. L. Bassler, Annu. Rev. Cell Dev. Biol. 2005, 21, 319. 
27  (a) M. B. Miller, B. L. Bassler, Annu. Rev. Microbiol. 2001, 55, 65; (b) C. D. Nadell, J. B. Xavier, 
S. A. Levin, K. R. Foster, PLoS Biol. 2008, 6, 171, (c) M. Boyer, F. Wisniewski-Dyé, FEMS 
Microbiol. Ecol. 2009, 70, 1. 
28  W. Ng, B. L. Bassler, Annu. Rev. Genet. 2009, 43, 197. 
29  A. Tomasz, Nature 1965, 208, 155.	
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behavior of bacterial populations.30 Five years later, Hastings and co-workers reported 
the control of luminescence in the marine Gram-negative bacterium Vibrio fischeri 
promoted by AIs.31 Moreover, the authors were able to show that light emission in 
Vibrio fischeri and Vibrio harveyi does not correlate with bacterial growth. The in 
vivo bioluminescence emerged at a later stage and much faster than the bacterial 
population growth and the researchers termed this phenomenon “autoinduction”. 
The combined findings of Tomasz and Hastings suggested that certain bacterial 
strains use signaling molecules to examine their environment and to control group 
behavior based on the population density. However, at that time, this cell-to-cell 
signaling pathway was thought to be anomalous and restricted to only a few 
specialized bacteria.30 The discovery of the structure of N-3-(oxo-
hexanoyl)homoserine lactone (OHHL) of Vibrio fischeri as an AI and its capability to 
diffuse into and out of the cells reported in 1981 was a major breakthrough in this 
field.32 The QS system of Vibrio fischeri was later found in other bacteria and caused 
a change to the current view that QS is a common mechanism for cell-to-cell 
communication in many bacterial species.33 All these results demonstrate that QS is 
not a rare phenomenon for specialized bacteria but a rather important tool in the 
bacterial world. 
 
2.3 Quorum Sensing Pathways 
To date, a wide variety of QS pathways have been identified and characterized.34 
The differentiation between the different pathways is based on the chemical structure 
of the used AIs. However, the fundamental steps involved in detecting and responding 
to fluctuations in cell density are analogous in all known QS systems. In order to be 
classified as “quorum sensing molecules”, a moiety has to match four different criteria 
as described by Winzer et al.:35 
 
                                                
30  B. L. Bassler, R. Losick, Cell 2006, 125, 237. 
31  K. H. Nealson, T.Platt L. W. Hastings, J. Bacteriol. 1970, 104, 313. 
32  A. Eberhard, A. L. Burlingame, C. Eberhard, G. L. Kenyon, K. H. Nealson, N. J. Oppenheimer, 
Biochemistry 1981, 20, 2444. 
33  E. P. Greenberg, ASM News 1997, 63, 371. 
34  L. Eberl, K. Riedel, Proteomics 2011, 11, 3070. 
35 K. Winzer, K. R. Hardie, P. Williams, Curr. Opin. Microbiol. 2002, 5, 216. 
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1. The molecule has to be produced during specific stages of cell growth or in 
response to a particular environmental change. 
2. QS molecules accumulate in the extra-cellular environment and are 
recognized by a specific receptor. 
3. A concerted response has to be stimulated by the accumulation of a 
threshold concentration of AIs. 
4. The cellular response should be greater than the physiological 
modifications required to detoxify or metabolize the molecule. 
The chemical entity of AIs highly depends on the bacterial species. Some 
representative examples of chemical structures used as QS signaling molecules are 
shown in Figure 4. The most prevalent QS pathway used by Gram-negative 
proteobacteria is mediated by acylated homoserine lactones (AHLs, XIII) and is 
composed of a homoserine lactone ring carrying C4-C12 acyl side chains. 36  
Gram-positive bacteria, for their part, use a completely different pathway mediated by 
linear, cyclic, or modified peptides (autoinducing peptides, AIPs, XIV) as signaling 
molecules. Furthermore, a third important pathway uses 4,5-dihydroxy-2,3-
pentanedione (DPD, XV) derivatives, referred to as autoinducer-2 (AI-2), which is 
shared by both Gram-positive and Gram-negative bacteria and probably allows them 
to cross talk. These three major communication pathways will be discussed in more 
detail in the following sections. 
An additional extracellular signaling molecule is called Pseudomonas quinolone 
signal (PQS, XVI) and is exclusively produced by the opportunistic pathogen 
Pseudomonas aeruginosa. 37  Together with two well-studied AHL signaling 
molecules, XVI is responsible for the control of a number of genes required for 
virulence factor expression and biofilm formation. PQS (XVI) is rather hydrophobic, 
obscuring any obvious mechanism for it to act as an extra-cellular signal. However, 
Whiteley and co-workers demonstrated that a specialized vesicular transport 
mechanism conveys XVI signals packed in vesicles between bacterial cells.38 These 
vesicles are believed to be crucial for efficient information transfer between 
P. aeruginosa cells existing in biofilms.39 
                                                
36  A. M. Stevens, Y. Queneau, L. Soulère, S. V. Bodman, A. Doutheau, Chem. Rev. 2011, 111, 4.  
37  N. Ni, M. Li, J. Wang, B. Wang, Med. Res. Rev. 2009, 29, 65. 
38  L. M. Mashburn, M. Whiteley, Nature 2005, 437, 422. 
39  A. Camilli, B. L. Bassler, Science 2006, 311, 1113. 
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A further specific QS pathway is used by Streptomycetes. These common soil-
dwelling Gram-positive bacteria use γ-butyrolactones (XVII), which are structural 
analogues of AHLs (XIII), as communication signals. However, no cross recognition 
between the two pathways has been reported to date.30 
Last, a signaling molecule termed diffusible signal factor (DSF, XVIII) is known 
to stimulate QS in several bacterial strains, such as Xanthomonas campestris, Xylella 
fastidosa, or Burkholderia cenocepacia.38 
 
    
Figure 4: Chemical structures of bacterial communication signals. 
 
Bacteria can use several pathways and balance them to compensate each other and 
also change their sensitivity towards QS to face evolutionary pressure in order to 
survive. In the following sections, we will briefly discuss the molecular mechanisms 
of the three most common cell-to-cell communication systems mediated by AHLs, 
AI-2, and AIPs.  
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2.4 Acylated Homoserine Lactone Mediated Quorum Sensing 
The AHL mediated QS pathway is the most commonly used by Gram-negative 
bacteria for intraspecies communication and is also the best-studied example.40 All 
AHLs are composed of a homoserine lactone moiety and only differ in the fatty acyl 
side chains, which can have various lengths from C4 to C18, generally in increments of 
two, unsaturated double bonds, and oxidation/reduction state of the third carbon in the 
acyl chain.28 Even though the chemical discrepancy between different AHLs might be 
minimal, they are very specific for certain QS receptors and therewith for individual 
bacterial species.  
The first QS system to be discovered was found in the marine bacterium Vibrio 
fischeri and OHHL (XIII) was identified as the natural AI. This species lives in 
symbiosis with the Hawaiian bobtail squid Euprymna scolopes and colonizes its 
host’s light organ as shown in Figure 5. Bacteria produce light at HCD in exchange 
for a nutritious environment.41 The produced light can be of high importance for the 
host. The marine squid Euprymna japonicas, for example, uses the emitted light to 
mask its shadow and therewith remain invisible for predators. Another fascinating 
biological application can be observed in the pinecone fish Monocentris japonicus, 
which uses the emitted light to attract sexual partners.42  
 
                                                
40  S. Schauder, B. L. Bassler, Genes Dev. 2001, 15, 1468. 
41  K. L. Visick, M. J. McFall-Ngai, J. Bacteriol. 2000, 182, 1779. 
42  (a) E. G. Ruby, Annu. Rev. Microbiol. 1996, 50, 591; (b) K. J. Boettcher, E. G. Ruby, J. Bacteriol. 
1990, 172, 3701. 
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Figure 5: Hawaiian bobtail squid, Euprymna scolopes.43 
 
 
Additionally, Vibrio fischeri has one of the simplest and best understood QS 
communication pathways. Therefore, it is considered a model for studies of the basic 
mechanism of QS in Gram-negative proteobacteria (Figure 6). The apparatus of this 
species is controlled by an AHL synthase and an AHL receptor protein termed LuxI 
and LuxR, respectively.44 LuxI produces a basal level of OHHL (XIII) at LCD that 
can then freely diffuse in and out of the cell.45 As the cell population increases, the 
intra- and extracellular concentration of AHLs raises proportionally in the growth 
medium.27 On reaching a critical threshold concentration, the signaling molecule 
binds and activates LuxR.46 The LuxR-AHL complex acts as the transcriptional 
activator of the luciferase luxICDABE operon.47 LuxR proteins are unstable in the 
absence of AHL ligands and are rapidly degraded. Upon accumulation, the complex 
recognizes a consensus binding sequence upstream of the luxICDABE operon and 
                                                
43  Used with permission from William Ormerod, University of Wisconsin-Madison. 
44  (a) C. Fuqua, M. R. Parsek, E. P. Greenberg, Annu. Rev. Genet. 2001, 35, 439; (b) S. Swift, J. A. 
Downie, N. A. Whitehead, A. M. L. Barnard, G. P. C. Salmond, P. Williams, Adv. Microb. Physiol. 
2001, 45, 199. 
45  J. A. Engebrecht, M. Silverman, Proc. Natl. Acad. Sci. U. S. A. 1984, 81, 4154. 
46  J. A. Engebrecht, K. Nealson, M. Silverman, Cell 1983, 32, 773. 
47  (a) B. L. Hanzelka, E. P Greenberg, J. Bacteriol. 1995, 177, 815; (b) A. L. Schaefer, B. L. 
Hanzelka, A. Eberhard, E. P. Greeberg, J. Bacteriol. 1996, 178, 2897; (c) A. M. Stevens, K. M. 
Dolan, E. P. Greenberg, Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 12619; (d) A. M. Stevens, N. 
Fujita, A. Ishihama, E. P. Greenberg, J. Bacteriol. 1999, 181, 4704; (e) A. M. Stevens, E. P. 
Greenberg, J. Bacteriol. 1997, 179, 557.	
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activates its expression. This operon consists of three parts: luxI, which is responsible 
for LuxI production, luxAB, which encodes the enzyme luciferase, and luxCDE, 
which activates the proteins required for the biosynthesis of long chain aldehydes 
necessary for bioluminescence.42 The expression of luxI leads to an exponential 
increase in AHL biosynthesis and to the flooding of the surrounding environment 
with signaling molecules. This positive feedback loop is necessary in order to switch 
the entire population from a LCD into a HCD mode. Once an even higher 
concentration of AIs is reached, luxR is down-regulated as a compensatory measure.46 
 
  
Figure 6: LuxIR QS system of Vibrio fischeri. (1) Free diffusible AHLs are produced by LuxI and 
(2) accumulate in the extra-cellular space. (3) When HCD is reached, AHLs bind their cognate 
LuxR receptor, (4) thereby inducing the expression of the regulated luxICDAB genes, (5) which 
encode for luxCDE (light) and luxI. (6) Overexpression of luxI leads to an exponential increase of 
the synthase LuxI. 
 
The QS circuits of Gram-negative bacteria are in most circumstances similar to the 
ones found in Vibrio fischeri and contain at least two homologues of the LuxI and 
LuxR regulatory proteins. Some examples of different QS systems used by 
Gram-negative bacteria are shown in Table 1. Several insights can be gained by 
studying this data. First, some AHL signals are used by different bacteria. For 
example, Pseudomonas aeruginosa and Seratia liquefaciens both use C4-AHL as an 
AHL signal. The overlap of signals is interesting, because it means that bacteria that 
live in the same environment may use these signaling molecules for interspecies 
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communication. Furthermore, one AHL can act as the signaling molecule for more 
than one receptor within a single species (e.g., OHHL and the ExpR and CalR 
receptors in Erwinia carotovora). This feature could allow the bacteria to conserve 
valuable resources, or provide a means to carefully modulate the activity of receptors, 
for example, if one signaling molecule binds to two receptors with different affinities. 
 
Table 1: Representative AHL systems and their corresponding bacteria.  
Bacterium AHL Nomenclature LuxI/R  
Agrobacterium 
tumefaciens  
OOHL,  
3-oxo-C8-AHL 
TraI/R 
Burkholderia 
cenocepacia  
OHL, C8-AHL CepI/R 
Chromobacterium 
violaceum  
HHL, C6-AHL CviI/R 
Erwinia carotovora 
 
OHHL,  
3-oxo-C6-AHL 
ExpI/R; 
CarI/R 
Pseudomonas 
aeruginosa 
 
BHL, C4-AHL RhlI/R 
 
OdDHL,  
3-oxo-C12-AHL 
LasR/I; QscR 
Pseudomonas putida 
 
OdDHL,  
3-oxo-C12-AHL 
PpuI/R 
Serratia sp. ATC39006  
BHL, C4-AHL 
SmaI/R; CarRsma 
 
HHL, C6-AHL 
Seratia liquefaciens 
MG1 
 
BHL, C4-AHL 
SwrI/R 
 
HHL, C6-AHL 
Serratia marcescens 
AS-1 
 
OHHL, 3-oxo-C6-AHL 
SpnI/R 
 
HHL, C6-AHL 
Vibrio fischeri 
 
OHHL, 3-oxo-C6-AHL LuxI/R 
Vibrio harveyi 
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Even though the AHL system is predominantly used for bacterial communication, 
some evidence has been found that also plants and animals are able to recognize 
AHLs of symbiotic bacterial species.48 
 
2.4.1 AHL Biosynthesis 
As described in the previous section, AHLs are produced by a LuxI-type synthase 
and involves S-adenosyl methionine (SAM, XIV) and particular acyl carrier proteins 
(ACP) from lipid metabolism as shown in Figure 7.49 LuxI catalyzes acylation and 
lactonization reactions between the substrates SAM (XIV) and acyl-ACP (XV) 
followed by elimination of methylthioadenosine (MTA, XVI) to give AHLs (XVII). 
MTA (XVI) is a toxic byproduct, which is then cleaved in a second process by the 
nucleosidase enzyme Pfs into two nontoxic products, adenine and methylthioribose 
(MTR).50 A great diversity of AHLs is made possible due to the fact that acyl-ACPs 
are common intermediates in the biosynthesis of fatty acids.  
 
  
Figure 7: Biosynthesis of AHLs. 
 
 
                                                
48  (a) V. V. Kravchenko, G. F. Kaufmann, J. C. Mathison, D. A. Scott, A. Z. Katz, D. C. Grauer, M. 
Lehmann, M. M. Meijler, K. D. Janda, R. J. Ulevitch, Science 2008, 321, 259; (b) M. Cooley, S. R. 
Chhabra, P. Williams, Chem. Biol. 2008, 15, 1141; (c) A. G. Palmer, H. E. Blackwell, Nat. Chem. 
Biol. 2008, 4, 452. 
49  (a) Y. Jiang, M. Camara, S. R. Chhabra, K. R. Hardie, B. W. Bycroft, A. Lazdunski, G. P. Salmond, 
G. S. A. B. Stewart, P. Williams, Mol. Microbiol. 1998, 28, 193; (b) M. I. Moré, L. D. Finger, J. L. 
Stryker, C. Fuqua, A. Eberhard, S. C. Winans, Science 1996, 272, 1655. 
50  (a) B. L. Bassler, Cell 2002, 109, 421; (b) M. R. Parsek, D. L. Val, B. L. Hanzelka, J. E. Cronan Jr., 
E. P. Greenberg, Proc. Natl. Acad. Sci. USA 1999, 96, 4360; (c) M. I. Moré, L. D. Finger, J. L. 
Stewart, P. Williams, Mol. Microbiol. 1998, 28, 1655.	
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2.4.2 Synthetic AHLs 
The development of new synthetic AHL analogues has obtained large scientific 
interest in the last three decades due to two main reasons. On the one hand, the 
fundamental mechanisms involved in QS communication pathways were not known. 
On other hand, inhibition of QS (quorum quenching) by such synthetic signaling 
molecules could lead to new therapeutic strategies to inhibit bacterial virulence as an 
alternative to anti-bacterial approaches. Therefore, various research groups have 
designed and synthesized a large variety of AHL analogues, thereby modifying the 
lactone ring, the acyl side chain, or both. These compounds were tested with agonism 
or antagonism assays using absorbance (β-galactosidase fusion), fluorescence (green 
fluorescent protein (GFP)) or luminescence (luciferase fusion) to determine the ligand 
activity in AHL-LuxR-type complexes.51  
The first report of synthetic AHL analogues goes back to the year 1986 and was 
published by Eberhard et al.52 The special focus in this study was to investigate and 
determine the mechanism of action involved in QS pathways. With a small collection 
of about 20 AHL derivatives (XVIII and XIX, Figure 8), the researchers tested their 
compounds for the induction activity and for their ability to inhibit the action of the 
natural agonists in Vibrio fischeri B-61. The used bacteria served as a natural “dim” 
strain, since more light is produced with the addition of exogenous OHHL (XIII). The 
authors concluded that the γ-lactone and the length of the acyl side chain were crucial 
for LuxR activation with an optimal length of six carbon atoms. Longer side chains 
led to a switch from the role of agonist to antagonist. Furthermore, the presence of a 
carbonyl functionality at C-3 position was determined to be essential for strong 
agonistic activity. Modifications of this group led to a decrease or even complete 
vanish of the activity. The natural agonist OHHL (XIII) proved to possess the highest 
agonistic activity compared to the non-natural ones. However, it should be pointed out 
that all synthetic analogues were prepared as racemic mixtures, which most probably 
has an impact on the reported results. 
 
                                                
51  Review: G. D. Geske, J. C. O`Neil, H. E. Blackwell, Chem. Soc. Rev. 2008, 37, 1432. 
52  A. Eberhard, C. A. Widrig, P. McBath, J. B. Schineller, Arch. Microbiol. 1986, 146, 35.	
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Figure 8: Examples of synthesized racemic AHLs by Eberhard and co-workers.52  
 
The next study did not appear until a decade later, when, in 1996, Greenberg and 
co-workers presented their results on similar synthetic AHL analogues compared to 
the ones described by Eberhard but in non-racemic form of the γ-lactone ring (XX-
XXVIII, Figure 9).53 These analogues were tested using an E. coli reporter strain 
containing luxR but lacking functional luxI. The results were in agreement with the 
earlier findings and suggested that the γ-lactone moiety is important for LuxR 
binding. Most analogues with substitutions in the homoserine lactone ring (XXII, 
XXIV, and XXV) did not show evidence of binding to LuxR, except for 
homocysteine thiolactone XXI. Also the introduction of double (XXVI) and triple 
bonds (XXVII) in the side chain lowered the agonistic activity, suggesting that a 
flexible side chain is preferred for binding. Interestingly, substrates XX and XXIII 
were shown to possess weak agonistic activity.  
 
  
Figure 9: Structures of AHLs investigated by Greenberg and co-workers.53  
 
 
 
 
                                                
53  A. L. Schaefer, B. L. Hanzelka, A. Eberhard, E. P. Greenberg, J. Bacteriol. 1996, 178, 2897. 
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In 2002, Doutheau and co-workers prepared a series of AHL analogues with bulky 
substituent at the side chain terminus and retained 3-oxo functionality (XXIX-
XXXVII, Figure 10).54 Small substituents at C-5 position, such as cyclopropyl- 
(XXIX) or cyclohexyl-groups (XXX), were found to induce luminescence in Vibrio 
fischeri. In contrast, large substituents and aryl groups lead to the loss of agonistic 
activity or even antagonistic properties. 
 
 
Figure 10: Examples of sterically hindered AHLs studied by Doutheau and co-workers. IC50 values 
given for antagonists and EC50 values for agonistic substrates.54  
 
In the same year, Nielsen and co-workers expanded the substitution pattern by 
introducing different groups at C-3’ and C-4’ position of the lactone ring (XXXVIII-
XLIII, Figure 11).55 The synthetic analogues were tested in an E. coli JM105 strain, 
harboring the LuxR-type QS system of Vibrio fischeri. Substitution at C-4’ position 
(XLI, XLII and XLIII) led only to weak inhibition of QS. However, C-3’-substituted 
analogues XXXVIII and XXXIX showed agonistic activities in the range of the 
native ligand OHHL (XIII) and weak activity when R-configured and sterically not 
too demanding (XL).   
 
                                                
54  S. R. Everchon, B. Chantegrel, C. Deshayes, A. Doutheau, N. Cotte-Pattat, Bioorg. Med. Chem. 
Lett. 2002, 12, 1153. 
55  J. A. Olsen, R. Severinsen, T. B. Rasmussen, M. Hentzer, M. Givskov, J. Nielsen, Bioorg. Med. 
Chem. Lett. 2002, 12, 325.	
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Figure 11: AHL analogues studied by Nielsen and co-workers.55  
 
In later studies by the Doutheau group, a different approach was explored by using 
sulfoneamide (XLIV-XLVII, Figure 12) and urea side chains instead of amides 
(XLVIII-LI). 56  The racemic sulfonyl derivatives did not display any agonistic 
activities but were rather found to be potent LuxR inhibitors. Also the urea derivatives 
proved to be potent antagonists and the inhibitory effect appeared to be increasing 
with the hydrophobic character of the ligand.  
                                                
56  (a) S. Castang, B. Chantegrel, C. Deshayes, R. Dolmazon, P. Gouet, R. Haser, S. Reverchon, W. 
Nasser, N. Hugouvieux-Cotte-PAttat, A. Doutheau, Bioorg. Med. Chem. Lett. 2004, 14, 5145; 
(b) M. Frezza, S. Castang, J. Estephane, L. Soulère, C. Deshayes, B. Chantegrel, W. Nasser, Y. 
Queneau, S. Reverchon, A. Doutheau, Bioorg. Med. Chem. 2006, 14, 4781. 
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Figure 12: Examples of AHL-analogues prepared by Doutheau and co-workers. IC50 values given 
for antagonistic substrates.56  
 
The Blackwell group synthesized a combinatorial library of AHL analogues with 
the goal of establishing structure-activity-relationships in different bacterial strains.57 
The synthesized AHLs differed in the chain length, absolute configuration of the 
lactone, and substitution patterns on the acyl side chain (LII-LVI, Figure 13). Their 
studies on V. fischeri showed that phenylacetyl homoserine lactones (PHLs) are 
highly potent antagonists when an electron-withdrawing group is placed into the para 
position (LII, LIII and LIV). However, PHLs can be turned into LuxR agonists by 
relocating the electron-withdrawing groups from para to meta position. Thus, a 
10-fold higher activity compared to the native ligand OHHL (XIII) was observed 
when a nitro group was installed in meta position of the phenyl ring (LV). 
Compounds with opposite absolute configuration at the lactone ring or with indole, 
furane, and thiophene substituents did not show any activity in the biological assays. 
 
                                                
57  (a) G. D. Geske, R. J. Wezeman, A. P. Siegel, H. E. Blackwell, J. Am. Chem. Soc. 2005, 127, 
12762; (b) G. D. Geske, J. C. O`Neill, D. M. Miller, M. E. Mattmann, H. E. Blackwell, J. Am. 
Chem. Soc. 2007, 129, 13613; (c) G. D. Geske, J. C. O`Neill, D. M. Miller, M. E. Mattmann, Q. 
Lin. R. J. Wezeman, H. E. Blackwell, ChemBioChem 2008, 9, 389; (d) G. D. Geske, J. C. O`Neil, 
H. E. Blackwell, ACS Chem. Biol. 2007, 2, 315. 
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Figure 13: AHL analogues tested for QS activity in Vibrio fischeri by Blackwell and co-workers. 
IC50 values given for antagonists and EC50 values for agonistic substrates.57  
 
Later studies by Iglewski,58 Kline,59 Suga,60 Kato,61 and Blackwell57 focused on the 
QS system of the pathogenically highly relevant strain P. aeruginosa. These studies 
concluded that a certain chain length is important for LasR binding and that the 3-oxo 
group increases agonistic activity but was not essential for binding. Furthermore, the 
γ-lactone moiety could be replaced by five- or six-membered rings bearing a similar 
hydrogen bond acceptor motif for activation.  Exchange of the γ-lactone by an 
aromatic ring with a hydrogen bond acceptor capability resulted in QS inhibition. 
Last, sterically bulky and structurally diverse acyl groups were tolerated by LasR due 
to a large ligand-binding site.  
More recently, the research groups of Janda62 and Maison63 have been focusing on 
the synthesis of clickable AHL analogues (Figure 14). Both groups reported on the 
preparation on either azide (LVII) or alkynyl functionalized (LVIII) AHLs at the 
terminus of the acyl side chain. Even though in vitro binding to the QS receptors 
could be observed in both cases, it remains to be shown that such analogues have the 
potential to be applied for in vivo studies. 
 
                                                
58  L. Passador, K. D. Tucker, K. R. Guertin, M. P. Journet, A.S. Kende, B. H. Iglewski, J. Bacteriol. 
1996, 178, 5995. 
59  T. Kline, J. Bowman, B.H. Iglewski, T. de Kievit, Y. Kakai, L. Passador, Bioorg. Med. Chem. Lett. 
1999, 9, 3447. 
60  (a) K. M. Smith, Y. Bu, H. Suga, Chem. Biol. 2003, 10, 81. (b) K. M. Smith, Y. Bu, H. Suga, Chem. 
Biol. 2003, 10, 563-571. c) G. J. Jog, J. Igarashi, H. Suga, Chem. Biol. 2006, 13, 123. 
61  T. Ishida, T. Ikeda, N. Takiguchi, A. Kuroda, H. Ohtake, J. Kato, Appl. Environ. Microbiol. 2007, 
73, 3183. 
62  A. L. Garner, J. Yu, A. K. Struss, C. A. Lowery, J. Zhu, S. K. Kim, J. Park, A. V. Mayorov, G. F. 
Kaufmann, V. V. Kravchenko, K. D. Janda, Bioorg. Med. Chem. Lett. 2011, 21, 2702. 
63  H. Thomanek, S. T. Schenk, E. Stein, K.-H. Kogel, A. Schikora, W. Maison, Org. Biomol. Chem. 
2013, 11, 6994.	
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Figure 14: Clickable AHL derivatives.62,63  
 
The results obtained in analogue studies by these groups established five activity 
trends:51 
1. The length of the acyl side chains is crucial for QS activity. Chains with a 
similar length as the natural AHL have increased activity. 
2. The presence of an oxo-group at C-3 position is important but not essential 
for activity. 
3. The configuration of the lactone ring is critical for recognition. 
4. The lactone ring can be replaced by different cyclic groups carrying 
hydrogen bond acceptors. Modifications of the lactone moiety are accepted 
but generally lead to decreased activity. 
5. Aromatic substituents at the end of the acyl side chains result in 
antagonistic activity. 
 
2.4.3 AHL Reporter Strains 
Synthetic AHLs possess the potential to modulate bacterial behavior by interacting 
with the QS pathways. A reliable readout from biological assays is however essential 
in order to discover new modulators. Screening for molecules that inhibit QS (quorum 
quencher) scan for repressed phenotypes typically induced by QS, such as biofilm 
formation. However, what is often not studied in detail is the fact that QS activation 
and quenching highly depends on the added concentration of the substrate. This 
means that an agonist also possesses antagonistic activity at high concentrations. 
Unless biological evaluations have not been performed over a wide concentration 
range, a substrate should not be determined as a quorum quencher.  
In order to overcome the problems associated with the biological evaluations of 
quorum quenchers, we decided to focus our interest on finding new AHL mimics. The 
induction of QS can be monitored using GFP-tagged biosensors as described by Eberl 
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and co-workers.64 The advantage of such a sensor is the simple read-out, which can be 
realized by measuring the emitted fluorescence. To facilitate our screening efforts, we 
decided to focus on two sensors containing either pAS-C8 or pKR-C12 plasmids. 
These sensors are especially interesting for pathogenic reasons as they contain the QS 
receptors of Burkholderia cenocepacia and Pseudomonas putida, respectively.  
The biosensors consist of Pseudomonas putida strains containing either pAS-C8 or 
pKR-C12 plasmids (Figure 15). The pAS-C8 plasmid was incorporated in a P. putida 
ISO F117 wild-type strain in which the natural QS systems was replaced by a GFP-
based system. This QS system is based on the cep genes of B. cenocepacia and 
contains a translational cepI-gfp fusion and a cepR receptor under control of Plac. This 
means that CepR is expressed in the cells, but not CepI, which was replaced by a 
GFP-synthase. Therefore, this sensor is able to detect AHLs, but in contrast to natural 
conditions, it does not produce AHLs by itself. The strain produces GFP upon binding 
of AHLs to the receptor, which can be measured due to produced fluorescence. This 
sensor is most sensitive for OHL and DHL as shown in Table 1. 
 
  
Figure 15: Schematic drawing of the las- and cep-based AHL sensor plasmids.64  
 
The second biosensor is also a P. putida ISO F117 wild-type strain that contains a 
pKR-C12 plasmid. This sensor is based on a translational fusion of lasB elastase 
genes of P. aeruginosa to GFP and the lasR receptor under control of a lac-type 
promoter. LasR is one out of three QS receptors used by P. aeruginosa and is 
especially sensitive to the natural AHL OdDHL. 
The advantage of such biosensors is the lack of AHL production by the bacteria 
since their synthase genes are knocked out and therefore AHLs need to be added 
externally for a response. Furthermore, quantitative measurements are feasible since 
the induced GFP fluorescence correlates to the concentration of the modulators.    
                                                
64  K. Riedel, M. Hentzer, O. Geisenberger, B. Huber, A. Steidle, H. Wu, N. Høiby, M. Givskov, S. 
Molin, L. Eberl, Microbiology 2001, 147, 3249. 
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mob GmR rep
pKR-C12
mob GmR rep
cepR gfp (ASV)
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2.5 QS in Gram-Positive Bacteria 
QS communication is not restricted to Gram-negative bacteria, but is also used by 
Gram-positive bacteria.65 However, in the later case, the communication is primarily 
mediated by chemically modified oligopeptides in a two-component signal-
transduction cascade.30,66 These so called autoinducing peptides (AIPs) range from 5 
to 17 amino acids in length and are impermeable to biological membranes. Therefore, 
AIPs are unable to diffuse into and out of cells. This is carried out by specialized 
secretion transporters, which are usually connected with signal release. As it is the 
case for Gram-negative bacteria, the concentration of secreted peptides increases as a 
function of the cell-population density. One major difference between the AHL 
mediated and the oligopeptide-based QS systems is the location of the cognate 
receptors. LuxR-based receptors are cytoplasmic, whereas AIP receptors are 
membrane-bound. Each species produces a unique sequence for a peptide signal since 
AIPs are genetically encoded in contrast to Gram-negative bacteria where AHLs can 
be recognized by multiple species. In Staphylococcus aureus, for example, four 
different AIPs have been found leading to four subtypes of this species. Each AIP 
must bind to its corresponding receptor to produce signaling interactions. Interactions 
between AIPs and non-cognate receptors result in quorum quenching due to 
competitive binding. However, all AIPs belong to the histidine kinase protein family 
and therefore, they share overall homology.50  
The signaling pathway (Figure 16) is different from the one used by Gram-
negative bacteria. The initially synthesized peptides are posttranslationally modified 
by the secretion transporter AgrB by incorporation of lactone and thiolactone rings, 
lanthionines, and isoprenyl groups.26,28,39 As in AHL QS systems, AIPs accumulate in 
the extra-cellular space until the minimal concentration is reached. The signaling 
peptides are then recognized by a membrane-bound two-component histidine kinase 
receptor AgrA and stimulate its intrinsic autophosphorylation activity. This results in 
an ATP-driven phosphorylation of a conserved histidine residue in the cytoplasm 
(H in Figure 16). The phosphoryl group is transferred to an aspartate residue of the 
cognate response regulator ArgC. The activated receptor regulates gene transcription 
by inducing the expression of a regulatory RNA. A positive feedback loop is mostly 
                                                
65  I. Joint, J. A. Downie, P. Williams, Phil. Trans. R. Soc. B. 2007, 362, 1115. 
66  C. Fuqua, E. P. Greenberg, Nature Rev. Mol. Cell Biol. 2002, 3, 685.	
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accompanied by this event by stimulation of the AIP precursor synthase, similar to the 
one described in the previous section for Gram-negative bacteria. 
 
  
Figure 16: AIP dependent QS pathway. (1) argD (not shown) encodes a propeptide, (2) which is 
processed and actively exported by AgrB. (3) Mature AIPs interact with the sensor kinase AgrA, 
(4) leading to the phosphorylation of the response regulator ArgC, (5) which in turn activates the 
expression of regulated genes. 
 
2.6 AI-2 Mediated Pathway 
QS was for a long time thought to be a communication system exclusively used 
within one bacterial strain. In was only in 1994 when Bassler et al. found a different 
signaling molecule, which could regulate bioluminescence in Vibrio harveyi.67 The 
identified compound was not structurally related to AHLs and so the authors 
postulated that a different pathway must be involved, which was termed autoinducer 2 
(AI-2). The protein responsible for the synthesis of AI-2 is LuxS, which is encoded by 
luxS and is found in both Gram-positive and Gram-negative bacteria.68 This finding 
suggests that AI-2 may connect the two major classes of QS systems by acting as the 
universal language. AI-2 mediated QS systems have been shown to control 
                                                
67  B. L. Bassler, M. Wright, M. R. Silverman, Mol. Microbiol. 1994, 13, 273. 
68  M. G. Surette, M. B. Miller, B. L. Bassler, Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 1639.	
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pathogenicity in Escherichia coli, Salmonella typhimurium and Vibrio cholerae and is 
also known to influence bacterial fitness.69 
 To date, two different AI-2 ligands have been identified, namely R-THMF (LIX) 
and S-THMF-borate (LX).70 Interestingly, both signaling molecules are derived from 
the common intermediate 4,5-dihydroxy-2,3-pentanedione (DPD, LXI) as shown in 
Scheme 1.71 The small metalloenzyme LuxS is involved in the activated methyl cycle, 
which is responsible for the production of DPD (LXI). The produced LXI can 
undergo spontaneous rearrangements and exists in equilibrium with its two isomers, 
which depending on the bacterial species can be found in one or the other form. 
Different species of bacteria recognize distinctly rearranged DPD moieties, thereby 
allowing them to respond to AI-2 derived from their own DPD and also to that 
produced by other bacterial species.39 This phenomenon enables the possibility for 
interspecies communication in the natural environment. Even though only two AI-2 
signaling molecules have been discovered to date (LX from Vibrio harveyi and LIX 
from Salmonella enterica serovar Typhimurium), over 55 types of bacteria are known 
to possess LuxS homologues. 
 
   
Scheme 1: Isomerization of DPD (LXI) to the resulting AI-2 molecules LX and LXI. DPD (LXI) 
undergoes various rearrangements and additional reactions to form distinct biological active AI-2 
signal molecules. 
 
Some species, like Vibrio harveyi, took advantage of this feature by being able to 
monitor their own and the surrounding population density in mixed cultures.27 AI-2 
mediated interactions could occur in natural alcoves, and furthermore, eukaryotes 
                                                
69  (a) B. L. Bassler, Curr. Pin. Microbiol. 1999, 2, 582; (b) A. Vendeville, K. Winzer, K. Heurlier, C. 
M. Tang, K. R. Hardie, Nat. Rev. Microbiol. 2005, 3, 383. 
70  X. Chen, S. Schauder, N. Portier, A. Van Dorsselaer, I. Pelezer, B. L. Bassler, F. M. Hughson, 
Nature 2002, 415, 545. 
71  K. B. Xavier, B. L. Bassler, Nature 2005, 437, 750.	
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could profit from these signaling manipulations by developing particular associations 
with bacteria that use or interfere with AI-2 mediated communication. 
The exact regulation mechanism of luxS and LuxS is not yet fully understood and 
therefore, it is not possible to assign a specific role for AI-2.72 However, it has been 
shown that inactivation of luxS in several pathogenic strains affected important 
functions for virulence, such as biofilm production, motility, and toxin production.73
 
                                                
72  S. C. J. De Keersmaecker, K. Sonck, J. Vanderleyden, Trends Microbiol. 2006, 14, 114. 
73  A. Venderville, K. Winzer, K. Heurlier, C. M. Tang, K. R. Hardie, Nat. Rev. Microbiol. 2005, 3, 
383.	
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3 Catechol-Based Immobilization of QS Modulators 
3.1 Health Care-Associated Infections 
Nosocomial infections still remain a major problem for patients worldwide and are 
rising at an alarming rate.74 Among those, bacterial infections of implant materials 
and devices, such as catheters and stents, pose a major threat on the quality of life of 
those affected.75 Recent studies showed that almost half of all nosocomial infections 
are caused by such device-associated infections.76 The likeliness of an early stage 
infection has much been ameliorated by improved procedures in sterilization, proper 
hygiene, and operating techniques.77 However, infections occurring weeks or months 
after surgery have barely decreased.  
Bacteria possess the ability to attach themselves to biomedical implants and 
thereby trigger infections in the host organism. Such infections are usually not 
detected before some damage has occurred to tissue of the host organism. After 
adherence of the intruders, the microorganisms grow and accumulate in multilayered 
cell clusters, thereby forming biofilms, which are considered to be the first steps in 
nosocomial infections.78 In this state, bacteria defend themselves against the host’s 
innate immune system by forming an exocellular polysaccharide matrix, which also 
protects them from antibiotics. When bacteria exist as a biofilm, they can become 
10-1000 times more resistant to the effects of a direct systemic treatment with 
antibiotics.79 The likelihood of a successful treatment is furthermore complicated by 
                                                
74  (a) P. W. Stone, D. Braccia, E. Larson, Am. J. Infect. Control 2005, 33, 501; (b) D. Cardo, T. 
Horan, M. Andrus, M. Dembinski, J. Edwards, G. Peavy, J. Tolson, D. Wagner, Am. J. Infect. 
Control 2004, 32, 470; (c) L. L. Leape, T. A. Brennan, N. Laird, A. G. Lawthers, A. R. Lacolio, B. 
A. Barnes, L. Hebert, J. P. Newhouse, P. C. Weiler, H. Hiatt, N. Engl. J. Med. 1991, 324, 377.  
75  (a) J. L. Del Pozo, R. Patel, N. Engl. J. Med. 2009, 361, 787; (b) W. Zimmerli, A. Trampuz, P. E. 
Ochsner, N. Engl. J. Med. 2004, 351, 1645. 
76  (a) R. O. Darouiche, Int. J. Artif. Organ 2007, 30, 820; (b) B. Foxman, Am. J. Med. 2002, 113, 5S; 
(c) K. L. Garvin, A. D. Hanssen, J. Bone Jt. Surg. Am. Vol. 1995, 77, 1576; (d) N. Rao, G. L. 
Soxman, Op. Techn. Orthop. 2002, 12, 131; (e) S. Saint, C. E. Chenoweth, Infect. Dis. Clin. North 
Am. 2003, 17, 411; (f) J. W. Warren, Med. Clin. North Am. 1991, 75, 481. 
77  C. Muto, C. Herbert, E. Harrison, J. R. Edwards, T. Horan, M. Andrus, J. A. Jernigan, P. K. Kutty, 
MMWR 2005, 54, 1013. 
78  (a) J. M. Higashi, I.-W. Wang, D. M. Shlaes, J. M. Anderson, R. E. Marchant, J. Biomed. Mater. 
Res. 1998, 39, 341; (b) K. M. Cunnion, J. C. Lee, M. M. Frank, Infect. Immun. 2001, 69, 6796. 
79  (a) T.-F. C. Mah, G. A. O’Toole, TRENDS Microbiol. 2001, 9, 34; (b) H. S. Gold, R. C. Moellering, 
N. Engl. J. Med. 1996, 335, 1445; (c) J. M. Rodriguez-Martinez, A. Pascual, Rev. Med. Microbiol. 
2006, 17, 65; (d) A. J. J. Wood, H. S. Gold, R. C. Moellering, N. Engl. J. Med. 1996,  335, 1445.	
  	
  
    CHAPTER 3 30 
the rise of resistant bacterial strains.80 As a result, current treatment usually requires 
surgical replacement of the infected devices, combined with a prolonged intravenous 
and oral administration of antibiotics.81 The outcome of such complications is not 
only additional costs to the health care system, but most importantly suffering of the 
patients and occasionally their death. It has been estimated that biofilms are 
associated with 65% of nosocomial infections. 82  Therefore, about 30% of the 
hospitals in the US are using antimicrobial catheters to prevent hospital-acquired 
urinary tract infections.83 In these cases, the release of silver ions is mostly used to 
prevent infections. The usage of silver containing medical devices should however be 
undertaken with caution since recent studies demonstrated that silver exhibits a 
certain level of toxicity to mammalian cells. 84  Furthermore, the extensive and 
uncontrolled use of silver-containing products may result in more bacteria evolving 
resistance,85 and the clinical efficiency of silver-coated catheters is controversial.86  
The urgent need for new bioactive surfaces that can prevent infections of implants 
has driven many research groups to seek for alternatives. Many different techniques 
have been established in recent years for the coating of biomedical devices. Some of 
the approaches include biopassive and bioactive surfaces, with either a covalently 
attached bioactive moiety or one that is released into the surrounding area. Our special 
interest goes to the use of a biomimetic coating strategy inspired by the strong 
adhesion of mussels, which will be discussed in more detail in following section.  
 
 
 
                                                
80  (a) J. P. Burke, N. Engl. J. Med. 2003, 348, 651; (b) J. W. Costerton, Science 1999, 284, 1318; (c) 
C. Walsh, Nature 2000, 406, 775; (d) J. W. Costerton, P. S. Stewart, E. P. Greenberg, Science 1999, 
284, 1318. 
81  A. S. Lynch, G. T. Robertson, Annu. Rev. Med. 2008, 59, 415. 
82  L. K. Archibald, R. P. Gaynes, Infect. Dis. Clin N. Am. 1997, 11, 245.  
83  S. Saint, C. P. Kowalski, S. R. Kaufman, T. P. Hofer, C. A. Kauffman, R. N. Olmsted, J. Forman, J. 
Banaszak-Holl, L. Damschroder, S. L. Krein, Clin.  Infect. Dis. 2008, 46, 243. 
84  (a) L. Braydich-Stolle, S. Hussain, J. J. Schlager, M. C. Hofmann, Toxicol. Sci. 2005, 88, 412; (b) J. 
M. Schierholz, J. Beuth, G. Pulverer, Am. J. Med. 1999, 107, 101. 
85  S. Silver, FEMS Microbiol. Rev. 2003, 27, 341. 
86  J. M. Schierholz, N. Yucel, A. F. E. Rump, J. Beuth, G. Int. J. Antimicrob. Agents 2002, 19, 511.	
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3.2 Bioinspired Adhesion 
The adhesion of bioactive molecules to surfaces has been explored by numerous 
research groups. Especially the preparation of self-assembled monolayers (SAMs) has 
attracted significant attention in this field since their introduction in 1980.87 SAMs are 
formed by the adsorption of compounds from solution or from the gas phase onto a 
surface. Many different functional groups, such as thiols, 88  silanes, 89  and 
phosphates, 90  have been established as anchoring moieties for gold and silver 
surfaces, glass surfaces or various metal surfaces, respectively. However, there has 
been a limitation that the binding chemistry to be applied is determined by the surface 
chemistry of the substrate materials. Therefore, surface binding anchoring groups with 
wide substrate applicability, easy handling, long-term stability and inertness towards 
environmental conditions are still highly desired. 
Recently, catechols have been described as a promising alternative for the use as a 
mild, rapid, and efficient functionalization of metal and metal oxide surfaces by 
convenient dip-and-rinse protocols.91 The development of catechols as molecular 
anchors has been inspired by the adhesive properties of marine and freshwater 
mussels to all kind of surfaces (Figure 17).92 The extremely strong wet adhesion of 
mussels relies on the production of mussel adhesive proteins (MAPs), which are 
secreted by the marine organisms.92b,93 The key constituent for adhesion of MAPs has 
been shown to be the posttranslationally modified amino acid 3,4-dihydroxyphenyl-L-
alanine (DOPA, LX), which makes up about 27% of all amino acids.92a  
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Figure 17: Mussels secrete proteins for adherence to surfaces, such as TiO2. 
 
The research groups of Waite,91a Grätzel,91b Messersmith/Textor,91c-f Wilker,94 and 
Xu 95  demonstrated the benefits of catechols as anchoring moieties for the 
functionalization of surfaces. Their findings lead to the establishment of many 
different bioactive applications. 96  Catechol derivatives have been studied and 
compared for their binding capacities (LX-LXV, Figure 18). Dopamine (LXI) and 
L-DOPA (LX) exhibit strong binding capacity, but these moieties can easily be 
oxidized and polymerize, rendering their handling and storage problematic.97 More 
stable catechol moieties can be found in nature, such as, for example, the anachelin 
chromophore (LXII), a cyanobacterial siderophore.98 These bacteria use anachelin to 
bind and sequester iron, since iron can become a growth-limiting nutrient in marine 
environment due to its very low bioavailability.99  The chromophore contains a 
quaternary ammonium substituent that renders this compound oxidatively more stable 
than dopamine (LXI). Additionally, the positive charge increases the affinity of this 
anchor towards negatively charged surfaces. Even superior binding properties to 
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metal oxides are exhibited by this anchoring moiety.100 Nonsubstituted catechols 
possess the disadvantage of being easily oxidized and polymerized, which is not 
beneficial for the stability of adsorbed monolayers. These limitations can be overcome 
by introducing a substituent in the aromatic ring. The purely chemical derivative 
nitro-catechol (LXIV) demonstrated excellent binding properties, which could be 
derived from the significantly lower pKa of its catechol hydroxyl group as a 
consequence of the strong electron withdrawing NO2 group.97a Although this anchor 
possesses slightly weaker binding properties than the anachelin chromophore, it is 
synthetically readily accessible as it can be prepared in a single step from the 
commercially available and inexpensive dopamine, whereas LXII requires multiple 
synthetic steps, involving heavy-metal-based101 or enzymatic102 conversions.  
 
  
Figure 18: Catechol-based molecular anchors. 
 
Although catechols have been known to be the only functional element required 
for adhesion and cross-linking, the exact adhesion mechanism is not yet fully 
understood. Two different coordination schemes were recently proposed for dopamine 
binding to metal cations of metal oxide surfaces (Figure 19).97a,103 One possible 
coordination comprises monodentate binding, in which one of the two catechol 
hydroxyl groups dissociates and binds to a metal cation and the second one forms 
hydrogen bond to the next catechol neighbor or hydroxyl group on the metal oxide 
surface. The second coordination mode is the mixed monodentate-bidentate, where 
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both hydroxyl groups dissociate and become coordinated to two adjacent metal 
cations.  
  
Figure 19: Two possible coordination modes of nitro-dopamine (LXIV) adsorbed on TiO2: (I) 
monodentate binding with a hydrogen bridge to a neighboring surface hydroxide and (II) bidentate 
binding.103  
 
Dopamine and its derivatives could be used for the coating of most metal oxide 
surfaces. Nevertheless, we were particularly interested in the functionalization of 
titanium dioxide (TiO2) since this metal oxide has been shown to be biocompatible 
and is also frequently applied in the field of medical devices.104  
 
3.3 Catechol-Based Coating Strategies 
Much effort has been devoted to the creation of surfaces that can prevent bacterial 
infections, especially in the preparation of either antifouling or antibacterial surfaces. 
The following sections will present the latest achievements in this field based on 
catechol-derived adsorption on TiO2 surfaces. 
3.3.1 Antifouling Coating 
Biofouling has been defined as the nonspecific attachment of proteins, 
carbohydrates, and microorganisms onto surfaces upon their immersion in biological 
fluids.105 Once a surface has been covered with proteins, it can easily be colonialized 
by bacterial populations.78 Therefore, antifouling materials have been the subject of 
much interest and extensive research in recent years.106 Much effort has been made 
for the development of thin polymer coatings by a number of techniques e.g. plasma 
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polymerization.107 The efficiency of such a coating strategy strongly depends on 
various parameters, such as substrate and polymer type, adsorption time, pH, 
temperature, solvent choice, and polymer concentration, thereby hampering a facile 
design of the polymer. Molecular self-assembly systems can overcome these 
problems by forming well controlled, structurally defined interfaces.  
The prevention of bacterial adhesion can be achieved by the formation of 
biopassive surfaces that decrease the direct contact between the microorganisms and 
the surface. Polyethylene glycol (PEG) has been shown to possess antifouling 
properties on the surface of various materials.108 Various techniques have been 
adapted for this purpose. All these approaches using PEG-coated biomaterials were 
shown to drastically decrease the amount of adsorbed proteins due to the formation of 
an interfacial layer without directly interfering with the bacteria.  
Catechols can offer the perfect anchoring properties as already described in the 
previous section. The key advantage of such a system is the facile functionalization of 
the surface, which can be achieved by a simple dip-and-rinse procedure in aqueous 
solutions.97, 109  The combination of the binding properties of catechols and the 
antifouling properties of PEG was previously realized in the Gademann research 
group. Various catechol-based anchors were conjugated to a PEG unit to provide 
coating agents LXVI-LXIX as shown in Figure 20.97a, 110  These hybrids were 
adsorbed onto TiO2 plates and tested for their antifouling properties. A remarkable 
reduction of the protein adlayer thickness of over 95% was observed upon exposure to 
full human serum in comparison to untreated control surfaces. This strategy enabled 
the formation of a stable, protein-resistant adlayer. The best results were obtained 
with anachelin and the nitro-dopamine derivatives LXVI and LXVII, respectively. 
These two entities proved to be particularly useful due to the excellent binding 
strength of the anchor moiety and the oxidative stability when compared to other 
dopamine derivatives.  
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Figure 20: PEG-catechol derivatives as antifouling agents.97a,111 
 
Antifouling surfaces have an enormous potential for industrial applications and 
especially for marine transportation techniques.111 However, in terms of preventing 
bacterial infections, an approach that exhibits bactericidal properties would be 
advantageous. Therefore, alternative strategies that can actively alter bacterial 
behavior have been explored.  
 
3.3.2 Antibacterial Coating 
An appealing strategy to actively interact with bacteria is the incorporation of 
active biocides into the implant material or their adsorption onto the surface.104b,112 
Such antibiotic surfaces possess the ability to actively combat bacteria upon exposure, 
in contrast to antifouling surfaces. The mode of action can either be by slow release of 
the active compound into the local tissue or by killing upon contact with the 
bacteria.113 The major advantage of this approach is the high local concentrations of 
antibiotics at the surface interface, therewith maximizing impact and minimizing 
undesired side effects.114 Customary antimicrobials that have been incorporated into 
such materials include antibiotics, 115  antibodies, 116  and nitric oxide. 117  Default 
procedures for the immobilization of antibiotics usually requires multiple chemical 
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steps on the solid surface and scale-up of these processes can be challenging.118 These 
disadvantages could be circumvented by the preparation of coated implant surfaces 
via simple dip-and-rinse procedures. This was achieved by linking vancomycin, a 
well-studied antibiotic agent frequently used against bacterial infections, to the 
anachelin chromophore via a PEG chain (Figure 21).119 This natural product hybrid 
LXX possesses three important features: strong binding capacity to metal oxide 
surfaces due to the anachelin chromophore moiety, antifouling character of the PEG 
linker in order to prevent bacterial adhesion onto the surface, and antiseptic properties 
against Gram-positive bacteria due to the antibiotic vancomycin. 
 
  
Figure 21: Antibacterial coating agent.120  
 
Biological evaluation of the treated surfaces against Bacillus subtilis showed that 
the desired antibacterial properties could be retained on the surface. In addition, 
recycling of the used surfaces proved to be successful, as they could be rinsed with 
water and reused without loss in antimicrobial activity.  
The application field for such antibiotic surfaces might even be expanded by 
combining different antibiotics on biomedical surfaces. Even though it could be 
shown that bacterial populations can be reduced by exposure to such surfaces, further 
investigations are required in order to test if resistances of bacteria are developed 
upon exposure and if accumulation of bacterial biomass on the coated surface will 
lead to reduction of its antimicrobial activity over a long period of time. The major 
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concern with this approach is the rise of resistant bacterial strains, which might even 
be accelerated by misuse of antibiotics.  
 
3.4 QS Modulating Coating 
The previously described approaches are characterized by specific drawbacks that 
hamper the application as effective inhibitors of bacterial infections on surface 
implants. The scope of the present thesis consists of a completely different approach 
to prevent biofilm formation, namely by inhibition of QS.120 Extracellular polymer 
production, surface attachment, sporulation, and the secretion of virulence factors are 
only few examples of functions that are controlled by QS in various bacterial 
populations. This means that interfering with the QS system represents an alternative 
approach to inhibit biofilm development. 
Many organisms have found and developed ways to protect themselves from 
bacterial infections. It is therefore no surprise that some examples of antibiofilm 
strategies based on the inhibition of QS communication pathways can be found in 
nature. One of the most fascinating examples can be found in Delisea pulchra, a 
native red algae of southeastern Australia.121 This microorganism has the ability to 
store anti-QS substances in vesicles situated on the outside of the algae to inhibit 
bacterial colonization. The active compounds secreted by the algae are composed of a 
range of halogenated furanones named fimbrolides. Based on these findings, several 
research groups have investigated various synthetic methods to immobilize furanones 
on polymer materials to inhibit biofilm formation. 122  The drawback of these 
approaches is the cytotoxic and mutagenic properties expressed by such furanones, 
which limits their practical applications.123 
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More recent immobilization strategies are based on the molecular interference with 
QS pathways for the prevention and eradication of bacterial biofilms.124 Blackwell 
and co-workers demonstrated a first approach by achieving controlled release of 
non-native QS modulators from thin PLG films.125 However, we focused on preparing 
coated TiO2 surfaces bearing covalently bound QS modulators. Based on the previous 
results obtained in our research group, we envisaged attachment of a QS modulator to 
a dopamine-based molecular anchor. A large variety of different AHL analogues with 
different chain lengths and substituents at the terminus of the acyl side chain were 
prepared in the Gademann research group (Figure 22).126 Preliminary screening with 
the AHL biosensor strain C. violaceum CV026127 showed that hybrids bearing a C12 
linker were able to induce QS. Especially two out of these hybrids caught our 
attention, namely the dopamine and the anachelin chromophore hybrids LXXI and 
LXXII. Compounds with shorter alkyl linker (LXXIII) did not show any QS 
modulating properties. Interestingly, hybrid LXXIV bearing biotin at the alkyl chain 
terminus revealed no agonistic properties in contrast to its dopamine counterparts. 
This observation might arise from steric hindrance induced by the biotin moiety. 
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Figure 22: AHL analogues previously prepared.127 
 
These initial findings suggested that AHLs bearing a catecholic moiety at the 
terminus and a chain of twelve carbon units may be used for the coating of TiO2 
surfaces, providing that the molecular anchor is sterically not too bulky. The synthetic 
and biological results obtained in our further studies will be discussed in the following 
section. 
 
3.5 Results and Discussion128 
3.5.1 Synthesis of the Nitro-Dopamine Containing QS Modulator  
A first challenge consisted in finding a more suitable surface anchor moiety that 
remains to be recognized by the bacteria as QS modulator. The previously shown 
hybrids were either not stable to oxidative conditions or require multiple synthetic 
steps. Therefore, we envisaged using nitro-dopamine as the binding group since this 
moiety has been shown to bind strongly to several metal oxides. Furthermore, it can 
be used for the generation of SAMs using a simple dip-and-rinse procedure.  
The bioactive moiety was chosen to be the native AHL as used by Gram-negative 
bacteria. The length of the linker had been shown to be crucial. Hybrids bearing other 
linker sizes did not lead to QS induction, even at high concentrations. The synthesis of 
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the target molecule 1 is shown in Scheme 2 and could be achieved in only three 
chemical steps from commercial dodecandioic acid (2) in an overall yield of 72%. 
The purification proved to be cumbersome, since no separation of the desired product 
could be achieved by using flash chromatography on silica gel. A high purity was 
obtained by using size exclusion chromatography on Sephadex LH-20 with methanol 
as the mobile phase.  
 
 
Scheme 2: a) NSC, pyridine, MeCN, r.t., 7 h, quant.; b) nitro-dopamine, Et3N, THF/DMSO, r.t., 
20 h; c) (S)-α-amino-γ-butyrolactone hydrobromide, Et3N, THF/DMSO, r.t., 20 h, 72% over two 
steps. 
 
The purified hybrid was then incubated with the two GFP-based biosensors P. 
putida Iso F117 pAS-C8 and pKR-C12. We were pleased to see that fluorescence 
could only be observed in the pAS-C8 strain, as we were hoping to get selectivity for 
this sensor. The activation levels were similar to the ones achieved by using 
N-octanoyl-L-homoserine lactone (C8-AHL), for which it is most sensitive. After 
having established that compound 1 was able to interfere with QS in a liquid based 
assay, we wanted to evaluate its activity after immobilization on surfaces.  
 
3.5.2 Immobilization on TiO2 Beads 
TiO2 served as the perfect surface material for our purposes as this metal oxide is 
widely used for orthopedic and dental implants due to its biocompatibility.104 As we 
were uncertain about the possible mode of action, we decided to use small TiO2 beads 
with a diameter of either 1 or 44 µm. The use of beads allowed for the monitoring of 
the exact position of the QS-active bacteria. The immobilization was performed with 
a modified procedure, since dipping and rinsing is not practicable with such small 
particles. Thus, the beads were incubated in a dilute solution of 1 in high salt buffer 
(0.1 M MOPS/0.6 M NaCl/0.6 M K2SO4) for 4 hours at 50 °C and subsequently 
centrifuged. The obtained beads were then washed with water to remove the 
remaining salts and unattached hybrids. Next, the resulting beads were incubated with 
the biosensor P. putida F117 (pAS-C8) and again GFP fluorescence could be induced. 
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These results demonstrate that the bioactive properties of the hybrids can be 
transferred to the metal oxide surface. 
We then wondered if the immobilized hybrids could be removed from the beads by 
sequential washing operations. Therefore, the beads were washed up to ten times with 
water and evaluated again as shown in Figure 23. Remarkably, no discrepancy in the 
biological activity could be observed upon repeated rinsing by measuring the GFP 
levels in the pAS-C8 reporter strain. The retained activity can be attributed to the 
strong binding capacity of nitro-dopamine and demonstrates its potential for 
biological applications. 
 
 
Figure 23: Induced GFP fluorescence after repeated washing of the beads (0.6 mg mL-1) compared 
to the sensor as the negative and C8-AHL as the positive control (0.3 µM). 
 
The next point we needed to address was the mode of action of the functionalized 
beads. The advantage of using beads instead of larger surfaces is the possibility to 
determine if QS is induced exclusively at the surface or in the entire bacterial 
population by fluorescence microscopy. Therefore, the functionalized beads were 
again incubated for two hours with the pAS-C8 biosensor strain along with a positive 
and a negative control. The negative control experiment was performed without 
addition of an inducer and no fluorescence could be detected as expected (Figure 24 A 
and B). Incubation with hybrid 1 served as the positive control for this experiment and 
the reporter strain produced GFP (C and D). The incubated functionalized beads 
showed to induce QS in the entire bacterial population similarly to the free 
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modulators (E and F). These findings showed that the microorganism do not adhere to 
the activated surfaces, thereby suggesting a different mechanisms of action. One 
possibility is that QS is induced upon contact of a bacterium with the surface by 
concomitant capture, implying that QS receptors are present at the cell-surface. 
Another possibility is that the active compounds are slowly released from the surface 
and subsequently induce QS in the reporter strain. 
 
  
  
  
Figure 24: Phase contrast (A) and GFP fluorescence (B) of the sensor as a negative control. Phase 
contrast (C) and GFP fluorescence (D) of the sensor incubated with hybrid 1 as a positive control. 
Phase contrast (E) and GFP fluorescence (F) of the sensor incubated with the functionalized beads. 
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3.5.3 Dialysis Experiments 
In order to provide more data to establish a mechanism, we performed dialysis 
assays using cellulose ester membranes with a 3.5-5 kDa molecular weight cut off. In 
these assays, the beads were placed inside dialysis bags before incubating with the 
medium. The membrane does not permit diffusion of the beads, whereas released 
AHL mimics can simply diffuse into the surrounding medium and induce the 
biosensor. Dialysis was performed overnight in buffer solution, and the supernatant 
was then incubated with the sensor for 3 hours at 30 °C. The supernatant was capable 
of inducing QS in the reporter strain, which supports the mechanism that AHL mimics 
are released from the beads. 
To investigate the release rate, aliquots were taken after different dialysis times and 
compared the induced GFP fluorescence to known C8-AHL concentrations. The 
results are shown in Figure 25 and demonstrate that the positive control using 
dialyzed compound C8-AHL reaches its maximum activity after a short induction 
period as expected. AHLs are known to be slowly hydrolyzed non-enzymatically 
under physiological condition, explaining the activity decreased after overnight 
incubation.129 The release of the hybrids from the beads is, in contrast, much slower 
and an increasing activity is observed even in the overnight incubation experiment. 
The precise mechanism of release is not yet fully understood, but the measurements of 
QS activity follow a linear increase in time. Hydrolysis of the released hybrids could 
falsify the obtained results, as only the non-hydrolyzed AHLs are capable of inducing 
QS in biosensor strain. Thus, compound 1 was heated at 50 °C and pH 6 for 4 hours 
in an aqueous buffer solution, however, no traces of the hydrolyzed product could be 
observed by UPLC-MS analysis.  
                                                
129  (a) F. G. Glansdorp, G. L. Thomas, J. K. Lee, J. M. Dutton, G. P. C. Salmond, M. Welch, D. R. 
Spring, Org. Biomol. Chem. 2004, 2, 3329; (b) J. T. Byers, C. Lucas, G. P. C. Salmond, M. Welch, 
J. Bacteriol. 2002, 184, 1163. 
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Figure 25: Comparison of activity of coated beads (0.6 mg mL-1) and the positive control C8-AHL 
(0.3 µM) in a dialysis experiment (data is reported as mean ± SEM, N = 9). 
 
The measured GFP fluorescence was quantified by comparison to the measured 
induction for C8-AHL concentrations (Figure 26). The measured concentration was 
calculated to increase from 4 to 270 nM after 1 hour and 16 hours incubation time, 
respectively. However, it is difficult to measure the exact concentration of hybrids per 
mg of TiO2 beads. Quantification of the washout proved to be unsuccessful as well as 
other performed techniques, such as IR measurements. These problems arise from the 
large distribution of particles sizes and the fact that larger beads break apart during 
centrifugation.  
 
 
Figure 26: Correlation between GFP-activity and concentration of C8-AHL (logarithmic scale). 
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3.5.4 Surface Labeling 
Even though we were able to induce a biological response with the coated surfaces, 
there was still no strong evidence that the hybrids were immobilized on the TiO2 
surface. In order to address this, we designed and synthesized hybrid 3 bearing the 
nitro-catechol moiety as a molecular anchor, which was combined with a fluorescent 
dye as shown in Figure 27. Boc-protected lysine (blue in Figure 27 left) served as the 
linker for this purpose. The synthesis could be achieved with two simple amide 
coupling reactions with rhodamine B and nitro-dopamine to yield the labeled anchor 
in 25% overall yield.  
 
 
Figure 27: Left: Fluorescently labeled molecular anchor 3. Right: Coated TiO2 bead with 3. 
 
Compound 3 was coated on TiO2 particles using our established immobilization 
procedure. The functionalized beads were subsequently analyzed by fluorescence 
microscopy to verify the presence of 3 on the surface. Figure 27 (right) shows a 
typical TiO2 bead visualized by a fluorescent microscopy and it is clearly visible that 
the hybrids are located on the surface, as expected. However, quantification of the 
loading remains difficult due to unknown amount of hybrids washed out and surface 
area. 
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3.6 Conclusion 
In summary, we could achieve the preparation of a natural product hybrid bearing 
a nitro-dopamine anchor and a bioactive acylated homoserine lactone moiety. Not 
only are these derivatives still recognized by the AHL biosensor P. putida F117 (pAS-
C8) as QS modulators, but also coating of TiO2 beads was achieved by a simple dip-
and-rinse procedure. The beads retain the activity of the free compounds even after 
extensive washing with water. The mechanism of action was determined to be by 
slow release of the active compounds from the beads’ surface as suggested by dialysis 
assays. Furthermore, we could demonstrate by using fluorescently labeled molecular 
anchors that the active compounds are effectively attached to the TiO2 surface. This 
method might be a highly attractive approach for the preparation of coated surfaces in 
medical devices capable to interrupt the QS signaling pathway in a wide range of 
different bacterial strains. Numerous applications for this approach are feasible, such 
as medical implants, agriculture and material sciences.  
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4 Labeling OF QS PATHWAYS 
4.1 Burkholderia Cenocepacia 
Burkholderia cenocepacia are Gram-negative bacteria and of a bacterial group 
collectively referred to as the Burkholderia cepacia complex (Bcc). 130  These 
organisms are prevalently found in soil, water, and agricultural environments and 
belong to the genus Burkholderia.131 Various species from this genus cannot only be 
found throughout the environment, but are also part of universal contaminants in 
cosmetics and other pharmaceutical solutions. The Bcc is composed of 17 genetically 
distinct but phenotypically similar Burkholderia.132 Some of these species have shown 
to be capable of degrading organic compounds, such as herbicides,133 pesticides,134 
and trichloroethylene,135 thus, bearing a great potential for them as bioremediation 
agents.   
The scope of interactions between Burkholderia species and their environment or 
hosts is complex, and often contradictory. Some species of Burkholderia exist as free-
living cells while others occur in endosymbiotic relationships with fungi or plants,136 
such as B. kirkii, which is living inside plant leaf galls.137 However, the exact 
mechanism by which the bacteria survive and persist within the hosts in not yet fully 
understood. 
Originally identified as plant pathogens, 138  Bcc strains have emerged as a 
significant opportunistic pathogen, which can cause nosocomial infections as well as 
severe illnesses in neonates, patients with cystic fibrosis (CF) or cancer, transplant 
                                                
130  S. C. Miller, J. J. LiPuma, J. L. Parke, Appl. Environ. Microbiol. 2002, 68, 3750. 
131  (a) T. Coenye, P. Vandamme, Environ. Microbiol. 2003, 5, 719; (b) E. Mahenthiralingam, T. A. 
Urban, J. B. Goldberg, Nat. Rev. Microbiol. 2005, 3, 144. 
132  E. Vanlaere, A. Baldwin, D. Gevers, D. Henry, E. De Brandt, J. J. LiPuma, E. Mahenthiralingam, 
D. P. Speert, C. Dowson, P. Vandamme, Int. J. Syst. Evol. Microbiol. 2009, 59, 102. 
133  R. Y. Stanier, N. J. Palleroni, M. Doudoroff, J. Gen. Microbiol. 1966, 43, 159. 
134  A. Holmes, J. Govan, R. Goldstein, Emerg. Infect. Dis. 1998, 4, 221.  
135  B. R. Folsom, P. J. Chapman, P. H. Pritchard, Appl. Environ. Microbiol. 1990, 56, 1279. 
136  T. Coenye, P. Vandamme, Burkholderia: Molecular Microbiology and Genomics. Horizon 
Bioscience, 2007. 
137  S. R. van Oevelen, P. de Wachter, P. Vandamme, E. Robbrecht, E. Prinsen, Int. J. Syst. Evol. 
Microbiol. 2002, 52, 2023. 
138  W. H. Burkholder, Phytopathology 1950, 40, 115.	
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recipients, and other immunocompromized patients.139 The infection rates caused by 
Bcc strains have noticeably increased in the past two decades and pose a dramatic 
threat to the health-care system. Among those, B. cenocepacia is considered the most 
problematic pathogen and can cause life-threatening lung infections and has the 
ability to spread epidemically between CF patients with prevalence rates in some CF 
centers of up to 40%.140 Furthermore, it is responsible for several recent nosocomial 
outbreaks.131b,141 CF patients often acquire B. cenocepacia in the late course of the 
disease after precedent chronicle colonization with Pseudomonas aeruginosa.142 The 
formed mixed biofilms are often associated with reduced survival and the risk of 
developing a fulminated and fatal pneumonia, the so-called cepacia syndrome.143 To 
date, only very little is known about the pathogenic mechanism and virulence 
determinants of B. cenocepacia.  
The formation of biofilms on the epithelial cell surface of the lung is believed to be 
the critical step in the infection progress. Once a biofilm is formed, bacteria can 
withstand host immune responses and exhibit an increased resistance towards 
antibiotics. The expression of the responsible pathogenic traits has been shown to be 
regulated by two QS pathways in B. cenocepacia. The first described system is the 
cep system, which is widely distributed among the Bcc strains.144 There, an AHL 
synthase termed CepI is responsible for the production of N-octanoyl homoserine 
lactone (C8-AHL) and minor amounts of N-hexanoyl homoserine lactone (C6-AHL)145 
and the activation or repression of the transcription of genes is regulated by CepR.146 
Epidemic strains of B. cenocepacia also possess the cci QS system that produces the 
same AHLs as CepI. These two systems form a global gene regulatory system. The 
cep system was shown to positively regulate biofilm formation, swarming motility, 
and production of extracellular proteolytic and chitinolytic activity.147 Interestingly, 
                                                
139  (a) P. Drevinek, E. Mahenthiralingam, Clin. Microbiol. Infect. 2010, 16, 821; (b) E. 
Mahenthiralingam, A. Baldwin, C. G. Dowson, J. Appl. Microbiol. 2008, 104, 1539. 
140  T. Coenye, P. Vandamme, J. R. W. Govan, J. J. LiPuma, J. Clin. Microbiol. 2001, 39, 3427. 
141  D. P. Speert, Infect. Med. 2001, 18, 49. 
142  L. Saiman, G. Cacalano, A. Prince, Infect. Immun. 1990, 58, 2578. 
143  (a) A. M. Jones, Thorax 2004, 59, 948; (b) O. C. Tablan, W. J. Martone, C. F. Doershuk, R. C. 
Stern, M. J. Thomassen, J. D. Klinger, J. W. White, C. L. A, W. R. Jarvis, Chest 1987, 91, 527. 
144  Review: L. Eberl, Int. J. Med. Microbiol. 2006, 296, 103.  
145  S. Lewanza, P. A. Sokol, J. Bacteriol. 2001, 183, 2212. 
146  (a) S. Lewenza, B. Conway, E. P. Greenberg, P. A. Sokol, J. Bacteriol. 1999, 181, 748; (b) S. 
Inhülsen, C. Aguilar, N. Schmid, A. Suppiger, K. Riedel, L. Eberl, Microbiologyopen 2012, 1, 225. 
147  P. A. Sokol, R. J. Malott, K. Riedel, L. Eberl, Future Microbiol. 2007, 2, 555.	
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this is the QS system targeted in the previous chapter. Thus, we wondered if we could 
use the same recognition pattern as already successfully applied for the surface 
functionalization and add a fluorescent marker to be able to label the QS receptor. 
Such a labeling technique could not only serve for sample analysis, but moreover, for 
the monitoring of QS pathways.  
 
4.2 Selective QS Receptor Labeling 
The labeling of QS pathways is a very interesting and challenging problem 
addressed by many different research groups. Several methods for the identification of 
Burkholderia have been developed and their most prominent examples include 
fluorescence in situ hybridization (FISH)148 and rRNA gene-based PCR assays.149 
Nevertheless, in spite of the importance of QS for virulence and biofilm development, 
knowledge of the temporal and spatial production of AHL signaling molecules within 
biofilms or within the infection host is scarce. The lack of techniques to visualize 
AHL-mediated communication at the single cell level needs to be overcome in order 
to furnish better knowledge about this communication system. Even though GFP-
based biosensors have been used for this purpose,64 they are limited to genetically 
engineered experimental model settings.  
Recently, there were two examples reported in the literature in order to overcome 
this problem. The first one was described by Meijler and co-workers in 2011 
(Figure 28).150 These studies are based on previous findings that the isothiocyanate 
functionalized AHL ITC-12 (LXXV) is able to covalently bind to a cysteine residue 
of LasR (LXXVI), which is one of the QS receptors used by Pseudomonas 
aeruginosa. Upon binding to the protein, the AHL analogue can be labeled by the 
fluorescent marker aminooxy-BODIPY (LXXVII) through an aniline-catalyzed 
bio-orthogonal ligation giving LXXVIII. This two-step labeling strategy was 
successfully applied to live cells and a high labeling quality could be achieved. 
However, the drawback of this approach is that it is restricted to the absence of native 
AHLs. That is why the experimental settings were performed with the double mutant 
strain P. aeruginosa JP2 (lasI/rhlI-deleted), which does not produce competitive 
                                                
148  A. R. Brown, J. R. W. Govan, J. Clin. Microbiol. 2007, 45, 1920. 
149  K. Stoecker, C. Dorninger, H. Daims, M. Wagner, Appl. Environ. Microbiol. 2010, 76, 922. 
150  J. Rayo, N. Amara, P. Krief, M. Meijler, J. Am. Chem. Soc. 2011, 133, 7469.	
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AHLs by itself. This disadvantage hampers its application as a possible tool for the 
investigation of bacteria-host communication pathways. 
 
  
Figure 28: Selective in vivo and in vitro labeling of ITC-12 (LXXV) covalently bound to LasR by 
aminooxy-BODIPY (LXXVII).151  
 
The second report was published by Janda and co-workers.151 The authors focused 
on a fluorescently labeled multivalent scaffold for bacterial species utilizing Lsr-type 
AI-2 receptors, used by both Gram-negative and Gram-positive bacteria (see 
chapter 2). This approach is limited to membrane bound receptors and only very 
moderate labeling of Salmonella typhimurium could be achieved. Even though this 
represents the first trial towards selective AI-2 fluorescent labeling, the results are far 
from practical utility. 
We wondered if a more general approach using a labeled ligand with a fluorescent 
tag could be achieved using our recognition pattern. The general drawbacks for such 
methods are the usually observed decrease in affinity of the modified ligand for its 
target protein and the competition with native AHLs.152 
 
 
 
 
                                                
151  A. L. Garner, J. Park, J. S. Zakhari, C. A. Lowery, A. K. Struss, D. Sawada, G. F. Kaurmann, K. D. 
Janda, J. Am. Chem. Soc. 2011, 133, 15934. 
152  A. E. Speers, G. C. Adam, B. F. Cravatt, J. Am. Chem. Soc. 2003, 125, 4686.	
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4.3 Results and Discussion153 
4.3.1 First Generation FLAQS154 
The design of a fluorescent labeling agent for QS receptors (FLAQS) was the first 
challenge to be accomplished. We envisaged using the GFP-based P. putida F117 
pAS-C8 biosensor to monitor the correlation between QS activity and labeling. This 
reported strain was chosen for preliminary results due to its lack of the AHL synthase 
gene ppuI to prevent competition with native AHLs. Furthermore, this strain had been 
shown to be sensitive for our biomimetic moiety and better labeling should be 
expected compared to wild-type (WT) bacteria since cepR is overexpressed. The 
reporter strain produces GFP upon activation. In order to compare activity and 
labeling, the fluorescent properties of GFP and the fluorescent dye should not 
interfere. For this reason, we decided to use the rhodamine B fluorophore due to its 
high luminescence quantum yield and the red fluorescence, which can be clearly 
separated from the green fluorescence of the biosensor. 
The designed fluorescently marked AHL 4 was synthesized in three steps from 
commercially available rhodamine B (5) via intermediate 6 using peptide coupling 
chemistry in 49% overall yield as shown in Scheme 3.  
 
 
Scheme 3: a) N-hydroxysuccinimid, EDC, r.t., 15 h; 1,2-diaminoethane, Et3N, MeCN, r.t., 6 h, 
56%. b) EP2, Et3N, MeCN, r.t., 4 h; c) (S)-α-amino-γ-butyrolactone hydrobromide, MeCN, r.t., 19 
h, 88% over two steps. 
 
                                                
153  Parts of this chapter were published in: J. Gomes, N. Huber, A. Grunau, L. Eberl, and K. 
Gademann, Chem. Eur. J. 2013, 19, 9766. 
154 N. Huber, Master Thesis, Basel, 2012. 
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We then continued our studies by incubating FLAQS 4 with the two biosensors 
P. putida F117 pAS-C8 and pKR-C12 for 3 hours. The resulting GFP fluorescence 
was measured and only the pAS-C8 biosensor was found to induce QS. These 
observations are in agreement with our previous finding that AHL hybrids bearing a 
C12 linker exhibit the desired selectivity towards CepR. 
Next, labeling of the activated bacteria was monitored by fluorescence microscopy. 
Therefore, a 1.3 mM concentration of FLAQS 4 was incubated with the P. putida 
F117 pAS-C8 sensor for 3 hours and the bacteria were subsequently washed before 
monitoring. The results are presented in Figure 29. The appearance of green 
fluorescent cells (A) indicated that QS was induced in the entire population and 
FLAQS 4 acts as a CepR agonist. The red fluorescence labeling (C) is in good 
correlation with the GFP fluorescence as shown in the overlay picture (D). These 
results indicate that FLAQS 4 not only activates the receptors, but also accumulates 
within the bacteria.  
 
       
       
Figure 29:  GFP fluorescence (A), phase contrast (B), red fluorescence (C) and overlay of A, B and 
C (D) of P. putida pAS-C8 sensor incubated with first generation FLAQS 4 with a concentration of 
1.3 mM.  
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The labeling of the biosensors was facilitated by the fact that no competition with 
the native AHL had to be considered and that the target receptor was overexpressed in 
the reporter strains. Encouraged by the obtained results, we next tested labeling of 
CepR in the wild-type strain B. cenocepacia H111, a strain isolated from a CF patient 
in Hannover.155 Its CepIR QS system was shown to be responsible for biofilm 
formation and swarming motility.156 This strain was used for rather practical reasons, 
as it does not belong to an epidemic lineage in contrast to other B. cenocepacia 
pathogens. Furthermore, it is advantageous due to its lack of the CciR/I QS system 
that is present in some B. cenocepacia strains.157 The labeling of the wild-type is a 
challenging problem compared to the reporter strain because on one hand, the 
receptor is not overexpressed, and on the other hand, competition between the natural 
agonist and the synthetic FLAQS is expected. B. cenocepacia H111 was incubated 
with hybrid 4 using similar conditions as in the standard protocol. However, only few 
labeled cells could be observed. Increasing the concentration of this poorly water-
soluble compound was not feasible since higher solvent (DMSO) concentrations led 
to cell lysis. Furthermore, FLAQS 4 crystals were not fluorescent in solution due to 
the formation of the rhodamine base. However, this state could be changed by 
addition of trifluoracetic acid (TFA) due to reopening of the ring and instauration of 
the delocalized π-system (Scheme 4).  
 
 
Scheme 4: Formation of the non-fluorescent rhodamine form. 
 
Solvatochromic fluorophores offer various advantageous properties for the 
monitoring of several biological systems.158 However, in our case, such a dependency 
                                                
155  O. Geisenberger, M. Givskov, K. Riedel, N. Hoiby, B. Tummler, L. Eberl, FEMS Microbiol. Lett. 
2000, 184, 273. 
156 B. Huber, K. Riedel, M. Hentzer, A. Heydorn, A. Gotschlich, M. Givskov, S. Molin, L. Eberl, 
Microbiology 2001, 147, 2517.  
157  A. Baldwin, P. A. Sokol, J. Parkhill, E. Mahenthiralingam, Infect. Immun. 2004, 72, 1537. 
158 G. S. Loving, M. Sainlos, B. Imperiali, Trends Microbiol. 2009, 28, 73.	
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is not desired as we wished to be able to observe the labeled hybrids throughout the 
entire process. Consequently, FLAQS 4 proved unsuitable for an efficient labeling of 
B. cenocepacia H111, hence other rhodamine-based dyes had to be considered. 
 
4.3.2 Second Generation FLAQS154 
In search for appropriated fluorophores, we intended to investigate lissamine 
rhodamine B sulfonyl chloride (Figure 30, 7), rhodamine isothiocyanate (8), and two 
rhodamine B derivatives (9 and 10159) from which we expected to achieve better 
solubility and pH independence.  
 
 
Figure 30: Various red fluorescent dyes. 
 
In order to change only one parameter, we coupled these dyes to our C12-AHL 
recognition pattern. Most synthesized fluorescent hybrids proved to be difficult to 
purify and decomposition was observed during silica gel and size exclusion 
chromatography, but also during reverse phase HPLC. The only exception was hybrid 
11, which could be obtained in pure form after preparative reverse phase HPLC 
purification. This fluorophore had recently been prepared and used by Caddick and 
co-workers. The synthesis of this fluorescently labeled AHL analogue was achieved 
in five synthetic steps from commercially available rhodamine B and dodecandioic 
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acid as shown in Scheme 5. The advantage of this rhodamine moiety compared to 
rhodamine B is the fact that it cannot build the non-fluorescent spirolactone form due 
to the presence of the non-nucleophilic tertiary amide making it pH independent and 
water-soluble.  
 
Scheme 5: a) Ref [158]; b) N,N'-disuccinimidyl carbonate, pyridine, MeCN, 6 h, r.t.; 
c) (S)-α-amino-γ-butyrolactone hydrobromide, Et3N, MeCN, 7 h, r.t.; d) CH2Cl2, TFA, 5 h, r.t.; 
(e) MeCN, 15 h, r.t.,  71 % over four steps. 
 
With the stable hybrid in hand, we wanted to evaluate the fluorescence properties 
of FLAQS 11 in aqueous medium. The measured fluorescence spectrum (Figure 31) 
shows almost no overlap of both bands providing improved fluorescence properties 
compared to rhodamine B (5). Furthermore, the absorption maximum is located at 
560 nm with almost no absorption occurring at 510 nm, which accords to the 
maximum GFP emission wavelength. It is crucial for the experimental settings that no 
interaction between the two fluorophores can occur in order to prevent fluorescence 
quenching, which otherwise could negatively influence the activity assays. The 
emitted maximum wavelength is located in the red spectral area at 600 nm.  
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Figure 31: Fluorescence spectrum of 11. 
 
Appropriate fluorescence properties are essential for the success of the 
experimental set-up, but even more important is the induced activity of the 
synthesized AHL analogue 11. Therefore, we proceeded to compare the QS activities 
of the synthetic and the natural agonists with respect to binding to the receptor 
proteins. As we wanted to obtain a labeled signaling molecule with similar properties 
as the natural agonist, we decided to compare the induced GFP fluorescence of the 
P. putida F117 (pAS-C8) biosensor over a large concentration range from 58 pM to 
488 µM. The natural agonist C8-AHL showed the expected QS induction with a 
maximum activity at a concentration of 15 µM (blue in Figure 32). Low 
concentrations do not activate the QS pathways until the quorum is reached. It is also 
worth mentioning that high concentrations of agonist lead to quorum quenching. This 
means, that AHLs can act as both agonist and antagonist, depending on the 
concentration. The synthetic AHL 11 shows a very similar activity profile compared 
to the native C8-AHL. The activity maximum was observed at 4 µM as shown in red 
in Figure 32. Many different synthetic AHL analogues have been reported in literature 
over the last decades (see section 2.4.2), but our results show the first AHL analogue 
that mimics the activity of the natural ligand over such a large concentration range. 
A negative control was performed using the fluorophore 10 under identical conditions 
and no QS activity was found at any concentration (purple in Figure 32).  
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Figure 32: Activity tests with the P. putida F117 (pAS-C8) biosensor comparing FLAQS 11, 
fluorescent dye 10, and the natural C8-AHL (data is reported as mean ± SEM, N = 3). 
 
The obtained results were fascinating and we continued our studies with the 
labeling of WT bacteria. We therefore first investigated the labeling of the wild-type 
strain B. cenocepacia H111 with the new FLAQS. The used reporter strain has the 
advantages that CepR is overexpressed and no competition between the natural 
agonist and the synthetic FLAQS is possible in contrast to the wild-type. The first 
labeling experiments were performed with the B. cenocepacia H111 strain by 
incubation with a 244 µM concentration of FLAQS 11 for 3 hours. Upon washing, the 
bacteria were evaluated by confocal microscopy. We were pleased to find that 
labeling of the entire bacterial population could be achieved with the new red FLAQS 
as shown in Figure 33 A. The distribution of red fluorescence was found to be equal 
over the bacteria, suggesting that the binding CepR receptor is a soluble cytoplasmic 
protein.  
We subsequently studied the minimal concentration of FLAQS to still achieve 
sufficient labeling. Therefore, B. cenocepacia H111 cells were incubated with 
different concentrations of hybrid 11 and the captured fluorescent pictures were 
compared. An excellent yield of red fluorescence labeling could be observed with a 
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concentration of 31 µM (B), however, only minor or no fluorescence was achieved at 
lower concentrations as shown with 8 and 2 µM concentrations (C and D, 
respectively) due to competition with the natural agonists. A required concentration of 
about 30 µM is highly satisfying for practical uses since no cytotoxicity could be 
observed in this range. 
           A                               B                               C                                D 
 
 
Figure 33: Burkholderia cenocepacia H111 incubated in the presence of (A) 244 µM, (B) 31 µM, 
(C) 8 µM, and (D) 2 µM FLAQS 11. Phase contrast images are shown at the top, red fluorescence 
images at the bottom. 
 
To exclude possible random binding of FLAQS 11 to the bacterial population we 
decided to incubate the marker with the double knockout mutant B. cenocepacia H111 
ΔcepRI. In this strain, where the cepR and cepI genes were knocked out, no labeling 
should occur due to the lack of the QS receptor. Incubation was performed under the 
same conditions used for the wild-type. No fluorescent labeling was detected, which 
showed that no unspecific binding could occur in the absence of the QS receptor 
(Figure 34, A). Two further negative control experiments were performed to ensure 
our results. The first one was done by using an E. coli XL1-Blue strain. This strain 
does not encode an AHL-dependent QS system, and as expected, no fluorescence 
labeling was observed under the same incubation conditions (B). For the last control 
experiment, B. cenocepacia H111 was incubated with the fluorophore 10 alone to 
confirm that the labeling properties do not originate from fluorophore moiety alone, 
but that the bioactive moiety is indeed responsible for the selective binding towards 
CepR. Again, no labeling of the bacteria could be monitored (C). This indicates that 
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the rhodamine derivative is not incorporated into the cells or accumulated in the 
bacterial cell walls. 
 
                          A                                          B                                           C 
        
        
Figure 34:.Burkholderia cenocepacia mutant ΔcepR/I incubated in the presence of (A) 244 µM 
FLAQS 11. Escherichia coli XL1-Blue incubated in the presence of (B) 244 µM FLAQS 11. 
Burkholderia cenocepacia H111 incubated in the presence of (C) 244 µM 10. Phase contrast 
images are shown at the top, red fluorescence images at the bottom. 
 
The site of action was the next target to be investigated. We assumed that the 
synthetic FLAQS bind to the same target site as the natural AHL molecule. However, 
in order to verify this hypothesis, we performed competition assays between the 
synthetic and the natural ligands as shown in Table 2. Therefore, the wild-type strain 
B. cenocepacia H111 was treated and incubated with a certain concentration of 
FLAQS 11 (244 µM) and different concentrations of C8-AHL (1 µM and 100 µM 
entry 1 and 2, respectively). The results reveal that higher concentrations of the 
natural agonist lead to a decrease in labeling. Furthermore, more fluorescent labeling 
could be obtained by using the sensor overexpressing CepR (entry 3). Thus, we can 
conclude that both compounds compete for the same binding pocket of the CepR 
receptor in B. cenocepacia.  
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Table 2: Competition assays between FLAQS 11 (244 µM) and C8-AHL. 
Entry Strain 
C8-AHL 
concentration 
Overlay red fluorescence 
and phase contrast 
Red fluorescence 
1 H111 100 µM 
  
2 H111 1 µM 
  
3 cepR+ 1 µM 
  
 
One possible application for this tool could be the analysis of sputa in order to 
identify the presence of B. cenocepacia. Therefore, the labeling of a pathogenic 
B. cenocepacia strain should work in the presence of other bacteria present in the 
lung, such as P. aeruginosa. That is why we decided to use a mixed bacterial culture 
of the cepR overexpression strain H111 (cepR+) and the GFP-tagged cepR knockout 
mutant H111ΔcepR:GFP. These two strains are only differentiated by the presence of 
the CepR, our target receptor. Thus, the mixed strains were incubated with FLAQS 11 
for 3 hours and visualization was performed by fluorescence microscopy. The pictures 
shown in Figure 35 clearly demonstrate that the GFP-tagged knockout mutant (green) 
could not be labeled with FLAQS 11 in contrast to the strain overexpressing CepR 
(red). These results enable the selective labeling of bacteria based on their unique 
requirements for AHL signaling with FLAQS. 
 
A 
 
 B 
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Figure 35: . Phase contrast (A), red fluorescence (B), GFP fluorescence (C), and overlay of B and 
C (D) of a bacteria mixture (B. cenocepacia mutant cepR+ and B. cenocepacia mutant ΔcepR-GFP) 
incubated with FLAQS 11 (244 µM). 
 
 
Furthermore, the study of bacterial interspecies communication pathways based on 
a given AHL chemotype has become a hot topic and is explored by many research 
groups. In this regard, FLAQS could deliver the perfect tool for this research area and 
lead to the discovery of new common communication pathways used by different 
organisms. Furthermore, it could lead to in vivo visualization of pathogenic and 
symbiotic interactions between bacteria and their eukaryotic hosts. 
 
 
 
 
 
 B 
 
A 
 
C 
 
 D 
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4.3.3 3-Oxo FLAQS 
After having achieved a method for the selective labeling of B. cenocepacia, we 
wondered if other QS receptors could be targeted by FLAQS. The selectivity of the 
synthetic analogues depends on the acyl side chain, so we hypothesized that other QS 
receptors could be labeled by changing the length or oxidation state at C3-position of 
the FLAQS. We were especially interested in the labeling of LasR, which is one of 
the QS receptors used by P. aeruginosa. Such a LasR selective FLAQS could, in 
combination with FLAQS, lead to an extremely fast, simple and inexpensive tool to 
analyze sputa of CF patients, since co-infection of both species is often observed in 
clinical infection. LasR is target in the natural habitat by OdDHL, an AHL signaling 
molecule with a ketone at C3 position. For this reason, we synthesized various AHL 
analogues 12-16 with this oxidation pattern as shown in Figure 36. 
 
 
Figure 36: Synthesized 3-oxo FLAQS with different rhodamine dyes and chain lengths. 
 
The biological evaluation was performed on the P. putida ISO F117 (pKR-C12) 
reporter strain, which expresses the desired LasR receptor. As this biosensor is based 
on the production of GFP upon activation, we used the rhodamine dyes as 
fluorophores in order to distinguish the activity from the labeling. The most promising 
preliminary results were obtained with hybrid 15 bearing the fluorophore 10 and a 
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chain length of C14. This analogue was obtained in six steps and with an overall yield 
of 30% after purification by preparative reverse phase HPLC. 
We were next interested in the fluorescent properties of this compound. The 
measured fluorescence spectrum is shown in Figure 37 and the results are similar to 
the previous one obtained with the same fluorescent dye. The absorption maximum is 
located at 561 nm and the emission maximum at 591 nm.  
 
 
Figure 37: Fluorescence spectrum of 15. 
 
We subsequently determined the concentration dependency of QS induction in the 
reporter strains. Therefore, activity tests were performed with the pAS-C8 and 
pKR-C12 biosensors over a large concentration range (Figure 38 and 39). 
Surprisingly, FLAQS 15 was able to induce QS in both biosensors, although higher 
activity could be observed for the pKR-C12 sensor. Unfortunately, both positive 
controls (blue) showed an unusual concentration behavior. The problem associated 
with these assays was the quality of the added native AHLs. Nevertheless, both assays 
showed a remarkable concentration dependent response of the sensors with FLAQS 
15 with activity maxima at about 15 µM for the pAS-C8 and between 2 and 8 µM for 
the pKR-12 sensor. This shows that this hybrid is recognized by both types of 
receptors (CepR and LasR), in contrast to compound 11, which was only accepted by 
CepR. 
 
400 450 500 550 600 650 700 750
0
20
40
60
80
100
absorption
emission
Wavelenght [nm]
 
Re
l. 
ab
so
rp
tio
n/
em
iss
io
n 
[%]
CHAPTER 4 
 
66 
 
Figure 38: Activity tests with the P. putida F117 (pAS-C8) biosensor comparing FLAQS 15 and 
the natural C8-AHL (data is reported as mean ± SEM, N = 2). 
 
 
Figure 39: Activity tests with the P. putida F117 (pKR-C12) biosensor comparing FLAQS 15 and 
the natural C12-AHL (data is reported as mean ± SEM, N = 2). 
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However, since QS could be induced in both reporter strains, in contrast to the 
previously analyzed FLAQS, we carried out our investigations using fluorescence 
microscopy to distinguish green and red fluorescence from GFP and rhodamine, 
respectively. Therefore, the pKR-C12 reporter strain was incubated with a 244 µM 
concentration of FLAQS 15 for 3 hours. We were pleased to discover that overlapping 
green and red fluorescence could be observed as shown in Figure 40. However, QS 
could not be induced in the entire population and not all the bacteria showed red 
fluorescence. Nevertheless, these first results are extremely promising and higher 
concentrations of FLAQS could lead to an even better level of labeling. Furthermore, 
different labeling stages were observed by confocal microscopy. Smaller bacteria 
showed red fluorescence only at the poles of the cells, whereas larger bacteria 
demonstrated a unitary fluorescence distribution. The former observation is in 
agreement with the findings by Meijler and co-workers with their two-step approach 
(see section 6.2). The results indicate a possible cell division dependent labeling of 
the cells. However, further experiments are required to investigate these observations 
in detail and clarify the mode of labeling. 
 
   
   
Figure 40: Phase contrast (A), red fluorescence (B), GFP fluorescence (C) and overlay of phase 
contrast, A, B, and C (D) of pKR-C12 sensor incubated with 15 (244 µM). 
 
A B 
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FLAQS 15 was also incubated with the pAS-C8 sensor to verify the selectivity of 
this AHL mimic for LasR. The obtained results shown in Figure 41 were surprising, 
because the red and green signals did not overlap at all. Even though QS was induced 
in some bacteria, none of those showed red labeling. The higher the concentration of 
FLAQS 15, the less green cells could be observed. These results are especially 
interesting because CF patients with bacterial lung infections are often co-infected 
with P. aeruginosa and B. cenocepacia. Investigations in the Eberl group showed that 
these two strains are capable to communicate with each other in a unidirectional way. 
Only B. cenocepacia is able to perceive AHLs from P. aeruginosa for activating QS. 
This mechanism might proceed though a different binding site of CepR. FLAQS 15 
could play an essential role in elucidating this communication pathway.  
 
   
   
Figure 41: Phase contrast (A), red fluorescence (B), GFP fluorescence (C) and overlay of phase 
contrast, A, B, and C (D) of pAS-C8 sensor incubated with 15 (244 µM). 
 
Our initial target was the labeling of wild-type bacteria with FLAQS. So we 
preceded our studies by using two different wild-type bacterial strains, namely 
P. aeruginosa PAO1 and B. cenocepacia H111 (Figure 42). A moderate labeling of 
P. aeruginosa could be achieved after co-incubation with the marked hybrid 15 at 
high concentrations (A and B). On the other hand, no fluorescent labeling of 
A B 
C D 
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B. cenocepacia H111 could be detected (C and D), demonstrating the potential of this 
AHL mimic.  
 
  
  
Figure 42: Red fluorescence (A) and overlay of A and phase contrast (B) of P. aeruginosa PAO1 
incubated with 15 (2.44 mM). Red fluorescence (C) and overlay of C and phase contrast (D) of B. 
cenocepacia H111 incubated with 15 (244 µM). 
 
4.3.4 Green FLAQS 
FLAQS have the potential to become a powerful tool for the quick and inexpensive 
selective labeling of mixed bacterial strains. Therefore, differently labeled FLAQS 
with affinity for differing receptors could be used to identify mixed unknown bacterial 
samples. Therewith, bacteria with different QS receptors would be labeled with 
different colors and could be identified by fluorescence microscopy. In order to 
achieve this goal, various fluorescently tagged AHLs need to be prepared.  
We decided to synthesize a green FLAQS by using our recognition pattern for 
B. cenocepacia. We hoped that this AHL mimic would behave just like its red 
counterpart. Dansyl was chosen as the fluorescent dye, as this moiety is widely used 
for biological evaluations. Hybrid 17 was achieved in four steps starting from 
A 
 
B 
 
C 
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commercially available 12-aminododecanoicacid and dansyl chloride in 70% overall 
yield (Figure 43).  
 
 
Figure 43: Structure of the green FLAQS 17. 
 
First, we investigated the fluorescent properties of hybrid 17. The corresponding 
spectrum is shown in Figure 44. The maximum absorption is located at 335 nm, 
whereas the maximum emission can be found at 517 nm. The maximum excitation 
peak is situated at a much lower wavelength, compared with GFP. Thus, activity 
assays with the GFP reporter strains can still be performed.  
 
 
Figure 44: Fluorescence spectrum of 17. 
 
QS induction was tested for the two biosensors P. putida Iso F117 pAS-C8 and 
pKR-C12. As expected, better activity as obtained with the pAS-C8 sensor 
(Figure 45), whereas only weak QS induction was observed with the latter 
(Figure 46). However, compound 17 does not possess the same binding capacities as 
its rhodamine counterpart 11. In order to further investigate the potential of the green 
FLAQS 17, a more detailed study is required. 
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Figure 45: Activity tests with the P. putida F117 (pAS-C8) biosensor comparing FLAQS 17 and 
the natural C8-AHL. 
 
 
Figure 46: Activity tests with the P. putida F117 (pKR-C12) biosensor comparing FLAQS 17 and 
the natural C12-AHL. 
 
We continued our studies with the labeling of the wild-type strain B. cenocepacia 
H111, which was previously already successfully labeled with red FLAQS. Therefore, 
green FLAQS 17 was incubated with the WT strain as shown in Figure 47. 
Unfortunately, only very moderate labeling could be visualized by fluorescent 
microscopy analysis. The observed results cannot be solely attributed to deficient 
properties of the labeling compound, since labeling of the incubated cells was clearly 
seen in normal daylight. We could not improve the quality of the labeling due to 
limitations of the available instruments, especially the absence of an adequate filter. 
However, enhanced labeling is expected with the right equipment. Nevertheless, we 
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were able to synthesize a green FLAQS and the preliminary activity and labeling 
results obtained are highly promising and should be further investigated. 
 
        
Figure 47: Phase contrast (A), overlay of phase contrast and green fluorescence (B) and green 
fluorescence (C) of Burkholderia cenocepacia H111 incubated with 17 (244 µM). 
 
4.4 Conclusion 
Our results demonstrate that easily synthesized FLAQS can be successfully used 
for the operationally simple and selective labeling of QS receptors. We could achieve 
two types of FLAQS that possess different properties for this purpose. Hybrids 
bearing a C12-linker are selective for CepR and the labeling of B. cenocepacia H111, a 
pathogen isolated from a cystic fibrosis patient, was achieved with remarkable 
quality. Furthermore, application of FLAQS 11 suggested the presence of CepR as a 
soluble cytoplasmic protein. The selectivity of FLAQS 11 has been applied to specific 
QS labeling in a mixed bacterial culture.  
The second type of FLAQS bearing 3-oxo functionality in the acyl side chain 
proved to be recognized by CepR and LasR. FLAQS 15 was successfully used for the 
fluorescent labeling of the wild-type P. aeruginosa PAO1. Even though we could not 
achieve the same level of labeling as with CepR, the obtained results are extremely 
promising. In addition, we successfully expanded the FLAQS library by introducing a 
green labeling agent.  
We think that FLAQS could be utilized for the fast analysis of QS in various 
environmental and clinical samples, such as e.g. sputa from CF patients.  
Furthermore, FLAQS could potentially be applied for the investigation and 
visualization of bacteria-host communication pathways. This is especially interesting 
as only very little is known about this phenomenon. 
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5 SYNTHESIS OF MAJUCIN-TYPE SESQUITERPENES 
5.1 Introduction 
5.1.1 Neurodegenerative Diseases 
Since ancient times, people have been seeking for agents that could preserve their 
youth and give eternal life. The search for the fountain of youth has not only been part 
of stories and tales but has been the focus of research by a variety of scientists. The 
most remarkable progress has been accomplished by medicine. Due to novel drugs, 
improved treatments and hygiene standards, a longer average lifetime has been 
achieved. However, there is a downside to this enormous success since the human 
body, especially the brain, has evolutionary not experienced such a long life span. The 
most serious concern in our aging society is the enormous increase of 
neurodegenerative diseases, which has become a major medical threat over the last 
century.160 Many different disorders are attributed to this family, such as Parkinson’s 
and Huntington’s disease, amyotrophic lateral sclerosis and peripheral neuropathy. 
However, the most prevalent disorder among those is the Alzheimer’s disease (AD), 
which affects approximately 36 million people worldwide. 161  This malady is 
characterized by the formation of amyloid plaques, dysfunctional neurons and loss of 
cognitive functions, thereby making a normal life impossible.162 The pathogenesis of 
AD is not yet fully understood, but both genetic and environmental factors are 
believed to contribute to the progress of the illness.163 Current therapies of dementia 
consist of administrating acetylcholine esterase inhibitors in order to prevent the 
breakdown of acetylcholine. 164  This results in cognitive improvement in most 
patients, often for 6 to 9 months or longer.165 However, this simply delays the 
progression and does not lead to a cure and re-establishment of the brain function.166  
                                                
160  M. C. Via, Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders, Pharma 
Reports 2008.  
161  World Alzheimer Report, Alzheimer’s Disease International, 2012. 
162  (a) G. Vantini, D. Skaper, Pharmacol. Res. 1992, 26, 1; (b) H. W. Querfurth, F. M. LaFerla, N. 
Engl. J. Med. 2010, 362, 329. 
163  D. K. Lahiri, B. Maloney, M. R. Basha, Y. W. Ge, N. H. Zawia, Curr. Alzheimer Res. 2007, 4, 219. 
164  T. Mohamed, P. P. N. Rao, Curr. Med. Chem. 2011, 18, 4299. 
165  E. Giacobini, Neurochem. Int. 1998, 32, 413.  
166  (a) C. Holden, Science 1987, 236, 253; (b) J. L. Cummings, N. Engl. J. Med. 2004, 351, 56.	
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In recent studies, the progression of neurodegenerative diseases have been linked 
to decreased neurotrophic support. 167  It was previously believed that nerve 
regeneration in the central nervous system was irreversible, but recently it has become 
apparent that neurotrophins, a class of polypeptidyl agents, are involved in the 
survival of developing neurons and in the maintenance of mature neurons throughout 
life.167   
The first neurotrophin to be isolated and characterized was the nerve growth factor 
(NGF) in 1948.168 NGF is released by target tissue of sympathetic and sensory fibers 
and is taken up by the fibers where it increases the length and volume of neuron 
cells.169 It is then retrogradely transported to the cell body. Initially regarded as 
promising therapeutic agents for the cure of neurodegenerative diseases, 
neurotrophins are large molecules that cannot penetrate into the target brain through 
the blood-brain barrier and suffer from a lack of bioavailability and stability.170  
An attractive alternative approach is based on the search for orally available small 
organic molecules that could mimic or enhance neurotrophin action. Some recent 
examples of neuroregeneration by small natural products will be discussed in the 
following section. 
 
5.1.2 Small Molecules 
The search for small molecules that are able to mimic the biological effect of the 
natural neurotrophic factors or to stimulate their synthesis and secretion has promoted 
the interest of many research groups. Current literature suggests that the combination 
of NGF and compounds from natural sources could be employed for that purpose.171 
Hence, natural products may successfully be used for the treatment of neuronal 
injuries. Recently, many compounds isolated from natural sources have been 
determined to exhibit neuroprotective and neurotrophic properties and to enhance the 
neurite outgrowth activity of NGF in various experimental models.171 In contrast to 
                                                
167  (a) M. R. Bennett, W. G. Gibson, G. Lemon, Auton. Neurosci-Basic Clin. 2002, 95, 1;  (b) D. 
Dawbarn, S. J. Allen, Neuropathol. Appl. Neurobiol. 2003, 29, 211.  
168  E. D. Bueker, Anat. Rec. 1948, 102, 369.  
169  B. L. Irwin, K. K. Leonard, Neuron Cell Mol. Biol. 2002, 3, 410.  
170  R. M. Wilson, S. J. Danishefsky, Acc. Chem. Res. 2006, 39, 539.  
171  For current reviews, see: (a) F. M. Longo, S. M. Massa, Nature Rev. 2013, 12, 507; (b) S. V. More, 
S. Koppula, I.-S. Kim, H. Kumar, B.-W. Kim, D.-K. Choi, Molecules 2012, 17, 6728; (c) J. Xu, M. 
H. Lacoske, E. A. Theodorakis, Angew. Chem. Int. Ed. 2014, 53, 956.	
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the relatively structurally large neurotrophins, small molecules have the advantage to 
be generally easier available by synthesis and can therefore lead to new drugs for 
medical treatment.172  
Various different classes of natural products have been shown to possess 
neuritotrophic properties. The first non-protein neurotrophic factor to be discovered 
was (+)-lactacystin (LXXIX, Figure 48), a sulfur-containing γ-lactam produced by a 
culture broth of Streptomyces sp. OM-6519.173 This compound was shown to exhibit 
significant neuritogenic activity at a concentration of 1.3 µM in mouse neuroblastoma 
cell line Neuro 2A. Shortly after, Corey and Reichard reported its first total 
synthesis.174 Another example for such a target is littoralisone (LXXX), a natural 
product from the iridoid glycoside family. Originally isolated from Verbena littoralis 
in 2001,175 the first total synthesis was reported by MacMillan and co-workers in 
2005 using organocatalysis in various key steps.176 Many more complex natural 
products have been synthesized for this purpose, such as scabronine G (LXXI)177 and 
merrilactone A (LXXII),178 both reported first by Danishefsky and co-workers.  
 
 
Figure 48: Examples of synthesized neuritotrophic natural products. 
 
Due to the importance of such molecules for the understanding of 
neurodegenerative diseases, it is imperative to have access to larger quantities of 
material, which is mostly not possible by extraction from the natural source. The 
Gademann research group has been successful in the synthesis of natural products 
                                                
172  S. S. Gill, N. K. Patel, G. R. Hotton, K. O’Sullivan, R. McCarter, M. Bunnage, D.  J. Brooks, C. N. 
Svendsrem, P. Heywood, Nature Med. 2003, 5, 589.  
173  S. Omura, T. Fujimoto, K. Otoguro, K. Matsuzaki, R. Moriguchi, H. Tanaka, Y. Sasaki, J. Antibiot. 
1991, 44, 113. 
174  E. J. Corey, G. A. Reichard, J. Am. Chem. Soc. 1992, 114, 10677. 
175  Y. S. Li, K. Matsunaga, M. Ishibashi, Y. Ohizumi, J. Org. Chem. 2001, 66, 2165. 
176 I. K. Mangion, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 3696. 
177  S. P. Waters, Y. Tian, Y.-M. Li, S. J. Danishefsky, J. Am. Chem. Soc. 2005, 127, 13514. 
178  V. B. Birman, S. J. Danishefsky, J. Am. Chem. Soc. 2002, 124, 2080.	
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exhibiting neuritotrophic properties. The total synthesis and biological evaluation of 
various natural products such as withanolide A (Figure 49, LXXXIII),179 militarinone 
D (LXXXIV),180 cyrneine A (LXXXV),181 and gelsemiol (LXXXVI)182 have been 
accomplished in elegant strategies.  
 
  
Figure 49: Synthesized neuritotrophic natural products by the Gademann group. 
 
Even though structurally diverse molecules have been shown to possess 
neuritotrophic properties in model systems, the mode of action of most substrates still 
remains unknown. In order to enable possible drug candidates, further studies are 
essential and require further biochemical and synthetic efforts. That is why we were 
interested in a new class of natural products to expand the neuritotrophic chemical 
library. 
 
                                                
179  C. K. Jana, J. Hoecker, T. M. Woods, H. J. Jessen, M. Neuburger, K. Gademann, Angew. Chem. Int. 
Ed. 2011, 50, 8407. 
180  H. J. Jessen, A. Schumacher, T. Shaw, A. Pfaltz, K. Gademann, Angew. Chem. Int. Ed. 2011, 50, 
4222. 
181  E. Elamparuthi, C. Fellay M. Neuburger, K. Gademann, Angew. Chem. Int. Ed. 2012, 51, 4071. 
182  M. Binaghi, P. Burch, M. Scherer, C. Wentzel, D. Bossert, L. Eberhardt, M. Neuburger, P. 
Scheiffele, K. Gademann, Chem. Eur. J. 2013, 19, 2589.	
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5.2 The Genus Illicium 
5.2.1 Overview 
Plants hold a breath-taking amount of different chemical compounds. We became 
interested in natural products derived from the genus Illicium, a species of flowering 
plants, evergreen shrubs and trees that occur in the West Indies, eastern North 
America, Mexico, and eastern Asia due to their impressive chemical diversity.183 The 
fruits of Illicium species are distinctive star-shaped follicles with a characteristic 
refreshing flavor. The best-known example is the Chinese star anise, also known as 
Illicium verum, which has been traditionally used in Asian cooking as spice 
throughout ages. However, not all fruits from this species can be used for culinary 
purposes, as some have been known for several centuries to contain toxic compounds, 
such as the fruits of Illicium anisatum, better known as Japanese star anise. These 
toxic substances have been the focus of many researchers since the mid-19th century. 
It was not before 1952 that the toxic principle component was identified by Lane et al. 
and the pure toxic ingredient was named anisatin (Figure 50, LXXXVII).184 The 
structure elucidation was recalcitrant and was only completed in 1968 by Yamada and 
Hirata.185 Anisatin is recognized as one of the most potent neurotoxins of plant 
origin.186 
 
 
Figure 50: Structure of anisatin. 
 
Since the discovery of anisatin, components of the Illicium family have been 
intensively chemically investigated and many biologically active compounds have 
been identified to date.187 It was shown that a number of these natural products have 
                                                
183  A. C. Smith, Sargentia 1947, 7, 1.  
184  J. F. Lane, W. T. Koch, N. S. Leeds, G. Gorin, J. Am. Chem. Soc. 1952, 74, 3211. 
185  K. Yamada, S. Takeda, S. Nakamura, Y. Hirata, Tetrahedron 1968, 24, 199. 
186  T. J. Schmidt, M. Gurrath, Y. Ozoe, Bioorg. Med. Chem. 2004, 12, 4159. 
187  Y. Fukuyama, J.-M. Huang, Illicium, Pimpinella, and Foeniculum; M. M. Jodral, Ed.; CRC LLC; 
New York, 2004, p 31.	
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potent neurite outgrowth activity in primary cultured rat cortical neurons.187 Further 
studies on chemical components in Illicium plants were carried out by Kawano,188 and 
later by Schmidt189 and Fukuyama190 and their corresponding research groups. A 
variety of unique seco-prezizaane-type sesquiterpenes or so called Illicium 
sesquiterpenes were found exclusively in these plants. The majority of the active 
compounds were determined to be sesquiterpenes bearing a bicyclo[4.3.0]nonane 
carbon skeleton. These chemical moieties were further classified into six subgroups 
depending on the lactone-type. In the following section, structures, classes, and 
variety of these sesquiterpenes from Illicium species will be discussed. 
 
5.2.2 seco-Prezizaane-Type Sesquiterpenes 
The core structure of this class of natural products has been proposed to be derived 
from farnesol pyrophosphate (FPP, LXXXVIII) as shown in Scheme 6.190 The 
proposed biosynthetic pathway suggests that FPP (LXXXVIII) can rearrange through 
intermediate LXXXIX and acorane (XC) to allo-cedrane (XCI). The seco-prezizaane 
core structure XCII is then finally formed by breaking the C-6-C-11 bond. 
 
 
Scheme 6: Plausible biosynthesis of seco-prezizaane (XCII) through a common key biosynthetic 
intermediate, allo-cedrane (XCI). 
 
seco-Prezizaane-type sesquiterpenes all have the same carbon skeleton but, 
depending on the subgroup, possess diverse lactone moieties. The structures of natural 
products that the six subtypes are named after (LXXXVII, XCIII-XCVII) are shown 
                                                
188  I. Kouno, N. Kawano, J. Chem. Cos. Perkin Trans. 1988, 1537. 
189  T. J. Schmidt, H. M. Schmidt, E. Müller, W. Peters, F. R. Fronczek, A. Truesdale, N.  H. Fischer, J. 
Nat. Prod. 1998, 61, 230.  
190  Y. Fukuyama, J.-M. Huang, Studies in Natural Products Chemistry; A. Rahman, Ed.; Elsevier: 
New York, 2005, Vol. 32, p 395.	
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in Figure 51. The following section will focus on the subtype of our interest in the 
present work, namely the majucin-type sesquiterpenes. 
 
 
Figure 51: Six subtypes of seco-prezizaane-type sesquiterpenes from Illicium species. 
 
5.2.3 Majucin-Type Sesquiterpenes 
The common feature of this subtype is the presence of a γ-lactone ring (Figure 52). 
Majucin (XCIII) was the first compound to be structurally assigned by extensive 
spectroscopic analysis in 1988.191 Ever since, many more natural products from this 
subgroup have been isolated and fully characterized.190 Amazingly, several of these 
molecules have been shown to be neurotrophically active. The most active members 
of this family are jiadifenin (XCVIII),192 jiadifenolide (IC),193 (2S)-hydroxy-3,4-
dehydroneomajucin (C),192 jiadifenoxolane A (CI),193 and the norsesquiterpenoid 
(2R)-hydroxy-norneomajucin (CII).194 Furthermore, also the synthetic carboxylic acid 
derivative of jiadifenin CIII showed potent neurite outgrowth promoting activity in 
primary cultured rat cortical neurons.190 
 
                                                
191  C.-S. Yang, I. Kuono, N. Kawano, S. Sato, Tetrahedron Lett. 1988, 29, 1165. 
192  R. Yokoyama, J.-M. Huang, C. Yang, Y. Fukuyama, J. Nat. Prod. 2002, 65, 527. 
193  M. Kubo, C. Okada, J.-M. Huang, K. Harada, H. Hioki, Y. Fukuyama, Org. Lett. 2009, 11, 5190. 
194  M. Kubo, K. Kobayashi, J.-M. Huang, K. Harada, Y. Fukuyama, Tetrahedron Lett. 2012, 53, 1231. 
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Figure 52: Majucin-type sesquiterpenes possessing neurotrophic activity. 
 
With over 20 majucin-type sesquiterpenes having been isolated and characterized 
to date, only two of them have been synthesized so far. Therefore, further synthetic 
efforts are required in order to provide the required access to this class of natural 
products. Furthermore, no insight in the mode of action of these natural products has 
been obtained from previous research, making a more detailed structure-reactivity 
study necessary. The pharmacophore of these compounds may be found and used for 
additional investigations towards a real drug candidate. 
A particularly interesting member of the majucin-type family of sesquiterpenes is 
jiadifenolide (IC). It does not only possess a highly oxidized and caged pentacyclic 
core structure, it also promotes neurite outgrowth at 10 nM concentrations.193 
Jiadifenolide (IC) has the same origin as jiadifenin (XCVIII) as both natural products 
were isolated from the East-Asian plant Illicium jiadifengpi. The architectural 
complexity combined with the desired bioactivity makes jiadifenolide the ideal target 
for total synthesis.  
As previously mentioned, two of the majucin-type sesquiterpenes have already 
been synthesized. The following section will be focused on the successfully 
accomplished syntheses. 
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5.3 Previous Total Syntheses of Majucin-Type Sesquiterpenes 
The synthesis of majucin-type sesquiterpenes has awaked the interest of various 
research groups.195 However, only two have been accomplished to date, namely 
jiadifenin (XCVIII) and jiadifenolide (IC). The majority of the synthetic efforts have 
been directed to the preparation of XCVIII. The first racemic total synthesis was 
reported by Danishefsky and co-workers in 2004. 196  Since then, various 
enantioselective approaches towards this class of natural compounds have been 
reported in literature. 197   Theodorakis and co-workers reported the first 
enantioselective synthesis in 2011.198 Another elegant total synthesis of (–)-jiadifenin 
(XCVIII) was reported by Zhai and coworkers shortly after.199 Very recently, Xu 
et al. reported the first total synthesis of (–)-jiadifenolide (IC).200 
 
5.3.1 Danishefsky’s Total Synthesis of (±)-Jiadifenin197 
The first synthesis of a majucin-type sesquiterpene was elegantly accomplished by 
Danishefsky and co-workers (Scheme 7).196 The synthesis began with the 
commercially available cyclohexanone CIV and the authors obtained ketone CV as a 
3:1 mixture of diastereoisomers in five steps by stepwise stereoselective alkylation. 
An intramolecular Horner-Wadsworth-Emmons reaction formed the A ring of CVI, 
which was followed by an intramolecular Claisen condensation to form the tricycle 
motif CVII. Oxidation of the β-keto ester with m-CPBA introduced the C-6 hydroxyl 
group as a single isomer. The formation of the trans-diol CVIII was achieved via 
stereo- and regioselective reduction of the C-7 ketone followed by methylation. 
Ozonolysis of the terminal alkene and subsequent Jones oxidation and stereoselective 
reduction of the ketone moiety led to the formation of lactone CIX. The introduction 
of the C-10 hydroxyl group of CX was achieved by treatment with Davis 
oxaziridine.201 The synthesis of (±)-jiadifenin (XCVIII) was completed by Jones 
                                                
195  D. Urabe, M. Inoue, Tetrahedron 2009, 65, 6271. 
196  Y. S. Cho, D. A. Carcache, Y. Tian, Y. M. Li, S. J. Danishefsky, J. Am. Chem. Soc. 2004, 126, 
14358. 
197  (a) K. Harada, A. Imai, K. Uto, R. G. Carter, M. Kubo, H. Hioki, Y. Fukuyama, Org. Lett. 2011, 
13, 988; (b) G. Mehta, H. M. Shinde, R. S. Kumaran, Tetrahedron Lett. 2012, 53, 4320. 
198  L. Trzoss, J. Xu, M. H. Lacoske, W. C. Mobley, E. A. Theodorakis, Org. Lett. 2011, 13, 4554. 
199  Y. Yang, X. Fu, J. Chen, H. Zhai, Angew. Chem. Int. Ed. 2012, 51, 9825. 
200  J. Xu, L. Trzoss, W. K. Chang, E. A. Theodorakis, Angew. Chem. Int. Ed. 2011, 50, 3672. 
201  F. A. Davis, O. D. Stringer, J. Org. Chem. 1982, 47, 1774.	
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oxidation. The mono-oxidized intermediate CXI was also isolated and could be 
further oxidized to the natural product. 
 
 
Scheme 7: a) LiHMDS, THF, -78 °C; MeI, -78°C to r.t.; b) 10% KOH, MeOH, HCHO (aq.), 0 °C; 
c) TBSOTf, 2,6-lutidine, CH2Cl2, 0 °C, 64% over three steps; d) LiHMDS, THF, –78 °C; allyl 
bromide, –78 °C to r.t., 73%; e) LDA, THF, –78 °C to –20 °C; BrCH2CO2Et, HMPA, –78 °C, 97%, 
d.r. = 3:1; f) LiCH2P(O)(OMe)2, THF, –78 °C, 81%; g) NaH, THF, reflux, 91%; h) 2 M HCl, THF, 
94%, i) ClCO2Et, pyridine, DMAP, CH2Cl2, 0 °C to r.t., 93%; j) NaH, THF, reflux, 94%; 
k) m-CPBA, CH2Cl2, 90%; l) NaBH4, THF/MeOH (1:1), –78 °C, 93%; m) LDA, THF, –40 °C to            
–15 °C; n) MeI, HMPA, –35 °C, 64% over two steps; o) O3, Sudan 7B Red, CH2Cl2/EtOH (1:1),    
–78 °C; p) Jones reagent, acetone, 90%; q) NaBH4, CeCl3·7H2O, THF/MeOH (3:1), –65 °C, 88%; 
r) NaHMDS, THF, –78 °C; s) Davis’s oxaziridine, THF, –78 °C, 42% over two steps; t) Jones 
reagent, acetone; MeOH, 40% XCVIII and 29% CXI. 
 
The first total synthesis of (±)-jiadifenin (XCVIII) was accomplished in 18 linear 
steps with an overall yield of 1.9% and provided several synthetic analogues to 
establish an initial SAR profile of this family. Interestingly, the fully synthetic 
intermediate CXI displayed even stronger neurotrophic activity in the assay than the 
natural product. However, these results should be considered with caution since the 
biological evaluations were performed on the racemic mixtures. 
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5.3.2 Theodorakis’ Total Synthesis of (–)-Jiadifenolide201 
Recently, Xu et al. reported on the first enantioselective total synthesis of a 
majucin-type sesquiterpene (Scheme 8).200 Commercially available diketone CXII 
was used as the starting point for the synthesis, which was transformed into the 
prochiral triketone CXIII by allylation and subsequent Michael addition to methyl 
vinyl ketone. Following the Tu/Zhang protocol,202 the authors could prepare the 
Parrish-type203 diketone CXIV in optically enriched form (> 90% e.e.). Highly 
diastereoselective alkylation gave CXV, possibly controlled by the steric bulk of the 
allyl group. Further transformations afforded CXVI, which was treated with the 
McMurry reagent and then carbomethoxylated to the lactone CXVII. The tricyclic 
intermediate CXVII was epoxidized with alkaline hydrogen peroxide solution 
followed by oxidation to give the carboxylic acid that spontaneously triggered a 
“6-exo-tet” epoxide opening to furnish the bis-lactone CXVIII. Epoxidation of the 
double bond upon silyl deprotection and subsequent treatment the resulting epoxide 
with Dess-Martin periodinane triggered the key oxidative rearrangement to give rise 
to lactone CXIX. Even though the rearranged CXIX was susceptible to further 
oxidation, it could be secured in a 38% yield. Hydrogenation and protection led to 
ketone CXX, which was treated with Comins reagent and the resulting enol triflate 
was coupled with excess Me3Al employing palladium catalysis to furnish compound 
CXXI. Hydrogenation of the trisubstituted alkene at 90 bar overpressure and 
hydroxylation of the lactone with Davis oxaziridine204 afforded intermediate CXXII, 
which reacted with Jones reagent to complete the total synthesis of (–)-jiadifenolide 
(IC). 
                                                
202  X.-M. Zhang, M. Wang, Y.-Q. Tu, C.-A. Fan, Y.-J. Jiang, S.-Y. Zhang, F.-M. Zhang, Synlett 2008, 
2831.  
203  Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1974, 39, 1615 .  
204  F. A. Davis, S. Chattopadhyay, J. C. Towson, S. Lal, T. Reddy, J. Org. Chem. 1988, 53, 2087.	
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Scheme 8: a) Allyl acetate, [PdC3H5Cl2]2, BSA, cat. NaOAc, THF, reflux 24 h, 90%; b) methyl 
vinyl ketone, H2O, r.t., 54%; c) D-prolinamide (30 mol %), PPTS (30 mol %), MeCN, 40 °C, 14 d, 
74% (>90% e.e.); d) NaBH4 (0.25 eq.), EtOH, 0 °C, 1 h; e) TBSCl, NH4NO3, DMF, r.t., 12 h, 92% 
for two steps; f) MMC, DMF, 130 °C, 3 h; Et3O+BF4- , i-Pr2NEt, CH2Cl2, 0 °C, 5 min; g) TMSOTf, 
2,6-lutidine, CH2Cl2, 0 °C to r.t., 1 h; TBAF (1.0 eq.), MeI, THF, –78 °C to r.t., 3 h, 43% for two 
steps; h) LiAlH4, THF, 0 °C to r.t., 1 h; i) TBSCl (1.0 eq.), imidazole, CH2Cl2, 0 °C, 30 min; j) IBX, 
DMSO, 80 °C, 1 h, 85% for three steps; k) KHMDS, PhNTf2, THF, –78 °C, 1 h; l) CO (1 atm), 
[Pd(PPh3)4] (1 mol%), MeOH, DMF, Et3N, 50 °C, 2 h; TFA, CH2Cl2, r.t., 5 h, 69% for two steps; 
m) H2O2, 3M NaOH, THF, 0 °C to r.t., 5 h, 99%; n) OsO4 (1 mol%), NaIO4, 1,4-dioxane, H2O, r.t., 
12 h; o) Jones reagent, acetone, 0 °C, 30 min, 70% for two steps; p) TBAF, THF, r.t., 30 min, 95%; 
q) m-CPBA, THF, 50 °C, 3 h; r) Dess-Martin periodinane, acetone, r.t., 2h, 38% for two steps; s) H2 
(6 atm), 10% Pd/C (5 mol%), MeOH, r.t., 24 h; t) TESOTf, 2,6-lutidine, THF, 0 °C to r.t., 30 min, 
90% for 2 steps; u) KHMDS, Comins reagent, THF, –78 °C, 1.5 h; v) AlMe3, [Pd(PPh3)4] 
(50 mol%), THF, r.t., 2 h, 57% for two steps; w) H2 (90 atm), PtO2 (20 mol%), MeOH, r.t., 24 h; 
x) NaHMDS, (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine, THF, –78 °C to r.t., 1.5 h; g) Jones 
reagent, acetone, 0 °C, 15 min, 33% for three steps.  
 
The first total synthesis of (–)-jiadifenolide (IC) was accomplished in 25 linear 
steps in 0.5% overall yield from the commercially available cyclopentane 1,3-dione 
(CXII).  
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5.3.3 Theodorakis’ Total Synthesis of (–)-Jiadifenin199 
The first enantioselective total synthesis of (–)-jiadifenin (XCVIII) was reported 
by the research group of Theodorakis shortly after the initial jiadifenolide synthesis as 
shown in Scheme 9.200 The previously described methods were employed to construct 
the tetracyclic lactone CXXIII, an intermediate from the synthetic route towards 
jiadifenolide (IC). Starting compound CXXIII was first dehydrated using Martin’s 
sulfurane and the derived diene was hydrogenated to yield alkene CXXIV. Allylic 
oxidation at the C-2 position gave rise to the α,β-unsaturated ketone CXXV, which 
was then hydroxylated with Davis’ oxaziridine to give lactone CXXVI. The final 
synthetic strategy is analog to the one described by Danishefsky and co-workers in the 
synthesis the racemic natural product.196 Methylation with LDA/MeI/HMPA 
furnished the C-1 methylated product CXXVII with the required configuration. 
Alcohol CXXVII was then finally oxidized and rearranged under Jones conditions 
giving rise to (–)-jiadifenin (XCVIII) after methanolic work up, as described in the 
previous reports.196 
 
 
Scheme 9: a) Martin’s sulfurane, THF, r.t., 2 h; b) H2, Pd/C, MeOH, r.t., 1 h, 72% over two steps; 
c) MnO(OAc)9, t-BuOOH, EtOAc, 3 Å MS, 40 °C, 16 h, 65%; d) NaHMDS, Davis’ oxaziridine, 
THF, –78 °C, 1 h, 61%; e) LDA, MeI, THF, HMPA, –78 °C to –10 °C, 4 h, 60% brsm; f) Jones 
reagent, acetone, r.t., 20 min; MeOH, r.t., 15 min, 45%.  
 
The first enantioselective total synthesis of (–)-jiadifenin (XCVIII) could be 
accomplished in six chemical steps from the previously described intermediate 
CXXIII. Overall, the synthesis preceded over 19 linear steps from readily available 
diketone CXII with an overall yield of 1.1%. 
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5.3.4 Zhai’s Total Synthesis of (–)-Jiadifenin200 
Another enantioselective route toward (–)-jiadifenin (XCVIII) was recently 
reported by the Zhai research group (Scheme 10). Their approach started with the 
coupling of readily available allylic bromide CXXVIII with lithiated propyne. 
Asymmetric dihydroxylation followed by a two-step acetal protection and 
deprotection of the terminal alcohol led to acetal CXXIX in good enantiomeric purity 
(> 93% e.e.). Jones oxidation and coupling of the corresponding carboxylic acid to the 
known alcohol CXXX205 delivered ester (E)-CXXXI. Closure of the C ring was 
achieved using an Ireland-Claisen rearrangement with a good diastereoselective ratio 
of product CXXXII (d.r. = 7:1). Dihydroxy deprotection and selective silylation of 
the secondary hydroxy group led to enyne CXXXIII, which was then used for the key 
step, a Pauson–Khand reaction, to form the tricyclic intermediate CXXXIV. 
Subsequently, an interesting [2+2] cycloaddition between the enone moiety and allene 
furnished the head-to-head photocycloproduct CXXXV in a diastereoselective 
manner. Ozonolysis and ring opening with methanolic NaOMe led to CXXXVI as a 
fragmentation product upon oxidation applying the Ito-Saegusa protocol.206 After 
exposure to TBAF, tandem desilylation and lactonization of enone CXXXVI 
furnished the according dilactone. The synthesis was completed by α-hydroxylation 
and Jones oxidation of this intermediate as already described by the Danishefsky196 
and Theodorakis200 research groups. 
Overall, Zhai’s group completed the synthesis of (–)-jiadifenin (XCVIII) in 
18 steps and 0.7% overall yield from allylic bromide CXXVIII in comparison to 
19 steps and 1.1% yield in Theodorakis’ synthesis.  
 
 
                                                
205  A. Reichenberg, M. Hintz, Y. Kletschek, T. Kuhl, C. Haug, R. Engel, J. Moll, D. N. Ostrovsky, H. 
Jomaa, M. Eberl, Bioorg. Med. Chem. Lett. 2003, 13, 1257.  
206  Y. Ito, T. Hirao, T. Saegusa, J. Org. Chem. 1978, 43, 1011. 
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Scheme 10: a) 1-Bromo-1-propene, n-BuLi, CuI, THF, –78 °C to r.t., 74%; b) AD-mix-β, 
MeSO2NH2, t-BuOH/H2O (1:1), 0 °C, 95%, >93% e.e.; c) KOH, CH2I2, [18]-crown-6, CH2Cl2, 
reflux, 80%; d) CAN, MeCN/H2O (2.5:1), 90%; e) Jones reagent, acetone, -78 °C to r.t.; f) DCC, 
DMAP, LI, THF, r.t., 70% for two steps; g) LDA, TMSCl, THF, –78 °C to r.t. to reflux; 
h) TsOH·H2O, MeOH, reflux, 54% for two steps, d.r. = 7:1; i) Ph3CBF4, CH2Cl2, reflux, 60%; 
j) TBSOTf, Et3N, CH2Cl2, RT, 85%; k) [Co2(CO)8], Bu3PS, toluene, RT to 75 °C, 67%; l) hv, 
allene, THF, –78 °C, 87%, d.r. = 4.8:1; m) O3, MeOH, CH2Cl2; Me2S, –78 °C to RT; NaOMe, 
MeOH, 89%; n) LDA, TMSCl, Et3N, THF, –78 °C to –20 °C; o) Pd(OAc)2, O2, DMSO, 75 °C, 
92% over two steps; p) TBAF, THF, RT, 96%; q) NaHMDS, (–)-trans-2-(phenylsulfonyl)-3-
phenyloxaziridine, THF, -78 °C, 55%; r) Jones reagent, acetone, 0 °C; MeOH, RT, 46%.  
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5.4 Synthetic Studies on Illicium Sesquiterpenes 
5.4.1 Retrosynthetic Analysis 
Jiadifenolide (18) is a highly oxygenated sesquiterpene featuring a unique 
seco-prezizaane-type skeleton. Densely embedded in the framework of this 
cage-shaped molecule are seven stereocenters, including two separate all-carbon 
quaternary centers (C-5 and C-9). The previously described syntheses of majucin-type 
sesquiterpenes by the groups of Danishefsky,196 Theodorakis,200 and Zhai199 were 
accomplished with a ring-construction sequence of BàABàABC, AàABàABC, and 
of CàBCàABC, respectively. We propose a different strategy by first attaching the C 
ring to the A ring and then use an intramolecular ring-closing strategy to obtain the 
ABC core-structure as shown in Scheme 11. 
 
 
Scheme 11: Retrosynthetic analysis of (–)-jiadifenolide (18). 
 
As outlined in Scheme 11, we envisioned that jiadifenolide (18) may be accessible 
through a series of transformations including an intramolecular and diastereoselective 
Nozaki-Hiyama-Kishi (NHK) cross coupling. We decided to start with the known 
keto ester 19,207 which can be obtained from D-pulegone (20) in three synthetic steps. 
The methyl group in 19 possesses the necessary (R) configuration of the A ring 
methyl in jiadifenolide. Starting with a natural product from the chiral pool has the 
advantage that we do not have to take into account any enantioselective step. 
Time-consuming optimization efforts to find the perfect chiral ligand and reaction 
conditions can be avoided by carefully choosing a suitable starting material. Nature 
offers us an enormous variety of chiral molecules, which many of them have been 
commercialized and can be used as a starting point for total syntheses. 
                                                
207  R. M. Coates, P. R. Vettel, J. Org. Chem. 1980, 45, 5430.  
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Tetronic acid (21) was envisioned to serve as the C ring moiety, which should be 
coupled to the A ring via a C2-linker. The key step of the synthesis was planned to be 
a NHK cross coupling to form the C-4-C-5 bond. NHK reactions are frequently used 
in synthetic chemistry to couple vinylic halides or triflates to aldehydes. Even though 
rarely applied, some examples in literature demonstrate that ketones can be used as 
coupling reagents.208 The reported yields are rather poor, but our intramolecular 
variation might effectively furnish the desired tricyclic core structure.  
Insertion of the remaining C-14 methyl group was planned to be derived from a 
1,4-addition to the unsaturated γ-lactone or via a two-step procedure including Corey-
Chaykovsky cyclopropanation and subsequent Birch reduction.209 Further oxidation 
of the core structure and homologation of the ester moiety should deliver the second 
γ-lactone after hydrolysis. The hydroxyl group at C-6 position was expected to be 
derived from the corresponding epoxide between C-6 and C-7. 
It is noteworthy that the desired stereoselectivity of the complete synthesis is 
supposed to be directed by the methyl group of D-pulegone (20) by diastereoselective 
transformations.  
 
5.4.2 Attachment of the C Ring 
The synthesis started with the preparation of keto ester 19 as shown in Scheme 12. 
Bromination of D-pulegone (20) and subsequent treatment of the double brominated 
intermediate with methanolic NaOMe triggered the Favorskii rearrangement and ester 
22 was obtained as a 1:1 mixture of diastereoisomers. Ozonolysis of 22 gave the 
known keto ester 19 in an excellent 76% overall yield. Modifications of the literature 
protocols207 were necessary in order to obtain the desired product in satisfactory yield.  
 
 
Scheme 12: a) Br2, NaHCO3, Et2O, 0 °C, 40 min; b) NaOMe, MeOH, reflux, 2.5 h, 76% over two 
steps; c) O3, CH2Cl2/MeOH (5:1), –78 °C; Zn, AcOH, –78 °C to r.t., 97%. 
                                                
208  (a) J. J. Miller, M. S. Sigman, J. Am. Chem. Soc. 2007, 129, 2752; (b) P. Knochel, C. J. Rao, 
Tetrahedron 1993, 49, 29; (c) R. Angell, P. J. Parsons, A. Naylor, Synlett 1993, 189; (d) K. Suzuki, 
H. Takayama, Org. Lett. 2006, 8, 4605; (e) K. Takai, K. Kimura, T. Kuroda, T. Hiyama, H. Nozaki, 
Tetrahedron Lett. 1983, 24, 5281. 
209  T. E. Janini, P. Sampson, J. Org. Chem. 1997, 62, 5069.	
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With the A ring in hand, the next step was the attachment of the C ring. We 
decided to use linker 23, prepared in a single step following a known procedure,210 to 
attach the C ring moiety. Alkylation of keto ester 19 gave the desired silyl ether in a 
good diastereomeric ratio of 7:1, which was further iodinated to 24 using in situ 
prepared TMSI following the Olah/Narang protocol211 (Scheme 13). The primary 
iodide 24 quickly decomposed to a single crystalline product under normal light 
exposure. X-ray crystal structure analysis showed that spiro compound 25 was 
formed. Even though the obtained product did not serve any synthetic purpose, it still 
verified that the desired configuration was introduced in C-9 position. Direct 
alkylation of 24 with 1,2-diiodoethane did not yield the expected product 24 and only 
complex mixtures were obtained under various reaction conditions. 
Next, iodide 24 was reacted with tetronic acid (21) under basic conditions. 
However, preliminary results showed that the O-alkylated vinyl ether 26 was formed 
exclusively and not the desired C-alkylated product. Due to the moderate yields and 
undesired regioselectivity of the reactions, we decided to seek for a better synthetic 
strategy.  
 
 
Scheme 13: a) K2CO3, 23, acetone, r.t. to reflux, 2d, 53%, d.r. = 7:1; b) TMSI, MeCN, r.t., 1 h, 
52%; c) tetronic acid (21), LiI, DBU, THF, reflux, 36 h; DMPU, reflux, 2 d. 
 
Alternatively, keto ester 19 was allylated as shown in Scheme 14. The desired 
product 27 was obtained in superb 92% yield as an 11:1 mixture of diastereoisomers, 
which were easily separated by flash chromatography on silica gel. The improved 
selectivity can be explained by the milder reaction conditions applied due the superior 
electrophilic reactivity of allyl bromide compared to 23. Ozonolysis gave pure 
aldehyde 28 after simple filtration over celite in quantitative yield. With aldehyde 28 
in hand, we next envisioned to couple tetronic acid (21) via a Knoevenagel 
                                                
210  C. Desroches, C. Lopes, V. Kessler, S. Parola, Dalton Trans. 2003, 2085. 
211  G. A. Olah, S. C. Narang, Tetrahedron, 1982, 38, 2225.	
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condensation.212 However, no desired product could be isolated due to the strong 
electrophilic properties of the formed intermediate, which quickly reacted with the 
remaining 21 in solution to form the corresponding Michael adduct. 
 
 
Scheme 14: a) NaH, THF/DMPU (4:1), r.t., 1 h; allyl bromide, 0 °C to r.t., 13 h, 92%, d.r. = 11:1; 
b) O3, CH2Cl2/MeOH (5:1), -78 °C; Zn, AcOH, –78°C to r.t., quant.; c) Hantzsch’ ester, tetronic 
acid (21), L-proline (10 mol%), MeOH, 24 h, r.t., 81%. 
 
Facing a similar problem, Ramachary and co-workers reported a cascade 
three-component reductive alkylation using Hantzsch’ ester as reducing agent to 
couple tetronic acid to carbonyl moieties.213 Optimized reaction conditions using this 
procedure led to product 29 in 81% yield.212 Best results were obtained using 
0.1 equivalents of L-proline and 2.2 equivalents of Hantzsch’ ester, as reducing the 
amounts of any of the reagents led to a significant drop in yield. 
As an alternative, we envisaged to couple tetronic acid to a higher oxidized 
substrate in order to overcome later oxidation state adjustments. Thus, aldehyde 28 
was oxidized to the corresponding carboxylic acid 30 using sodium chlorite in 
quantitative yield (Scheme 15). For the ensuing acylation step we tested a method 
reported by Yoshii et al., which allows a one-pot acylation procedure involving a 
DMAP-mediated Fries rearrangement of the kinetic O-acylation product.214 Following 
the reported method, 31 could be isolated by preparative HPLC separation in 19% 
yield since decomposition of the substrate was observed on silica gel. Even with a 
successful isolation of the product, it was shown to be very unstable and 
decomposition could be detected after short time, even under protecting atmosphere at 
4 °C. Therefore, we decided to pursue our synthetic strategy with the more stable 
product 29. 
 
                                                
212  E. Kaufmann, Master Thesis, Basel, 2011. 
213  D. P. Ramachary, M. Kishor, Org. Biomol. Chem. 2008, 6, 4176.  
214  K. Nomura, K. Hori, M. Arai, E. Yoshii, Chem. Pharm. Bull. 1987, 35, 4368.	
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Scheme 15: a) 2-Methyl-2-butene, sodium chlorite, sodium phosphate, t-BuOH/H2O (1:2), r.t., 2 h, 
quant.; b) DMAP, DCC, 21, N,N-diisopropylethylamine, CH2Cl2, 0 °C to r.t., 16 h, 19%. 
 
After having attached the C ring moiety, we turned our attention towards the key 
step of the synthesis, the formation of the B ring.  
 
5.4.3 Formation of the B Ring 
5.4.3.1 Nozaki-Hiyama-Kishi Approach 
The formation of the six-membered B ring was addressed next. For this, we 
envisioned to use a NHK cross coupling reaction to obtain the tricyclic core structure. 
First, C-5 position had to be activated in order to allow oxidative addition of nickel 
during the process. Vinyl halides and triflates are most commonly used as starting 
reagents for NHK reaction. Therefore, substrate 29 was triflated to yield compound 32 
in quantitative yield (Scheme 16). The resulting triflate 32 was treated with CrCl2 and 
a catalytic amount of NiCl2 in degassed DMF at 50 °C for 24 h to give the desired 
product 33 as a single stereoisomer in 69% yield, which was confirmed by X-ray 
crystal structure analysis as shown in Figure 16. 
 
  
Scheme 16: a) 2,6-Lutidine, Tf2O, CH2Cl2, –78 °C to r.t., 7 h, quant.; b) NiCl2 (10 mol%), CrCl2, 
3 Å MS, DMF, 50 °C, 24 h, 69%. 
 
To the best of our knowledge, this represents the first completely diastereoselective 
and intramolecular NHK coupling with a ketone. In order to further optimize these 
excellent results and reduce the required excess of chromium needed, we investigated 
some variations of the NHK reaction. 
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Figure 53: X-ray crystallographic analysis of the tricyclic intermediate 33. Red = O, grey = C, 
white = H. 
 
Fürstner and co-workers presented catalytic in chromium variation of the NHK 
reaction.215 The authors used manganese as reducing agent in the presence of less 
hygroscopic CrCl3 and TMSCl to cleave the formed chromium oxygen bond due to 
the stronger silyl-oxygen bonding properties. In order to reduce the high amount of 
Cr(II), which is toxic and relatively expensive, different reaction conditions were 
screened as shown in Table 3.216 
First, we tested if CrCl2 could be replaced by CrCl3 by addition of manganese 
(entries 1 and 2). Unfortunately, the obtained yields were not better than with CrCl2. 
Also the use of a CrCl2 and CrCl3 mixture did not improve the results (entry 3). 
Interestingly, by mixing a large excess of CrCl2 with manganese afforded lower yields 
compared to manganese free reaction conditions (entry 4). Furthermore, addition of 
TMSCl and LiCl in presence of catalytic amount of chromium sources did not 
improve the results (entries 5-7). 
In conclusion, the NHK reactions catalytic in chromium were not to be applicable 
to this specific example. However, first results demonstrate that CrCl3 serves as an 
alternative to CrCl2 in the presence of manganese.  
 
 
                                                
215  (a) A. Fürstner, N. Shi, J. Am. Chem. Soc. 1996, 118, 2533; (b) A. Fürstner, N. Shi, J. Am. Chem. 
Soc. 1996, 118, 12349.  
216  C. Daeppen, Master Thesis, Basel, 2012. 
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Table 3: Screening different reaction conditions for the NHK reaction. 
Entrya CrCl2  
(eq.) 
CrCl3  
(eq.) 
Mn  
(eq.) 
Additive  
(eq.) 
Yield of 
33 (%) 
1 - 2.3 1.5 - 28 
2 - 4.0 2.0 - 55 
3 3.0 1.0 - - 43 
4 10.0 - 2.0 - 31 
5 0.2 - 1.7 TMSCl, 2.4 0 
6 - 0.2 1.5 TMSCl, 1.3 12 
7 - 0.5 2.0 LiCl, 2.5 3 
a) All reaction were performed in DMF at 50 °C for 5 hours with 10 mol% of NiCl2. 
 
5.4.3.2 Shapiro Approach 
Although excellent results were obtained with the NHK approach, we wondered if 
we could circumvent the use of large amounts of chromium needed for the scale-up of 
the synthesis. An intriguing alternative approach would be an intramolecular Shapiro 
reaction to form the six-membered B ring. Shapiro reactions are typically used to 
couple tosylhydrazones and ketones under strongly basic conditions.217 However, 
these reactions are generally used for intermolecular coupling of rather 
unfuctionalized starting materials. Nevertheless, we expected that the corresponding 
hydrazone might be formed, which can eventually be used for the Shapiro reaction.  
Therefore, substrate 29 was treated with tosylhydrazine in ethanol at 50 °C for two 
days as shown in Scheme 17.212 The desired product 34 was obtained in relatively 
poor yield along with a crystalline side-product, which was characterized by X-ray 
crystal structure analysis as the tetracyclic diazo compound 35 (Figure 54). We 
assume that the formation of the 1-pyrazoline ring is derived from decomposition of 
tosylhydrazone at C-4 position to the corresponding diazoalkane, which then 
undergoes a 1,3-dipolar cycloaddition to the α,β-unsaturated lactone. Such 
intramolecular 1,3-dipolar cycloaddition reactions were first reported by Padwa in 
1980 by heating ω-alkenyltosylhydrazones in the presence of NaH to give 
1-pyrazolines. 218  Very recently, Valdés and co-workers reported on a one-pot 
                                                
217  R. H. Shapiro, M. F. Lipton, K. J. Kolonko, R. L. Buswell, L. A. Capuano, Tetrahedron  Lett. 1975, 
16, 1811.  
218  A. Padwa, H. Ku, J. Org. Chem. 1980, 45, 3756.	
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diastereoselective synthesis of bicyclic 1-pyrazolines under basic conditions.219 It is 
noteworthy, that the construction of such a tetracyclic ring system with three newly 
formed stereocenters using tosylhydrazone in a one-pot reaction is to the best of our 
knowledge unprecedented. 
 
 
Scheme 17: a) 4-Methylbenzenesulfonhydrazide, EtOH, 50 °C, 2 d, 38% for 34 and 15% for 35. 
 
 
Figure 54: X-ray crystallographic analysis of the tetracyclic side-product 35. Blue = nitrogen, 
red = O, grey = C, white = H. 
 
Despite the beauty of this new [5,5,5,5]-tetracyclic compound 35, it did not serve 
for the planed synthetic strategy. However, with hydrazone 34 in hand, we decided to 
examine the planned intramolecular Shapiro reaction. Unfortunately, treatment of 34 
with n-BuLi at –78 °C did not lead to the desired tricyclic intermediate 33 as only a 
complex mixture was obtained under these reaction conditions. Due to these results 
obtained with this strategy, we decided to consider another approach. 
 
 
                                                
219 R. Barroso, M. Escibano, M.-P. Cabal, C. Valdés, Eur. J. Org. Chem. 2014, DOI: 
10.1002/ejoc.201301587. 
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5.4.3.3 Vinyl bromide Approach 
As another alternative, we decided to study ring closure via vinyl bromide 36, 
which was obtained either by direct bromination of enol 29 using the 
Vilsmeier-Haack reagent220 or by treatment of vinyl triflate 32 with TBAB in a 
toluene/THF mixture as shown in Scheme 18.212 The desired product 36 was obtained 
under both reaction conditions in 42% and 51% yield, respectively.  
 
  
Scheme 18: For 29: a) DMF, oxalylbromide, CH2Cl2, 0 °c to r.t., 5 d, 42%; For 32: b) TBAB, 
toluene/THF (1:1), 50 °C to 60 °C, 24 h, 51%; c) n-BuLi, THF, –78 °C to r.t., 1 h, 26%. 
 
With 36 in hand, radical cyclization was tested using 2,2′-azobis(2-
methylpropionitrile) (AIBN) and tributyltin hydride in benzene at reflux. Surprisingly, 
no conversion could be observed under different reaction conditions and with careful 
exclusion of oxygen. Therefore, transmetallation with organo lithium reagent and 
subsequent cyclization was employed as an alternative. The reaction using 
n-butyllithium in THF at –78 °C gave the desired product 33 along with a multitude 
of side-products. Due to the insufficient yields for the formation of the vinyl bromide 
36 and for the cyclization step, we decided to pursue our synthetic strategy using the 
NHK coupling reaction as key step.  
 
5.4.4 Formation of the D Ring 
In accordance to our AàACàABC approach, we continued our efforts with the 
formation of the D ring moiety. Therefore, we intended to reduce the ester group to 
the corresponding primary alcohol, which should then be oxidized to the aldehyde 37. 
A variety of reduction conditions were tested for this purpose. The use of LiAlH4 
proved to be too harsh as several product were detected by crude NMR analysis, 
whereas reactions with NaBH4 in ethanol at 60 °C and superhydride (LiEt3BH) in 
THF at 0 °C selectively reduced the lactone part of the molecule while the 
                                                
220  A. Vilsmeier, A. Haack, Ber. Dtsch. Chem. Ges. 1927, 60, 119. 
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methylester remained untouched. However, reduction with borane dimethyl sulfide 
led to aldehyde 37 in 76% yield as shown in Scheme 19.212 Only traces of the 
corresponding alcohol could be isolated. We assume that the arrangement of the 
tertiary alcohol and the ester group might lead to a stable complex in the transition 
state with the borane, thus preventing further reduction to the alcohol. This reaction 
outcome is an advantage discovered by serendipity.  
 
 
Scheme 19: a) Borane dimethyl sulfide, THF, 0 °C to 45 °C, 2.5 h, 76%; b) KCN, THF/H2O (1:1), 
r.t., 2 d, 65%; c) PCC, CH2Cl2, r.t., 16 h, 83%; d) 2,6-lutidine, TMSOTf, CH2Cl2, 0 °C, 3 h, 99%; 
e) Et3N, imidazole, TESCl, CH2Cl2, 0 °C to r.t., 14 h, 77%. 
 
For the completion of the second γ-lactone, we planned to install the remaining 
C-11 carbon by cyanide addition followed by hydrolysis, leading to lactonization. 
Cyanidation with TMSCN and Et3N did not give the desired product. As an 
alternative, potassium cyanide was added to an aqueous THF solution of aldehyde 37. 
To our great delight, not the expected cyanohydrin could be isolated after completion 
of the reaction, but a different crystalline product was obtained. X-ray crystal 
structure analysis of the resulting product showed that the tetracyclic lactone 38 was 
formed (Figure 55, left). Astonishingly, the obtained product 38 suited our synthetic 
pathway and could be achieved in a single step from aldehyde 37 in 65% yield. 
To this point, the exact reaction mechanism is speculative, as no precedence can be 
found in literature for hydrolysis of cyanohydrins under neutral reaction conditions. 
We believe that the formation of the lactone moiety proceeds via nucleophilic attack 
of the neighboring C-4 hydroxy group to the cyanide to form the corresponding 
imine. As the reaction is conducted in aqueous organic solvent, hydrolysis of the 
imine leads the α-hydroxy lactone 38. Surprisingly, the product was obtained as a 
single diastereoisomer. The reason for this observation is still unclear and various 
reasons might be responsible. Diastereoselective nucleophilic attack of the cyanide 
moiety to the aldehyde would explain the stereochemical outcome, but it is rather 
implausible due to the complete selectivity. A more reasonable explanation would be, 
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that both cyanohydrins are formed by addition of potassium cyanide by kinetic control 
in equilibrium with the aldehyde 37, and only one of them can further react to the 
thermodynamic product 38. Isomerization of the hydroxyl group due to steric effects 
with the proximate C-15 methyl group is possible, but rather improbable due to the 
poor acidity at C-10 position. 
Lactone 37 was further oxidized to the α-keto lactone 39 with pyridinium 
chlorochromate in 83% yield to have the appropriate oxidation state at C-10 position, 
which was confirmed was X-ray crystal structure analysis (Figure 55, right).  
 
 
Figure 55: Left: X-ray crystallographic analysis of compounds 38 (left) and 39 (right). Red = O, 
grey = C, white = H. 
 
With the key intermediates in hand, we addressed the introduction of the remaining 
C-14 methyl group. Moreover, silyl-protected lactones 40 and 41 were also prepared 
as further possible substrates, since the presence of the hydroxyl group in 38 could be 
incompatible for this purpose. 
 
5.4.5  Methylation Efforts 
Our initial strategy involved the insertion of the C-14 methyl group via 
1,4-addition of a methyl cuprate reagent to the α,β-unsaturated lactone. However, all 
of the reaction condition studied with 33, 38, or 40 remained ineffective as shown in 
Table 4. The addition of TMSCl221 (entries 2, 4, 5, and 8) and the use of higher order 
                                                
221  A. Alexakis, J. Berlan, Y. Besace, Tetrahedron Lett. 1986, 27, 1047.  
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cyanocuprates222  (entries 6 and 10) did not promote conjugate addition of the 
cuprates. 
 
Table 4: Screening different reaction condition for insertion of the C-14 methyl group. 
 
Sampson and co-workers described a similar scenario and attributed the lack of 
reactivity to a competitive γ-deprotonation pathway, which affords an aromatic furan 
oxide rather than the conjugate addition.223 To overcome this side-reaction, the 
authors applied an efficient cyclopropanation/reduction protocol for introducing a 
methyl group at the 4-position of a 3,4-disubstituted 2(5H)-furanone via a 
Corey-Chaykovsky reaction followed by a Birch reduction. Identical reaction 
conditions as described in literature were applied to 33, 38, 40 and 41, however, no 
conversion could be observed in any case. In addition, epoxidation of the conjugated 
double bond with large excess of several epoxidating reagents only resulted in 
recovery of the starting material. Therefore, we concluded that steric interactions 
protect the β,β-disubstituted lactone to allow for reaction with active reagents. 
To prove our hypothesis, a less bulky model system was tested. The commercially 
available cyclic anhydride 42 was therefore reduced by NaBH4 in THF to give the 
known butenolide 43.224 The electronic properties of 43 should be comparable with 
our synthetic intermediates, though, lacking the bulky A ring and ester moieties. 
Various conjugate addition reactions were tested using organocopper reagents. In 
                                                
222 B. H. Lipshutz, Tetrahedron Lett. 1983, 24, 127.  
223  T. E. Janini, P. Sampson, J. Org. Chem. 1997, 62, 5069.  
224  D. Butina and F. Sondheimer, Synthesis 1980, 543. 
Entry Substrate Methyl source Copper Source Additive Solvent 
1 33 MeLi, 3.0 eq CuI, 1.5 eq - Et2O 
2 33 MeLi, 2.2 eq CuI, 1.1 eq TMSCl CH2Cl2 
3 38 MeLi, 2.4 eq CuI, 1.2 eq - Et2O 
4 38 MeLi, 2.4 eq CuI, 1.2 eq TMSCl CH2Cl2 
5 38 MeLi, 5.0 eq CuI, 2.5 eq TMSCl CH2Cl2 
6 38 MeLi, 5.0 eq CuCN, 5.5 eq n-Bu3P Et2O 
7 38 MeMgBr, 1.5 eq CuI, 4.0 eq - Et2O 
8 40 MeLi, 5.0 eq CuI, 2.5 eq TMSCl CH2Cl2 
9 40 MeLi, 3.0 eq CuI, 3.0 eq BF3 Et2O 
10 40 MeLi, 5.0 eq CuCN, 5.5 eq n-Bu3P Et2O 
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contrast to previous results (Table 4, entries 2, 4 and 8), Me2CuLi in the presence of 
TMS in CH2Cl2 afforded the desired methylated lactone 44 in 41% yield (Scheme 20). 
Reactions performed in Et2O as solvent did only result in recovery of unreacted 
starting material. Yamamoto and co-workers reported that the described reaction 
conditions are especially powerful for the methylation of sterically congested 
α,β-enoates.225 Facing a similar problem, we resolved to apply the described reaction 
conditions to our system. 
We decided reduce the steric bulk of our substrate, which mainly arises from the A 
ring. Thus, compound 33 was dehydrated under mild reaction conditions to diene 45, 
which was then further regioselectively hydrogenated to lactone 46 in 93% yield over 
both steps. Hydrogenation occurred exclusively from the less hindered face of the 
molecule, leaving the convex face completely free from bulky residues. 
 
  
Scheme 20: a) NaBH4, THF, 0 °C to r.t., 4 h, 75%; b) CuI, MeLi, TMSCl, CH2Cl2, –78 °C to r.t., 
14 h, 41%; c) Burgess reagent, THF, r.t., 3.5 h, 93%; d) Pd/C, H2 (5 bar), 45 min, r.t., quant.; 
e) CuI, MeLi, TMSCl, CH2Cl2, –78 °C to r.t., 16 h. 
 
X-ray crystal structure analysis of diene 45 showed that the convex face of the 
molecule is planar due to the conjugated diene moiety and should therefore not 
sterically influence conjugate addition reactions of organocuprates.  
 
                                                
225  N. Asao, S. Lee, Y. Yamamoto, Tetrahedron Lett. 2003, 44, 4265. 
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Figure 56: X-ray crystallographic analysis of diene 45. Red = O, grey = C, white = H. 
 
With 45 in hand, 1,4-addition reaction conditions were tested as shown in 
Table 5.216 Various methyl cuprates were prepared in situ and added to diene 45 under 
the described reaction conditions. The results were either complex mixtures (entries 2 
and 3) or double alkylation at the C-12 carbonyl position (entries 1, 4, and 5).  
 
Table 5: Screening for methylation of diene 45. 
 
Entry Conditions Observation 
1 3.0 eq. MeLi, 1.5 eq. CuI, –78 °C to r.t., Et2O Only 49 obtained 
2 3.0 eq. MeLi, 1.5 eq. CuI, –78 °C to r.t., THF Complex mixture 
3 1.5 eq. MeMgBr, 4.0 eq. CuI, 0 °C to r.t., Et2O Complex mixture 
4 2.0 eq. AlMe3, 0.2 eq. Cu(CO3CF3)2, –30 °C to r.t., toluene Only 49 obtained 
5 2.0 eq. AlMe3, 0.2 eq. Cu(CO3CF3)2, –30 °C to r.t., Et2O Only 49 obtained 
 
Corey-Chaykovsky cyclopropanation of 45 could serve as an alternative reaction 
pathway. Even though full conversion was obtained using the same conditions as 
applied by Janini et al.,223 cyclopropanation only occurred between C-3 and C-4, 
leaving the tetrasubstituted double bond untouched. 
Since diene 45 was not electrophilic enough at C-5 position, we continued our 
studies with the hydrogenated lactone 46. Same reaction conditions as described by 
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Asao et al.225 were applied to 46. However, no conversion of the starting material was 
observed and 46 was recovered after the work-up.  
In summary, the introduction of the methyl group proved not to be applicable to 
our substrate scope. As all attempts to introduce it via conjugate addition or 
cyclopropanation and subsequent Birch reduction failed, we considered alternative 
strategies for the completion of the natural product. 
 
5.4.6 Alternative Cyclization Efforts 
5.4.6.1 Paternò-Büchi Cycloaddition 
Since conjugate addition and other reactions were ineffective with the 
α,β-unsaturated lactone, we opted for introducing the remaining methyl group before 
construction of the B ring. Thus, vinyltriflate 32 was an ideal starting material for this 
purpose. Fürstner and co-workers demonstrated that inexpensive and readily available 
iron salts could serve as excellent precatalysts for the cross-coupling of Grignard 
reagents with alkenyl triflates.226 Following this protocol, β-methyl lactone 50 was 
obtained in excellent 96% yield as shown in Scheme 21.216  
 
  
Scheme 21: a) MeMgBr, Fe(acac)3, NMP, THF, –30 °C, 1 h, 96%; b) hv (300 nm), benzene, r.t., 3 h, 
19% for 51 and 14% for 52. 
 
With 50 in hand, the formation of the C-4-C-5 bond was studied. The 
Paternò-Büchi reaction was chosen as a potential pathway for this purpose.227 
Intramolecular Paternò-Büchi photoaddition reactions between α,β-unsaturated 
carbonyl and ketone moieties have been used for the formation of oxetanes.228 
Therefore, we were optimistic that the desired carbon-carbon bond could be formed 
by this approach. 
                                                
226  B. Scheiper, M. Bonnekessel, H. Krause, A. Fürstner, J. Org. Chem. 2004,  69, 3943.  
227  G. Büchi, C. G. Inman, E. S. Lipinsky, J. Am. Chem. Soc. 1954, 76, 4327. 
228  J. Iriondo-Alberdi, J. E. Perea-Buceta, M. F. Greaney, Org. Lett. 2005, 7,  3969.	
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The reaction was performed under inert conditions with degassed benzene in a 
Rayonet® UV-reactor and 50 was irradiated for 3 hours at 300 nm wavelength. Two 
cyclized products were isolated after purification by flash chromatography. The 
structure of the major product was determined by X-ray crystallographic analysis. 
Unfortunately, the undesired regioisomer was obtained, after bond formation between 
C-4 and C-6. Surprisingly, the methyl group at C-1 and the ester group at C-9 position 
were trans configured. We assume that this cis to trans isomerization occurs via an 
α-cleavage induced by a Norrish type I reaction.229 Norrish type I and II are known 
side-reactions in Paternò-Büchi cycloaddition reactions. A possible reaction 
mechanism is shown in Scheme 22. α-Cleavage in the excited state of 50 leads to the 
acyl-alkyl diradical species 53. Due to the formation of this diradical intermediate, 
radical recombination can lead to the isomerized compound 54. Paternò-Büchi 
reaction of both 50 and 54 gives the corresponding oxetanes 52 and 51, respectively. 
 
 
Scheme 22: Isomerization mechanism and Paternò-Büchi reaction. 
 
Although we could not verify the structure of the minor product by X-ray 
crystallographic analysis, we are confident that oxetane 52 was formed based on 
intense NMR studies. These results imply that the desired endo-oxetane cannot be 
formed under Paternò-Büchi conditions. Therefore, we continued our efforts towards 
another cyclization method. 
 
 
                                                
229  T. Laue, A. Plagens, Named Organic Reactions, 2nd Ed., John Wiley & Sons  Ltd., West Sussex 
England, 2005.  
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5.4.6.2 Heck Coupling 
Alternatively, we examined an intramolecular Heck coupling reaction for the 
formation of the B ring. Therefore, ketone 50 was modified to the corresponding enol 
triflate 55 in 34% yield as shown in Scheme 23. The reaction conditions for this 
transformation were not further optimized. 
 
 
Scheme 23: a) LiHMDS, N-phenylbis(trifluoromethanesulfonimide), THF, –20 °C to 0 °C, 3.5 h, 
34%; b) Pd(OAc)2, TBAC, NaHCO3, DMF, 50 °C, 3 d. 
 
With triflate 55 in hand, we decided to use Jeffery conditions for the Heck 
reaction.230 This protocol is especially advantageous as it accelerates the rate of the 
reaction to the extent that lower reaction temperatures are possible by using a 
combination of tetraalkylammonium salts (phase transfer catalysts) and insoluble 
bases. However, Heck reaction of 55 showed no conversion to the desired alkene 56. 
NMR analyses of the major products suggest that the mechanism follows first a 
5-exo-trig instead of a 6-endo-trig cyclization. This intermediate can then further react 
via a cascade 3-exo-trig reaction and/or β-hydride elimination. We abandoned this 
approach due the observed undesired regioselectivity of the Heck coupling with this 
substrate and turned our attention to another approach. 
 
5.4.6.3 SmI2 Approach 
Ketone-alkene coupling reactions using samarium(II) diiodide have been shown to 
be incredibly useful in synthetic chemistry. Samarium-induced reduction of ketones 
gives rise to ketyl radicals, which may be coupled to a variety of alkenic species. 
Furthermore, excellent diastereoselectivities can be achieved with intramolecular 
coupling of ketyl radical with α,β-unsaturated esters.231  
                                                
230  T. Jeffery, Tetrahedron, 1996, 52, 10113. 
231  (a) S. Fukuzawa, M. Iida, A. Nakanishi, T. Fujinami, S. Sakai, J. Chem. Soc., Chem. Commun. 
1987, 920; (b) S. Fukuzawa, A. Nakanishi, T. Fujinami, S. Sakai, J. Chem. Soc., Perkin Trans. 1 
1988, 1669; (c) E. J. Enholm, A. Trivellas, Tetrahedron Lett. 1989, 30, 1063; (d) E. J. Enholm, H. 
Satici, A. Trivellas, J. Org. Chem. 1989, 54, 5841. 
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Thus, radical carbon-carbon bond formation between C-4 and C-5 of the pre-
methylated lactone 50 was investigated next. According to Baldwin rules, both 5-exo-
trig and 6-endo-trig-type cyclizations are favored in this case.232 However, in our case 
a 6-endo-trig cyclization is expected to be dominating due to the stability of the 
resulting conjugated α-carbonyl radical intermediate. Therefore, different reaction 
condition were applied to ketone 50 using SmI2 as shown in Table 6. Reaction with 
the reagent in THF without any further additives led mostly to the formation of an 
unidentified side-product at 0 °C as well as at reflux (entries 1 and 2). Despite HMPA 
is known to effectively promote intramolecular coupling of inactivated alkenic 
ketones,233 no reaction could be observed with HMPA as shown in entry 3. Also the 
addition of protic additives such as MeOH and t-BuOH did not lead to the formation 
of the desired product 57 (entries 4, 6 and 7). Some reactions of SmI2 can be 
efficiently accelerated by the addition of catalytic amount of NiI2.234 However, this 
did not lead to lactone 57 in our case (entry 5). 
 
Table 6: Different reaction conditions for SmI2-induced radical cyclization of 50. 
 
Entry Conditions Observation 
1 3 eq. SmI2, THF, 0 °C to r.t., 1 h Mostly side-product isolated 
2 3 eq. SmI2, THF, 0 °C to 75 °C, 1 h Mostly side-product isolated 
3 3 eq. SmI2, 4 eq. HMPA, THF, 0 °C to r.t., 2 h Starting material recovered 
4 3 eq. SmI2, 10 eq. MeOH, THF, 0 °C to r.t., 4 h Mostly side-product isolated 
5 3 eq. SmI2, 1 eq. NiI2, THF, 0 °C to r.t., 3 h Mostly side-product isolated 
6 4 eq. SmI2, 2 eq. MeOH, THF, r.t. to 75 °C, 40 min Mostly side-product isolateda 
7 3 eq. SmI2, 2 eq. t-BuOH, THF, –78 °C to r.t., 5 h Mostly side-product isolateda 
a Also reduced ketone isolated. 
 
Since the intramolecular SmI2 cyclization did not lead to the expected tricyclic 
intermediate 57, other cyclization methods were more promising.  
 
                                                
232  J. E. Baldwin, J. Chem. Soc., Chem. Commun. 1976, 734. 
233 G. A. Molander, J. A. McKie, J. Org. Chem. 1992, 57, 3132.  
234  F. Machrouhi, B. Hamann, J.-L. Namy, H. B. Kagan, Synlett 1996, 633.	
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5.4.6.4 Further Cyclization Efforts 
As already mentioned in section 5.4.3.2, we envisioned that ring closure might be 
achieved via an intramolecular Shapiro reaction. The required hydrazone was formed 
at C-4 position of the pre-methylated ketone 50 as shown in Scheme 24. The reaction 
was performed in ethanol at room temperature and the desired tosylhydrazone 58 was 
obtained in 50% yield.  
With 58 in hand, the Shapiro reaction was performed by addition of n-BuLi in 
hexane at –78 °C. However, no conversion was observed under the describe reaction 
conditions and starting material was recovered. We assume that the low solubility of 
the starting material in hexane contributed to this effect. However, further addition of 
TMEDA did not lead to any observable conversion. 
 
 
Scheme 24: a) 4-Methylbenzenesulfonhydrazide, 1 M HCl, EtOH, r.t., 25 h, 50%; b) n-BuLi, 
TMEDA, hexane, –78 °C to r.t., 17 h; c) NiCl2 (10 mol%), CrCl2, 3 Å MS, DMF, 100 °C, 4 h. 
 
Inspired by our previous results with the NHK reaction, we wondered if this 
approach would allow the B ring formation with the methylated precursor 50. In 
contrast to the non-methylated substrate 32, no conversion was observed under the 
established reaction conditions even at 100 °C.  
Attempts to convert ketone 50 into the corresponding vinyl bromide or iodide, 
which could then be further used for Barbier-type cyclizations remained inefficient. 
Since all performed reaction with pre-methylated intermediates showed either 
undesired regioselectivity or no reactivity at all, we decided to pursue a radical change 
in the approach by modification of the A ring.  
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5.4.7 Hydroxyl-Directed Cyclopropanation Approach 
As an alternative to the Corey-Chaykovsky reaction, a directed cyclopropanation 
was studied. A variety of stereoselective cyclopropanation reactions have been 
intensively investigated over the last decades.235 For our purpose, we were especially 
interested in hydroxyl-directed variations of this reaction type. Therefore, the 
configuration of the tertiary hydroxyl group of the tricyclic intermediate 33 needed to 
be inverted. Diene 45 was epoxidized with m-CPBA to give compound 60 in 90% 
yield as shown in Scheme 25. The stereoselective outcome of the reaction was 
confirmed by X-ray crystal structure analysis of 60.  
Next, reduction of epoxide 60 to alcohol 61 was attempted. However, reactions 
with lithium aluminum hydride and L-selectride did not lead to the desired product 
but resulted in complex mixtures after work-up. 
 
 
Scheme 25: a) m-CPBA, CH2Cl2, 0 °C to r.t., 3 d, 90%; b) L-selectride, THF, r.t., 2.5 h; c) lithium 
aluminium hydride, THF, r.t., 1 h. 
 
Next, we investigated bismuth(III) chloride mediated epoxide opening reactions,236 
but no desired product was observed after completion of the reaction. Since the 
introduction of the hydroxy group proved to be more problematic than expected, we 
decided to head for the dihydroxylated lactone 62.  
Dihydroxylation was performed with catalytic OsO4 and NMO as co-oxidant in a 
t-BuOH/water mixture. The desired diol 62 was obtained in 84% yield in a 
diastereomeric ratio of 10:1 as shown in Scheme 26. To verify the configuration of 
the formed diol moiety, 62 was further protected to acetal 63, which was obtained as a 
crystalline compound. X-ray crystal structure analysis confirmed our assumption that 
dihydroxylation occurs from sterically less hindered bottom face. 
In order to overcome possible coordinative effects of the secondary hydroxyl 
group, diol 62 was protected as the corresponding silyl ether and 64 was isolated in 
                                                
235  For review on stereoselective cyclopropanation reactions, see: H. Lebel, J.-F. Marcoux, C. 
Molinaro, A. B. Charette, Chem. Rev. 2003, 103,  977.  
236  R. M. A. Pinto, J. A. R. Salvador, C. L. Roux, Tetrahedron 2007, 63, 9221.	
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68% yield. The allylic alcohol moiety was believed to be the perfect directing group 
for cyclopropanation reactions on the α,β-unsaturated lactone. 
 
 
Scheme 26: a) OsO4 (5 mol%), NMO, t-BuOH/H2O (3:1), 0 °C to r.t., 3 d, 84%, d.r. = 10:1; 
b) 2-methoxypropene, p-TSA, THF, r.t., 14 h, 71%; c) TBSOTf, 2,6-lutidine, 0 °C to r.t., 4 h, 68%. 
 
Cyclopropanation of the allylic alcohol 64 was investigated under a variety of 
reaction conditions as shown in Table 7.216 Initial results with the Nishimura 
variation237 of the Simmons-Smith reaction led to recovery of the stating material or 
deprotection (entries 1 and 2). Further experiments with more reactive 
chloroiodomethane238 and different solvents only yielded in the unprotected diol 62 
(entries 3 and 4). 
The use of samarium/mercury 239  and chromium 240  in conjugation with 
diidomethane or chloroiodomethane to initiate cyclopropanation did not form 
isolatable amounts of product 65 (entries 5-7). Moreover, the treatment of 
trialkylaluminium with chloroiodomethane241 in the presence of 64 was investigated. 
However, the reaction did not afford any cyclopropane 65 (entry 8). 
Since none of the reactions described in Table 7 formed any measurable amount of 
cyclopropanated product 65, we chose to modify the starting material 64.   
                                                
237  J. Furukawa, R. Kawabata, J. Nishimura, Tetrahedron Lett. 1966, 28, 3353.  
238  S. E. Denmark, J. P.  Edwards, J. Org. Chem. 1991, 56, 6974.  
239  G. A. Molander, L. S. Harring, J. Org. Chem. 1989, 54, 3525. 
240  J. M. Concellón, H. Rodríguez-Solla, C. Méjica, E. G. Blanco, Org. Lett. 2007, 9, 2981. 
241  D. B. Miller, Tetrahedron Lett. 1964, 989.	
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Table 7: Directed cyclopropanation efforts of 64. 
 
Entry Conditions Observation 
1 5 eq. Zn(CH2CH3)2, 10 eq. CH2I2, CH2Cl2, –15 °C to r.t. No conversion 
2 10 eq. Zn(CH2CH3)2, 10 eq. CH2I2, DCE, –27 °C to r.t. Deprotection 
3 10 eq. Zn(CH2CH3)2, 10 eq. CH2ICl, CH2Cl2, –15 °C to r.t. Deprotection 
4 5 eq. Zn(CH2CH3)2, 10 eq. CH2ICl, THF, –15 °C to r.t. Deprotection 
5 4 eq. CrCl2, 4 eq. CH2ICl, THF, 83 °C No conversion 
6 4 eq. Sm, 0.4 eq. HgCl2, 4 eq. CH2I2, THF, –78 °C to r.t. No conversion 
7 4 eq. Sm, 0.4 eq. HgCl2, 4 eq. CH2ICl, THF, –78 °C to r.t. No conversion 
8 1 eq. AlMe3, 1 eq. CH2ICl, THF, 0 °C No conversion 
 
We assumed that the lacking reactivity might either be attributed to steric 
hindrance of the allylic alcohol moiety or to aromatization of the γ-lactone ring under 
the reaction conditions.  
To address the second scenario, lactone 64 was reduced to the sensitive lactol 66 in 
quantitative yield as shown in Scheme 27.216 The product was obtained in a 
diastereomeric ration of 1:1.6 and subsequently cyclopropanated following the 
Nishimura protocol.237 However, the anticipated product 67 could not be isolated and 
only decomposition of the starting material was observed under the reaction 
conditions. 
Due to the instability of the lactol moiety, 66 was etherificated with methanol to 
give the stable acetal 68 in 67% yield. Unfortunately, acetal 68 also proved to be 
unstable under cyclopropanation conditions and a variety of side-products were 
obtained after completion of the reaction without formation of 69.  
 
 
Scheme 27: a) DIBAL-H, CH2Cl2, –78 °C to r.t., 3 h, quant., d.r. = 1.6:1; b) MeOH, p-TSA 
monohydrate, r.t., 15 h, 67%; c) diethylzinc, CH2Cl2, –15 °C to r.t., CH2ICl, 3 h; d) diethylzinc, 
CH2Cl2, –15 °C to r.t., CH2I2, 5 h. 
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As no evidence for a successful cyclopropanation reaction could be observed, we 
decided to look for a different strategy for the introduction of the methyl group. 
 
5.4.8 Oxidative A Ring Opening 
As described in the previous section, we assumed that the lacking reactivity of the 
α,β-unsaturated lactone might be derived from steric hindrance of the A ring moiety. 
Therefore, the σ-bond between C-3 and C-4 of the diol 62 was oxidatively cleaved in 
the presence of sodium periodate to give ketoaldehyde 70 in quantitative yield after 
simple work-up as shown in Scheme 28. Aldehyde 70 proved to be somewhat 
unstable, for which reason it was protected either as the corresponding acetal 71 or 
1,3-dithiolane 72.  
While the acetal moiety in 71 was envisioned solely as a protecting group to 
prevent decomposition of the starting material, dithiolane groups may serve as 
reactive intermediates for further umpolung reactions242 in a later re-closure of the A 
ring. However, the initial goal was the introduction of the required methyl group. 
Cyclopropanation reactions of α,β-unsaturated ketoester by a Corey-Chaykovsky 
reaction have been described in literature.243 Hence, both protected aldehydes 71 and 
72 were treated under the same reaction conditions. However, cyclopropanation to 
product 73 or 74 was not observed after completion of the reaction as both substrates 
proved not to be stable under the applied reaction conditions.  
 
 
Scheme 28: a) NaIO4, THF/H2O (2:1), r.t., 1 h, quant.; b) 1,2-ethanedithiol, BF3·Et2O, CH2Cl2, r.t., 
20 min, 54%; c) ethylene glycol, p-TSA monohydrate, 3 Å MS, benzene, 90 °C, 6 h, 83%; 
d) trimethylsulfoxonium iodide, NaH, DMSO, r.t., 3 h. 
 
Since introduction of the methyl group via nucleophilic attack of the 
α,β-unsaturated carbonyl moiety was inefficient, it was decided to alter the strategic 
perception.  
                                                
242  D. Seebach, E. J. Corey, J. Org. Chem. 1975, 40, 1975.  
243  P. H. Lee, B. Lee, J. Lee, S. K. Park, Tetrahedron Lett. 1999, 40, 3427.	
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In order to alter the electronic properties at C-5 position, we chose to reduce the 
carbon-carbon double bond while having a carbonyl group at C-4 position. This 
would introduce the desired nucleophilic properties for the trapping of methylating 
agents. Thus, diol 62 was hydrogenated to the corresponding lactone 75 (Scheme 29). 
Reactions with Pd/C and Pd(OH)2 as catalyst (EtOH, 60 bar H2, 2.5 h, r.t.) resulted in 
complex mixtures, whereas the Crabtree catalyst244 (CH2Cl2, 2.5 h, 60 bar H2) showed 
no reactivity. Reduction with NaBH4/NiCl2245 led to the desired product 75. However, 
the reaction did not reach full conversion even with large excess of reagent. Finally, 
best results were obtained with Rh/C/Al2O3-catalyst at 60 bar hydrogen pressure in 
EtOAc. Compound 75 was isolated in quantitative yield after a short filtration of the 
crude reaction mixture over celite. The desired product 75 was obtained as a single 
diastereoisomer, which was confirmed by X-ray crystal structure analysis. 
Diol 75 was further oxidized to keto aldehyde 76 using sodium periodate in 
quantitative yield. Slow decomposition of the resulting aldehyde was observed over 
time. NMR and LC-MS analyses indicated that side-product 77 was formed via 
intramolecular aldol reaction. In order to prevent this side-reaction, aldehyde 76 was 
protected as the corresponding acetal 78 or 1,3-dithiolane 79.  
 
    
Scheme 29: a) Rh/C/Al2O3 (10 mol%), H2 (60 bar), EtOAc, r.t., 3 h, quant.; b) NaIO4, THF/H2O 
(2:1), r.t., 1.5 h, quant.; c) 1,2-ethanedithiol, BF3·Et2O, CH2Cl2, r.t., 1 h, 56%; d) ethylene glycol, 
p-TSA monohydrate, benzene, 90 °C, 2 h, quant. 
 
                                                
244  R. Crabtree, Acc. Chem. Res. 1979, 12, 331. 
245  N. Abe, F. Fujisaki, K. Sumoto, S. Miyano, Chem. Pharm. Bull. 1991, 39, 1167.	
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5.4.9 Successful Methyl Insertion 
Having installed ketone functionality at C-4 position, we envisaged inserting the 
methyl group to the α-position. The formation of the aldol decomposition product 77 
implies that the C-5 position possesses the desired nucleophilic properties for this 
purpose.  
 Initially, we planed to use iodomethane as the electrophilic partner for this 
accomplishment. Various bases such as DBU and LDA were tested with 78 and 79 for 
this purpose. However, basic conditions resulted in opening of the lactone ring upon 
deprotonation of the α-hydrogen. As a result, complex mixtures were obtained after 
reaction completion in accordance with literature on similar substrates. 246 
Furthermore, amine catalyzed methylation was attempted, however, decomposition of 
starting material was observed.  
Since direct methylation did not yield the desired product due to decomposition 
under basic and deprotection under acidic conditions, we decided to search for a more 
reactive electrophilic species.  
Inspired by the formation of the intramolecular side-product 77, 
α-hydroxymethylation of 78 using formaldehyde was tested next. The results of the 
extensive screening are summarized in Table 8.247 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
246  J. López-Pérez, E. del Olmo, B. de Pascual-Teresa, M. Merino, S. Martín, A. San Feliciano, 
Tetrahedron 1995, 51, 6343. 
247  A. Heikinheimo, Master Thesis, Aalto, 2012. 
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Table 8: Screening of hydroxymethylation conditions for the formation of 80. 
 
 
 
 
a Reaction performed in a sealed pressure tube. 
 
Entry Reagent Additive Solvent Temperature Time Observation 
1 Formaline (2 eq.) KHCO3 THF r.t. 3 d Decomposition 
2 Formaline (270 eq.) p-TSA THF r.t. 2 d Traces of 77  
3 Formaline (260 eq.) - THF r.t. 2 d No conversion 
4 Formaline (230 eq.) - THF 60 °C 4 h No conversion 
5 Formaline (230 eq.) - THF 70 °C 3 d 
40% 80,  
50% 78 
6 Formaline (130 eq.) - THF 70 °C 3 d 
Only 78 
observed 
7a Formaline (150 eq.) - THF 100 °C 2 d 
Complex 
mixture 
8a Formaline (150 eq.) - THF 120 °C 21 h 
Complex 
mixture 
9 Formaline (100 eq.) - THF 70 °C 3 d No conversion 
10a 
Paraformaldehyde 
(20 eq.) 
- THF 70 °C 3 d No conversion 
11 Formaline (84 eq.) - THF 70 °C 4 d 
Only 78 
observed 
12a 
Paraformaldehyde 
(50 eq.) 
- THF 160 °C 18 h 
Complex 
mixture 
13a 
Paraformaldehyde 
(170 eq.) 
AlCl3 THF 160 °C 18 h 
Complex 
mixture 
14 Formaline (220 eq.) - THF 70 °C 12 d 
Only 78 
observed 
15 Formaline (230 eq.) - 
THF  
 pH 6 
70 °C 3 d 92% 80 
16 Formaline (230 eq.) - 
THF  
pH 7 
70 °C 3 d 
Complex 
mixture 
17 Formaline (230 eq.) - 
THF  
pH 8 
70 °C 3 d 
Complex 
mixture 
18 Formaline (230 eq.) - 
THF  
pH 6 
40 °C 14 h 94% 80 
O
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The use of a weak base such as KHCO3 resulted in nearly complete decomposition 
of the starting material, underlining the poor tolerance of 78 towards basic conditions 
(entry 1). On the other hand, addition of catalytic amount of p-TSA led to slow 
conversion to several products along with side-product 77 (entry 2). Reactions 
without addition of further reaction partners were performed with formaline as co-
solvent. However, no conversion could be detected at room temperature and raising 
the temperature to 60 °C for four hours (entries 3 and 4). A exceptional discovery 
was, that reactions performed at 70 °C for three days proved to deliver the desired 
hydroxymethylated product 80 in 40% yield along with 50% unreacted starting 
material (entry 5).  
A variety of different conditions were tested to further improve the results 
(entries 6-14). Conditions free of water were investigated by using solid 
paraformaldehyde in dry THF and high temperatures (entries 10, 12 and 13). 
However, omission of water led to either to recovery of the starting material or 
complex mixtures. By careful analysis of the performed reactions, we found out that 
the pH of the reaction mixture slightly dropped after prolonged reaction time and the 
longer reactions were carried out, the more side-product 77 was obtained.  
In order to avoid the increase of acidity of the reaction mixture, a variety of 
aqueous buffer solutions were prepared from citric acid and sodium biphosphate. 
Thus, hydroxymethylation was performed by addition of different buffer solutions. 
Reactions over three days in buffers of pH 7 and 8 resulted in complex mixtures 
(entries 16 and 17). Delightfully, at pH 6 and stirring at 70 °C over three days gave 
the desired product 80 in excellent yield as a single diastereoisomer (entry 15). After 
further optimization efforts, the reaction was found to proceed in nearly full 
conversion at 40 °C over night giving the hydroxymethylated product 80 in 94% yield 
(entry 18). The pH was found to be crucial for this reaction to proceed.  
The stereochemical outcome of the reaction was verified by 2D-NMR studies. 
Hydroxymethylation was expected to be stereospecific due to the formation of the 
thermodynamically favorable cis-fused bicyclic ring system.248  
For the deoxygenation of 80, we considered the Barton-McCombie reaction to be 
suitable for this purpose.249  This reaction sequence begins with the formation of a 
                                                
248  D. A. Lightner, J. E. Gurst, Organic Conformational Analysis and Stereochemistry from Circular 
Dichroism Spectroscopy; Wiley-VCH: New York, 2000, 173. 
249  D. H. R. Barton, S. W.  McCombie, J. Chem. Soc., Perk. Trans. 1 1975, 1574.	
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xanthate or oxothiocarbonly from the corresponding alcohol. Radical cleavage of the 
inserted thiocarbonyl moiety by a trialkyl tin radical is subsequently initiated by 
AIBN to form an alkyl radical, which can then be reduced by a tinhydride reagent.250 
This protocol has been widely used for an impressive range of total syntheses due to 
its large tolerance towards various functional groups. 
In order to test this reaction, thiocarbonyl and xanthate formation were attempted 
on alcohol 80. However, neither of them could be formed under any reaction 
condition studied and only starting material was recovered in each case. The lacking 
reactivity might be attributed to steric hindrance of the neopentyl alcohol moiety. 
More reactive thiocarbonyl reagents, such as pentafluoro- or trichlorophenoxy 
thiocabonyls,251 were not investigated for this purpose. 
An alternative sequence would include halogenation of the alcohol and subsequent 
radical dehalogenation to form the desired intermediate. Halogenation under standard 
Appel conditions252 using CCl4 in combination with PPh3 resulted in no conversion 
and complete recovery of the starting material. Due to the relatively wide scope 
described for the PPh3/CCl3CN reagent couple, 253  this protocol was tested on 
hydroxymethylated substrate 80. Indeed, chlorinated product 81 was isolated in 85% 
yield with only traces of side-products present in the crude material (Scheme 30).  
Radical dehalogenation of 81 was initially attempted with n-Bu3SnH and catalytic 
amounts of AIBN under oxygen-free conditions, however, no conversion was 
observed. Nonetheless, changing to Ph3SnH under the same reaction conditions gave 
82 in 16% yield. We assume that Ph3SnH is more suitable for this reaction due to the 
reduced steric bulk compared to the tributyl derivative. To improve the yield of the 
dehalogenation step, it was decided to introduce the more reactive iodide instead of 
the chloride moiety. 
Iodination was achieved in 75% yield from the starting substrate 80. Radical 
dehalogenation of iodide 83 with n-Bu3SnH gave the methylated product 82 in 84% 
yield. The reaction gave a second product, which was identified as ring-expanded 
                                                
250  For mechanistic studies on Barton-McCombie reactions, see: (a) D. H. R. Barton, D. Crich, A. 
Löbberding, S. Z.  Zard, Tetrahedron 1986, 42, 2329; (b) D. Crich, Tetrahedron Lett. 1988, 29, 
5805.  
251  D. H. R. Barton, J. C. Jaszberenyi, A. I. Morrell, Tetrahedron Lett. 1991, 32, 311. 
252  R. Appel, Angew. Chem. Int. Ed. 1975, 14, 801. 
253  E. D. Matveeva, A. I. Yalovskaya, I. A. Cherepanov, Y. G. Bundel, A. L. Kurts, Zh. Org. Khim. 
1991, 27, 1611.	
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7,5-bicyclic product 84 (Figure 57). This product is formed via a Beckwith-Dowd-
type rearrangement after initial primary radical formation.254 Attempts to suppress this 
side-reaction by excessive addition of tin hydride reagent were not effective giving 
the same ration of 82:84 due to kinetic reaction control.   
 
 
Scheme 30: a) PPh3, trichloroacetonitrile, MeCN, 85 °C, 16 h, 82%; b) Ph3SnH, AIBN, benzene, 
85 °C, 22 h, 16%; c) PPh3, imidazole, I2, benzene, r.t., 12 h, 75%; d) n-Bu3SnH, AIBN, benzene, 
85 °C, 3 h, 84% and 16% 84. 
 
 
Figure 57: X-ray crystallographic analysis 84. Red = O, grey = C, white = H. 
 
In summary, the methyl group was successfully introduced in a stereoselective 
manner after numerous approaches. 
 
                                                
254  (a) A. L. J. Beckwith D. M. O’Shea, S. W. Westwood, J. Am. Chem. Soc. 1988, 110, 2565; (b) P. 
Dowd, S.-C. Choi, J. Am. Chem. Soc. 1987, 109, 3493. 
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5.4.10 Reclosure of the A Ring 
Having introduced the C-14 methyl group, we turned our focus on reclosure of the 
A ring. First, acetal deprotection was carried out in acidified aqueous acetone and 
aldehyde 85 was isolated after extraction in quantitative yield without the need for 
further purification (Scheme 31).   
The shortest route to provide the desired tricyclic alkene 48 would be a McMurry 
coupling of the aldehyde and ketone moieties.255 This reaction is characterized by 
coordination of both carbonyl oxygens to low-valent titanium and subsequent C-C 
bond formation. Reduction of this intermediate gives then the olefinic product. 
Therefore, titanium chloride is typically combined with a reducing agent such as zinc. 
Treatment of aldehyde 85 under McMurry conditions gave a single product. 
Surprisingly, it was not the expected alkene 48, but β-keto ester 86. Further studies on 
this reaction showed that aldehyde 85 undergoes fast retro-Michael addition upon 
addition of a Lewis acid and is therefore not suitable for McMurry coupling reactions. 
 
 
Scheme 31: a) 1 M HCl, acetone, r.t., 14 h, quant.; b) TiCl4, Zn, DME, 90 °C, 3 h; 
c) 88, hexafluoro-2-propanol, r.t., 16 h, 85%; d) PPh3, imidazole, I2, r.t., 16 h, 95%. 
 
Sodium borohydride reduction of 85 to alcohol 87 at –78 °C in a CH2Cl2/ethanol 
mixture gave not very robust results ranging from 97% to 0% yield. Toshima and 
co-workers recently described the preparation of a chemoselective reducing agent 
under especially mild conditions.256 Sodium tris(hexafluoroisoproopoxy)borohydride 
(88), can be easily synthesized from sodium borohydride and hexafluoro-2-propanol 
and showed smooth reduction of aldehydes in presence of ketones in excellent yields 
                                                
255  (a) J. E. McMurry, Acc. Chem. Res. 1974, 7, 281; (b) J. E. McMurry, Chem. Rev. 1989, 89, 1513.	
  
256  Y. Kuroiwa, S. Matsumura, K. Toshima, Synlett 2008, 16, 2523. 
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at room temperature. Reduction of 85 following this protocol gave alcohol 87 in 85% 
yield and with excellent reproducibility. Intermediate 87 was subsequently iodinated 
to 89 using Appel conditions. Iodinated product 89 was isolated in 95% yield as a 
crystalline substance. X-ray crystal structure analysis finally proved the desired 
configuration of the methyl group at C-5 position as shown in Figure 58. 
 
 
Figure 58: X-ray crystallographic analysis of iodide 89. Red = O, grey = C, purple = I, white = H. 
 
Having iodide 89 in hand, we turned our attention towards the critical reclosure of 
the A ring. Different reaction mechanisms are feasible for this transformation. A 
variety of different reaction conditions are summarized in Table 9. First, we envisaged 
using a Barbier-type cyclization for this purpose. Therefore, iodide 89 was treated 
with t-BuLi and n-BuLi at –78 °C in THF for 20 min before quenching of the reaction 
(entries 1 and 2). However, mostly complex mixtures were obtained after reaction 
completion. Addition of an organolithium reagent proved to be extremely reactive, 
even at –78 °C. Nevertheless, minor amounts of 57 could be isolated in the t-BuLi 
promoted reaction.  
An alternative approach by a radical cyclization was examined as this method 
allows higher chemoselectivity for the ketone moiety as the organolithium approach. 
A variety of radical initiators have been studied for this purpose. First, we 
investigated the Et3B/O2 induced reaction, as this would provide a mild and tin-free 
approach.257 Thus, a 1 M Et3B solution was added to iodide 88 dissolved in toluene 
and oxygen was passed through the reaction mixture for one hour at 0 °C (entry 3). 
                                                
257  For review on organoboranes as source of radicals, see: C. Ollivier, P. Renaud, Chem. Rev. 2001, 
101, 3415. 
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Even though some traces of 57 were formed during the reaction, most of the starting 
material remained unreacted after extended reaction period.  
SmI2-mediated cyclization reactions have been demonstrated to efficiently promote 
formation of medium-sized rings.258  Addition of SmI2 to iodide 89 led to the 
formation of a complex mixture, while no conversion of the starting was observed 
with NiI2 as further additive (entries 4 and 5). Gratifyingly, addition of HMPA 
provided the compound 57 in remarkable 76% yield (entry 6). The product was 
isolated as a single diastereoisomers due to the formation of the thermodynamically 
favorable cis-fused bicyclic 6,5 ring system. As a side-reaction of this transformation, 
radical decomposition of 89 to 86 and monomethyl cyclopropane was observed. 
Though, a mild and efficient cyclization method for the formation of 57 could be 
established. 
 
Table 9: Different reaction conditions for the cyclization and reclosure of the A ring. 
 
Entry Conditions Observation 
1 1 eq. t-BuLi, THF, –78 °C, 20 min Minor amount of 57 isolated 
2 2 eq. n-BuLi, pentane/Et2O (3:2), –78 °C, 1 h Complex mixture 
3 20 eq. Et3B, O2, toluene, 0 °C, 1 h Traces of 57, mostly 89 recovered 
4 6 eq. SmI2, THF to r.t., 0 °C 1 h Complex mixture 
5 3 eq. SmI2, 1 eq. NiI2, 0 °C, 1h Recovery of staring material 
6 3 eq. SmI2, 10 eq. HMPA, THF, r.t., 1 h 76% 89 and 9% 86 
 
As an alternative strategy, we wondered if the bis-halogenated product 90 could be 
used as a feasible intermediate. We assumed that a four-step synthesis from aldehyde 
76 would be possible. However, since we still had some remaining chloride 81 in 
hand, we decided to use it as starting material due to faster access. For that reason, 81 
was deprotected under aqueous acidic conditions and the resulting aldehyde was 
reduced with sodium borohydride to alcohol 91 in excellent 73% yield over both steps 
(Scheme 32). The iodination step was performed under standard conditions and 90 
                                                
258  (a) P. Girard, J. L. Namy, H. B. Kagan, J. Am. Chem. Soc. 1980, 102, 2693; (b) G. A. Molander, J. 
A. McKie, J. Org. Chem. 1993, 58, 7216.  
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was isolated in a compromised yield of 12%. In addition, product 90 proved to be 
unstable and fast decomposition was observed. 
 
 
Scheme 32: a) 1 M HCl, acetone, r.t., 14 h; b) NaBH4, EtOH/CH2Cl2 (1:4), –78 °C, 2.5 h, 73% over 
two steps; c) PPh3, imidazole, I2, r.t., 2 h, 12%. 
 
Due to the unsatisfactory yield and instability of the bis-halogenated product 90, 
we focused on the completion of the total synthesis. 
 
5.4.11 Formation of the D Ring – Part II 
Tricyclic lactone 57 is structurally similar to the methyl-free intermediate 33. 
Therefore, we envisaged that the same reaction sequence could be applied for the 
formation of the D ring. To prove this assumption, methylester 57 was reduced with 
borane dimethyl sulfide to give aldehyde 92 in 66% yield after chromatographic 
separation on silica gel. 
To further improve this reaction, crude aldehyde 92 was used for the follow-up 
cyanide addition and lactone 93 could be isolated in outstanding 63% yield over two 
steps as a single diastereoisomer (Scheme 33). The (S) configuration of the carbinol 
C-10 position was verified by NOESY experiments. Lactone 93 features the complete 
carbon-skeleton of jiadifenolide (18) with other oxidation states at C-6, C-7 and C-10.  
The first oxidation was performed at C-10 using Dess-Martin periodinane and 94 
was obtained in quantitative yield.  
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Scheme 33: a) Borane dimethyl sulfide, THF, 0 °C to 45 °C, 2.5 h; b) KCN, THF/H2O (1:1), r.t., 
2 d, 63% over two steps; c) DMP, CH2Cl2, r.t., 2 h, quant. 
 
The tetracyclic core-structure of jiadifenolide was achieved in 22 linear steps from 
the enantiomerically pure natural product D-pulegone. For the investigation of the 
remaining chemical steps we decided to use model-substrates.  
 
5.4.12 Model Studies for the E Ring Formation 
Looking for a model to investigate the remaining steps, we decided to use the 
previously synthesized tetracyclic intermediate 38. This product was obtained in ten 
linear steps as shown in section 5.4.4 and can therefore be produced in larger amounts 
than the methylated counterpart 93. 
To further improve the structural resemblance of the model system, 38 was 
hydrogenation to 95 in quantitative yield as shown in Scheme 34. The 
diastereoselectivity of the reduction was confirmed by X-ray crystal structure analysis 
as shown in Figure 59. In terms of conformation and electronic properties at C-6 
position, 95 and the methylated 93 should have assimilable properties.  
 
  
Scheme 34: a) Rh/C (10 mol%), H2 (60 bar), EtOH, 16 h, r.t., quant.; b) DMP, CH2Cl2, r.t., 2 h, 
quant.; c) Pd(OH)2/C (10 mol%), H2 (70 bar), 16 h, r.t., quant.; d) LiHMDS, O2, P(OPh)3, –78 °C, 
2 h, 47%. 
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Two more advanced model compounds were prepared, namely α-keto lactone 96 
and silylether 97. Both compounds were synthesized in quantitative yield from their 
precursors 38 and 41, respectively. Diversified model studies allow to access the 
intricate details of the reaction.  
Initial trials with TES-protected lactone 97 showed that the hydroxyl group at C-6 
position could be effectively installed. Therefore, 97 was deprotonated with LiHMDS 
at –78 °C and oxygen was passed through the reaction mixture. Addition of triphenyl 
phosphite finally reduced the formed peroxide and alcohol 98 was isolated in 47% 
yield along with some amounts of starting material. The desired oxidation state at C-6 
position was therefore successfully introduced. The drawback of this approach is the 
fact that oxidation of the C-7 position is no longer possible, unless the hydroxyl 
moiety would eliminate, accumulating additional steps to the synthesis. 
 
 
Figure 59: X-ray crystallographic analysis of hydrogenated lactone 95. Red = O, grey = C, 
white = H. 
 
Oxidation at C-6 position was investigated with the test substrate 96. Our initial 
goal was α-selenation of this position, which could then be oxidized to the 
corresponding selenoxide and subsequently eliminated after basic work-up to the 
α,β-unsaturated lactone.259 This approach has been widely used in various total 
syntheses including the recently published synthesis of virosaine A by 
Miyatake-Ondozabal et al.260  
                                                
259  H. J. Reich, S. Wollowitz, Org. React. 1993, 44, 1. 
260  H. Miyatake-Ondozabal, L. Bannwart, K. Gademann, Chem. Commun. 2013, 49, 1921.	
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The reactions studied with α-keto lactone 96 are summarized in Table 10. 
Reactions performed with diphenyl diselenide or chloroselenobenzene after 
α-deprotonation of the lactone moiety led to either formation of a complex mixture of 
recovery of the starting material (entries 1-3). Furthermore, hydroxylation applying 
the (PhO)3P, O2 conditions did not yield any desired product (entry 4). As no product 
could be obtained, we tested the stability of 96 upon deprotonation with LiHMDS and 
quenching with deuterated methanol as shown in entry 5. Surprisingly, decomposition 
of the starting material was observed. Therefore, another model system was studied in 
the following reactions. 
 
Table 10: Different reaction conditions for the oxidation of 96. 
  
Entry Conditions Observation 
1 1.5 eq. LiHMDS, 1.3 eq. (PhSe)2, THF, –78 °C to 0 °C, 2.5 h Complex mixture 
2 1.5 eq. LDA, 1.3 eq. PhSeCl, THF, –78 °C to r.t., 1.5 h Starting material recovered 
3 1.5 eq. LDA, 1.3 eq. (PhSe)2, THF, –78 °C to 0 °C, 2.5 h Complex mixture 
4 1.5 eq. LiHMDS, 1.5 eq. (PhO)3P, O2, THF, –78 °C to r.t., 16 h Starting material recovered 
5 1.5 eq. LiHMDS, d4-MeOD, THF, –78 °C to r.t., 14 h Complex mixture 
 
α-Selenation was tested on the two model structures 95 and 97. However, both 
compounds proved to be unstable under the applied reaction conditions and complex 
mixtures were obtained upon work-up. 
As we already had some methylated tetracyclic substrate 93 in hand, we decided to 
investigate oxidative reactions with this substrate in order to promote the progress of 
the project.  
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5.4.13 Formation of the E Ring 
α-Selenation of 93 was carried out in THF at –78 °C by addition of LDA and 
subsequent treatment with phenylselenyl bromide (Scheme 35). 1H NMR analysis of 
the crude material showed a newly formed product corresponding to the expected 
selenated intermediate along with some unreacted starting material. The resulting 
mixture was treated with H2O2 in acetic acid for two hours to form the selenoxide 
derivative, which was eliminated by basic work-up. Even though traces of the 
expected α,β-unsaturated lactone could be detected in the crude material, another 
major product was formed during work-up. Intensive NMR analysis and finally X-ray 
crystal structure analysis of the isolated product showed that the cyclized substrate 99 
was formed in 48% yield (Figure 60). The formation of the remaining E ring moiety 
occurred via intramolecular oxa-Michael addition due to the basic work-up conditions 
applied. From a structural point of view, 99 is very similar to the natural product 
jiadifenolide (18) solely missing both hydroxy groups at the C-6 and C-10 position.  
At first, we wanted to introduce the C-6 hydroxy group. Therefore, α-oxidation of 
lactone 99 was tested using our established LiHMDS, O2 and (PhO)3P procedure as 
described in the previous section. Curiously, deprotonation of the α-proton led to E 
ring opening, which could be trapped as the corresponding silyl ethers 100 or 101. 
These transformations were carried out on a small scale of less than 1 mg, which is 
why we were not able to determine the exact yield for each step. However, NMR 
analysis of the crude reaction mixtures showed the obtained compounds as sole 
products and good yields are expected for larger scale reactions. This exciting 
structural behavior is extremely interesting, since both forms can be isolated 
depending on the reaction conditions. Addition of lithium amide bases favor the 
tetracyclic structure due to the strong Li-O-bond formed, which can be trapped with 
various oxophilic electrophiles. On the other hand, addition of weaker bases or acids 
to the E ring-open substrate leads to oxa-Michael addition and reclosure of the E ring. 
These observations are exceedingly advantageous as they add flexibility to the 
synthetic strategy. 
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Scheme 35: a) LDA, PhSeBr, H2O2, THF, –78 °C to 0 °C, 1.5 h, 48%; b) LiHMDS, TMSCl,          
–78 °C to 0 °C, 1 h; c) LiHMDS, TESCl, –78 °C to 0 °C, 1 h; d) NaOH, H2O2, MeOH/THF (3:1), 
0 °C to r.t., 16 h; e) NaOH, H2O2, MeOH/THF (3:1), 0 °C to r.t., 14 h. 
 
Due to these observations, we decided to epoxidize the carbon-carbon double 
bond, which was expected to be diastereoselective due to the strong steric bias. 
Therefore, the TMS-protected substrate 100 was treated with a methanolic alkaline 
hydrogen peroxide solution as described by Theodorakis and co-workers for a similar 
intermediate.200 The TMS protecting group was cleaved under the applied reaction 
condition. Nevertheless, the epoxidation of the double bond was successful. 
Interestingly, the C-10 hydroxyl moiety spontaneously triggered a “5-exo-tet” epoxide 
opening to furnish the E ring and 102 was obtained as the sole reaction product. 
Reactions with the TES-protected substrate 101 as starting material gave the 
pentacyclic compound 102 as major product along with smaller amounts of 
epoxidized protected alcohol. Treatment of the crude material with TBAF solution led 
to 102 as the sole product. As no unprotected epoxide could be detected after these 
reactions, we concluded that epoxide opening occurred rapidly after silyl deprotection 
of the alcohol.  
 
 
Figure 60: X-ray crystallographic analysis of pentacyclic substrate 99. Red = O, grey = C, white = H. 
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Interestingly, epoxidation of the TMS-protected compound 100 led to full 
conversion of the starting material and no oxa-Michael product 99 could be detected 
after the reaction. Nevertheless, the protecting group proved to be labile and easily 
cleavable. Therefore, we assumed that the E ring closure to 102 is reversible in basic 
methanolic solution. This implies that a one-pot epoxidation of 99 to 102 should be 
possible. 
To test this assumption, little amounts of 99 (< 1 mg) were treated with sodium 
hydroxide and hydrogen peroxide in methanol for 5 h and 1H NMR analysis of the 
crude product showed that formation of 102 was achieved. Nevertheless, these 
preliminary results demonstrate that this strategy allows a simpler access to 10-deoxy-
jiadifenolide (102) compared to the previous route, as no protecting group 
manipulation is required. 
Due to the resemblance of 102 and the natural product jiadifenolide (18), we 
decided to compare the NMR spectra of both products as shown in Table 11. 
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Table 11: 1H NMR and 13C NMR datum comparison of jiadifenolide (18) with synthetic 10-deoxy-
jiadifenolide (102). 
 
 
 
Both carbon and proton NMR shifts perfectly match except for the C-10 signals. 
This is due to the lacking hydroxyl group of the synthetic intermediate. In order to 
obtain the natural product, various approaches were conducted on different substrates 
as discussed in the following section. 
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5
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6
789
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Position δ 1H (18) 
(d4-MeOD) 
δ 1H (102) 
(d4-MeOD) 
δ 13C (18) 
(d4-MeOD) 
δ 13C (102) 
(d4-MeOD) 
1 2.21 (qdd, 12.3, 12.3, 
7.1) 
2.25 (m) 41.6 38.6 
2α 1.27 (dddd, 12.3, 12.3, 
12.3, 6.0) 
1.19 (m) 33.0 32.5 
2β 1.88 (brdddd, 12.3, 
12.3, 12.3, 4.1) 
1.99 (m) - - 
3α 2.08 (ddd, 12.9, 12.3, 
6.0) 
2.08 (m) 35.2 34.3 
3β 2.00 (brdd, 12.9, 4.1) 2.06 (m) - - 
4 - - 97.5 100.5 
5 - - 48.1 47.6 
6 - - 77.6 78.4 
7 4.41 (d, 5.8) 4.39 (d, 5.8) 79.1 81.2 
8α 2.09 (d, 12.9) 2.12 (d, 13.0) 32.1 33.0 
8β 2.46 (dd, 12.9, 5.8) 2.24 (dd, 13.0, 6.0) - - 
9 - - 58.8 60.4 
10 -   3.97 (s) 101.9   78.3 
11 - - 173.6 174.6 
12 - - 178.3 177.9 
13 1.22 (s, 3H) 1.22 (s, 3H) 19.9 19.3 
14α 3.79 (d, 9.3) 3.82 (d, 9.4) 74.6 74.5 
14β 4.60 (d, 9.3) 4.63 (d, 9.4) - - 
15 1.20 (d, 7.1, 3H) 1.07 (d, 7.0, 3H) 14.7 15.3 
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5.4.14 The Missing Last Step 
To complete the total synthesis of jiadifenolide (18), oxidation at C-10 position is 
necessary. Inspired by the ring-opening capability of the closely related substrate 99, 
we envisaged that 102 would behave similarly under basic conditions and allow 
epoxide formation between C-6 hydroxyl group and C-7 position. Oxidation of the 
resulting alcohol moiety at C-10 position would subsequently lead to the formation of 
jiadifenolide (18) upon E ring formation under aqueous conditions. Furthermore, this 
epoxide was suggested to be an intermediate in the biosynthesis of jiadifenolide from 
neomajucin as described by Fukuyama and co-workers.193 Technically, E ring 
opening can be realized under basic or acidic conditions via deprotonation of C-6 
hydroxyl group or via protonation of the tetrahydrofuran moiety, respectively. Thus, 
several reaction conditions were tested as shown in Table 12.  
We assumed that 102 might be in equilibrium with its corresponding epoxide in 
solution. If so, oxidation of the latter and subsequent aqueous work-up would lead to 
18. Thus, 102 was treated with Dess-Martin periodinane in sub-milligram scales in 
CH2Cl2 and dioxane at room temperature or at 50 °C, respectively (entries 1 and 2). 
However, no conversion of the starting material could be observed. Next, Jones 
oxidation was attempted at room temperature and at 70 °C, however, only starting 
material could be detected after work-up (entries 3 and 4). 
Since acidic reaction conditions did not lead to the desired result, we attempted the 
application of basic reaction conditions. Therefore, 102 was deprotonated with 
sodium hydride and subsequently treated with Dess-Martin periodinane (entry 5). 
However, only 102 could be recovered in this reaction. Given that our first trials did 
not affect conversion of the starting material, we sought of more practical oxidative 
procedures. Zhang and co-workers reported on effective oxidation conditions using 
iodobenzene dichloride as stoichiometric oxidant in the presence of 2,2,6,6-
tetramethylpiperidin-1-yloxy (TEMPO) and pyridine.261 Iodobenzene dichloride was 
prepared as described by the authors and the reaction was carried out in chloroform at 
50 °C for 5 hours (entry 6). Unfortunately, no product could be detected after the 
reaction and unreacted starting material was recovered. As an alternative, we tested 
the Mukaiyama protocol262 using N-chlorosuccinimide (NCS) and a catalytic amount 
                                                
261  X.-F. Zhao, C. Zhang, Synthesis 2007, 551. 
262  T. Mukaiyama, J.-I. Matsuo, D. Iida, H. Kitagawa, Chem. Lett. 2001, 30, 846. 
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of commercially available N-tert-butylbenzenesulfenamide, however, no product was 
formed (entry 7).  
As none of the performed reactions led to any detectable formation of jiadifenolide 
(18), 102 was deprotonated using the same conditions as with the 6-deoxy derivative 
99 to eventually isolate the E ring opened intermediate (entry 8). However, only 
starting material was obtained. Furthermore, trapping of the potentially formed 
alcoholate with TMSCl as applied to 102 was not successful and only traces of TMS-
protected C-6 hydroxyl group were detected by NMR analysis (entry 9).  
Due to the lacking reactivity of 102 an attempt to oxidize the molecule using the 
Fenton’s reagent was tested.263 The combination of iron(II) and hydrogen peroxide 
produces iron(III), hydroxyl anions and hydroxyl radicals. The free radicals generated 
by this process are highly reactive, non-selective oxidation agents. Thus, Fenton’s 
reagent is used industrially for the destruction of harmful organic compounds. Due to 
its high reaction potential, Fenton’s reagent has been rarely used in organic synthesis. 
An exceptional example involves the oxidation of barbituric acid to alloxane.264 
Therefore, we hoped that 102 would eventually react under these conditions and lead 
to the natural product via oxidation at C-10 position.  
To test the reaction, substrate 102 and iron sulfate were dissolved in an 
acetonitrile/water mixture at room temperature (entry 10). Hydrogen peroxide was 
slowly added to the mixture and the solution changed the color from green to orange 
and gas formation was observed. The crude material was filtered over celite and silica 
gel after two hours reaction time. Curiously, the subsequent 1H NMR analysis 
revealed that the starting material did not react under these rather harsh conditions. 
Due to the stability of 102, we decided to search for a different approach.  
 
 
 
 
                                                
263  H. J. H. Fenton, J. Chem. Soc. Trans. 1894, 65, 899. 
264  H. J. Brömme, W. Mörke, E. Peschke, J. Pineal. Res. 2002, 33, 239.	
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Table 12: Different reaction conditions tried for the last step of the total synthesis. 
 
Entry Conditions Observation 
1 3 eq. DMP, CH2Cl2, r.t., 1.5 h No conversion 
2 3 eq. DMP, dioxane, 50 °C, 14 h No conversion 
3 10 eq. Jones reagent, acetone, r.t., 3 h No conversion 
4 10 eq. Jones reagent, acetone, 70 °C, 3 h No conversion 
5 3 eq. NaH, 3 eq. DMP, dioxane, r.t. to reflux, 2 h No conversion 
6 1.5 eq. iodobenzene dichloride, 8 mol% TEMPO, 3 eq. pyridine, 
CHCl3, 50 °C, 5 h 
No conversion 
7 10 eq. K2CO3, 1.5 eq. NCS, 0.5 eq. N-tert-butylbenzenesulfenamide, 
CH2Cl2, r.t., 3 h 
No conversion 
8 3 eq. LiHMDS, THF, –78 °C to r.t., 2 h No conversion 
9 1 eq. LiHMDS, TMSCl, THF, –78 °C to r.t., 1 h Mostly 102a 
10 FeSO4, H2O2, MeCN/H2O 1:1, r.t., 2 h No conversion 
a Traces of TMS-protected C-6 hydroxyl group detected by 1H NMR. 
 
Since 10-deoxy-jiadifenolide (102) proved to be unreactive, we investigated earlier 
oxidations of the C-10 hydroxyl moiety. Thus, 99 was deprotonated and the derived E 
ring opened intermediate 103 was directly oxidized to α-keto lactone 104 as shown in 
Scheme 36. The yield could not be determined due to the small reaction scale of less 
than 1 mg, but 104 was obtained as sole product. Moreover, direct oxidation of 99 
with Dess-Martin periodinane to give 104 was investigated, but the starting material 
did not react and was completely recovered after the reaction. Nevertheless, with 104 
in hand, we hoped that epoxidation of the α,β-unsaturated lactone and subsequent 
aqueous work-up would lead to jiadifenolide (18). Epoxidation was performed in 
methanol by addition of NaOH and H2O2 and the mixture was stirred over night at 
room temperature but only decomposition products were observed in this reaction. 
We concluded that the electrophilic properties of the ketone dominate over the 
Michael acceptor capability, which could lead to endoperoxides and Baeyer-Villiger 
oxidation products. 
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Scheme 36: a) LiHMDS, –78 °C to r.t., 2 h; b) DMP, CH2Cl2, r.t., 16 h; c) NaOH, H2O2, 
MeOH/THF (3:1), 0 °C to r.t., 14 h. 
 
These findings suggest that the reaction order is crucial for accomplishment of the 
natural product. Since the presence of the C-10 ketone is not compatible with the 
epoxidation conditions, protection of this functional group as the ethylene glycol 
acetal was examined. Unfortunately, acetal formation was not effective as only traces 
of the desired product could be observed by 1H NMR analysis even after several days 
of reaction time at reflux and using ethylene glycol as solvent.  
Karimi and co-workers reported on an efficient aerobic oxidation of TBS-silyl 
ethers to carbonyl compounds catalyzed with N-hydroxyphthalimide and Co(II) 
complexes.265 TBS protecting groups are in the order of 103 more stable than TES in 
basic media and should therefore be stable during the applied epoxidation conditions. 
Oxidative deprotection would then finally give jiadifenolide (18) upon aqueous 
work-up. To test this hypothesis, 103 was treated with TBSCl and TBSOTf, but no 
alcohol protection could be detected. TBS showed to be too sterically hindered for 
substrate 103. 
As an alternative, we envisaged to invert the C-10 hydroxyl group of 103. The 
advantage of this approach is that the targeted inverted alcohol moiety cannot attack 
at C-7 position upon epoxidation to cyclize and could be oxidized to the 
corresponding ketone as the final step. Therefore, 99 was mesylated to 105 and 
subsequently treated with sodium hydroxide to give a single product (Scheme 37). 
1H NMR analyses of the obtained product suggest that the desired inverted alcohol 
106 was formed. Due to the small scale of the reaction (< 1 mg) it was used for the 
epoxidation reaction without further purification. 
 
                                                
265  B. Karimi, J. Rajabi, Org. Lett. 2004, 6, 2841.  
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Scheme 37: a) LiHMDS, MesCl, –78 °C to r.t., 2 h; b) 1 M NaOH, H2O/EtOH (2:1), r.t., 1 h; 
c) NaOH, H2O2, MeOH/THF (3:1), 0 °C to r.t., 14 h. 
 
Treatment of crude 106 with sodium hydroxide and hydrogen peroxide in methanol 
for 14 hours led to the formation of a major product. 1H NMR analysis of the obtained 
product in deuterated methanol was in accordance with the desired compound 107 
(blue in Figure 61 A). Unfortunately, the obtained product decomposed in the NMR 
tube over night. Analysis of the proton NMR spectra showed that a major product was 
formed after one day in the deuterated solvent (green in Figure 61 B). Most 
surprisingly, formation of a third product was observed and 1H-NMR analysis after 
two days showed the third product as major compound in solution (red in 
Figure 61 C). This phenomenon was rather surprising since epoxidation of 106 was 
performed in methanol for 14 hours without formation of any measurable side-
products. So far, the mechanism involved in this transformation it is not entirely clear. 
Nucleophilic attack of the solvent at the α,β-unsaturated lactone via Michael addition 
could be one explanation, but NOESY experiments of the final product showed strong 
correlation between C-15 methyl group and C-10 hydroxyl moiety, which suggests 
that a rearrangement has occurred in this process. Furthermore, Jones oxidation of the 
crude product instantly after epoxidation did not show any formation of the natural 
product.  
With the analytic data suggesting that desired 107 was formed initially and then 
decomposed into unknown compounds, further investigations are required to 
understand the process involved in these observations. 
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Figure 61: 1H NMR spectra of decomposition of 107 in d4-MeOD (A) directly after epoxidation, 
(B) after 1 day, and (C) after 2 days. 
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As an alternative, we intended to introduce both hydroxyl groups at C-6 and C-7 
position prior to D and E ring formation. Thus, lactone 57 was oxidized to the 
α,β-unsaturated lactone 108 via α-selenation and subsequent oxidative elimination in 
54% yield (81% brsm) as shown in Scheme 38. Next, we envisaged to oxidize 108 to 
the corresponding epoxide and subsequently transform it to the trans-diol under acidic 
aqueous conditions. However, epoxidation using hydrogen peroxide and sodium 
hydroxide followed by acidic work-up did not lead to the desired product. Instead, 
tetracyclic substrate 109 was obtained according to 1H NMR analysis. The formation 
of 109 can be explained by hydrolysis of the ester moiety to the carboxylic 
intermediate followed by lactonization, or by lactonization of the formed diol. Product 
109 is not a useful intermediate for the total synthesis of jiadifenolide (18). 
Interestingly, 109 is structurally related to the neurotrophically active natural product 
(2R)-hydroxy-norneomajucin (110). 
In search of a milder epoxidation procedure, 108 was treated with m-CPBA. The 
reaction was initially tested in dichloromethane at room temperature, but no 
conversion of the starting material was observed. Heating the reaction mixture to 
50 °C in chloroform for 19 h proved to be more efficient and full conversion was 
finally achieved. The desired product 111 could be obtained as a nearly 1:1 mixture of 
diastereoisomers as shown in Figure 62. We assume that the loss of regioselectivity is 
due to the coordinating effect of the methyl ester to m-CPBA compared to the 
hydrogen peroxide epoxidation procedure. 
 
 
Scheme 38: a) LDA, PhSeBr, H2O2, THF, –78 °C to 0 °C, 1.5 h, 54% (81% brsm); b) NaOH, H2O2, 
MeOH/THF (3:1), 0 °C to r.t., 14 h; c) m-CPBA, CHCl3, 50 °C, 19 h.  
 
a
O
O
O O
HOH b
O
O
O
O
O
OH
HO
O
HO
O
O
c
O
O
O
HO
O
O
(2R)-hydroxy-norneomajucin (110)
O
O
OH
O
HO
O
HO
57 108 109
111
SYNTHESIS OF MAJUCIN-TYPE SESQUITERPENES 
 
135 
 
Figure 62: 1H NMR spectra of the epoxidation product 111 in CDCl3. 
 
Unfortunately, we could not pursue this promising approach due to short of further 
starting material and lack of time. However, we are confident that other 
non-coordinative epoxidation methods will lead to the desired epoxidized product. 
 
5.5 Conclusion and Outlook 
In this chapter the synthetic studies on majucin-type sesquiterpenes from Illicium 
species are described. Due to the exceptional biological activity of various members 
of this family of natural products, these compounds can be considered as powerful 
neuritotrophic agents sparking great interest in chemistry, biology and medicine. 
Jiadifenolide (18) was chosen as target molecule due to its highly oxidized and caged 
structure combined with its exceptional neuritogenic properties. 
We started our synthetic efforts from a member of the chiral pool, which 
overcomes the need for an enantioselective transformation. Starting from D-pulegone 
(20) we could access the tricyclic core intermediate 33 in eight linear steps including a 
cascade three-component reductive alkylation using Hantzsch’ ester and a 
diastereosective intramolecular Nozaki-Hiyama-Kishi coupling with a ketone in 39% 
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overall yield. The studies were carried on towards the formation of the D ring moiety, 
which was astonishingly accomplished in two unprecedented steps via reduction of 
the ester group to the corresponding aldehyde with borane dimethyl sulfide and 
cyanide addition and hydrolysis under neutral conditions. Several methyl insertion 
approaches were tested on various substrate and alternative cyclization methods with 
pre-methylated substrates, such as Paternò-Büchi cycloaddition, Heck coupling or 
Shapiro reaction, showed either undesired regioselectivity or lacking reactivity. The 
missing methyl group was finally successfully installed in 12 steps through oxidative 
A ring opening, hydroxymethylation and ring reclosure via SmI2-promoted 
intramolecular Barbier-type reaction. D ring formation was accomplished using our 
established reduction and cyanide addition protocol. Selenation of 93 and subsequent 
oxidative elimination of the resulting selenoxide gave the pentacyclic product 99, 
which was then further oxidized to 10-deoxy-jiadifolide (102). Tragically, the final 
oxidation did not succeed due the inertness of 102 under various reaction conditions 
up to Fenton conditions.  
Further promising preliminary results towards the completion of the total synthesis 
using different final approaches were established and could lead to the completion of 
the synthesis. These results should be replicated in larger scales as they were only 
tested on sub-milligram scales so far. As an alternative, aldehyde 92 could be 
vinylated to 112 and thereafter oxidized to 113 via selenation and subsequent 
oxidative elimination as shown in Scheme 39. Epoxidation to 114 and subsequent 
oxidative cleavage of the terminal double bond using sodium periodate combined 
with RuCl3266 has the potential to give the natural product 18 with 115 as reactive 
intermediate. Furthermore, other natural products, such as majucin, could be prepared 
from intermediate 57. This would be especially interesting, as most of these natural 
products have not been synthesized to date.  
                                                
266  For review on Ru-catalyzed reactions, see: T. Naota, H. Takaya, S.-I. Murahashi, Chem. Rev. 1998, 
98, 2599.  
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Scheme 39: Proposed total synthesis of jiadifenolide (18). 
 
In summary, we accomplished the synthesis of 10-deoxy-jiadifolide (102) in 
25 linear steps from the chiral pool molecule D-pulegone (20) with an overall yield of 
3.7% for the first 24 steps. These results prompt further investigation of new 
neuroactive derivatives and the completion of the natural product.  
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6 CONCLUSION 
This thesis entitled “Synthesis of Majucin-Type Sesquiterpenes and Immobilization 
and Visualization of Quorum Sensing Signaling Molecules” showcases the utility of 
modern synthetic chemistry in addressing fundamental human needs. The main focus 
of this work is the combination of synthetic chemistry with biological applications to 
investigate and improve healthcare-associated problems. Natural products served as 
inspiration for the design of new tools in the search for new therapeutics due to their 
evolutionary wisdom richness. 
 
The first chapter described the synthesis and evaluation of dopamine-based natural 
product hybrids with dual properties. A nitro-dopamine anchor served for the surface 
functionalization, whereas an acylated homoserine lactone was used as the bioactive 
signaling moiety. These synthetic hybrids were immobilized by a simple dip-and-
rinse procedure on titanium dioxide, a biocompatible metal frequently used in the 
field of medical devices, and the functionalized beads were shown to modulate 
quorum sensing in bacterial reporter strains. Quorum sensing is an important 
communication pathway used by bacteria to determine the density of their population 
and is responsible for various pathogenic properties, such as biofilm maturation or 
virulence. The length of the linker was shown to be crucial for bacterial recognition 
and a C12-chain length was determined as ideal for the recognition of the CepR 
receptor, the quorum sensing receptor used by Burkholderia cenocepacia. The mode 
of action was determined to be via slow release of the bioactive hybrid compounds. 
This method is a highly attractive approach for the preparation of coated surfaces in 
medical devices capable to interrupt the quorum sensing signaling pathway. 
 
The application of quorum sensing modulating hybrids was expanded in the second 
chapter of this thesis. Knowledge of the temporal and spatial production of quorum 
sensing signaling molecules within biofilms or within the infection host is scarce, but 
current techniques lack the possibility to visualize acylated homoserine 
lactone-mediated communication at the single cell level. To overcome this deficit, 
fluorescent labeling agents for quorum sensing (FLAQS) were developed by 
combining the determined recognition pattern for quorum sensing receptors with 
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rhodamine dyes. This concept was successfully applied to the selective labeling of the 
CepR in live cells. Further improvement of the FLAQS allowed the labeling of B. 
cenocepacia H111, a pathogenic wild-type strain isolated from a cystic fibrosis 
patient, with remarkable quality and the results suggest that CepR is a soluble 
cytoplasmic protein. The selectivity was also successfully applied to the specific 
labeling of mixed bacterial cultures. Second generation FLAQS bearing 3-oxo 
functionality in the acyl side chain proved to be recognized by CepR and LasR. The 
later is one of the quorum sensing receptors used by Pseudomonas aeruginosa. Even 
though the same level of labeling as with CepR could not be achieved, extremely 
promising results were obtained with the wild-type P. aeruginosa PAO1. In addition, 
the FLAQS library was expanded by introducing a green labeling agent. FLAQS 
could be used for the fast analysis of quorum sensing in various environmental and 
clinical samples and enable investigation and visualization of bacteria-host 
communication pathways. 
 
The last chapter was dedicated to the synthesis of majucin-type sesquiterpenes 
from Illicium species. Due to the exceptional biological activity of various members 
of this family of natural products, these compounds can be considered as powerful 
neuritotrophic agents sparking great interest in chemistry, biology and medicine. 
Jiadifenolide was chosen as target molecule due to its highly oxidized and caged 
structure combined with its exceptional neuritogenic properties. The synthesis of 
10-deoxy-jiadifenolide was accomplished in 25 steps with an overall yield of 3.7% for 
the first 24 steps. The reaction sequence was initiated from D-pulegone and the key 
features include a cascade three-component reductive alkylation, a diastereoselective 
intramolecular Nozaki-Hiyama-Kishi coupling with a ketone, and an unprecedented 
cyanide addition to an aldehyde with subsequent lactonization under neutral 
conditions. Even though 10-deoxy-jiadifenolide could not be further transformed to 
the natural product, a variety of structurally related products were accomplished. 
These derivatives can be used to study the mode of action and the structure-activity 
relationship for this class of natural products. 
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7 EXPERIMENTAL PART 
7.1 General Methods and Materials 
Unless otherwise stated, chemicals were purchased from Sigma-Aldrich, Acros, 
Alfa Aesar, or Fluka and used without further purification. Solvents for work-up and 
chromatography were distilled from technical quality. Solvents used for chemical 
transformations were either puriss. quality or dried by filtration through activated 
aluminium oxide under argon or nitrogen (H2O content < 30 ppm, Karl-Fisher 
titration). All non-aqueous reactions were run in oven-dried or flame dried glassware 
under a positive pressure of argon or nitrogen. Concentration under reduced pressure 
was performed by rotary evaporation at 40 °C (unless otherwise specified). Yields 
refer to purity, dried and spectroscopically pure compound.  
Analytical thin layer chromatography (TLC) was performed on Merck silica gel 60 
F254 plates (0.25 mm thickness) precoated with fluorescent indicator. The developed 
plates were examined under UV light (254 nm or 366 nm) and stained with ceric 
ammonium molybdate or aqueous KMnO4/Na2CO3 solution followed by heating. 
Flash chromatography was performed using silica gel 60 (230-240 mesh) from 
Fluka using a forced flow eluent at 0.3-0.5 bar pressure.  
All 1H and 13C NMR spectra were recorded using either Varian Gemini 300 MHz 
(1H) or 75 MHz (13C), Varian Mercury 300 MHz (1H) or 75 MHz (13C), Bruker DRX 
500 MHz (1H) or 125 MHz (13C), Bruker DRX 400 MHz (1H) or 100 MHz (13C), 
Bruker DRX 600 MHz (1H) or 150 MHz (13C), Bruker Advance 800 MHz (1H) or 
200 MHz (13C) FT spectrometers at room temperature. Chemical shifts δ are reported 
in ppm, multiplicity is reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, quint. = quintet, sext. = sextet, sept. = septet, m = multiplet or unresolved and 
coupling constant J in Hz. Spectra were calibrated related to solvent’s residual proton 
chemical shift (CHCl3, δ = 7.26; d4-MeOD, δ = 4.78, 3.31; d6-DMSO, δ = 2.50) and 
solvent’s residual carbon chemical shift (CDCl3, δ = 77.16; d4-MeOD, δ = 49.00; 
d6-DMSO, δ = 39.52), 
Analytical high-performance liquid chromatography (HPLC) was performed on a 
Dionex Chromatography System (Interface Chromeleon, ASI-100 automated sample 
injector, UV detector 170U or PDA-100 photodiode array detector, pump P680, TCC 
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thermostated column compartment, degaser, MSQ-ESI mass spectrometric detector). 
The flow rate was 1 mL / min. Column: Phenomenex Gemini (5 µm) (C18 (150 x 
4.6 mm)), solvent A: H2O, solvent B: MeOH).  
Photoluminescence measurements were performed with a Shimadzu RF-5301PC 
fluorometer. 
IR spectra were recorded using a Varian 2000 FT-IR ATR Spectrometer or Varian 
800 FT-IR ATR Spectrometer. The absorption is reported in cm-1.  
Optical rotation [α]D were measured at the sodium D line using a 1 mL cell with a 
1 dm path length on a Jasco P-2000 digital polarimeter and the concentration c is 
given in g/100 mL and the used solvent is CHCl3 or MeOH.  
Elementary analysis were performed by Mikroanalyse Labor of the Laboratorium 
für Organische Chemie at the University of Basel.  
Melting points (M.p.) were determined using a Büchi B-545 apparatus in open 
capillaries and are uncorrected. Photoluminescence measurements were performed 
with a Shimadzu RF-5301PC fluorometer. 
Mass spectra (HRMS ESI) were recorded by the Mass spectrometric Service of the 
University of Bern on a Sciex QSTAR Pulsar mass spectrometer or by H. Nadig at the 
University of Basel on a Bruker maXis 4G using electrospray ionization in both cases. 
X-ray analyses: Data collections for both crystal structures were performed at low 
temperature (123 K) using Mo-Ka radiation on a Bruker KappaAPEX diffractometer. 
Integration of the frames and data reduction was carried out using APEX2.267 The 
structures were solved by direct methods using SIR92.268 All non-hydrogen atoms 
were refined using anisotropically by full-matrix least squares on F using 
CRYSTALS.269 Hydrogen atoms were placed in calculated positions by means of the 
“riding” model.  
Preparative HPLC purification was performed on an Ultimate 3000 RS Variable 
Wavelength Detector using a Gemini C18, 10µm (250 mm x 2.12 mm) column at a 
flow rate of 20 mL/min and a gradient of 2.5-100% water/ACN in 1 h. 
Reaction indicated with 154, 212, 216 and 247 were performed and characterized by 154 
                                                
267  Bruker Analytical X-ray Systems, Inc., 2006. Apex2, Version 2 User Manual, M86-E01078, 
Madison, WI. 
268  A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, M. C. Burla, G. Polidori, M. Camalli, J. 
Appl. Cryst. 1994, 27, 435. 
269  P. W. Betteridge, J. R. Carruthers, R. I. Cooper, K. Prout, D. J. Watkin, J. Appl. Cryst. 2003, 36, 
1487.	
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Natalie Huber, 212 Elias Kaufmann, 216 Christophe Daeppen, or 247 Annakaisa 
Heikinheimo. 
Compounds not mentioned in the theoretical part, but in the experimental part are 
labeled as EPX starting with X = 1 and are shown in order of affiliation. 
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7.2 Catechol-Based Immobilization of QS Modulators 
7.2.1 Material Preparation 
All glassware used for surface modification was cleaned in “piranha solution” 
(H2SO4/H2O2 = 7:3; Fluka/Sigma-Aldrich) and extensively rinsed with ultrapure 
water (sterile filtered, Sigma). 
Preparation of MOPS buffer: 2.09 g N-morpholinopropanesulphonic acid 
(≥ 99.5 %, Sigma), 3.52 g sodium chloride (≥ 99.5 %, Sigma-Aldrich), and 10.46 g 
potassium sulfate (≥ 99.0 %, Sigma-Aldrich) were dissolved in 100 mL ultrapure 
water (sterile filtered, Sigma). 
The TiO2 particles were cleaned using toluene (HPLC quality), 2 x 10 min 
ultrasonication and 2-propanol (HPLC quality), 2 x 7 min ultrasonication, dried under 
a nitrogen stream and finally put overnight in an oven at 120 °C.  
 
7.2.2 Functionalization of TiO2 beads 
General procedure for functionalization of TiO2 particles: 50 mg cleaned particles 
(99.6 %, ∼325 mesh powder, Alfa Aesar) were placed into glass vials with 3 mL of 
buffer and 1.5 mg of the natural product hybrids. After 4 h incubation at 50 °C, the 
resulting particles were centrifuged for 5.5 min at 4’500 rpm, and the aqueous layer 
was decanted. The resulting particles were washed with water and dried with a stream 
of nitrogen. Further washing with methanol and water was carried out the same way 
(particles suspended in H2O or MeOH for 5-20 min, and centrifugation 10-30 min at 
4’500 rpm).  
 
7.2.3 Sensor Strains 
Pseudomonas putida Iso F117 (putI-knockout) pAS-C8; highly sensitive towards 
OHL (N-octanoyl-L-homoserine lactone), less sensitive for DHL  (N-decanoyl-L-
homoserine lactone), almost no sensitivity for BHL (N-butyryl-L-homoserine 
lactone). The quorum-sensing regulated promoter pcepI is from Burkholderia 
cenocepacia, and controls expression of green-fluorescent protein (GFP). Plasmid-
encoded resistance to gentamycin. 
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Pseudomonas putida Iso F117 (putI-knockout) pKR-C12; highly sensitive 
towards Od-DHL  (N-(3-oxo-decanoyl)-L-homoserine lactone), almost no sensitivity 
for shorter AHLs. The quorum-sensing regulated promoter plasB is from Pseudomonas 
aeruginosa, and controls expression of GFP. Plasmid-encoded resistance to 
gentamycin. 
Culture conditions: The sensor strains were initially cultivated on LB-agar plates 
with gentamycin (20ug/mL). Single colonies were suspended in 5 mL LB (Luria-
Bertani broth) for overnight cultivation (with gentamycin). These stationary phase 
starter cultures were diluted 1:100 into fresh LB and grown to mid logarithmic phase 
(OD600nm = 0.8) at 30°C with shaking (Infors HT incubator, Bottmingen, 
Switzerland). At this point, cultures were used for inoculation with test  compounds. 
 
7.2.4 Assessment of Biological Activity 
The TiO2-conjugated AHLs were suspended as a 10% slurry (w/v) in 1:1 
DMSO/H2O. Initial sensor activation experiments were conducted with a final 
concentration range of 0.05% - 0.25% conjugated beads added to mid-log phase 
sensor cultures (a total of 200 mL culture volume).  After these initial tests, a final 
conjugated beads concentration of 0.1% was used throughout for further activation 
assays and for microscopy. 
Culture/beads suspensions were incubated in black lidded 96-well microtiter plates 
(Nunc, Denmark), in the dark at 30oC for two hours, and induction of GFP 
fluorescence was assessed by spectrofluorimetry, with excitation and emission 
wavelengths at 485nm at 520nm, respectively (Microplate reader, BioTek 
Instruments, VT, USA) or by fluorescence microscopy (DM6000B, Leica, Germany).  
Positive control: OHL (10 nM – 1 mM, diluted from 10mM stock solutions in ethyl 
acetate) was incubated with the sensor cultures in the same way. 
Negative control: Sensor cultures with corresponding aliquots of 1:1 DMSO/H2O 
or ethyl acetate. 
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7.2.5 Dialysis Experiments  
Dialysis experiments were conducted to assess the chemical stability of the 
conjugated TiO2-beads in the presence and absence of P. putida pAS-C8 sensor cells.  
Briefly, 1% suspensions of conjugated beads were prepared in either 1 mL PBS pH 
6.5, or phosphate-buffered LB medium containing 105 - 106 CFU/mL sensor cells and 
placed inside 1 mL-capacity dialysis tubes (SpectraPor „Float-a-lyzer“, 1 mL, 
3.5-5 kDa MWCO). The dialysis tubes were tightly capped and were then allowed to 
float freely inside culture flasks containing 30 mL sterile LB supplemented with 
20mg/mL gentamycin. As a positive control, 10mM OHL in 1 mL PBS pH 6.5 was 
dialyzed under the same conditions. 
The culture flasks were placed in a slow-shaking incubator in the dark at 30oC. 
Aliquots were removed from the LB dialysis medium at various time intervals during 
incubation and stored at -20oC. After the final dialysis period of 16 hours, the frozen 
aliquots were thawed and used to each resuspend ca. 108 CFU/mL uninduced sensor 
cells. Induction of GFP fluorescence was subsequently assayed as described above. 
 
7.2.6 Synthetic Part 
Nitro-dopamine (EP1): A mixture of 3-hydroxytyramine hydrochloride (946.6 mg, 
5.0 mmol, 1.0 eq.) and sodium nitrite (757.5 mg, 11 mmol, 2.2 eq.) 
was dissolved in water (13 mL) and cooled down to 0 °C. Sulfuric 
acid (8.7 mmol in 5 mL of water) was added slowly to the mixture, and a yellow 
precipitate was formed. After stirring at r.t. overnight, the precipitate was filtered and 
recrystallized from water. The product was dried under high vacuum to yield EP1 
(641.1 mg, 1.6 mmol, 64%) as the brown hemisulfate salt.  
 
1H-NMR (400 MHz, D2O) δ = 7.69 (s, 1H), 6.85 (s, 1H), 3.30 (t, J = 7.0 Hz, 2H), 
3.19 (t, J = 7.0 Hz, 2H).  
 
Analytical according to reference: S. Knaggs, H. Malkin, H. M. I. Osborn, N. A. O. 
Williams, P. Yaqoob, Org. Biomol. Chem. 2005, 3, 4002. 
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Activated C12-linker (EP2): Dodecandioic acid (2, 235.0 mg, 1.0 mmol, 1.0 eq.) was 
dissolved in MeCN (3 mL) and pyridine 
(0.16 mL, 2.0 mmol, 2.0 eq.) and 
N,N’-disuccinimidyl carbonate (539.0 mg, 
2.0 mmol, 2.0 eq.) were added at room temperature. After 7 h, the solvent was 
removed by rotary evaporation. The residue was poured into a 1M aqueous HCl 
solution and extracted with CH2Cl2. The organic layer was evaporated to yield the 
desired product EP2 (423.7 mg, 1.0 mmol, quant.) as a white solid.  
 
1H-NMR (400 MHz, CDCl3) δ = 2.84 (s, 8H), 2.60 (t, J = 7.54 Hz, 4H), 1.79-1.69 (m, 
4H), 1.40-1.30 (m, 12H). 13C-NMR (101 MHz, CDCl3) δ = 169.3, 168.8, 31.1, 29.3, 
29.1, 28.9, 25.7, 24.7. 
 
Analytical according to reference: Fujimoto, K.; Oimoto, N.; Katsuno, K.; Inouye, M. 
Chem. Commun. 2004, 1280. 
 
 
Nitro-dopamine-C12-AHL-hybrid (1): To a solution of dodecanedioic acid 
(69.2 mg, 0.3 mmol, 1.0 eq.) in 
THF/DMSO (7.0 mL/0.4 mL) were 
added EDC hydrochloride (116.6 mg, 
0.6 mmol, 2.0 eq.) and N-hydroxysuccinimine (69.6 mg, 0.6 mmol, 2.0 eq.). The 
resulting mixture was stirred overnight at r.t. Hemisulfate EP1 (74.9 mg, 0.15 mmol, 
0.5 eq.) and Et3N (0.13 mL, 0.9 mmol, 3.0 eq.) were added and the resulting mixture 
was stirred for 20 h before addition of (S)-α-amino-γ-butyrolactone hydrobromide 
(54.6 mg, 0.3 mmol, 1.0 eq.). After further 24 h, the mixture was filtrated and 
concentrated in vacuo.  The crude was extracted with EtOAc (3 x) and water. 
Combined organic layers were subsequently washed with brine, dried over Na2SO4 
and concentrated in vacuo. The crude product was purified by size exclusion 
chromatography (Sephadex LH-20, MeOH) to afford 1 (107.2 mg, 0.2 mmol, 72 %) 
as an orange solid.  
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Optical rotation: [α]D = –7.3 (c = 0.49, CHCl3). FTIR ν = 2921, 2852, 2488, 2437, 
1776, 1697, 1636, 1526, 1467, 1287, 1222, 1173, 1007, 946 cm-1. 1H NMR 
(400 MHz, d4-MeOD) δ = 7.54 (s, 1H), 6.71 (s, 1H), 4.58 (t, J = 10.0 Hz, 1H), 4.43 
(td, J = 9.0, 1.8 Hz, 1H), 4.29 (ddd, J = 10.5, 9.0, 6.5 Hz, 1H), 3.43 (t, J = 7.0 Hz, 
2H), 3.31 (dt, J = 3.3, 1.6 Hz, 2H), 3.02 (t, J = 6.9 Hz, 2H), 2.58-2.49 (m, 1H), 
2.30-2.19 (m, 5H), 2.13 (t, J = 7.6 Hz, 2H), 1.66-1.50 (m, 4H), 1.39-1.22 (m, 12H). 
13C NMR (101 MHz, d4-MeOD) δ = 177.8, 176.4, 174.9, 152.3, 145.3, 141.7, 129.3, 
119.3, 113.4, 67.2, 49.9, 40.7, 37.2, 36.7, 34.9, 34.2, 30.5, 30.4, 30.3, 30.2, 30.1, 29.7, 
27.0, 26.8, 26.3, 26.1. HRMS ESI calc. for C24H36N3O8 [M-H]+: 494.2497, 
found: 494.2487. 
 
 
Rhodamine derivative (EP3): EDC hydrochloride (200.1 mg, 1.04 mmol, 1.0 eq.) 
and N-hydroxysuccinimine (186.3 mg, 1.57 mmol, 
1.5 eq.) were added to a solution of rhodamine B (5, 
500.0 mg, 1.04 mmol, 1.0 eq.) in dry MeCN (10 mL) 
at r.t. and under argon atmosphere. The resulting 
mixture was stirred overnight before N-alpha-Boc-L-lysine (260.2 mg, 1.04 mmol, 
1.0 eq.) and Et3N (0.29 mL, 2.09 mmol, 2.0 eq.) were added and the mixture was 
stirred for 2 days at r.t. The solvent was removed by rotary evaporation. Water and 
EtOAc were added and the aqueous layer was extracted with EtOAc and CH2Cl2. 
Combined organic layers were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by flash chromatography 
(CH2Cl2/MeOH 10:1) to afford EP3 (428.0 mg, 0.64 mmol, 61%) as a pink solid. 
 
M.p.: Decomposes at 220 °C. Rf = 0.48 (CH2Cl2/MeOH 10:1). FTIR ν = 2971, 2929, 
1669, 1613, 1513, 1469, 1401, 1358, 1328, 1265, 1219, 1168, 1117, 1091, 1019, 864, 
819, 786, 702 cm-1. 1H NMR (400 MHz, d4-MeOD) δ = 7.87 (s, 1H), 7.56-7.54 (m, 
2H), 7.10-7.08 (m, 1H), 6.46-6.40 (m , 2H), 6.39-6.33 (m, 4H), 3.92-3.90 (m, 1H), 
3.40 (q, J = 7.0 Hz, 8H), 3.13-3.09 (m, 2H), 1.56-1.48 (m, 2H), 1.37-1.30 (m, 2H), 
1.18 (t, J = 6.9 Hz, 12H), 1.10-1.06 (m, 2H). 13C NMR (101 MHz, d4-MeOD) 
δ = 170.0, 157.9, 155.2, 154.8, 150.4, 134.1, 132.1, 129.7, 129.5, 125.1, 123.8, 109.5, 
O
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109.5, 106.1, 99.1, 80.3, 67.3, 45.4, 39.0, 32.5, 28.9, 28.8, 24.0, 13.0. HRMS ESI 
calc. for C39H51N4O6 [M-H]+: 671.3803, found: 671.3816.  
 
 
Rhodamine-nitro-dopamine-hybrid (3): Carboxylic acid EP3 (270.0 mg, 
0.40 mmol, 1.0 eq.) was dissolved MeCN 
(5 mL) and THF (2 mL) under argon 
atmosphere. N,N'-Disuccinimidyl carbonate 
(109.1 mg, 0.40 mmol, 1.0 eq.) and 
pyridine (33 µL, 0.40 mmol, 1.0 eq.) were 
added to the red solution. The resulting mixture was stirred for 4 h before EP1 
(99.5 mg, 0.20 mmol, 0.5 eq.) and Et3N (113 µL, 0.81 mmol, 2.0 eq.) were added. 
The mixture was stirred overnight and the solvent was removed by rotary evaporation. 
Water and EtOAc were added and the aqueous layer was extracted two times with 
EtOAc. Combined organic layers were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude product was purified by flash chromatography 
(CH2Cl2/MeOH 25-10:1) to afford 3 (145.0 mg, 0.17 mmol, 41%) as a red solid. 
 
M.p.: 84.0 °C. Rf = 0.49 (CH2Cl2/MeOH 10:1). FTIR ν = 3400, 3358, 3121, 3085, 
2928, 2852, 1712, 1633, 1591, 1527, 1332, 1289, 1181, 1130, 978, 933, 886, 813, 
759, 672, 636 cm-1. 1H NMR (400 MHz, d4-MeOD) δ = 8.55-8.52 (m, 1H), 7.86-7.82 
(m, 1H), 7.57-7.50 (m, 2H), 7.07 (d, J = 7.1 Hz, 1H), 6.69 (s, 1H), 6.42 (t, J = 2.0 Hz, 
2H), 6.39-6.30 (m, 4H), 3.83-3.75 (m, 1H), 3.41-3.34 (m, 8H), 3.16-3.06 (m, 2H), 
3.03-2.94 (m, 2H), 1.41 (s, 9H), 1.15 (t, J = 7.0 Hz, 12H). 13C NMR (101 MHz, 
d6-DMSO) δ = 172.6, 165.7, 164.1, 157.1, 155.5, 152.1, 152.0, 152.0, 147.5, 144.1, 
139.5, 132.7, 130.1, 130.0, 128.6, 128.5, 127.6, 127.5, 122.8, 121.4, 121.1, 117.4, 
111.3, 107.3, 96.4, 95.1, 78.0, 50.5, 44.4, 42.8, 39.2, 38.1, 36.0, 31.9, 27.9, 27.2, 24.3, 
12.8, 11.4. HRMS ESI calc. for C47H59N6O9 [M]+: 851.4338, found: 851.4354. 
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Rhodamine derivative (6): To a solution of rhodamine B (5, 1.0 g, 2.3 mmol, 
1.0 eq.) in MeCN (50 mL) N-hydroxysuccinimid (580.0 mg, 
5.0 mmol, 2.1 eq.) and EDC hydrochloride (900.0 mg, 
4.7 mmol, 2.0 eq.) were added under argon atmosphere at 
r.t., and the resulting mixture was stirred overnight.  
1,2-Diaminoethan (2.0 mL, 29.9 mmol, 13 eq.) and Et3N (3.2 mL, 23.0 mmol, 
10.0 eq.) were added. The solution was stirred for 6 h and the solvent was removed by 
rotary evaporation. The residue was dissolved in CH2Cl2 and extracted with H2O. The 
aqueous layer was extracted three times with CH2Cl2. Combined organic phases were 
washed with brine, dried over Na2SO4, filtered and the solvent was removed under 
reduced pressure. The crude compound was purified by flash chromatography 
(MeOH/CH2Cl2 1:25) to afford 6 (625.5 mg, 1.3 mmol, 56%) as brownish crystals.  
 
Rf = 0.44 (MeOH/CH2Cl2 1:7). FTIR ν = 3085, 3056, 3028, 2970, 2928, 2896, 1727, 
1682, 1615, 1545, 1513, 1466, 1428, 1378, 1352, 1330, 1307, 1267, 1218, 1153, 
1117, 1077, 1019, 969, 916, 813, 785, 764 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 7.93-7.87 (m, 1H), 7.47-7.41 (m, 2H), 7.12-7.06 (m, 1H), 6.45-6.41 (m, 2H), 
6.38-6.35 (m, 2H), 6.29-6.25 (m, 2H), 3.33 (q, J = 7.2 Hz, 8H), 3.18 (t, J = 6.7 Hz, 
2H), 2.40 (t, J = 6.7 Hz, 2H), 1.16 (t, J = 7.0 Hz, 12H). 13C NMR (126 MHz, 
d4-MeOD) δ = 168.8, 153.3, 148.9, 132.5, 131.1, 128.9, 128.7, 128.1, 123.9, 122.8, 
108.2, 105.5, 97.7, 65.1, 44.4, 43.5, 40.9, 12.6. HRMS ESI calc. for C30H37O2N4 
[M]+: 485.2911, found: 485.2924.   
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Rhodamine-nitro-dopamine-hybrid (EP4): To a solution of EP2 (87.2 mg, 
0.21 mmol, 1.0 eq.) in 
THF/DMSO (5 mL, 1:1) 
were added 6 (52.7 mg, 
0.21 mmol, 1.0 eq.) and 
Et3N (0.053 mL, 0.42 mmol, 2.0 eq.) under argon atmosphere. The resulting mixture 
was stirred overnight at r.t. Rhodamine B (5, 100.0 mg, 0.21 mmol, 1.0 eq.) and Et3N 
(0.053 mL, 0.4 mmol, 2.0 eq.) were added at r.t. and the mixture was stirred for 4 h. 
The reaction mixture was diluted with EtOAc. After addition of water, the organic 
layer was extracted 7 times with water. Combined organic layers were washed with 
brine, dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
compound was purified by flash chromatography (CH2Cl2/MeOH 50-13:1) yielding 4 
(95.0 mg, 0.11 mmol, 52%) as brown crystals.  
 
Rf = 0.40 (MeOH/CH2Cl2 1:7). FTIR ν 3311, 2972, 2926, 2855, 2362, 2340, 1633, 
1614, 1514, 1468, 1425, 1399, 1356, 1328, 1296, 1265, 1216, 1143, 1116, 1091, 
1044, 1017, 949, 885, 818, 787, 758, 717, 703, 668 cm-1. 1H NMR (400 MHz, 
d4-MeOD) δ = 7.90-7.83 (m, 1H), 7.58-7.49 (m, 3H), 7.07-7.04 (m, 1H), 6.70 (s, 1H), 
6.43 (s, 2H), 6.38 (s, 4H), 3.46-3.41 (m, 2H), 3.38 (q, J = 7.1 Hz, 8H), 3.22 (t, 
J = 6.4 Hz, 2H), 3.01 (q, J = 7.1 Hz, 4H), 2.12 (t, J = 7.6 Hz, 2H), 1.98 (t, J = 7.5 Hz, 
2H), 1.62-1.43 (m, 4H), 1.30-1.21 (m, J = 13.3 Hz, 12H), 1.16 (t, J = 7.0 Hz, 12H). 
HRMS ESI calc. for C50H65O6N8 [M]+: 877.4858, found: 877.4869.  
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7.3 Labeling of QS Pathways 
7.3.1 Bacterial Strains and Plasmids 
The used bacterial strains and plasmids are listed in Table 13.  
 
Table 13: Bacterial strains and plasmids used. 
 Strain or plasmid Relevant characteristic(s) Reference 
Bacterial strains   
 B. cenocepacia H111 Clinical isolate  [270] 
 B. cenocepacia  
H111-ΔcepR + pBAH27 
pBBR1MCS-5 containing the cepR genes of B. 
cenocepacia H111; Gmr 
[157] 
 
B. cenocepacia H111-ΔcepR/I cepI/R::FRT 
Eberl et al., 
unpublished 
 B. cenocepacia H111-ΔcepR-
pBAH8 (GFP) 
pBBR1MCS-5 containing PA1/04/03-gfp mut3-To-T1 [271] 
 P. putida F117 AHL-negative derivative of IsoF; PpuI- [64] 
 
E. coli XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac  
[F proAB lacIq ZΔM15 Tn10 (Tetr)] 
Stratagene 
    
Plasmids   
 pAS-C8 pBBR1MCS-5 carrying PcepI-gfp(ASV)-Plac-cepR; Gmr [64] 
 pKR-C12 pBBR1MCS-5 carrying PlasB-gfp(ASV)-Plac-lasR; Gmr [64] 
 
7.3.2 Preparation of Bacterial Strains 
Scrapes of glycerol stocks were added into LB-medium and raised over night at 
30 °C (plasmids pAS-C8 and pKR-C12) or 37 °C (B. cenocepacia, E. coli). 
Antibiotics were added as required at final concentrations of 25 mg of 
gentamycin/liter, 50 mg of kanamycin/liter, 100 mg of ampicillin/liter and 20 mg of 
chloramphenicol/liter. Overnight cultures (5 mL) were diluted into fresh LB medium 
(25 mL) and grown under vigorous shaking for around 1 h until an optical density 
(OD600nm) between 0.6-1.0 was reached. 
                                                
270 (a) S. Walter, P. Gudowius, J. Bosshammer, U. Römling, H. Weissbrodt, W. Schürmann, H. von der 
Hardt, B. Tummler, Thorax 1997, 52, 318; (b) K. Riedel, C. Arevalo-Ferro, G. Reil, A. Görg, F. 
Lottspeich, L. Eberl, Electrophoresis 2003, 24, 740. 
271 C. R. Wulff-Strobel, A. W. Williams, S. C. Straley, Mol. Microbiol. 2002, 43, 411. 
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7.3.3 In vivo Incubation with Test Compounds 
FLAQS were dissolved in DMSO and 1% acetic acid. FLAQS 4 was activated 
with TFA due to its pH dependence. Bacterial cultures were distributed into the wells 
of a 96 well microtiter plate. Wells of the first row were charged with 200 µL of 
bacterial culture and all other wells with 100 µL. Test-substances (5 µL) with a 
concentration of 10 mM were added to first row wells. The first column was used as 
negative control without addition of any AHL analog and the last column was used as 
positive control with addition of the corresponding natural AHL (5 µL) with a 
concentration of 100 µM. From the first row 100 µL were taken out and mixed with 
the well in row two. This dilution procedure was done from top to the bottom. The 
filled plates with bacteria cultures and the test compounds were incubated for a 
further 2 h at the corresponding temperatures.  
 
7.3.4 In vivo Activity Tests 
Activity tests were performed on a microtiter plate reader Synergy HT (MWG 
Biotech, Germany). Emission was measured at 515 nm with an excitation wavelength 
at 474 nm. Data were processed with KC4 software (BioTek Instruments) and 
corrected for auto fluorescence by subtracting the mean value of negative controls. 
The signals from well 1 of the positive controls with the natural AHL were set as 
100% relative green fluorescence.  
 
7.3.5 Microscopic Analysis in Live Cells 
For microscopic analysis bacteria samples were washed with 0.9% NaCl solution 
and centrifuged for 5 min at 5000 r.p.m. To detect motile bacteria a smear of bacterial 
cultures was fixed with 1% agarose on a glass slide. Fluorescence pictures were taken 
on a fluorescence microscope (DM6000, Leica) with a x100 oil objective. For red 
fluorescent pictures a RFP channel was used with an excitation filter BP546/12 and 
suppression filter BP605/75. Green fluorescence was measured with GFP (excitation 
filter: BP470/40; suppression filter: BP525/50) or GFG (excitation filter: D480/20; 
suppression filter: D520/20) channel. Additionally, a confocal laser scanning 
microscope (DM5500Q, Leica) equipped with a x100 oil objective was used. Data 
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were analyzed with Leica Application Suite (Mannheim, Germany) and the Imaris 
software package (Bitplane, Switzerland).  
 
7.3.6 Synthesis of FLAQS 
C12-FLAQS (4):154 To a solution of rhodamine B (5, 75.0 mg, 0.157 mmol, 1.0 eq.) 
in MeCN  (4.0 mL) was added 
N-hydroxysuccinimid (19.3 mg, 
0.167 mmol, 1.1 eq.) and 
1-(3-dimethyl aminopropyl)-3-
ethyl-carbodiimide (32.1 mg, 0.167 mmol, 1.1 eq.). The resulting mixture was stirred 
at room temperature for 15 h. 1,2-Diaminoethane (0.2 mL, 3.040 mmol, 20.0 eq.) and 
freshly distilled Et3N (0.4 mL, 3.040 mmol, 20.0 eq.) were added to the reaction 
mixture and it was stirred at room temperature for additional 6 h. The solvent was 
concentrated and the residue was extracted with H2O and CH2Cl2. The organic layer 
was washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The 
crude compound was purified by flash chromatography (SiO2, CH2Cl2/MeOH 2-8%) 
and subsequently dissolved in MeCN (4.0 mL). Activated linker EP2 (65.0 mg, 
0.157 mmol, 1.0 eq.) and freshly distilled Et3N (0.1 mL, 0.761 mmol, 5.0 eq.) were 
added and the mixture was stirred at room temperature for 4 h. Subsequently, 
(S)-α-amino-γ-butyrolactone hydrobromide (27.7 mg, 0.157 mmol, 1.0 eq.) was added 
and the mixture was stirred at room temperature for 19 h. The solvent was 
concentrated in vacuo and the residue was extracted with H2O and CH2Cl2. The 
organic layers was washed with brine, dried over Na2SO4, filtered, and concentrated 
in vacuo. The crude compound was purified by size-exclusion chromatography 
(Sephadex LH-20, MeOH) to yield the title compound (103.0 mg, 0.132 mmol, 88%) 
as a pink solid. 
 
M.p. = 98.2-101.9 °C. Rf = 0.30 (CH2Cl2/MeOH 7:1). FTIR ν 3383, 3315, 3075, 
2969, 2927, 2855, 2359, 2323, 2288, 2234, 2191, 2121, 2082, 1778, 1634, 1614, 
1546, 1514, 1468, 1427, 1377, 1356, 1330, 1304, 1266, 1219, 1117, 1017, 950, 820, 
787, 759, 703 cm-1. 1H-NMR (400 MHz, d4-MeOD) δ = 7.90-7.84 (m, 1H), 7.59-7.48 
(m, 2H), 7.06 (d, J = 7.4 Hz, 1H), 6.43 (s, 2H), 6.40-6.33 (m, 4H), 4.63-4.55 (m, 1H), 
4.47-4.40 (m, 1H), 4.33-4.22 (m, 1H), 3.42-3.33 (m, 8H), 3.26-3.10 (m, 2H), 
O NN
O
H
N N
H
O
Cl
H
N
O OO
H
EXPERIMENTAL PART 
 
155 
2.99-2.92 (m, 2H), 2.53 (dddd, J = 9.0, 6.3, 4.0, 1.9 Hz, 1H), 2.31-2.19 (m, 3H), 2.00 
(t, J = 7.5 Hz, 2H), 1.63-1.56 (m, 2H), 1.53-1.43 (m, 2H), 1.38-1.20 (m, 12H), 
1.18-1.12 (m, 12H). 13C-NMR (101 MHz, d4-MeOD) δ  = 179.8, 176.4, 173.4, 169.1, 
154.8, 150.5, 131.8, 129.5, 128.5, 126.7, 125.2, 123.6, 109.6, 101.4, 99.10, 67.1, 49.9, 
45.4, 40.7, 39.4, 36.7, 30.5, 30.4, 30.3, 30.2, 30.1, 30.0, 29.9, 29.6, 26.7, 12.9. 
HRMS-ESI calc. for C49H66O6N5 [M]+: 780.4695, found: 780.4713. 
 
 
FLAQS (11):154 Fluorophore 10159 (50.0 mg, 0.066 mmol, 1.0 eq.) was dissolved in 
CH2Cl2 (3.0 mL) and TFA 
(3.0 mL) and stirred at room 
temperature for 5 h. The reaction 
was concentrated in vacuo. To a 
mixture of EP2 (28.2 mg, 
0.066 mmol, 1.0 eq.) in MeCN (4.0 mL) was added (S)-α-amino-γ-butyrolactone 
hydrobromide (12.1 mg, 0.066 mmol, 1.0 eq.) and Et3N (0.02 mL, 0.133 mmol, 
2.0 eq.) and the resulting mixture was stirred at room temperature for 10 h. The 
previously deprotected fluorescent dye was dissolved in MeCN (1.0 mL) and added to 
the reaction mixture. The resulting mixture was stirred for additional 15 h at room 
temperature. The mixture was concentrated in vacuo and the residue was extracted 
with H2O and CH2Cl2 (3 x 15 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and concentrated in vacuo. The crude compound 
was purified by preparative RP HPLC (2.5-100% water/ACN over 1 h) to yield the 
title compound (39.0 mg, 0.047 mmol, 71%) as purple solid. 
 
M.p.: 97.6-100.3 °C. Rf = 0.30 (CH2Cl2/MeOH 7:1). FTIR ν = 3311, 3071, 2927, 
2854, 2360, 2338, 1777, 1737, 1690, 1642, 1587, 1550, 1466, 1412, 1336, 1273, 
1247, 1177, 1128, 1074, 1011, 977, 922, 823, 798, 717, 683 cm-1. 1H NMR 
(400 MHz, d4-MeOD) δ = 8.53 (s, 1H), 7.79-7.73 (m, 2H), 7.66 (dt, J = 4.0, 3.1 Hz, 
1H), 7.53-7.48 (m, 1H), 7.28 (dd, J = 9.5, 2.0 Hz, 2H), 7.07 (t, J = 9.7 Hz, 2H), 6.97 
(d, J = 2.3 Hz, 2H), 4.63-4.53 (m, 1H), 4.47-4.39 (m, 1H), 4.34-4.23 (m, 1H), 4.13 (d, 
J = 12.5Hz, 1H), 3.78-3.64 (m, 9H), 3.09-2.95 (m, 1H), 2.71-2.61 (m, 1H), 2.59-2.47 
(m, 1H), 2.27-2.19 (m, 3H), 2.12 (t, J = 7.4 Hz, 2H), 1.77 (t, J = 13.4 Hz, 2H), 1.58 
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(dd, J = 13.4, 6.7 Hz, 4H), 1.40-1.26 (m, 24H), 1.21-1.11 (m, 2H). 13C NMR 
(101 MHz, d4-MeOD) δ = 177.4, 176.3, 174.4, 169.4, 157.2, 157.0, 137.0, 133.2, 
131.9, 131.7, 131.3, 131.1, 128.5, 115.3, 114.8, 97.3, 67.3, 49.5, 47.8, 47.5, 46.9, 
41.8, 37.0, 36.7, 33.1, 31.8, 30.5, 30.4, 30.2, 30.1, 29.6, 27.0, 26.7, 12.9. HRMS ESI 
calc. for C49H66N5O6 [M]+: 820.5008, found: 820.5026. 
 
 
N-Boc-C12-AHL (EP5):154 A mixture of 12-aminododecanoic acid (444.0 mg, 
2.06 mmol, 1.0 eq.), di-tert-butyl dicarbonate 
(629.0 mg, 2.88 mmol, 1.4 eq.), NaOH 
(107.0 mg, 2.68 mmol, 1.3 eq.) in H2O (14.0 mL) and tert-butanol (7.0 mL) was 
stirred at room temperature for 23 h. The mixture was diluted with H2O and 1 M HCl 
solution and was extracted with EtOAc (3 x 15 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The 
residue was dissolved in MeCN (15.0 mL). N,N'-Disuccinimidyl carbonate (833.0 mg, 
3.09 mmol, 1.5 eq.) and pyridine (0.3 mL, 4.12 mmol, 2.0 eq.) were added to the 
solution. The mixture was stirred at room temperature for 18 h, concentrated in vacuo, 
and the residue was extracted with 1 M HCl solution and CH2Cl2 (3 x 15 mL). The 
combined organic layers were dried over Na2SO4, filtered, concentrated in vacuo. The 
residue was dissolved in MeCN (15.0 mL). (S)-α-Amino-γ-butyrolactone 
hydrobromide (562 mg, 3.09 mmol, 1.5 eq.) and freshly distilled Et3N (0.6 mL, 
4.12 mmol, 2.0 eq.) were added and the mixture was stirred at room temperature for 
18 h. The resulting mixture was concentrated and the residue was extracted with H2O 
and CH2Cl2 (3 x 15 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by 
flash-chromatography (SiO2, EtOAc/pentane 1:1) to yield the title compound 
(395.0 mg, 1.03 mmol, 50%) as white solid. 
 
M.p.: 110.9-111.3 °C. Rf = 0.60 (EtOAc/pentane 2:1). Optical rotation: [α]D = 0.0 
(c = 0.96, CH2Cl2). FTIR ν = 3325, 2922, 2852, 1776, 1688, 1645, 1538, 1469, 1446, 
1385, 1365, 1280, 1251, 1226, 1168, 1138, 1106, 1072, 1042, 1014, 997, 976, 948, 
871, 722, 656 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.26 (brs, 1H), 4.56 (ddd, 
J = 11.4, 9.1, 7.4 Hz, 2H), 4.45 (t, J = 9.0 Hz, 1H), 4.27 (ddd, J = 10.9, 9.4, 6.0 Hz, 
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1H), 3.15-3.00 (m, 1H), 2.90-2.72 (m, 1H), 2.23 (t, J = 7.6 Hz, 1H), 2.12 (ddd, 
J = 20.5, 11.5, 5.7 Hz, 1H), 1.62 (dt, J = 14.4, 7.3 Hz, 2H), 1.43 (s, 11H), 1.24 (s, 
14H). 13C NMR (101 MHz, CDCl3) δ = 175.8, 173.9, 156.1, 79.1, 66.2, 49.2, 40.7, 
36.2, 30.5, 30.1, 29.6, 29.5, 29.4, 29.3, 28.5, 26.9, 25.5. 
 
 
Protected C14-3-oxo AHL (EP6):154 A mixture of 12-aminododecanoic acid 
(71.5 mg, 0.332 mmol, 1.0 eq.), di-tert-
butyl dicarbonate (101.0 mg, 0.465 mmol, 
1.4 eq.) and NaOH (17.3 mg, 0.432 mmol, 1.3 eq.) in H2O (3 mL) and tert-butanol 
(1.5 mL) was stirred at room temperature for 23 h. The mixture was diluted with H2O 
and 1 M aqueous HCl solution and was extracted with EtOAc (3 x 10 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, filtered, 
concentrated and subsequently dissolved in CH2Cl2 (3 mL) and Meldrum`s acid 
(47.8 mg, 0.332 mmol, 1.0 eq.), N,N'-dicyclohexylcarbodiimide (75.3 mg, 
0.365 mmol, 1.1 eq.) and 4-dimethyl-aminopyridine (44.6 mg, 0.365 mol, 1.1 eq.) 
were added. The mixture was stirred at room temperature for 18 h and then filtered 
and the filtrate was concentrated. DMF (2 mL) and (S)-α-amino-γ-butyrolactone 
hydrobromide (61.0 mg, 0.332 mg, 1.0 eq.) were added to the residue. The mixture 
was heated to 60 °C, stirred for 4 h, and subsequently cooled down to room 
temperature. The mixture was diluted with EtOAc and washed with saturated 
NaHCO3 solution (10 mL), 1 M HCl solution (10 mL) and brine (10 mL). The organic 
layer was concentrated and the crude product was purified by flash-chromatography 
(SiO2, EtOAc/pentane 1:1 to 2:1) to yield EP6 (72.1 mg, 0.169 mmol, 51%) as a 
white solid. 
 
M.p. = 82.8-84.3 °C. Rf = 0.23 (EtOAc/pentane 2:1). Optical rotation: [α]D = 0.0 
(c = 0.69, CH2Cl2). FTIR ν = 3345, 3297, 3065, 2920, 2853, 2167, 1776, 1718, 1681, 
1645, 1525, 1470, 1364, 1322, 1274, 1251, 1180, 1107, 1015, 950, 870, 719, 
652 cm-1. 1H-NMR (400 MHz, CDCl3) δ = 13.23 (s, 1H), 7.70 (d, J = 5.0 Hz, 1H), 
4.59 (ddd, J = 11.5, 8.8, 6.8 Hz, 1H), 4.51 (brs, 1H), 4.46 (td, J = 9.1, 1.2 Hz, 1H), 
4.26 (ddd, J = 11.0, 9.3, 6.1 Hz, 1H), 3.11-3.04 (m, 2H), 2.80-2.65 (m, 1H), 2.51 (t, 
J = 7.4 Hz, 2H), 2.23 (ddd, J = 23.6, 11.3, 9.0 Hz, 1H), 1.59-1.53 (m, 2H), 1.42 (s, 
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9H), 1.24 (s, 16H). 13C-NMR (101 MHz, CDCl3) δ = 206.7, 174.9, 166.5, 79.1, 66.0, 
49.2, 48.2, 45.9, 44.0, 40.7, 30.2, 29.8, 29.6, 29.5, 29.4, 29.3, 29.0, 28.5, 26.9, 23.4. 
HRMS ESI calc. for C23H41N2O6 [M-H]+: 441.2959, found: 441.2971.  
 
 
 N-Boc-C11-AHL (EP7):154 A mixture of 11-aminoundecanoic acid (91.0 mg, 
0.452 mmol, 1.0 eq.), di-tert-butyl dicarbonate 
(13.8 mg, 0.633 mmol, 1.4 eq.), NaOH (23.5 mg, 
0.588 mmol, 1.3 eq.) in H2O (4.0 mL), and tert-butanol (2 mL) was stirred at room 
temperature for 23 h. The mixture was diluted with H2O and 1 M HCl solution before 
it was extracted with EtOAc (3 x 15 mL). The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The residue was 
dissolved in MeCN (5.0 mL). N,N'-Disuccinimidyl carbonate (146.0 mg, 0.542 mmol, 
1.1 eq.) and pyridine (0.1 mL, 0.904 mmol, 2.0 eq.) were added. The mixture was 
stirred at room temperature for 18 h after which time it was concentrated. The residue 
was extracted with 1 M HCl solution and CH2Cl2 (3 x 10 mL). The combined organic 
layers were dried over Na2SO4, filtered, concentrated in vacuo, and subsequently 
dissolved in MeCN (5.0 mL). (S)-α-Amino-γ-butyrolactone hydrobromide (123.0 mg, 
0.678 mmol, 1.5 eq.) and freshly distilled Et3N (0.1 mL, 0.903 mmol, 2.0 eq.) were 
added and the resulting mixture was stirred at room temperature for 18 h. The reaction 
mixture was concentrated in vacuo and the residue was extracted with H2O and 
CH2Cl2 (3 x 10 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by flash-chromatography (SiO2, EtOAc/pentane 1:1) to yield the title 
compound (155.0 mg, 0.403 mmol, 89%) as white solid. 
 
M.p. = 121.3-121.7 °C. Rf = 0.40 (EtOAc/pentane 2:1). Optical rotation: [α]D = 0.0 
(c = 0.72, CH2Cl2). FTIR ν = 3323, 2922, 2853, 1775, 1681, 1644, 1525, 1470, 1448, 
1425, 1385, 1366, 1339, 1284, 1274, 1248, 1226, 1167, 1108, 1042, 1013, 964, 948, 
869, 782, 721, 655, 633 cm-1. 1H-NMR (400 MHz, CDCl3) δ = 6.28 (brs, 1H), 4.55 
(ddd, J = 11.6, 8.5, 5.9, 1H), 4.46 (t, J = 9.0 Hz, 1H), 4.28 (ddd, J = 11.2, 9.4, 5.9 Hz, 
1H), 3.16-3.00 (m, 2H), 2.84 (dt, J = 12.5 Hz, 1H), 2.24 (t, J = 7.6 Hz, 2H), 2.14 (ddd, 
J = 23.8, 11.5, 8.9 Hz, 1H), 1.63 (dt, J =14.8, 7.4 Hz, 2H), 1.43 (s, 11H), 1.26 (s, 
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12H). 13C-NMR (101 MHz, CDCl3) δ = 175.7, 174.0, 66.2, 49.3, 40.7, 36.2, 30.6, 
30.1, 29.5, 29.4, 29.3, 29.2, 28.5, 26.8, 25.5. HRMS ESI calc. for C20H36N2O5 
[M-H]+: 385.2697, found: 385.2710.  
 
 
N-Boc-C13-3-Oxo-AHL (EP8):154 A mixture of 11-aminoundecanoic acid (30.4 mg, 
0.151 mmol, 1.0 eq.), di-tert-butyl 
dicarbonate (46.1 mg, 0.211 mmol, 1.4 eq.) 
and NaOH (7.85 mg, 0.196 mmol, 1.3 eq.) in H2O (3 mL) and tert-butanol (1.5 mL) 
was stirred at room temperature for 23 h. The mixture was diluted with H2O and 1 M 
HCl and was extracted with EtOAc (3 x 10 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated and subsequently 
dissolved in CH2Cl2 (3 mL) and Meldrum`s acid (21.8 mg, 0.151 mmol, 1.0 eq.), 
N,N'-dicyclohexylcarbodiimide (34.3 mg, 0.166 mmol, 1.1 eq.) and 4-dimethyl-
aminopyridine (20.3 mg, 0.166 mol, 1.1 eq.) were added. The mixture was stirred at 
room temperature for 18 h and then filtered and the filtrate was concentrated. DMF 
(2 mL) and (S)-α-amino-γ-butyrolactone hydrobromide (30.2 mg, 0.166 mg, 1.1 eq.) 
were added to the residue. The mixture was heated to 60 °C, stirred for 4 h and 
subsequently cooled down to room temperature. The mixture was diluted with EtOAc 
and washed with saturated NaHCO3 solution (10 mL), 1 M HCl solution (10 mL) and 
brine (10 mL). The organic layer was concentrated and the crude product was purified 
by flash chromatography (SiO2, EtOAc/pentane 1:1 to 2:1) to yield EP8 (60.8 mg, 
0.143 mmol, 94%) as a white solid. 
 
M.p. = 85.4-86.5 °C. Rf = 0.14 (EtOAc/pentane 2:1). Optical rotation: [α]D = –1.8 
(c = 0.59, CH2Cl2). FTIR ν = 3355, 3318, 2922, 2851, 1776, 1717, 1682, 1643, 1523, 
1469, 1409, 1365, 1277, 1251, 1171, 1106, 1013, 949, 871, 784, 725 cm-1. 1H-NMR 
(400 MHz, CDCl3) δ = 13.24 (s, 1H), 7.70 (d, J = 4.6 Hz, 1H), 4.59 (ddd, J = 11.5, 
8.7, 6.7 Hz, 1H), 4.50 (brs, 1H), 4.47 (t, J = 9.1 Hz, 2H), 4.27 (ddd, J = 11.0, 9.3, 
6.1 Hz, 1H), 3.09 (dd, J = 12.4, 6.0 Hz, 2H), 2.81-2.69 (m, 1H), 2.52 (t, J = 7.3 Hz, 
2H), 2.23 (ddd, J = 23.6, 11.4, 9.0 Hz, 1H), 1.61-1.52 (m, 2H), 1.43 (s, 11H), 1.26 (s, 
10H). 13C-NMR (101 MHz, CDCl3) δ = 206.7, 174.9, 166.5, 79.1, 66.0, 49.2, 48.2, 
45.9, 44.0, 30.2, 30.0, 29.5, 29.4, 29.1, 28.6, 26.9, 23.4. HRMS ESI calc. for 
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C22H39N2O6 [M-H]+: 427.2803, found: 427.2811.  
 
 
N-Boc-C14-3-oxo-AHL (EP9):154 Linker EP6 (149.6 mg, 0.341 mmol, 1.0 eq.) was 
dissolved in CH2Cl2 (0.5 mL) and 
TFA (0.5 mL) at r.t. and the 
resulting mixture was stirred for 5 h. 
The solvent was removed under rotary evaporation and the crude was redissolved in 
dry CH2Cl2 (2 mL). N-Boc-4-piperidinecarboxylic acid (78.2 mg, 0.341 mmol, 
1.0 eq.) was dissolved in dry MeCN (4 mL) and cooled down to 0 °C before 
N-hydroxysuccinimide (43.2 mg, 0.375 mmol, 1.1 eq.) and 
N,N'-dicyclohexylcarbodiimide (77.4 mg, 0.375 mmol, 1.1 eq.) were added. The 
mixture was stirred at r.t. for 16 h. The deprotected AHL analogue and triethylamine 
(96 µL, 0.682 mmol, 2.0 eq.) were added subsequently and the reaction mixture was 
stirred at r.t. for 3 h and 15 min. The solvent was evaporated and the residue was 
extracted with H2O and CH2Cl2 (3 x). The organic layers were combined, dried over 
Na2SO4, filtered and evaporated under reduced pressure. The residue was purified by 
flash chromatography (EtOAc/pentane 1:1) to yield the desired product (117.0 mg, 
0.212 mmol, 62%) as a white solid. 
 
M.p.: 108.2-110.9 °C. Rf = 0.05 (EtOAc/pentane 2:1). FTIR ν = 3296, 3076, 2920, 
2851, 1777, 1719, 1685, 1635, 1544, 1467, 1429, 1383, 1364, 1337, 1278, 1261, 
1246, 1216, 1176, 1130, 1104, 1067, 1016, 1003, 946, 872, 818, 763, 720, 688, 
609 cm-1. 1H NMR (500 MHz, CDCl3) δ = 13.54 (s, 1H), 7.71 (d, J = 5.8 Hz, 1H), 
5.51 (s, 1H), 4.58 (ddd, J = 11.4, 8.7, 6.6 Hz, 1H), 4.47 (td, J = 9.1, 1.2 Hz, 1H), 4.27 
(ddd, J = 11.0, 9.3, 6.1 Hz), 4.13 (d, J = 13.3 Hz, 2H), 3.23 (dd, J = 12.8, 6.9 Hz, 2H), 
2.75 (ddd, J = 21.3, 12.0, 1.8 Hz, 3H), 2.52 (t, J = 7.3 Hz, 2H), 2.26-2.17 (m, 2H), 
1.83-1.75 (m, 2H), 1.61 (ddd, J = 16.2, 12.7, 5.5 Hz, 6H), 1.45 (s, 9H), 1.30-1.21 (m, 
18H). 13C NMR (101 MHz, CDCl3) δ = 206.7, 174.9, 166.5, 154.8, 79.8, 66.0, 49.2, 
44.0, 43.6, 396, 30.0, 29.8, 29.7, 29.5, 29.4, 29.0, 28.8, 28.6, 27.0, 23.4. HRMS ESI 
calc. for C29H49N3NaO7 [M-Na]+: 574.3465, found: 574.3463. 
 
 
O
N
N
H
O
O
H
N
O OO
H
O
EXPERIMENTAL PART 
 
161 
C12-FLAQS (EP10):154 To a solution of EP5 (8.0 mg, 0.020 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA  
(0.5 mL) and the mixture was stirred at 
room temperature for 3 h. The reaction 
mixture was concentrated in vacuo and 
subsequently dissolved in MeCN 
(2.0 mL). Rhodamine B isothiocyanate 
(8, 10.1 mg, 0.020 mmol, 1.0 eq.) and freshly distilled Et3N (5.0 µL, 0.04 mmol, 
2.0 eq.) were added and the resulting mixture was stirred at room temperature for 
17 h. The solvent was removed with a nitrogen stream at room temperature. The 
residue was dissolved in a little amount of CH2Cl2 and precipitated in Et2O to yield 
13.5 mg of the impure title compound as a purple solid.  
 
M.p. = 86.9-90.1 °C. Rf = 0.30 (CH2Cl2/MeOH 7:1). FTIR ν = 3240, 3047, 2977, 
2928, 2855, 2623, 2607, 2499, 1778, 1756, 1646, 1588, 1529, 1465, 1398, 1337, 
1273, 1246, 1178, 1130, 1073, 1037, 1015, 976, 923, 825, 683 cm-1. 1H-NMR 
(400 MHz, d4-MeOD) δ = 8.54-6.59 (m, 9H), 4.63-4.53 (m, 1H), 4.44 (td, J = 9.0, 
1.8 Hz, 1H), 4.35-4.23 (m, 1H), 3.73-3.57 (m, 8H), 2.95-2.87 (m, 2H), 2.53 (ddd, 
J = 11.0, 9.6, 4.4 Hz, 1H), 2.29-2.21 (m, 3H), 1.72-1.55 (m, 4H), 1.36-1.26 (m, 25H). 
UPLC-MS (+ESI) m/z = 799.0 (M+H)+. 
 
 
C12-FLAQS (EP11):154 To a solution of EP5 (8.3 mg, 0.021 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA 
(0.5 mL) and the mixture was stirred at 
room temperature for 3 h. The reaction 
mixture was concentrated under 
reduced pressure. To a solution of rhodamine B (5, 10.0 mg, 0.021 mmol, 1.0 eq.) in 
MeCN (2.0 mL) was added N-hydroxysuccinimide (2.4 mg, 0.021 mmol, 1.0 eq.) and 
1-(3-dimethylaminopropyl)-3-ethylcarbo-diimide hydrochloride (4.0 mg, 0.021 mmol, 
1.0 eq.) and the resulting mixture was stirred at room temperature for 4 h. The 
previously deprotected EP5 and freshly distilled Et3N (6.0 µL, 0.042 mmol, 2.0 eq.) 
were added to the mixture and was stirred at room temperature for 15 h. The solvent 
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was evaporated under reduced pressure and the residue was extracted with H2O and 
CH2Cl2 (3 x 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by size-
exclusion chromatography (MeOH) to yield 20.9 mg of the impure title compound as 
a purple solid. 
 
Rf = 0.25 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 7.89-7.83 (m, 
1H), 7.72 (dd, J = 5.5, 3.4 Hz, 1H), 7.62 (dd, J = 5.8, 3.1 Hz, 1H), 7.59-7.50 (m, 2H), 
7.09 (dd, J = 6.0, 1.8 Hz, 1H), 6.48 (s, 2H), 6.37 (dd, J = 21.1, 8.0 Hz, 2H), 4.62-4.53 
(m, 1H), 4.43 (td, J = 9.0, 1.6 Hz, 1H), 4.29 (ddd, J = 10.2, 9.2, 6.6 Hz, 1H), 3.40 (dd, 
J = 14.0, 7.0 Hz, 8H), 3.05 (t, J = 6.5 Hz, 2H), 2.59-2.48 (m, 1H), 2.27-2.18 (m, 3H), 
1.63-1.57 (m, 2H), 1.34-1.27 (m, 4H), 1.16 (t, J = 7.0 Hz, 12H), 1.12-1.01 (m, 10H).  
 
 
C18-FLAQS (EP12):154 To a solution of rhodamine B (5, 9.6 mg, 0.020 mmol, 
1.0 eq.) in MeCN  (2 mL) 
was added NHS (2.5 mg, 
0.022 mmol, 1.1 eq.) and 
1-(3-dimethylamino-
propyl)-3-ethylcarbo-diimide hydrochloride (4.2 mg, 0.022 mmol, 1.1 eq.). This 
mixture was stirred at room temperature for 18 h. 6-Amino-hexanoic acid (2.6 mg, 
0.020 mmol, 1.0 eq.) and freshly distilled Et3N (6.0 µL, 0.040 mmol, 2.0 eq.) were 
added to the mixture and stirred at room temperature for 23 h. It was concentrated in 
vacuo and the residue was extracted with 1 M HCl solution and CH2Cl2 (3 x 5 mL). 
The combined organic layers were dried over Na2SO4, filtered, concentrated in vacuo, 
and purified by flash-chromatography (SiO2, 10% MeOH in CH2Cl2). To a mixture of 
EP5 (8.3 mg, 0.020 mmol, 1.0 eq.) in MeCN (2.0 mL) was added Et3N (6.0 µL, 
0.040 mmol, 2.0 eq.) and the mixture was stirred at room temperature for 7.5 h. The 
previously synthesized rhodamine B derivative in MeCN (1.0 mL) was added to the 
reaction mixture and stirred at room temperature for additional 15 h. The mixture was 
concentrated in vacuo and the residue was extracted with H2O and CH2Cl2 (3 x 5 mL). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by size-exclusion chromatography (MeOH) to 
yield 5.8 mg of the impure title compound as a purple solid. 
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Rf = 0.10 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 8.37-6.74 (m, 
10H), 4.58 (dd, J = 10.8, 9.3 Hz, 1H), 4.44 (td, J = 9.0, 1.7 Hz, 1H), 4.29 (ddd, 
J = 10.5, 9.1, 6.6 Hz, 1H), 3.69 (dt, J = 19.2, 7.0 Hz, 8H), 2.53 (dt, J = 13.7, 7.0 Hz, 
4H), 2.27-2.20 (m, 9H), 2.06-2.00 (m, 1H), 1.64-1.52 (m, 14H), 1.34-1.30 (m, 18H).  
 
 
C11-FLAQS (EP13):154 To a solution of EP7 (8.3 mg, 0.021 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA 
(0.5 mL) and the mixture was stirred at 
room temperature for 3 h. The reaction 
mixture was concentrated and used 
without further purification. To a solution of rhodamine B (5, 10.0 mg, 0.021 mmol, 
1.0 eq.) in MeCN (2 mL) was added N-hydroxysuccinimide (2.4 mg, 0.021 mmol, 
1.0 eq.) and 1-(3-dimethylaminopropyl)-3-ethylcarbo-diimide hydrochloride (4.0 mg, 
0.021 mmol, 1.0 eq.) and the mixture was stirred at room temperature for 4 h. To this 
mixture was added the previously deprotected EP7 and Et3N (6 µL, 0.042 mmol, 
2.0 eq.) and the mixture was stirred at room temperature for 15 h. The solvent was 
evaporated under reduced pressure and the residue was extracted with H2O and 
CH2Cl2 (3 x 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated. The crude product was purified by size exclusion 
chromatography (Sephadex LH-20, MeOH) to yield 20.9 mg of the impure product as 
a purple solid. 
 
Rf = 0.25 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 7.89-7.83 (m, 
1H), 7.72 (dd, J = 5.5, 3.4 Hz, 1H), 7.62 (dd, J = 5.8, 3.1 Hz, 1H), 7.59-7.50 (m, 2H), 
7.09 (dd, J = 6.0, 1.8 Hz, 1H), 6.48 (s, 2H), 6.37 (dd, J = 21.1, 8.0 Hz, 2H), 4.62-4.53 
(m, 1H), 4.43 (td, J = 9.0, 1.6 Hz, 1H), 4.29 (ddd, J = 10.2, 9.2, 6.6 Hz, 1H), 3.40 (dd, 
J = 14.0, 7.0 Hz, 8H), 3.05 (t, J = 6.5 Hz, 2H), 2.59-2.48 (m, 1H), 2.27-2.18 (m, 3H), 
1.63-1.57 (m, 2H), 1.34-1.27 (m, 4H), 1.16 (t, J = 7.0 Hz, 12H), 1.12-1.01 (m, 10H). 
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C11-FLAQS (EP14):154 To a solution of EP7 (8.0 mg, 0.020 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA (0.5 mL) 
and the mixture was stirred at room 
temperature for 3 h. The reaction mixture 
was concentrated and subsequently 
dissolved in MeCN (2 mL). Rhodamine B 
isothiocyanate (8, mixed isomers, 10.1 mg, 
0.020 mmol, 1.0 eq.) and Et3N (5 µL, 0.04 mmol, 2.0 eq.) were added and the mixture 
was stirred at room temperature for 17 h. The solvent was removed with a nitrogen 
stream. The residue was dissolved in a little amount of CH2Cl2 and precipitated in 
Et2O to yield 13.5 mg of the impure product as a purple solid.  
 
M.p. = 86.9-90.1 °C. Rf = 0.30 (CH2Cl2/MeOH 7:1). FTIR ν = 3240, 3047, 2977, 
2928, 2855, 2623, 2607, 2499, 1778, 1756, 1646, 1588, 1529, 1465, 1398, 1337, 
1273, 1246, 1178, 1130, 1073, 1037, 1015, 976, 923, 825, 683 cm-1. 1H-NMR 
(400 MHz, d4-MeOD) δ = 8.54-6.59 (m, 9H), 4.63-4.53 (m, 1H), 4.44 (td, J = 9.0, 
1.8 Hz, 1H), 4.35-4.23 (m, 1H), 3.73-3.57 (m, 8H), 2.95-2.87 (m, 2H), 2.53 (ddd, 
J = 11.0, 9.6, 4.4 Hz, 1H), 2.29-2.21 (m, 3H), 1.72-1.55 (m, 4H), 1.36-1.26 (m, 21H). 
UPLC-MS (+ESI) m/z = 799.0 (M+H)+. 
 
 
C10-FLAQS (EP15):154 Fluorophore 10 (11.0 mg, 0.017 mmol, 1.0 eq.) was dissolved 
in CH2Cl2 (1.5 mL) and TFA 
(1.5 mL) and stirred at room 
temperature for 5 h. The reaction was 
concentrated in vacuo. To a mixture 
of activated decandioic acid (5.5 mg, 
0.014 mmol, 0.8 eq.) in MeCN (1.0 mL) was added (S)-α-amino-γ-butyrolactone 
hydrobromide (3.1 mg, 0.017 mmol, 1.0 eq.) and freshly distilled Et3N (5 µL, 
0.034 mmol, 2.0 eq.) and the mixture was stirred at room temperature for 6.5 h. The 
previously deprotected 10 in MeCN (1.0 mL) was added and the mixture was stirred 
at room temperature for 15 h. It was concentrated under reduced pressure and the 
residue was extracted with H2O and CH2Cl2 (3 x 5 mL). The combined organic layers 
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were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified by size-exclusion chromatography (MeOH) to yield 12.6 
mg of the impure title compound as a purple solid. 
 
Rf = 0.25 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 7.80-7.78 (m, 
2H), 7.68-7.62 (m, 1H), 7.53-7.46 (m, 1H), 7.28 (dd, J = 9.5, 2.7 Hz, 2H), 7.07 (t, 
J = 8.4 Hz, 2H), 6.97 (d, J = 2.4 Hz, 2H), 4.62-4.52 (m, 1H), 4.43 (td, J = 9.0, 1.9 Hz, 
1H), 4.33-4.23 (m, 1H), 4.13 (d, J = 12.3 Hz, 1H), 3.79-3.66 (m, 9H), 3.08-2.97 (m, 
1H), 2.72-2.64 (m, 1H), 2.57-2.48 (m, 1H), 2.31-2.18 (m, 2H), 2.12 (t, J = 7.4 Hz, 
2H), 1.83-1.71 (m, 3H), 1.63-1.52 (m, 4H), 1.32 (t, J = 6.2 Hz, 24H).  
 
 
C13-3-Oxo-FLAQS (12):154 To a solution of EP8 (5.0 mg, 0.011 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA  
(0.5 mL) and the mixture was stirred 
at room temperature for 3 h. The 
reaction mixture was concentrated 
and used without further purification. 
To a solution of rhodamine B (5, 5.4 mg, 0.011 mmol, 1.0 eq.) in MeCN (2 mL) was 
added N-hydroxysuccinimide (1.31 mg, 0.011 mmol, 1.0 eq.) and 
1-(3-dimethylaminopropyl)-3-ethylcarbo-diimide hydrochloride (2.18 mg, 
0.011 mmol, 1.0 eq.) and the mixture was stirred at room temperature for 4 h. To this 
mixture was added the previously deprotected EP8 and Et3N (3 µL, 0.023 mmol, 
2.0 eq.) and the mixture was stirred at room temperature for 15 h. The solvent was 
evaporated under reduced pressure and the residue was extracted with H2O and 
CH2Cl2 (3 x 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated. The crude product was purified by size exclusion 
chromatography (Sephadex LH-20, MeOH) to yield 8.6 mg of impure product as a 
purple solid. 
 
Rf = 0.45 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 8.10 (dd, J = 7.4, 
1.2 Hz, 1H), 7.91-7.81 (m, 1H), 7.63 (ddt, J = 8.9, 7.4, 3.7 Hz, 2H), 7.56-7.48 (m, 
2H), 7.35-7.21 (m, 2H), 7.07 (dd, J = 5.2, 2.2 Hz, 1H), 6.99 (dd, J = 9.5, 2.5 Hz, 1H), 
4.61 (dd, J = 10.9, 9.2 Hz, 1H), 4.44 (td, J = 9.0, 1.7 Hz, 1H), 4.29 (ddd, J = 10.6, 9.0, 
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6.5 Hz, 1H), 3.65 (q, J = 7.1 Hz, 8H), 3.04 (t, J = 6.9 Hz, 2H), 2.59-2.53 (m, 2H), 
2.39-2.10 (m, 2H), 1.57-1.51 (m, 2H), 1.29 (t, J = 7.1Hz, 12H), 1.16 (t, J = 7.0 Hz, 
16H). 
 
 
C14-3-Oxo-FLAQS (13):154 To a solution of EP6 (10.0 mg, 0.023 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA 
(0.5 mL) and the mixture was stirred 
at room temperature for 3 h. The 
reaction mixture was concentrated 
and subsequently dissolved in MeCN 
(1.5 mL). Rhodamine B 
isothiocyanate (8, mixed isomers, 11.4 mg, 0.023 mmol, 1.0 eq.) and Et3N (5 µL, 
0.045 mmol, 2.0 eq.) were added and the mixture was stirred at room temperature for 
17 h. The solvent was concentrated and the residue was extracted with H2O and 
CH2Cl2 (3 x 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated. The crude product was recrystallized with CH2Cl2 
in EtO2 to yield 34.9 mg of impure product as a purple solid.  
 
Rf = 0.20 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 8.09-6.81 (m, 
9H), 4.66-4.52 (m, 1H), 4.47-4.37 (m, 1H), 4.34-4.19 (m, 1H), 3.69-3.55 (m, 8H), 
2.57 (ddd, J = 11.5, 6.0, 3.6 Hz, 2H), 2.33-2.08 (m, 2H), 1.61-1.50 (m, 2H), 1.39-1.21 
(m, 14H), 1.10, (dt, J = 14.0, 7.0 Hz, 16H). 
 
 
C14-3-Oxo-FLAQS (14):154 To a solution of EP6 (7.7 mg, 0.023 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA 
(0.5 mL) and the mixture was 
stirred at room temperature for 3 h. 
The reaction mixture was 
concentrated under reduced pressure. To a solution of rhodamine B (5, 10.9 mg, 
0.023 mmol, 1.0 eq.) in MeCN (1 mL) was added N-hydroxysuccinimide (2.6 mg, 
0.023 mmol, 1.0 eq.) and 1-(3-dimethylaminopropyl)-3-ethylcarbo-diimide 
hydrochloride (4.35 mg, 0.023 mmol, 1.0 eq.) and the mixture was stirred at room 
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temperature for 4 h. To this mixture was added the previously deprotected EP6 and 
Et3N (6 µL, 0.045 mmol, 2.0 eq.) and the mixture was stirred at room temperature for 
15 h. The solvent was evaporated under reduced pressure and the residue was 
extracted with H2O and CH2Cl2 (3 x 5 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered, and concentrated. The crude product 
was purified by size exclusion chromatography (Sephadex LH-20, MeOH) to yield 
37.2 mg of the impure title compound as a purple solid. 
 
Rf = 0.30 (CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 8.11 (dd, J = 7.5, 
1.4 Hz, 1H), 7.70-7.59 (m, 2H), 7.26 (dd, J = 10.6, 5.5 Hz, 2H), 6.99 (dd, J = 9.5, 
2.4 Hz, 2H), 6.91 (d, J = 2.4 Hz, 2H), 6.34 (ddd, J = 15.1, 5.7, 3.9 Hz, 1H), 4.66-4.52 
(m, 1H), 4.44 (ddd, J = 15.1, 5.7, 3.9 Hz, 1H), 4.35-4.25 (m, 1H), 3.65 (q, J = 7.1 Hz, 
8H), 3.22-3.10 (m, 2H), 2.63-2.49 (m, 2H), 2.43-2.21 (m, 2H), 2.43-2.21 (m, 2H), 
1.29 (t, J = 7.0 Hz, 18H), 1.15 (dd, J = 13.0, 6.1, 12H).  
 
 
C14-3-Oxo-FLAQS (15): Hybrid EP9 (100.0 mg, 0.181 mmol, 1.0 eq.) was dissolved 
in CH2Cl2 (1 mL) and TFA 
(1 mL) at r.t. and the 
resulting mixture was stirred 
for 5 h. The solvent was 
removed under rotary 
evaporation and the crude was redissolved in dry MeCN (1 mL). Rhodamine B (5, 
87.2 mg, 0.182 mmol, 1.0 eq.) was dissolved in dry MeCN (5 mL) and 
N-hydroxysuccinimide (23.1 mg, 0.200 mmol, 1.1 eq.) and 
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (38.4 mg, 
0.200 mmol, 1.1 eq.) were added. The mixture was stirred at r.t. over night. The 
deprotected AHL analogue and triethylamine (51 µL, 0.364 mmol, 2.0 eq.) were 
added subsequently and the reaction mixture was stirred at r.t. over night. The solvent 
was evaporated and the residue was extracted with H2O and CH2Cl2 (3 x). The 
combined organic layers were washed with brine, dried over Na2SO4, filtered, and 
concentrated. The crude compound was purified by preparative RP HPLC (2.5-100% 
water/ACN over 1 h) to yield the title compound (49.4 mg, 0.054 mmol, 30%) as 
purple solid. 
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M.p.: 110.0-116.6°C. Rf = 0.15 (CH2Cl2/MeOH 7:1). FTIR ν = 2965, 2926, 2854, 
1779, 1715, 1645, 1629, 1585, 1529, 1508, 1481, 1466, 1411, 1394, 1334, 1272, 
1246, 1178, 1131, 1072, 1010, 978, 951, 921, 868, 820, 791, 758, 729, 710, 683, 664, 
630 cm-1. 1H-NMR (500 MHz, CDCl3) δ = 7.78-7.74 (m, 2H), 7.68-7.65 (m, 1H), 
7.51 (dd, J = 5.4, 3.3 Hz, 1H), 7.28 (t, J = 9.6 Hz, 2H), 7.07 (d, J = 9.6 HZ, 2H), 6.97 
(d, J = 2.2 HZ, 2H), 4.61 (dd, J = 10.9, 9.3 Hz, 1H), 4.44 (td, J = 9.0, 1.7 Hz, 1H), 
4.34-4.18 (m, 2H), 3.82 (d, J = 12.9 Hz, 1H), 3.70 (q, J = 7.1 Hz, 9H), 3.11 (t, 
J = 6.9 Hz, 2H), 3.06-2.59 (m, 1H), 2.60-2.52 (m, 4H), 2.38-2.22 (m, 2H), 1.71-1.58 
(m, 2H), 1.57-1.51 (m, 2H), 1.49-1.40 (m, 2H), 1.34-1.27 (m, 24H). 13C-NMR 
(101 MHz, CDCl3) δ = 206.3, 177.1, 176.6, 169.3, 159.3, 157.2, 157.1, 137.1, 133.3, 
133.2, 132.0, 131.7, 131.3, 131.0, 128.7, 1156.6, 114.8, 97.4, 97.3, 67.2, 50.1, 46.9, 
43.6, 43.4, 42.4, 40.3, 30.6, 30.6, 30.5, 30.5, 30.4, 30.3, 30.1, 29.6, 27.9, 24.4, 12.9. 
HRMS ESI calc. for C52H70N5O7 [M]+: 876.5270, found: 876.5276. 
 
 
C13-3-Oxo-FLAQS (16):154 To a solution of EP8 (5.00 mg, 0.011 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) was added TFA 
(0.5 mL) and the mixture was stirred at 
room temperature for 3 h. The reaction 
mixture was concentrated and 
subsequently dissolved in MeCN 
(2.5 mL). Rhodamine B isothiocyanate 
(8, mixed isomers, 5.7 mg, 0.011 mmol, 1.0 eq.) and Et3N (3 µL, 0.023 mmol, 2.0 eq.) 
were added and the mixture was stirred at room temperature for 17 h. The solvent was 
concentrated and the residue was extracted with H2O and CH2Cl2 (3 x 5 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, filtered, and 
concentrated. The crude product was recrystallized with CH2Cl2 in EtO2 to yield 
10.1 mg of impure product as a purple solid. 
  
Rf = 0.23 (SiO2, CH2Cl2/MeOH 7:1). 1H-NMR (400 MHz, d4-MeOD) δ = 8.24-6.85 
(m, 9H), 4.66-4.55 (m, 1H), 4.50-4.38 (m, 1H), 4.36-4.25 (m, 1H), 3.67 (d, 
N
H
O
ON N
N
H
HN
S
O
O O
O
O
H
EXPERIMENTAL PART 
 
169 
J = 6.6 Hz, 4H), 3.21 (dt, J = 7.0, 5.1 Hz, 2H), 2.96-2.86 (m, 1H), 2.64-2.51 (m, 2H), 
2.38-2.22 (m, 1H), 1.73-1.48 (m, 4H), 1.31 (dd, J = 7.0, 4.9 Hz, 22H). 
 
 
Green FLAQS (17): Hybrid EP5 (14.0 mg, 0.035 mmol, 1.0 eq.) was dissolved in 
CH2Cl2 (0.5 mL) and TFA (0.5 mL) at r.t. 
and the resulting mixture was stirred for 
3 h. The solvent was removed under rotary 
evaporation and the crude was redissolved in dry CH2Cl2 (2 mL). The solution was 
cooled down to 0 °C before triethylamine (5.0 µL, 0.035 mmol, 1.0 eq.) and dansyl 
chloride (9.5 mg, 0.035 mmol, 1.0 eq.) were added. After stirring for 1 h, the reaction 
mixture was allowed to warm up to r.t. and the stirring was continued for a further 
hour. TLC showed an incomplete conversion of the starting material, so more dansyl 
chloride (28.5 mg, 0.105 mmol, 3.0 eq.) was added and the mixture was stirred at r.t. 
overnight. The solvent was evaporated under reduced pressure and the residue was 
purified by flash chromatography (CH2Cl2/MeOH 10:1) to yield the desired product 
as a yellow solid (13.0 mg, 0.024 mmol, 70%). 
 
M.p.: 69.4-71.4°C. Rf = 0.43 (EtOAc/pentane 2:1). FTIR ν = 3318, 3078, 2923, 
2852, 2789, 1777, 1711, 1645, 1574, 1545, 1456, 1407, 1382, 1357, 1310, 1224, 
1160, 1139, 1092, 1075, 1013, 946, 789, 725, 682, 625 cm-1. 1H-NMR (500 MHz, 
CDCl3) δ = 8.78-8.50 (m, 1H), 8.46-8.29 (m, 1H), 8.23 (d, J = 7.0 Hz, 1H), 7.55 (dd, 
J = 15.3, 7.2 Hz, 2H), 7.30-7.16 (m, 1H), 6.49-6.31 (m, 1H), 5.16-4.94 (m, 1H), 4.95 
(ddd, J = 11.3, 8.6, 6.4 Hz, 1H), 4.44 (t, J = 8.7 Hz, 1H), 4.26 (ddd, J = 11.0, 9.3, 
6.0 Hz, 1H), 2.99-2.84 (m, 6H), 2.77 (ddd, J = 13.1, 8.2, 5.2 Hz, 1H), 2.26-2.19 (m, 
2H), 2.15 (dt, J = 2.06, 6.9 Hz, 1H), 1.61 (dt, J = 15.0, 7.5 Hz, 2H), 1.34 (dd, J = 13.8, 
6.7 Hz, 2H), 1.29-1.00 (m, 16H). 13C-NMR (101 MHz, CDCl3) δ = 175.9, 174.0, 
135.1, 130.2, 129.8, 128.30 123.8, 115.6, 77.5, 77.2, 76.8, 66.2, 49.2, 45.7, 43.4, 36.2, 
30.4, 29.6, 29.3, 29.3, 29.2, 28.9, 26.4, 25.5. HRMS ESI calc. for C28H42N3O5S 
[M-H]+: 532.2840, found: 532.2847. 
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7.4 Synthesis of Majucin-Type Sesquiterpenes 
Alkene (22): To a 25 mL round-bottom flask was added (R)-pulegone (0.83 mL, 
4.87 mmol, 1.0 eq.), sodium bicarbonate (131.1 mg, 1.55 mmol, 0.3 eq.), 
and Et2O (5 mL). The mixture was cooled down to 0 °C and stirred under 
argon atmosphere. Bromine (0.26 mL, 5.05 mmol, 1.0 eq.) was added drop-
wise over a 30 min period. The resulting mixture was stirred for 30 min at 0 °C, 
filtered, and added to a cold solution of sodium methoxide (594.2 mg, 11.00 mmol, 
2.3 eq.) in MeOH (22 mL). The reaction mixture was heated under reflux for 2.5 h 
with stirring. After cooling, aq. 1 M HCl solution was added and the resulting 
aqueous mixture was extracted three times with Et2O. The combined extracts were 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue 
was purified by flash chromatography (pentane/Et2O 100:1) to afford 22 (590.3 mg, 
3.26 mmol, 67%, d.r. = 1:1) as a colourless liquid. 
 
Rf = 0.44 (pentane/Et2O 17:1). FTIR: ν = 2952, 2872, 1730, 1456, 1434, 1374, 1349, 
1295, 1257, 1230, 1191, 1145, 1008, 907, 804, 741 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 3.67 (s, 3H) 3.65 (s, 3H), 3.41 (d, J = 8.0 Hz, 1H), 2.95 (d, J = 6.4 Hz), 
2.14-2.50 (m, 6H), 1.93-2.01 (m, 1H), 1.62-1.81 (m, 2H), 1.66 (s, 3H), 1.63 (s, 3H), 
1.61 (s, 3H), 1.57 (s, 3H), 1.31-1.29 (m, 1H), 1.04 (d, J = 6.7 Hz, 3H), 1.00 (d, 
J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 176.4, 174.7, 135.1, 134.4, 126.1, 
125.9, 55.8, 52.9, 51.8, 51.2, 41.0, 39.1, 32.9, 30.6, 30.4, 21.7, 21.3, 21.2, 21.1, 19.8, 
15.9. HRMS ESI calc. for C11H18NaO2 [M-Na]+: 205.1199, found: 205.1202. 
 
 
Keto ester (19): Into a solution of 22 (360 mg, 1.98 mmol, 1 eq.) in MeOH (20 mL) 
and CH2Cl2 (100 mL) at -78 °C was bubbled ozone until the solution 
became light blue. Ozone addition was stopped and the solution was stirred 
under argon at -78 °C for 15 min and at r.t. for 10 min. Zinc powder 
(526 mg, 7.96 mmol, 4.0 eq.) and acetic acid (0.46 mL, 7.96 mmol, 4.0 eq.) were 
added to the solution. The resulting mixture was stirred at r.t. for 30 min and filtered 
over celite. The filtrate was neutralized with saturated NaHCO3 solution and the 
aqueous layer was extracted two times with CH2Cl2. Combined organic layers were 
washed with water and brine, dried over Na2SO4, filtered and evaporated under 
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reduced pressure to afford 19 (300.6 mg, 1.92 mmol, 97%) as a colourless liquid. 
 
Rf = 0.13 (pentane/Et2O 9:1). Optical rotation: [α]D = +93.5 (c = 0.46, CHCl3). 
FTIR: ν = 2959, 2875, 1754, 1724, 1436, 1335, 1289, 1260, 1202, 1128, 1006 cm
-1. 
1H NMR (400 MHz, CDCl3) δ = 3.76 (s, 3H), 2.77 (d, J = 11.4 Hz, 1H), 2.67-2.53 
(m, 1H), 2.48-2.39 (m, 1H), 2.38-2.26 (m, 1H), 2.20 (dddd, J = 12.7, 8.3, 6.2, 2.0 Hz, 
1H), 1.48 (dtd, J = 12.6, 11.2, 8.5 Hz, 1H), 1.18 (d, J = 6.5 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 212.0, 169.7, 63.1, 52.5, 38.9, 36.5, 29.5, 19.4. Elementary 
Analysis calc. for C8H12O3: C = 61.52, H = 7.74, N = 0.00, found: C = 61.49, 
H = 7.60, N = 0.00. HRMS ESI calc. for C8H13O3 [M-H]+: 157.0859, found: 
157.0861. 
 
 
Silyl ether (23): A mixture of 2-iodoethanol (0.39 mL, 5.0 mmol, 1.0 eq.) and 
imidazole (511.2 mg, 7.5 mmol, 1.5 eq.) were dissolved in dry CH2Cl2 
(7 mL) under argon atmosphere. TBSCl (829.0 mg, 5.5 mmol, 1.1 eq.) 
was added at r.t. and the resulting mixture was stirred overnight. The reaction mixture 
was washed twice with water and brine. The organic layer was dried over Na2SO4, 
filtered and concentrated under reduced pressure to afford 23 (1.395 g, 4.88 mmol, 
98%) as an orange liquid. 
 
1H NMR (400 MHz, CDCl3) δ = 3.83 (t, J = 7.0 Hz, 2H), 3.20 (t, J = 7.0 Hz, 2H), 
0.90 (s, 9H), 0.08 (s, 6H). 
 
Analytical according to reference: C. Desroches, C. Lopes, V. Kessler, S. Parola, 
Dalton Trans. 2003, 2085.  
 
 
Silyl ether (EP16): Ketone 19 (300.0 mg, 1.92 mmol, 1.0 eq.) was dissolved in dry 
acetone (15 mL) under argon atmosphere. Linker 23 (630.1 mg, 
2.20 mmol, 1.2 eq.) and potassium carbonate (611.2 mg, 4.40 mmol, 
2.3 eq.) were added and the resulting mixture was stirred for 4 h at 
r.t., followed by stirring for 2 days at reflux. The solvent was removed by rotary 
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evaporation and the mixture was diluted with Et2O and washed with water. The 
aqueous layer was extracted twice with Et2O, and the combined organic layers were 
dried over Na2SO4, filtered and concentrated under reduced pressure. The crude 
product was purified by flash chromatography (pentane/Et2O 10:1) to afford EP16 
(317.4 mg, 1.01 mmol, 53%, d.r. = 7:1) as colourless oil. 
 
Rf = 0.44 (pentane/Et2O 4:1). Optical rotation: [α]D = +62.7 (c = 0.31, CHCl3). 
FTIR ν = 2955, 2930, 2884, 2857, 1751, 1732, 1463, 1434, 1405, 1398, 1255, 1229, 
1190, 1163, 1097, 1060, 1006, 970, 940, 906, 835, 810, 775, 729, 661 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 3.78-3.69 (m, 1H), 3.66 (s, 3H), 3.68-3.63 (m, 1H), 2.59-2.45 
(m, 2H), 2.34-2.25 (m, 1H), 2.20-2.13 (m, 1H), 2.09-1.96 (m, 2H), 1.77 (ddd, 
J = 23.9, 11.8, 8.5 Hz, 1H), 1.02 (d, J = 6.9 Hz, 3H), 0.86 (s, 9H), 0.02 (d, J = 4.3 Hz, 
6H). 13C NMR (101 MHz, CDCl3) δ = 216.1, 171.4, 62.0, 59.2, 51.9, 39.0, 38.6, 34.0, 
28.4, 26.0, 18.4, 15.9, -5.4, -5.4. HRMS ESI calc. for C16H31O4Si [M-H]+: 315.1986, 
found: 315.1986. 
 
 
Iodide (24): Sodium iodide (50.5 mg, 0.33 mmol, 1.1 eq.) was dissolved in MeCN 
(7 mL) under argon atmosphere. TMSCl (43 µL, 0.33 mmol, 1.1 eq.) 
was added drop-wise at r.t. The protected alcohol EP16 (100.1 mg, 
0.32 mmol, 1.0 eq.) was added and the resulting mixture was stirred for 
1 h. The Reaction mixture was quenched with aq. sat. NaHCO3 solution and diluted 
with Et2O. The aqueous layer was extracted two times with Et2O. Combined organic 
layers were dried over Na2SO4, filtered and evaporated under reduced pressure to 
afford 24 (50.9 mg, 0.16 mmol, 52%) as colourless oil, which slowly decomposed to 
the spiro compound 25. 
 
Rf = 0.25 (pentane/Et2O 10:1). 1H NMR (400 MHz, CDCl3) δ = 3.70 (s, 3H), 3.49 
(ddd, J = 12.6, 9.2, 4.7 Hz, 1H), 3.14 (ddd, J = 12.7, 9.2, 4.8 Hz, 1H), 2.59-2.45 (m, 
2H), 2.31-2.16 (m, 3H), 2.12-2.03 (m, 1H), 1.77 (qd, J = 11.9, 8.7 Hz, 1H), 1.05 (d, 
J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 215.5, 170.0, 64.6, 52.2, 41.3, 
38.6, 38.2, 28.4, 16.1, -1.1. 
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Rf = 0.50 (pentane/EtOAc 3:2). Optical rotation: [α]D = 117.8 (c = 0.22, 
MeOH). FTIR ν = 2968, 2917, 2883, 1756, 1726, 1460, 1376, 1224, 1180, 
1114, 1045, 1021, 973, 955, 911, 882, 832, 799 cm-1. 1H NMR (500 MHz, 
CDCl3) δ = 4.46 (td, J = 8.8, 6.2 Hz, 1H), 4.31 (td, J = 8.7, 6.2 Hz, 1H), 2.69 (dddd, 
J = 16.9, 8.3, 6.3, 3.9 Hz, 2H), 2.38-2.25 (m, 1H), 2.21 (ddd, J = 16.7, 9.8, 5.5 Hz, 
2H), 2.14-2.00 (m, 2H), 1.23 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ = 213.8, 173.2, 66.7, 61.0, 41.9, 37.4, 30.2, 27.0, 14.8. HRMS ESI calc. for 
C9H13O3 [M-H]+: 169.0859, found: 169.0859. X-ray crystal structure is given in the 
appendices section. 
 
 
Keto ester (26): To a stirred suspension of 2,4(3H,5H)-furandione (46.2 mg, 
0.149 mmol, 1.0 eq.) and anhydrous LiI (22.0 mg, 0.164 mmol, 
1.1 eq.) in dry THF (2 mL) was added DBU (24.7 µL, 
0.164 mmol, 1.1 eq.). The resulting mixture was stirred for 
30 min at r.t. before 24 (46.2 mg, 0.149 mmol, 1.0 eq.) dissolved in dry THF (2 mL) 
was added. The mixture was refluxed for 36 h with stirring, upon which time DMPU 
(0.5 mL) was added thereby dissolving the suspension in the reaction flask. The 
mixture was stirred at reflux for 2 days. Water and EtOAc were added and the 
aqueous layer was extracted twice times with EtOAc. The product was obtained after 
purification by flash chromatography on silica gel (pentane/EtOAc 3:2) giving the 
O-alkylated product 26 as the major product. 
 
Rf = 0.24 (pentane/EtOAc 3:2). 1H NMR (400 MHz, CDCl3) δ = 5.15 (s, 1H), 4.58 
(d, J = 1.0 Hz, 2H), 4.38 (ddd, J = 10.1, 8.7, 5.5 Hz, 1H), 4.22-4.14 (m, 1H), 3.71 (s, 
3H), 2.59 (ddd, J = 19.2, 8.7, 1.1 Hz, 1H), 2.38 (ddd, J = 14.8, 8.7, 6.4 Hz, 1H), 
2.32-2.17 (m, 2H), 2.15-2.01 (m, 2H), 1.80 (ddt, J = 14.7, 12.4, 7.2 Hz, 1H), 1.06 (d, 
J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 215.6, 179.0, 173.5, 170.2, 89.4, 
69.1, 67.9, 61.3, 52.4, 41.7, 38.4, 31.2, 28.4, 15.8. 
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Allylic ester (27): Ketone 19 (1.00 g, 6.4 mmol, 1.0 eq.) was dissolved in dry THF 
(14.0 mL) and freshly distilled DMPU (3.6 mL). Sodium hydride (60% 
dispersion in mineral oil, 307 mg, 7.7 mmol, 1.2 eq.) was added at r.t. 
and the grey suspension was stirred for 1 h after which it turned to a 
yellow solution. Allyl bromide (0.67 ml, 7.7 mmol, 1.2 eq.) was added at 0 °C and the 
milky mixture was stirred for 1 h at 0 °C before it was allowed to warm up to r.t. 
After 12 h the mixture was diluted with Et2O (20 mL) and washed three times with 
water. The aqueous layers were reextracted twice with Et2O. The combined organic 
layers were dried over Na2SO4, filtrated and evaporated under reduced pressure. Both 
diastereoisomers were separated by chromatography (pentane/Et2O 9:1) giving the 
desired product 27 (1.06 g, 5.4 mmol, 84%) and trans-product (95 mg, 0.5 mmol, 8%) 
as a colourless liquids. 
 
Rf = 0.48 (pentane/Et2O 4:1). Optical rotation: [α]D = +38.4 (c = 0.25, MeOH). 
FTIR ν = 3079, 2958, 2882, 1749, 1731, 1434, 1227, 1187, 1165, 998, 919 cm-1. 
1H NMR (400 MHz, CDCl3) δ = 5.56-5.67 (m, 1H), 5.09-5.13 (m, 1H), 5.08 (s, 1H), 
3.69 (s, 3H), 2.66 (dd, J = 14.2, 6.2 Hz, 1H), 2.47-2.58 (m, 2H), 2.27-2.38 (m, 1H), 
2.00-2.18 (m, 2H), 1.72-1.84 (m, 1H), 1.02 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 216.2, 171.1, 133.2, 119.6, 63.1, 52.0, 39.1, 38.7, 35.8, 28.3, 15.6. 
Elementary Analysis calc. for C11H16O3: C = 67.32, H = 8.22, N = 0.00, found: 
C = 67.29, H = 8.20, N = 0.00. EI-MS 70 eV, m/z (%) = 196.1 (22, M+), 168.1 (100), 
136.1 (63), 109.1 (90), 81.1 (68).  
 
Rf = 0.24 (pentane/Et2O 9:1). Optical rotation: [α]D = +5.1 (c = 0.30, 
MeOH). FTIR ν = 2957, 2889, 1728, 1640, 1458, 1435, 1245, 1212, 
1165, 1130, 1014, 993, 917, 848, 778 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 5.74-5.86 (m, 1H), 5.09-5.11 (m, 1H), 5.03-5.13 (m, 1H), 3.71 (s, 3H), 2.73-2.84 
(m, 1H), 2.55 (ddt, J = 14.5, 6.7, 1.3 Hz, 1H), 2.32-2.46 (m, 1H), 2.32-2.46 (m, 3H), 
2.05-2.15 (m, 1H), 1.65 (dq, J = 13.0, 8.8 Hz, 1H), 1.08 (d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 214.4, 172.0, 133.5, 118.4, 64.0, 52.6, 39.6, 37.1, 
33.5, 27.6, 14.8. HRMS ESI calc. for C11H16NaO3 [M-Na]+: 219.0992, 
found: 219.0994. 
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Aldehyde (28):212 Alkenyl 27 (2.50 g, 12.8 mmol, 1.0 eq.) was dissolved in a 
CH2Cl2/MeOH mixture (30 mL, 5:1) and cooled down to –78 °C. Ozone 
was bubbled through the stirring mixture until it turned slightly blue. The 
bubbling was stopped and the solution was stirred for 15 minutes at        
–78 °C during which time the mixture turned colourless again. Zinc powder (3.36 g, 
51.0 mmol, 4.0 eq.) and acetic acid (2.6 mL, 51.0 mmol, 4.0 eq.) were added. The 
resulting mixture was allowed to warm up to r.t. overnight. The crude was filtrated 
over celite and washed with CH2Cl2. After evaporation of the solvent the filtrate was 
suspended with CH2Cl2, filtrated, and evaporated again giving aldehyde 28 (2.54 g, 
12.8 mmol, quant.) as a colourless liquid. 
 
Rf = 0.68 (pentane/Et2O 9:1). Optical rotation: [α]D = +16.4 (c = 0.51, MeOH). 
FTIR: ν = 2959, 2881, 2857, 2746, 1749, 1717, 1629, 1599, 1456, 1435, 1401, 1397, 
1350, 1326, 1233, 1217, 1197, 1167, 1126, 1059, 1038, 1006, 904, 759 cm-1. 
1H NMR (400 MHz, CDCl3) δ = 9.66 (d, J = 0.5 Hz, 1H), 3.71 (s, 3H), 3.13 (d, 
J = 18.8 Hz, 1H), 2.91 (dd, J = 18.8, 1.2 Hz, 1H), 2.54-2.60 (m, 2H), 2.36-2.47 (m, 
1H), 2.08-2.18 (m, 1H), 1.79-1.92 (m, 1H), 1.01 (d, J = 6.9 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 215.3, 199.3, 170.3, 60.5, 52.4, 46.1, 40.1, 38.0, 28.6, 15.7. 
HRMS ESI calc. for C10H15O4 [M-H]+: 199.0965, found: 199.0963. 
 
 
Lactone (29):212 A solution containing the aldehyde 28 (0.49 g, 2.47 mmol, 1.0 eq.), 
Hantzsch`ester  (1.38 g, 5.44 mmol, 2.2 eq.), tetronic acid (0.26 g, 
2.47 mmol, 1.0 eq.) and L-proline (28.5 mg, 0.25 mmol, 0.1 eq.) in 
methanol (30 mL) was stirred for 24 h at r.t. After evaporation under 
reduced pressure the crude product was purified by flash chromatography 
(CH2Cl2/MeOH 20:1) giving 29 (0.56 g, 1.99 mmol, 81%) as a beige solid. 
 
M.p.: 125.5-125.9 °C. Rf = 0.23 (CH2Cl2/MeOH 10:1). Optical rotation: 
[α]D = +12.8 (c = 0.27, MeOH). FTIR: ν = 2961, 2942, 2882, 2699, 1746, 1729, 
1714, 1648, 1406, 1231, 1195, 1104, 1041, 988, 767 cm-1. 1H NMR (400 MHz, 
d4-MeOD) δ = 4.57 (s, 2H), 3.67 (s, 3H), 2.41-2.52 (m, 2H), 2.23-2.34 (m, 2H), 
2.05-2.16 (m, 2H), 1.85-2.17 (m, 2H), 1.77 (ddd, J = 23.8, 11.5, 8.5 Hz, 1H), 1.05 (d, 
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J = 6.9 Hz, 3H). 13C NMR (126 MHz, d4-MeOD) δ = 218.3, 178.4, 175.6, 172.6, 
100.8, 68.3, 64.1, 52.2, 40.7, 39.7, 30.6, 29.3, 17.0, 16.1. Elementary Analysis calc. 
for C14H18O6: C = 59.57, H = 6.43, N = 0.00, found: C = 59.27, H = 6.20, N = 0.00. 
EI-MS 70 eV, m/z (%) = 282.1 (1, M+), 251.1 (9), 157.2 (77), 141.1 (100), 109.1 (40). 
 
 
Carboxylic acid (30): Aldehyde 28 (0.555 g, 2.8 mmol, 1.0 eq.) was dissolved in 
t-BuOH (10 mL) and 2-methyl-2-butene (0.1 mL). Sodium chlorite 
(3.165 g, 28.0 mmol, 10 eq.) and sodium phosphate (3.359 g, 28.0 mmol, 
10 eq.) were dissolved in water (20 mL) and subsequently added to the 
mixture at r.t. The resulting mixture was stirred for 2 hours. Brine was added and the 
mixture was extracted three times with EtOAc. Combined organic layers were dried 
over Na2SO4, filtered and evaporated under reduced pressure. The acid 30 (600 mg, 
2.8 mmol, quant.) was obtained in pure form as a colourless oil. 
 
Rf = 0.21 (EtOAc/pentane 4:1). Optical rotation: [α]D = +39.7 (c = 0.74, MeOH). 
FTIR: ν = 2959, 2883, 1710, 1455, 1434, 1401, 1336, 1220, 1199, 1159, 1122, 1069, 
1052, 1002, 953, 877, 842, 809, 763, 736, 703 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 3.70 (s, 3H), 3.15 (d, J = 18.0 Hz, 1H), 2.84 (d, J = 18.0 Hz, 1H), 2.62-2.39 (m, 
3H), 2.16-2.06 (m, 1H), 1.83 (dt, J = 23.6, 11.8 Hz, 1H), 1.03 (d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 215.4, 176.0, 170.1, 60.8, 53.6, 52.4, 39.6, 38.1, 
35.9, 28.3, 24.6, 20.3, 15.6. HRMS ESI calc. for C10H14NaO5 [M-Na]+: 237.0733, 
found: 237.0735. 
 
 
Lactone (31): Carboxylic acid 30 (32.0 mg, 0.149 mmol, 1.0eq.) was dissolved in dry 
CH2Cl2 (2 mL) and 4-dimethylaminopyridine (5.5 mg, 0.0448 mmol, 
0.3 eq.) and N,N'-dicyclohexylcarbodiimide (37.0 mg, 0.179 mmol, 
1.2 eq.) were added. The mixture was cooled down to 0 °C before 
4-hydroxy-2(5H)-furanone (15.6 mg, 0.149 mmol, 1.0 eq.) and 
N,N-diisopropylethylamine (27 µL, 0.164 mmol, 1.1 eq.) were added. The resulting 
mixture was stirred for 1 h at 0 °C and subsequently at r.t. overnight. The solution was 
filtered and the solid was washed with CH2Cl2. The filtrate was concentrated under 
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reduced pressure, and the residue was taken up in EtOAc. The organic phase was 
washed with a 1 M HCl solution and the aqueous layer was extracted twice with 
EtOAc. Combined organic layers were dried over Na2SO4, filtered and evaporated 
again. The crude compound was purified by preparative RP-HPLC (ACN/H2O) to 
yield the desired product 31 (8.2 mg, 0.0277 mmol, 19%) as a yellow solid. 
 
1H NMR (400 MHz, CDCl3) δ = 4.71 (s, 1H), 3.73 (s, 2H), 3.49 (t, J = 18.2 Hz, 1H), 
2.61 (dd, J = 19.0, 9.1 Hz, 1H), 2.52–2.31 (m, 1H), 2.16–2.07 (m, 1H), 1.90-1.75 (m, 
1H), 1.05 (d, J = 6.8 Hz, 2H). HPLC/MS: Rt = 2.6 min, m/z (ES+) 297.1 (MH+). 
 
 
Vinyl triflate (32): Enolate 29 (228 mg, 0.81 mmol, 1.0 eq.) and 2,6-lutidine (95 µl, 
0.81 mmol, 1.0 eq.) were dissolved in dry CH2Cl2 (10 mL) and 
cooled down to –78 °C. Trifluoromethanesulfonic anhydride 
(0.14 mL, 0.81 mmol, 1.0 eq.) was added dropwise in 20 minutes. 
The reaction mixture was allowed to warm up to r.t. over 7 h. The yellow solution 
was treated with pentane (10 mL), filtrated and the filtrate was extracted with EtOAc, 
washed with saturated NaHCO3 solution and brine. The organic layers were dried 
over Na2SO4, filtrated and evaporated. Purification by flash chromatography 
(EtOAc/pentane 1:4) gave product 32 (334 mg, 0.81 mmol, quant.) as a slightly 
yellow solid. 
 
M.p.: 43.6-44.4 °C. Rf = 0.33 (EtOAc/pentane 1:4). Optical rotation: [α]D = +7.2 
(c = 0.28, MeOH). FTIR: ν = 2962, 2885, 2361, 2340, 1778, 1750, 1731, 1703, 1434, 
1221, 1136, 1087, 1046, 816 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.90-4.92 (m, 
2H), 3.71 (s, 3H), 2.72-2.52 (m, 2H), 2.41-2.20 (m, 3H), 2.01-2.14 (m, 2H), 1.73-1.95 
(m, 2H), 1.07 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 215.7, 170.5, 
169.8, 160.5, 120.3, 66.6, 62.2, 52.1, 41.2, 38.6, 29.4, 28.3, 17.8, 16.0. 19F NMR 
(376 MHz, CDCl3) δ = –72.81. Elementary Analyses calc. for C15H17F3O8S: 
C = 43.48, H = 4.14, N = 0.00, found: C = 43.60, H = 3.95, N = 0.00. EI-MS 70 eV, 
m/z (%) = 281.1 (16), 249.1 (52), 221.1 (57), 166.2 (62), 141.1 (100), 109.1 (68).  
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Alcohol (33): Nickel(II) chloride (106 mg, 0.821 mmol, 0.1 eq.), chromium(II) 
chloride (3.12 g, 7.72 mmol, 6.0 eq.) and some 3Å molecular sieves 
were dried in a round bottom flask under reduced pressure with a heat 
gun. Triflate 32 (1.70 g, 4.110 mmol, 1.0 eq.) dissolved in dry DMF 
(40 mL) was degassed and subsequently added to the dried chromium and nickel-
mixture. The green mixture was stirred at 50 °C for 24 h, then quenched by water 
(100 mL) and extracted with Et2O until no more product could be detected in the 
aqueous layer. The combined organic layers were dried over Na2SO4, filtrated and 
evaporated. The crude was purified by flash chromatography (EtOAc/pentane 1:4) to 
afford the cyclized product 33 (749.0 mg, 2.81 mmol, 69%) as a white solid. 
 
Or 
 
To a colourless solution of vinyl bromide 36 (250 mg, 0.72 mmol, 1.0 eq.) in dry and 
degassed THF (7 mL) was added n-butyllithium (1.6 M solution in THF, 0.63 mL, 
1.01 mmol, 1.4 eq.) dropwise at -78 °C. The yellow mixture was stirred subsequently 
for 1 h after which time it was allowed to warm up to r.t. and the resulting mixture 
was stirred over night. The solvent was evaporated and extracted with Et2O and 1 M 
HCl solution. The organic layer was washed with water and brine and the aqueous 
layer reextracted with Et2O. The combined organic layers were dried over Na2SO4, 
filtrated and evaporated. Purification was performed by flash chromatography 
(EtOAc/pentane 1:3) giving 33 (51 mg 0.19 mmol, 26%) as a white solid. 
 
M.p.: 129.5-129.7 °C. Rf = 0.30 (EtOAc/pentane 1:3). Optical rotation: [α]D = –37.0 
(c = 0.26, MeOH). FTIR: ν = 3346, 2956, 2899, 2360, 1728, 1675, 1443, 1245, 1194, 
1153, 1100, 1058, 1015, 653 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.06 (d, 
J = 1.9 Hz, 1H), 4.96-5.03 (m, 1H), 4.78 (dt, J = 17.5, 2.8 Hz, 1H), 3.77 (s, 3H), 
2.25-2.36 (m, 2H), 2.01-2.24 (m, 4H), 1.85-1.95 (m, 2H), 1.73-1.83 (m, 1H), 1.11 (d, 
J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 176.5, 173.4, 164.7, 124.8, 80.9, 
64.9, 60.2, 52.4, 41.7, 38.5, 32.9, 31.2, 20.4, 18.7. Elementary Analyses calc. for 
C14H18O5: C = 63.15, H = 6.81, N = 0.00, found: C = 63.02, H = 6.80, N = 0.00. 
EI-MS 70 eV, m/z (%) = 266.1 (45, M+), 238.1 (31), 206.1 (82), 178.1 (100), 
133.1 (39), 91.1 (26). X-ray crystal structure is given in the appendices section. 
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Hydrazone (34):212 Enolate 29 (150 mg, 0.53 mmol, 1.0 eq.) and 
4-methylbenzenesulfonhydrazide (102 mg, 0.53 mmol, 1.0 eq.) were 
dissolved in dry ethanol (1.4 mL). The resulting brown solution was 
stirred for 2 days at 50 °C. The solvent was evaporated and the crude 
product was purified twice by flash chromatography (CH2Cl2/MeOH 20:1 and 
EtOAc/pentane 1:1) giving hydrazone 34 (90 mg, 0.20 mmol, 38%) and the diazo 
compound 35 (24 mg, 0.08 mmol, 15%) as white solids. 
 
Rf = 0.24 (EtOAc/pentane 1:1). FTIR: ν = 3244, 2956, 1725, 1642, 1598, 1455, 
1403, 1339, 1236, 1208, 1162, 1123, 1091, 1041, 994, 814, 764 cm-1. 1H NMR 
(400 MHz, d4-MeOD) δ = 7.81 (d, J = 8.3 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 4.75 (s, 
2H), 3.65 (s, 3H), 2.46 (s, 3H), 2.36-2.49 (m, 3H), 2.19-2.33 (m, 2H), 2.05-2.14 (m, 
1H), 1.92-2.02 (m, 1H), 1.70-1.87 (m, 3H), 1.03 (d, J = 6.9 Hz, 3H). 13C NMR 
(126 MHz, d4-MeOD) δ = 218.6, 178.1, 172.8, 146.3, 135.5 (2C), 131.2 (2C), 129.5, 
96.3, 67.6, 64.1, 52.4, 40.9, 39.6, 31.0, 29.3, 21.6, 17.7, 16.2. HRMS ESI calc. for 
C21H27N2O7S [M-H]+: 451.1533, found: 451.1528. 
 
Rf = 0.35 (EtOAc/pentane 1:1). Optical rotation: [α]D = –5.4 (c = 0.18, 
MeOH). FTIR: ν = 3250, 2954, 2873, 1716, 1562, 1463, 1431, 1377, 
1255, 1243, 1223, 1190, 1172, 1124, 1057, 1030, 1008, 987, 968, 939, 
853, 814, 790, 754, 711 cm-1. 1H NMR (400 MHz, d4-MeOD) δ = 4.36 (d, J = 11.0 
Hz, 1H), 4.14 (d, J = 11.0 Hz, 1H), 3.75 (s, 3H), 2.60-2.70 (m, 1H), 2.34-2.46 (m, 
1H), 2.12-2.18 (m, 2H), 2.02-2.10 (m, 2H), 1.76-1.82 (m, 2H), 1.53-1.62 (m, 1H), 
0.99 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, d4-MeOD) δ = 177.7, 173.2, 121.8, 
119.0, 75.9, 71.0, 61.0, 52.0, 41.1, 33.9, 30.8, 29.7, 26.2, 14.3. HRMS ESI calc. for 
C14H19N2O5 [M-H]+: 295.1288, found: 295.1287. X-ray crystal structure is given in 
the appendices section. 
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Vinyl bromide (36):212 To a stirred solution of 29 (100 mg, 0.35 mmol, 1.0 eq.) in 
CH2Cl2  (1 mL) was added first DMF (50 µl, 0.71 mmol, 2.0 eq.) and 
subsequently oxalylbromide (40 µl, 0.43 mmol, 1.2 eq.) during 
30 min at 0 °C. The resulting green solution was stirred for 1 h at 
0 °C, allowed to warm up to r.t. and stirred overnight. More oxalylbromide (40 µl, 
0.43 mmol, 1.2 eq.) was added at 0 °C and the mixture was stirred for 5 days at r.t. 
Water was added to the reaction mixture and the aqueous layer was separated and 
extracted three times with EtOAc. The organic layers were combined and washed 
with aq. sat. NaHCO3 solution and brine, then dried over Na2SO4, filtrated and 
evaporated. The crude product was purified by flash chromatography (EtOAc/pentane 
1:2) giving the vinyl bromide 36 (51 mg, 0.15 mmol, 42%) as slightly orange oil. 
 
Or 
 
Triflate 32 (54 mg, 0.13 mmol, 1.0 eq.) and TBAB (84 mg, 0.26 mmol, 2.0 eq.) were 
dissolved in dry toluene (1 mL) and dry THF (1 mL). The resulting colourless mixture 
was stirred at 50 °C overnight. Then it was heated to 60 °C and more TBAB (84 mg, 
0.26 mmol, 2.0 eq.) was added. The reaction mixture was quenched with water after 
2 h and subsequently extracted four times with Et2O. The combined organic layers 
were dried over MgSO4, filtrated and evaporated under reduced pressure. Purification 
was performed by flash chromatography (EtOAc/pentane 1:3) giving vinyl bromide 
36 (23 mg, 0.07 mmol, 51%) as colourless oil. 
 
Rf = 0.53 (pentane/EtOAc 2:1). 1H NMR (400 MHz, CDCl3) δ = 4.76-4.78 (m, 2H), 
3.71 (s, 3H), 2.52-2.66 (m, 2H), 2.20-2.38 (m, 3H), 1.88-2.15 (m, 3H), 1.80 (ddd, 
J = 24.0, 11.5, 8.6 Hz, 1H), 1.08 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ = 215.9, 171.0, 170.7, 140.1, 132.2, 73.1, 62.4, 52.0, 40.6, 38.7, 29.3, 28.3, 19.9, 
16.1. 
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Aldehyde (37):212 Borane dimethyl sulfide complex (2 M in THF, 0.826 mL, 
1.65 mmol, 2.0 eq.) was added dropwise to a solution of the methylester 
33 (220 mg, 0.826 mmol, 1.0 eq.) in dry THF (4 mL) at 0 °C. The 
colourless solution was stirred subsequently for 0.5 h and then warmed 
up to 45 °C for 2 h. After cooling down to r.t., ethanol was added until the exothermic 
reaction and bubbling ceased. After evaporation, the crude product was purified by 
flash chromatography (Et2O/pentane 3:1) giving aldehyde 37 (149 mg, 0.63 mmol, 
76%) as a white solid.  
 
M.p.: 158.1-158.5 °C. Rf = 0.21 (Et2O/pentane 3:1). Optical rotation: [α]D = –49.3 
(c = 0.23, MeOH). FTIR: ν = 3346, 2942, 2874, 2758, 1744, 1716, 1669, 1435, 1353, 
1224, 1107, 1061, 1016, 929, 753 cm-1. 1H NMR (400 MHz, CDCl3) δ = 9.70 (s, 1H), 
5.01 (ddd, J = 17.4, 3.4, 1.7 Hz, 1H), 4.80 (dt, J = 17.4, 2.7 Hz, 1H), 4.07 (d, 
J = 1.7 Hz, 1H), 2.04-2.36 (m, 6H), 1.72-1.99 (m, 3H), 1.17 (d, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ = 206.8, 173.1, 163.5, 125.2, 80.1, 69.5, 61.9, 40.3, 
37.7, 31.6, 28.6, 18.8, 17.7. Elementary Analyses calc. for C13H16O4: C = 66.09, 
H = 6.83, N = 0.00, found: C = 65.90, H = 6.75, N = 0.00. EI-MS 70 eV, 
m/z (%) = 236.1 (13, M+), 190.1 (100), 175.1 (66), 145.1 (42), 91.1 (27).  
 
 
Lactone (38):212 To the aldehyde 37 (43.0 mg, 0.18 mmol, 1.0 eq.), dissolved in 
THF/water (1:1, 5 mL), was added potassium cyanide (42.0 mg, 
0.64 mmol, 3.5 eq.). The resulting mixture was stirred for 2 d at r.t. 
before the aqueous reaction mixture was extracted several times with 
EtOAc until no more product could be detected in the organic layer. The 
combined organic layers were dried over Na2SO4, filtrated and evaporated. The crude 
product was purified by flash chromatography (EtOAc/cyclohexane 1:1) giving 
tetracyclic compound 38 (31.0 mg, 0.12 mmol, 65%) as a white solid. 
 
M.p.: 194.0-194.3 °C. Rf = 0.28 (EtOAc/cyclohexane 1:1). Optical rotation: 
[α]D = –32.6 (c = 0.19, MeOH). FTIR: ν = 3479, 2953, 2929, 2874, 2361, 1785, 
1725, 1682, 1442, 1359, 1217, 1191, 1133, 1086, 1046, 1022, 967 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 4.82-4.99 (m, 2H), 4.57 (d, J = 2.8 Hz, 1H), 2.91 (d, 
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J = 3.2 Hz, 1H), 2.45-2.54 (m, 2H), 2.21-2.30 (m, 1H), 2.00-2.10 (m, 3H), 1.83-1.98 
(m, 2H), 1.62-1.70 (m, 1H), 1.42-1.53 (m, 1H), 1.16 (d, J = 6.7 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 176.3, 172.5, 157.5, 127.8, 87.4, 69.6, 68.9, 56.2, 36.2, 35.9, 
30.7, 21.3, 15.8, 14.0. HRMS ESI calc. for C14H17O5 [M-H]+: 265.1071, found: 
265.1065. X-ray crystal structure is given in the appendices section. 
 
 
Keto lactone (39):212 To a solution of the alcohol 38 (8.5 mg, 0.03 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) were added pyridinium chlorochromate (23.0 mg, 
0.11 mmol, 3.3 eq.) and some silica gel. The resulting orange mixture 
was for 16 h at r.t. The reaction mixture was directly loaded onto a 
column. The column was eluted with CH2Cl2 first then with a 30:1 
mixture of CH2Cl2/MeOH giving the α-ketolactone 39 (7.0 mg, 0.03 mmol, 83%) as 
colourless crystals. 
 
Rf = 0.36 (EtOAc/cyclohexane 1:1). Optical rotation: [α]D = –83.2 (c = 0.17, 
CHCl3). FTIR: ν = 2965, 2932, 2862, 1788, 1748, 1678, 1437, 1385, 1354, 1308, 
1248, 1214, 1191, 1156, 1140, 1110, 1061, 1013, 969, 958, 896, 852, 831, 799, 764, 
745 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.00-5.06 (m, 1H), 4.85-4.92 (m, 1H), 
2.45-2.57 (m, 2H), 2.30-2.39 (m, 1H), 2.05-2.27 (m, 3H), 1.93-2.02 (m, 1H), 1.79 
(ddd, J = 14.0, 10.1, 5.3 Hz, 1H), 1.54-1.61 (m, 2H), 1.05 (d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 196.7, 171.4, 159.0, 156.0, 130.5, 89.4, 68.9, 58.7, 
46.6, 36.0, 32.7, 29.8, 18.0, 15.5. HRMS ESI calc. for C14H15O5 [M-H]+: 263.0914, 
found: 263.0912. X-ray crystal structure is given in the appendices section. 
 
 
TMS ether (40):212 To a solution of the alcohol 38 (23 mg, 0.09 mmol, 1.0 eq.) in 
CH2Cl2 (1.5 mL) were added 2,6-lutidine (0.3 mL, 0.26 mmol, 3.0 eq.) 
and trimethylsilane triflate (24 µl, 0.13 mmol, 1.5 eq.) at 0 °C. The 
colourless solution was stirred at this temperature for 3 h, quenched 
with water and extracted with EtOAc. The organic layer was dried over 
MgSO4, filtrated and evaporated. The resulting crude product was purified by flash 
chromatography (Et2O/pentane 2:1) to obtain the protected alcohol 40 (26 mg, 
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0.08 mmol, 99%) as a white solid. 
 
Rf = 0.71 (EtOAc/cyclohexane 1:1). 1H NMR (400 MHz, CDCl3) δ = 4.92-4.99 (m, 
1H), 4.80-4.86 (m, 1H), 4.54 (s, 1H), 2.42-2.51 (m, 1H), 2.20-2.28 (m, 1H), 1.79-2.07 
(m, 5H), 1.50-1.67 (m, 2H), 1.09 (d, J = 6.7 Hz, 3H), 0.22 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ = 175.2, 172.7, 158.2, 127.7, 86.6, 70.7, 69.0, 55.6, 36.8, 36.3, 
30.8, 22.3, 16.1, 14.1, 0.6. 
 
 
Silyl ether (41):212 To a solution of alcohol 38 (10.0 mg, 0.04 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) were added some drops of triethylamine and imidazole 
(7.7 mg, 0.11 mmol, 3.0 eq.). The mixture was treated with 
chlorotriethylsilane (20 µl, 0.11 mmol, 3.0 eq.) at 0 °C. The resulting 
colourless reaction mixture was allowed to warm up to r.t. overnight. As 
no reaction had occurred the solution was heated up to 35 °C and a catalytic amount 
of DMAP was added. After stirring for 2 h the reaction mixture was quenched with 
water. The aqueous reaction mixture was extracted four times with CH2Cl2 and the 
combined organic layers were dried over MgSO4, filtrated and evaporated under 
reduced pressure. Purification was performed by flash chromatography 
(EtOAc/pentane 1:1) to yield the protected alcohol 41 (11.0 mg, 0.03 mmol, 77%) as 
a white powder.  
 
Rf = 0.29 (EtOAc/pentane 1:4). 1H NMR (400 MHz, CDCl3) δ = 4.92-4.99 (m, 1H), 
4.79-4.87 (m, 1H), 4.56 (s, 1H), 2.41-2.51 (m, 1H), 2.19-2.26 (m, 1H), 1.78-2.08 (m, 
5H), 1.50-1.65 (m, 2H), 1.11 (d, J = 6.7 Hz, 3H), 0.98 (t, J = 7.9 Hz, 9H), 0.81-0.63 
(m, 6H). 13C NMR (101 MHz, CDCl3) δ = 175.1, 172.7, 158.3, 127.6, 86.5, 70.7, 
69.0, 56.0, 36.9, 36.4, 30.8, 22.3, 16.1, 14.1, 7.0, 5.4. HRMS ESI calc. for 
C20H31O5Si [M-H]+: 379.1935, found: 379.1932. 
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Butenolide (43): To a stirred suspension of 3,4,5,6-tetrahydrophthalic anhydride  (42, 
500.0 mg, 3.22 mmol, 1.0 eq.) in dry THF (8 mL) at 0 °C was added drop 
wise a solution of NaBH4 in dry THF (12 mL) over 3 h under argon 
atmosphere. The mixture was stirred for an additional hour at r.t., cooled 
down to 0 °C and acidified with 1 M HCl solution until pH 3. Some more water and 
CH2Cl2 were added and the aqueous layer was extracted 2 times with CH2Cl2. 
Combined organic layers were dried over Na2SO4, filtered and evaporated under 
reduced pressure. Purification was performed by flash chromatography 
(EtOAc/pentane 1:3) to yield butenolide 43 (331.5 mg, 2.40 mmol, 75%) as slightly 
yellow solid. 
 
Rf = 0.32 (pentane/EtOAc 3:1). 1H NMR (400 MHz, CDCl3) δ = 4.69-4.66 (m, 2H), 
2.35-2.24 (m, 2H), 2.25-2.18 (m, 2H), 1.83-1.62 (m, 4H).  
 
Analytical according to reference: D. Butina and F. Sondheimer, Synthesis 1980, 543. 
 
 
Lactone (44): Copper(I) iodide (84.4 mg, 0.434 mmol, 2.0 eq.) was heated up using a 
heating gun under vacuum. Dry Et2O (1 mL) was added and the mixture 
was cooled down to 0 °C under argon atmosphere. Methyl lithium (1.6 M in 
Et2O, 540 µL, 0.869 mmol, 4.0 eq.) was added dropwise and the colourless 
solution was stirred for 10 min. The solvent was removed under reduced pressure at 
0 °C and dry CH2Cl2 (1 mL) was added. The resulting solution was stirred for 5 min 
at 0 °C and the solvent was removed again under reduced pressure. Dry CH2Cl2 
(1 mL) was added and the mixture was cooled down to –78 °C. Chlorotrimethylsilane 
(0.057 µL, 0.434 mmol, 2.0 eq.) and 43 (dissolved in 0.5 mL CH2Cl2, 30.0 mg, 
0.217 mmol, 1.0 eq.) were added to the yellow solution. The mixture was slowly 
heated up to r.t. overnight and subsequently quenched by addition of a saturated 
aqueous NH4Cl solution, followed by extraction with CH2Cl2 (2 x). Combined 
organic layers were dried over Na2SO4, filtered and evaporated under reduced 
pressure. The crude product was purified by flash chromatography with 
pentane/EtOAc 5:1 to yield the desired product (13.7 mg, 0.089 mmol, 41%) in a 
1:3.5 diastereoisomeric mixture of the cis/trans bicyclic ring system as a white solid 
and some unreacted starting material (4.8 mg, 0.035 mmol).  
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Rf = 0.47 (pentane/EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ = 3.90 (d, J = 8.6 Hz, 
1H), 3.80 (d, J = 8.6 Hz, 1H), 2.28-2.23 (m, 1H), 2.09-2.00 (m, 1H), 1.65-1.51 (m, 
4H), 1.50-1.39 (m, 3H), 1.18 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 178.7, 80.0, 
46.2, 38.7, 33.1, 22.7, 21.6, 21.4, 21.3.  
 
Analytical according to reference: A. B. Smith III, M. Visnick, J. N. Haseltine, P. A. 
Sprengeler, Tetrahedron 1986, 42, 2957. 
 
 
Diene (45): Ester 33 (301 mg, 1.13 mmol, 1.0 eq.) was dissolved in dry THF (16 mL) 
and Burgess reagent (417 mg, 1.70 mmol, 1.5 eq.) was added. The clear 
solution was stirred for 3.5 h at r.t. After 1 h, a white precipitate was 
observable. Water (8 mL) was added and extracted with Et2O 
(3 x 25 mL). The combined organic layers were washed with brine (13 mL) and then 
dried over Na2SO4, filtered and evaporated to obtain a white solid. The crude was 
purified by flash chromatography (pentane/EtOAc 3:1) to obtain the desired olefin 45 
(262 mg, 1.06 mmol, 93%) as a white solid. 
 
M.p.: 124.9-125.6 °C. Rf = 0.24 (pentane/EtOAc 4:1). Optical rotation: 
[α]D = +193.5 (c = 0.16, CHCl3). FTIR ν = 2952, 2936, 2846, 1740, 1715, 1644, 
1439, 1346, 1239, 1172, 1042, 1014, 980, 761, 744 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 6.18 (s, 1H), 4.98-4.81 (m, 2H), 3.67 (s, 3H), 2.74-2.56 (m, 1H), 
2.52-2.15 (m, 2H), 1.35 (ddd, J = 12.8, 11.7, 5.8 Hz, 1H), 1.07 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 173.8, 173.1, 151.8, 136.2, 133.2, 126.5, 69.1, 59.9, 
52.0, 45.8, 40.6, 30.8, 19.7, 14.9. HRMS ESI calc. for C14H17O4 [M-H]+: 249.1121, 
found: 249.1119. X-ray crystal structure is given in the appendices section. 
 
 
Lactone (46): Diene 45 (8.4 mg, 0.0338 mmol, 1.0 eq.) was dissolved in EtOH 
(2 mL). A catalytic amount of Pd/C (10 % Pd) was added and the 
mixture was stirred for 45 min at 5 bar H2 atmosphere. The crude 
mixture was filtered over a pad of silica and celite and washed with 
EtOAc. The organic layer was evaporated under reduced pressure giving the reduced 
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product 46 (8.5 mg, 0.0338 mmol, quant.) as colourless oil. 
 
Rf = 0.21 (pentane/EtOAc 4:1). Optical rotation: [α]D = +12.4 (c = 0.40, CHCl3).  
FTIR: ν = 2957, 2925, 2853, 1722, 1436, 1380, 1351, 1259, 1196, 1078, 1017, 854, 
797, 741 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.83-4.70 (m, 2H), 3.61 (s, 3H), 
2.79-2.69 (m, 1H), 2.64 (dd, J = 13.3, 6.9 Hz, 1H), 2.51-2.40 (m, 1H), 2.39–2.27 (m, 
1H), 2.26-2.18 (m, 1H), 2.18-2.08 (m, 1H), 1.99-1.90 (m, 1H), 1.88-1.81 (m, 1H), 
1.53-1.45 (m, 2H), 0.99 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 174.0, 
173.3, 164.8, 124.6, 70.4, 59.1, 51.4, 47.8, 42.6, 32.0, 30.3, 22.7, 20.1, 15.7. 
HRMS ESI calc. for C14H19O4 [M-H]+: 251.1278, found: 251.1279. 
 
 
Lactone (50): To a dry and degassed solution of THF (12.0 mL) and NMP (0.6 mL) 
was added ester 32 (516.0 mg, 1.25 mmol, 1.0 eq.) and Fe(acac)3 
(22.0 mg, 62.3 µmol, 5 mol%) and cooled down to –30 °C. The 
mixture was stirred for 10 minutes at this temperature and MeMgBr 
(3.2 M in THF, 54.5 µl, 1.74 mmol, 1.4 eq.) was rapidly added to the orange solution. 
The mixture turned into a brown to green mixture, which ended in a colourless 
solution with brown precipitate. The reaction was quenched after 1 h with saturated 
NH4Cl solution at –30 °C. The mixture was allowed to warm up to r.t. and water was 
added and the organic layer was separated. The aqueous layer was extracted with 
EtOAc (4 x 20 mL) and the combined organic layers were dried over Na2SO4, filtered 
and evaporated under reduced pressure. The crude was purified by flash 
chromatography (pentane/EtOAc 2:1 then 1:1) to obtain the desired β-methyl lactone 
50 (333.9 mg, 1.19 mmol, 96%) as colourless oil.  
 
Rf = 0.24 (EtOAc/pentane 1:2). Optical rotation: [α]D = +61.0 (c = 0.29, CHCl3). 
FTIR: ν = 2985, 1743, 1678, 1451, 1228, 1166, 1032, 762 cm
-1. 1H NMR (400 MHz, 
CDCl3) δ = 4.61 (s, 2H), 3.69 (s, 3H), 2.59-2.45 (m, 2H), 2.42-2.32 (m, 1H), 
2.29-2.08 (m, 3H), 2.05 (brs, 3H), 1.92-1.87 (m, 2H), 1.85-1.73 (m, 1H), 1.07 (d, 
J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 216.4, 174.9, 171.0, 157.7, 127.0, 
72.7, 62.7, 52.0, 40.3, 38.9, 30.6, 28.4, 18.4, 16.1, 12.3. HRMS ESI calc. for 
C15H21O5 [M-H]+: 281.1384, found: 281.1383.  
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Oxetane (51 and 52):216 Ester 50 (53.0 mg, 189.0 µmol, 1.0 eq.) was dissolved in dry 
and degassed benzene  (19 mL) and added into a Quartz-tube under argon 
atmosphere and irradiated for 3 h. The crude was evaporated to obtain 
yellow oil, which was purified by flash chromatography (pentane/Et2O 
3:2) to obtain the oxetane 51 (10.0 mg, 35.7 µmol, 19%) and 52 (7.3 mg, 26.0 µmol, 
14%) as white solids.  
 
M.p.: 92.2-92.7 °C. Rf = 0.30 (Et2O/pentane 1:1). Optical rotation: [α]D = –1.4 
(c = 0.30, CHCl3). FTIR ν = 2955, 2927, 1759, 1722, 1452, 1274, 1249, 1130, 1015, 
797 cm-1. 1H NMR (500 MHz, CDCl3) δ = 4.56 (d, J = 10.6 Hz, 1H), 4.05 (d, 
J = 10.6 Hz, 1H), 3.75 (s, 3H), 2.73-2.64 (m, 2H), 2.24-2.17 (m, 1H), 2.12-2.03 (m, 
4H), 1.85-1.80 (m, 1H), 1.45 (s, 3H), 1.20-1.11 (m, 1H), 0.95 (d, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ = 176.0, 174.3, 106.0, 83.1, 78.9, 64.9, 60.1, 52.4, 
40.2, 34.3, 30.7, 30.6, 26.8, 19.7, 15.7. X-ray crystal structure is given in the 
appendices section. 
 
M.p.: 95.8-96.7 °C. Rf = 0.24 (Et2O/pentane 1:1). Optical rotation: 
[α]D = –15.0 (c = 0.02, CHCl3). FTIR ν = 2955, 2947, 1760, 1725, 1438, 
1246, 1151, 1114, 1025, 1002, 772 cm-1. 1H NMR (500 MHz, CDCl3) 
δ = 4.53 (d, J = 10.6 Hz, 1H), 4.04 (d, J = 10.6 Hz, 1H), 3.73 (s, 3H), 2.62 (ddd, 
J  = 13.9, 12.5, 8.1 Hz, 1H), 2.25-2.16 (m, 2H), 2.14-2.06 (m, 2H), 2.02-1.98 (m, 1H), 
1.88-1.69 (m, 3H), 1.47 (s, 3H), 0.91 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 176.0, 172.0, 105.0, 83.0, 79.3, 67.0, 59.5, 51.8, 40.0, 32.0, 31.4, 30.2, 
23.9, 20.1, 15.3. 
 
 
Vinyl triflate (55): Ketone 50 (165.0 mg, 0.589 mmol, 1.0 eq.) was dissolved in dry 
THF (5 mL) and cooled down to –40 °C under argon atmosphere. 
LiHMDS (1 mol/L in THF, 1.77 mL, 1.779 mmol, 3.0 eq.) was added 
drop wise while the reaction slowly rose to –20 °C. After stirring for 
30 min, N-phenylbis(trifluoromethanesulfonimide) (434.0 mg, 1.180 mmol, 2.0 eq.) 
was added and the reaction mixture was stirred for 3 h at 0 °C. A saturated NaHCO3 
solution was added drop wise (exothermic) to the brown solution, followed by water. 
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The crude was extracted three times with EtOAc. Combined organic layers were dried 
over Na2SO4, filtered and evaporated under reduced pressure. The residue was 
purified by flash chromatography (pentane/EtOAc 4:1) giving product 55 (82.3 mg, 
0.200 mmol, 34%) as a colourless oil. 
 
Rf = 0.33 (pentane/EtOAc 3:1). Optical rotation: [α]D = +3.0 (c = 0.90, MeOH). 
FTIR: ν = 2960, 2934, 1734, 1678, 1599, 1496, 1421, 1381, 1338, 1203, 1138, 1082, 
1047, 1005, 934, 900, 836, 767, 736, 696 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.86 
(t, J = 2.5 Hz, 1H), 4.62 (d, J = 0.8 Hz, 2H), 3.72 (s, 3H), 2.65-2.52 (m, 2H), 2.41 (td, 
J = 12.7, 4.4 Hz, 1H), 2.25-2.10 (m, 2H), 2.03 (s, 3H), 2.01-1.94 (m, 1H), 1.86 (ddd, 
J = 14.1, 12.3, 5.0 Hz, 1H), 1.03 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 174.9, 171.9, 157.7, 148.2, 129.6, 126.6, 123.7, 118.7, 72.7, 60.8, 52.1, 39.7, 35.2, 
31.7, 18.4, 16.5, 12.2. HRMS ESI calc. for C16H20F3O7S [M-H]+: 413.0876, 
found: 413.0875. 
 
 
Hydrazone (58): Ketoester 50 (7.5 mg, 26.8 µmol, 1.0 eq.) was dissolved in dry 
EtOH (0.2 mL). Tosylhydrazide (44.8 mg, 0.24 mmol, 9.0 eq.) and 
4 drops of an aqueous 1 M HCl solution were added. The resulting 
mixture was stirred for 25 h at r.t. To the clear solution was added 
water (1.0 mL) and then extracted three times with EtOAc. Combined organic layers 
were dried over Na2SO4, filtered and evaporated to obtain a colourless oil. The crude 
was purified by flash chromatography (pentane/EtOAc 3:1) to obtain the desired 
tosylhydrazone 58 (7.0 mg, 13.4 µmol, 50%) as a white solid.   
 
Rf = 0.18 (Et2O/pentane 3:1). 1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 
2H), 7.27 (d, J = 7.5 Hz, 2H), 5.61 (brs, 1H), 4.62 (s, 2H), 3.50 (s, 3H), 2.40-2.38 (m, 
4H), 2.23-2.11 (m, 3H), 2.07 (s, 3H), 2.01-1.86 (m, 4H), 1.67-1.56 (m, 1H), 0.94 (d, 
J = 6.8 Hz, 3H). 
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Epoxide (60): To a solution of the diene 45 (38.0 mg, 0.153 mmol, 1.0 eq.) in CH2Cl2 
(5 mL) was added m-CPBA (70%, 60.4 mg, 0.245 mmol, 1.6 eq.) at 
0 °C. The resulting mixture was stirred at 4 °C for 3.5 h and slowly 
heated up to r.t. and stirred for 3 days. The reaction mixture was poured 
into a mixture of aq. sat. NaHCO3 and excess sodium thiosulfate, and extracted with 
ether. The organic layer washed with saturated sodium bicarbonate solution and brine, 
dried over Na2SO4, filtered and reduced under reduced pressure. The crude residue 
was purified by flash chromatography (pentane/EtOAc 4:1) giving epoxide 60 
(36.2 mg, 0.137 mmol, 90%) as a crystalline compound. 
 
Rf = 0.24 (pentane/EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ = 4.79-4.67 (m, 2H), 
4.09 (s, 1H), 3.66 (s, 3H), 2.63-2.35 (m, 3H), 2.24 (dd, J = 13.6, 6.6 Hz, 1H), 1.83 
(dp, J = 10.2, 7.0 Hz, 1H), 1.72-1.59 (m, 2H), 0.91 (d, J = 7.2 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 172.5, 172.3, 155.0, 135.3, 68.5, 63.8, 63.0, 55.5, 51.9, 35.5, 
24.7, 20.1, 13.9. X-ray crystal structure is given in the appendices section. 
 
 
Diol (62): Olefin 45 (80.0 mg, 0.322 mmol, 1.0 eq.) and NMO (49.7 mg, 0.483 mmol, 
1.5 eq.) were dissolved in tert-butanol (3 mL) and water (1 mL). The 
clear solution was cooled to 0° C and OsO4 (4% solution in water, 
0.13 mL, 16.1 µmol, 5 mol%) was added dropwise. The clear solution 
was then allowed to warm up to r.t. and then stirred for 3 days. To the yellow solution 
was added saturated Na2SO3 solution (15 mL) and the orange to yellow emulsion was 
stirred for 30 minutes at r.t. The mixture was extracted with EtOAc (3 x 10 mL) and 
the combined organic layers were washed with brine (10 mL), dried over Na2SO4, 
filtered and evaporated to obtain a yellow oil. The crude was purified by flash 
chromatography (pentane/EtOAc 1:1) to obtain the desired diol 62 (76.7 mg, 
0.272 mmol, 84%, d.r. = 10:1) as a white solid. 
 
M.p.: 126.3-126.8 °C. Rf = 0.25 (pentane/EtOAc 1:1). Optical rotation: [α]D = +45.6 
(c = 0.16, CHCl3). FTIR ν = 3449, 2959, 2929, 2360, 1727, 1714, 1660, 1429, 1351, 
1255, 1202, 1037, 1021, 739 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.16 (dd, 
J = 12.2, 6.4 Hz, 1H), 5.03-4.70 (m, 2H), 3.69 (s, 1H), 3.62 (s, 3H), 2.72-2.53 (m, 
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1H), 2.50-2.40 (m, 1H), 2.40-2.22 (m, 3H), 2.22-2.09 (m, 1H), 1.90 (dd, J = 9.2, 
7.0 Hz, 2H), 0.90 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 173.9, 173.5, 
162.6, 128.0, 76.9, 71.5, 69.1, 63.3, 51.7, 41.4, 37.5, 22.4, 19.8, 15.7. HRMS ESI 
calc. for C14H19O6 [M-H]+: 283.1176, found: 283.1178. 
 
 
Acetal (63): To a solution of the diol 62 (33.5 mg, 0.119 mmol, 1 eq.) in dry THF 
(3 mL) were added 2-methoxypropene (114 µL, 1.19 mmol, 10.0 eq.) 
and a catalytic amount of p-TSA and the reaction mixture was stirred at 
room temperature overnight under argon atmosphere. The reaction 
mixture was quenched with saturated NaHCO3 solution and extracted 
three times with EtOAc. The combined organic layers were dried over Na2SO4, 
filtered and evaporated under reduced pressure. The crude product was purified by 
flash chromatography (pentane/EtOAc 3:1) to give the protected diol 63 (27.3 mg, 
0.085 mmol, 71%) as a white solid. 
 
Rf = 0.67 (pentane/EtOAc 2:1). Optical rotation: [α]D = +59.7 (c = 0.27, CHCl3). 
FTIR ν = 3011, 2963, 2938, 2874, 1759, 1717, 1665, 1460, 1432, 1345, 1290, 1264, 
1242, 1180, 1158, 1122, 1103, 1076, 1037, 1021, 972, 941, 897, 854, 813, 759, 744, 
689 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.08-5.03 (m, 1H), 5.02-4.94 (m, 1H), 
4.83 (dt, J = 17.4, 3.0 Hz, 1H), 3.60 (s, 3H), 2.58-2.29 (m, 4H), 2.09 (dt, J = 11.5, 
7.7 Hz, 1H), 1.93 (ddd, J = 14.7, 7.9, 1.0 Hz, 1H), 1.80 (ddd, J = 14.7, 11.5, 8.2 Hz, 
1H), 1.45 (s, 3H), 1.33 (s, 3H), 1.25 (s, 1H), 0.91 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 173.5, 173.2, 161.8, 128.9, 110.7, 87.3, 80.3, 69.9, 63.4, 51.9, 
41.3, 37.5, 29.6, 28.2, 22.5, 19.6, 15.2. HRMS ESI calc. for C17H22NaO6 
[M-Na]+: 345.1309, found: 345.1312. X-ray crystal structure is given in the 
appendices section. 
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TBS ether (64): Diol 62 (227.0 mg, 0.80 mmol, 1.0 eq.) was dissolved in dry CH2Cl2 
(40 mL) and cooled down to 0 °C. To this solution was added 
2,6-lutidine (0.10 mL, 0.89 mmol, 1.1 eq.) and then TBSOTf 
(0.20 mL, 0.89 mmol, 1.1 eq.) and stirred for 30 minutes at 0 °C. The 
clear solution was then allowed to warm up to r.t. for 3 h and was stirred for 1 h at this 
temperature. To the clear solution was added saturated NH4Cl solution (20 mL) and 
then extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were washed 
with brine (15 mL), dried over Na2SO4, filtered and evaporated to obtain a white to 
yellow solid. The crude was purified by flash chromatography on silica 
(pentane/EtOAc 7:1) to obtain the protected alcohol 64 (216.0 mg, 0.55 mmol, 68%) 
as a white solid. 
 
M.p.: 171.7-172.1 °C. Rf = 0.45 (cyclohexane/EtOAc 3:1). Optical rotation: 
[α]D = +18.4 (c = 0.20, CHCl3). FTIR: ν = 3506, 2955, 2860, 1742, 1712, 1354, 
1254, 1119, 1038, 1021, 903, 837, 778 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.12 
(dd, J = 8.3, 4.4 Hz, 1H), 4.91-4.68 (m, 2H), 4.31 (s, 1H), 3.62 (s, 3H), 2.69-2.55 (m, 
1H), 2.48-2.41 (m, 1H), 2.38-2.21 (m, 2H), 2.21-2.11 (m, 1H), 1.92-1.72 (m, 2H), 
0.92 (s, 9H), 0.89 (d, J = 7.1 Hz, 3H), 0.15 (s, 3H), 0.14 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 173.8, 173.8, 162.8, 127.7, 77.0, 72.5, 68.9, 62.8, 51.6, 41.6, 37.5, 25.8, 
22.3, 19.8, 17.8, 15.7, -4.0, -4.8. Elementary Analyses calc. for C20H32O6Si: 
C = 60.58, H = 8.13, N = 0.00, found: C = 60.47, H = 8.03, N = 0.00. HRMS ESI 
calc. for C20H33O6Si [M-H]+: 397.2041, found: 397.2036. 
 
 
Lactol (66):216 To a solution of ester 64 (31.0 mg, 78.2 µmol, 1.0 eq.) in CH2Cl2 
(3.0 mL) was added DIBAL-H (1 M in toluene, 0.24 mL, 
0.24 mmol, 3.0 eq.) at –78 °C. After 1.5 h at –78 °C additional 
DIBAL-H (1 M in toluene, 0.08 mL, 0.08 mmol, 1.0 eq.) was added 
and stirred for further 1.5 h. Water (1 mL) was added and the mixture was allowed to 
warm up to r.t., followed by addition of saturated NaHCO3 solution (1.5 mL) and 
extraction with EtOAc (4 x). Combined organic layers were dried over Na2SO4, 
filtered and evaporated under reduced pressure. The crude was purified by flash 
chromatography (pentane/EtOAc 3:1) to obtain the desired lactol 66 (31.7 mg, 
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79.5 µmol, quant., d.r. = 1.6:1) as colourless oil.  
 
Rf = 0.30 (EtOAc/pentane 1:3). 1H NMR (400 MHz, CDCl3) δ = 5.78 (dd, J = 8.1, 
3.4 Hz, 1H), 5.68 (dd, J = 10.5, 3.8 Hz, 1H), 5.05-5.01 (m, 2H), 4.77-4.73 (m, 1H), 
4.68-4.63 (m, 1H), 4.59-4.55 (m, 1H), 4.48-4.57 (m, 1H), 4.35 (s, 1H), 4.19 (s, 1H), 
3.83 (d, J = 10.7 Hz, 1H), 3.62, (s, 3H), 3.60 (s, 3H), 3.02 (d, J = 8.8 Hz, 1H), 
2.59-2.48 (m, 2H), 2.34-2.21 (m, 5H), 2.17-2.06 (m, 3H), 2.03 (s, 1H), 1.94 (s, 1H), 
1.81-1.76 (m, 4H), 0.89 (s, 18H), 0.11 (s, 6H), 0.09 (s, 6H). 13C NMR (101 MHz, 
CDCl3) δ = 174.2, 173.8, 140.3, 139.8, 135.9, 135.5, 104.2, 73.2, 72.0, 71.83, 63.3, 
62.9, 51.4, 51.3, 41.8, 41.7, 37.8, 37.7, 25.8, 25.8, 23.0, 22.5, 20.8, 17.9, 17.8, 15.7, 
15.6, -4.1, -4.1, -4.9, -5.0. 
 
 
Acetal (68):216 Lactol 66 (32.8 mg, 82.3 µmol, 1.0 eq.) was dissolved in dry MeOH 
(28.5 mL) and p-TSA monohydrate (2.7 mg, 14.0 µmol, 0.2 eq.) 
was added at r.t. and the resulting mixture was stirred overnight. 
The clear solution was quenched with brine (10 mL) and extracted 
with EtOAc (15 mL) and water (10 mL). The aqueous layer was extracted with 
EtOAc (3 x 5 mL). Combined organic layers were washed with saturated NaHCO3 
solution and brine. The organic layer was dried over Na2SO4, filtered and evaporated 
under reduced pressure. Purification was performed by flash chromatography 
(pentane/EtOAc 15:1) to obtain acetal 68 (22.6 mg, 54.8 µmol, 67%) as a white solid.  
 
Rf = 0.30 (EtOAc/pentane 1:15). 1H NMR (400 MHz, CDCl3) δ = 5.65 (t, J = 3.0 Hz, 
1H), 5.52 (d, J = 4.2 Hz, 1H), 5.09-5.02 (m, 2H), 4.80-4.74 (m, 1H), 4.68-4.58 (m, 
2H), 4.51 (d, J = 12.6 Hz, 1H), 4.23 (s, 1H), 4.12 (s, 1H), 3.61 (s, 6H), 3.30 (s, 3H), 
3.14 (s, 3H), 2.63-2.53 (m, 2H), 2.30-2.09 (m, 8H), 1.83-1.77 (m, 4H), 0.90 (s, 9H), 
0.90 (s, 9H), 0.86 (d, J = 7.1, 3H), 0.84 (d, J = 7.1, 3H), 0.12 (s, 3H), 0.11 (s, 3H), 
0.10 (s, 3H), 0.10 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 174.0, 141.8, 141.6, 
133.5, 133.3, 109.8, 109.6, 73.4, 73.1, 72.7, 63.2, 63.0, 53.0, 51.6, 51.3, 51.3, 41.8, 
41.7, 37.9, 37.8, 25.9, 25.8, 22.8, 22.7, 21.0, 20.9, 17.9, 15.7, -4.0, -4.9, -4.9.  
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Aldehyde (70):216 Diol 62 (18.4 mg, 65.2 µmol, 1.0 eq.) was dissolved in THF/H2O 
(2:1, 0.66 mL) and NaIO4 (45.1 mg, 0.21 mmol, 3.2 eq.) was added 
at r.t. The reaction was diluted after 1 h with EtOAc (7 mL). The 
mixture was filtered over Na2SO4 and the crystals were vigorously 
washed with EtOAc (3 x 4 mL). Combined organic layers were evaporated to obtain a 
white solid. The crude was purified by flash chromatography (pentane/EtOAc 2:1) to 
obtain the desired aldehyde 70 (18.3 mg, 65.2 µmol, quant.) as a white solid.  
 
M.p.: 101.2-101.8 °C. Rf = 0.56 (EtOAc/pentane 1:1). Optical rotation: [α]D = +64.0 
(c = 0.15, CHCl3). FTIR ν = 2957, 2826, 1755, 1725, 1685, 1435, 1234, 1203, 1026, 
886, 737 cm-1. 1H NMR (400 MHz, CDCl3) δ = 9.72 (d, J = 1.2 Hz, 1H), 5.02-4.88 
(m, 2H), 3.72 (s, 3H), 3.06-2.98 (m, 1H), 2.71-2.54 (m, 4H), 2.41 (ddd, J = 17.8, 8.8, 
1.9 Hz, 1H), 2.17 (ddd, J = 13.5, 8.9, 6.3 Hz, 1H), 1.06 (d, J = 6.9 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 200.4, 191.7, 172.0, 170.3, 151.5, 143.5, 68.8, 61.2, 53.1, 
46.8, 30.4, 29.0, 18.9, 16.8. 
 
 
Acetal (71):216 To ketoaldehyde 70 (4.7 mg, 16.8 µmol, 1.0 eq.) were added dry 
benzene (0.2 mL), ethylene glycol (62.5 mg, 1.01 mmol, 
60.0 eq.), p-TSA monohydrate (3.2 mg, 33.5 µmol, 2.0 eq.) and 
3 Å molecular sieves. The resulting mixture was heated to 90 °C 
for 6 h. The colourless solution was allowed to cool down to r.t. and EtOAc and an 
aqueous saturated NaHCO3 solution were added. The aqueous layer was extracted 
three times with EtOAc and the combined organic layers were washed with brine. 
The organic layer was dried over Na2SO4, filtered and evaporated to obtain a 
slightly brown oil. The crude was purified by flash chromatography 
(pentane/EtOAc 2:1) to obtain the desired acetal 71 (3.5 mg, 13.9 µmol, 83%) as 
a white solid. 
 
M.p.: 166.3-167.1 °C. Rf = 0.30 (pentane/EtOAc 2:1). Optical rotation: [α]D = +34.8 
(c = 0.18, CHCl3). FTIR: ν = 3359, 3189, 2961, 2923, 2852, 1767, 1733, 1690, 
1442, 1229, 1189, 1146, 1111, 1065, 1026, 954, 737 cm-1. 1H NMR (500 MHz, 
CDCl3) δ = 4.94 (qt, J = 17.5, 3.2 Hz, 2H), 4.90 (t, J = 4.8 Hz, 1H), 3.97-3.91 (m, 
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2H), 3.86-3.80 (m, 2H), 3.72 (s, 3H), 2.63-2.60 (m, 2H), 2.55-2.50 (m, 2H), 
2.27-2.21 (m, 1H), 1.67-1.65 (m, 2H), 1.10 (d, J = 6.9 Hz, 3H). 13C NMR (101 
MHz, CDCl3) δ = 191.9, 172.2, 170.5, 151.6, 143.4, 103.6, 68.9, 65.1, 64.8, 62.3, 
36.1, 32.9, 28.8, 19.0, 16.9. 
 
 
Dithian (72):216 Aldehyde 70 (6.6 mg, 23.5 µmol, 1.0 eq.) was dissolved in dry 
CH2Cl2 (0.1 mL) and 1,2-ethanedithiol (4.2 µl, 49.5 µmol, 2.1 eq.) 
and then BF3 etherate (2.7 µl, 21.2 µmol, 0.9 eq.) were added at r.t. 
The colourless solution was stirred for 20 min at r.t. The reaction 
mixture was quenched with saturated NaHCO3 solution and extracted three times with 
CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4, 
filtered and evaporated to obtain a white solid. The crude was purified by flash 
chromatography (pentane/EtOAc 4:1, then 1:1) to obtain the desired product 72 
(4.5 mg, 10.4 µmol, 54%) as white to slightly green solid.  
 
M.p.: 159.2-159.9 °C. Rf = 0.29 (EtOAc/pentane 1:4). FTIR ν = 2954, 2932, 2851, 
1746, 1726, 1681, 1441, 1227, 1195, 1029, 900, 730 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 4.94 (qt, J = 17.5, 3.0 Hz, 2H), 4.52 (dd, J = 10.5, 4.0 Hz, 1H), 3.72 (s, 
3H), 3.28-3.16 (m, 4H), 2.63-2.59 (m, 2H), 2.52 (dt, J = 13.9, 3.9 Hz, 1H), 2.45-2.37 
(m, 1H), 2.27-2.20 (m, 1H), 1.94-1.83 (m, 1H), 1.79-1.69 (m, 1H), 1.08 (d, 
J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 191.7, 172.1, 170.4, 151.5, 143.5, 
68.9, 62.2, 53.0, 52.0, 41.9, 38.7, 38.1, 37.3, 28.9, 19.0, 15.8. 
 
 
Lactone (75):216 Diol 62 (12.5 mg, 44.3 µmol, 1.0 eq.) and Rh/C/Al2O3 (5% Rh, 
9.1 mg, 4.43 µmol 0.1 eq.) were dissolved in dry EtOAc (0.3 mL) and 
hydrogenated at r.t. under a 60 bar H2 pressure. After 3 h, the reaction 
was filtered over celite and vigorously washed with EtOAc. The 
solvent was evaporated under reduced pressure to obtain a white solid. The crude was 
purified by flash chromatography (pentane/EtOAc 1:1) to obtain the desired 
hydrogenated lactone 75 (12.6 mg, 44.3 µmol, quant.) as a white solid.  
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M.p.: 197.7-198.5 °C. Rf = 0.31 (EtOAc/pentane 1:1). Optical rotation:            
[α]D = –110.8 (c = 0.12, CHCl3). FTIR ν = 3498, 3425, 2955, 2871, 1743, 1708, 
1366, 1202, 1038, 974, 716, 617 cm-1. 1H NMR (500 MHz, CDCl3) δ = 4.91 (dd, 
J = 9.2, 4.1 Hz, 1H), 4.24 (dd, J = 9.7, 8.3 Hz, 1H), 4.00 (dd, J = 11.5, 9.7 Hz, 1H), 
3.69 (s, 3H), 3.43 (s, 1H), 2.93-2.84 (m, 2H), 2.63-2.55 (m, 1H), 2.22 (dt, J = 13.0, 
3.6 Hz, 1H), 2.10 (brs, 1H), 2.06 (ddd, J = 10.6, 6.6, 3.5 Hz, 1H), 1.93-1.75 (m, 3H), 
1.56-1.47 (m, 1H), 0.77 (d, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 179.2, 
174.3, 80.0, 72.53, 67.4, 59.6, 51.7, 44.1, 39.9, 39.3, 38.2, 24.9, 22.1, 14.7. HRMS 
ESI calc. for C14H21O6 [M-H]+: 285.1333, found: 285.1334. X-ray crystal structure 
is given in the appendices section. 
 
 
Aldehyde (76):216 Diol 75 (11.3 mg, 39.7 µmol, 1.0 eq.) was dissolved in THF/H2O 
(2:1, 0.47 mL) and NaIO4 (27.8 mg, 0.13 mmol, 3.2 eq.) was added 
at r.t. After 1.5 h, the reaction mixture was diluted with EtOAc 
(2 mL) and filtered over Na2SO4. The filtrate was vigorously washed 
with EtOAc (4 x 2 mL). The solvent was evaporated to obtain a white solid. The 
crude was purified by flash chromatography (pentane/EtOAc 2:1) to obtain the 
desired ketoaldehyde 76 (12.5 mg, 43.6 µmol, quant.) as colourless oil, which slowly 
decomposes to 77.  
 
Rf = 0.38 (EtOAc/pentane 1:1). Optical rotation: [α]D = –137.3 (c = 0.12, CHCl3). 
FTIR ν = 2955, 1770, 1712, 1452, 1167, 998, 732, 626 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 9.71 (s, 1H), 4.86 (dd, J = 9.4, 1.9 Hz, 1H), 4.19 (dd, J = 9.4, 6.6 Hz, 1H), 
3.70 (s, 3H), 3.30-3.18 (m, 2H), 2.93-2.84 (m, 1H), 2.82-2.68 (m, 2H), 2.29-2.17 (m, 
2H), 2.15-2.04 (m, 2H), 1.07 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 205.4, 201.3, 176.7, 170.7, 66.2, 63.0, 52.5, 47.5, 45.6, 40.2, 29.1, 28.8, 18.8, 
15.8. 
 
Rf = 0.31 (EtOAc/pentane 1:1). 1H NMR (500 MHz, CDCl3) δ = 5.07 
(d, J = 9.5 Hz, 1H), 4.18 (d, J = 9.5 Hz, 1H), 3.85 (dd, J = 10.8, 4.4 Hz, 
1H), 3.75 (s, 3H), 3.39 (dd, J = 13.3, 6.0 Hz, 1H), 2.56-2.51 (m, 1H), 
2.38-2.17 (m, 5H), 1.90 (ddd, J = 14.3, 5.4, 2.4 Hz, 1H), 1.00 (d, J = 7.1 Hz, 3H). 
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13C NMR (126 MHz, CDCl3) δ = 205.5, 177.3, 172.1, 71.3, 67.9, 59.5, 59.2, 52.5, 
41.1, 35.8, 35.0, 34.9, 23.4, 16.1. 
 
 
Acetal (78):247 To the diol 75 (130.0 mg, 0.45 mmol, 1.0 eq.) dissolved in THF and 
H2O (3:1, 5 mL) was added sodium periodate (332.0 mg, 
1.60 mmol, 3.4 eq.). The mixture was stirred at r.t. for 2 h and 
subsequently dried by filtrating the mixture through a patch of 
Na2SO4 and washed with EtOAc. The solvent was evaporated, and crude product was 
obtained as colourless oil. The crude ketoaldehyde 76 was dissolved in dry benzene 
(4 mL), and ethylene glycol (27 µL, 0.48 mmol, 1.1 eq.) was added, followed by 
p-TSA (9.2 mg, 0.05 mmol, 0.1 eq.). The resulting solution was heated to reflux 
(90 °C). After 1 h 45 min the solution was allowed to cool to r.t., and was then treated 
with saturated NaHCO3 solution (3 mL) followed by extraction with EtOAc three 
times. The combined organic layers were washed with water, dried over Na2SO4 and 
evaporated under reduced pressure. The crude material was subjected to flash 
chromatography on silica (CH2Cl2/MeOH, 20:1) and concentrated to give protected 
aldehyde 78 (149.0 mg, 0.45 mmol, quant.) as a white solid. 
 
Rf = 0.63 (CH2Cl2/MeOH 20:1). Optical rotation: [α]D = –75.5 (c = 0.77, CHCl3). 
FTIR ν = 2954, 2887, 1773, 1737, 1709, 1450, 1372, 1343, 1297, 1220, 1188, 1148, 
1121, 1050, 1027, 998, 962, 734 cm-1. 1H NMR (500 MHz, CDCl3) δ = 4.95 (dd, 
J = 9.3, 1.8 Hz, 1H), 4.86 (dd, J = 6.4, 2.6 Hz, 1H), 4.14 (dd, J = 9.3, 6.5 Hz, 1H), 
3.97-3.90 (m, 2H), 3.87-3.79 (m, 2H), 3.70 (s, 3H), 3.47 (ddd, J = 10.0, 6.4, 1.7 Hz, 
1H), 3.18 (ddd, J = 10.1, 6.4, 5.1 Hz, 1H), 2.42-2.35 (m, 1H), 2.22-2.07 (m, 4H), 2.03 
(ddd, J = 14.9, 9.8, 2.6 Hz, 1H), 1.54 (ddd, J = 14.9, 6.4, 0.8 Hz, 1H), 1.09 (d, 
J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 205.2, 176.8, 170.9, 103.3, 66.0, 
65.1, 64.9, 64.2, 52.2, 45.7, 40.9, 36.8, 30.3, 29.1, 18.6, 15.4. HRMS ESI calc. for 
C16H23O7 [M-H]+: 327.1438, found: 327.1443. 
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Dithiolane (79):216 Ketoaldehyde 76 (7.7 mg, 27.3 µmol, 1.0 eq.) was dissolved in 
dry CH2Cl2 (0.1 mL) and 1,2-ethanedithiol (3.3 mg, 35.5 µmol, 
1.3 eq.) in dry CH2Cl2 (0.25 mL) and BF3 etherate (3.5 mg, 
24.5 µmol, 0.9 eq.) was added at r.t. After 1 h, the colourless 
solution was quenched with saturated NaHCO3 solution and extracted three times with 
CH2Cl2. Combined organic layers were washed with brine, dried over Na2SO4, 
filtered and evaporated to obtain a white solid. The crude was purified by flash 
chromatography (pentane/EtOAc 3:1) to obtain the desired dithiolane 79 (5.5 mg, 
15.3 µmol, 56%) as a white solid.  
 
Rf = 0.71 (EtOAc/pentane 1:1). Optical rotation: [α]D = –36.5 (c = 0.18, CHCl3). 
FTIR: ν = 2927, 1772, 1736, 1709, 1450, 1227, 1197, 1165, 1060, 997, 908 cm
-1. 
1H NMR (400 MHz, CDCl3) δ = 4.93 (dd, J = 9.3, 2.0 Hz, 1H), 4.53 (dd, J = 11.4, 
2.9 Hz, 1H), 4.18 (dd, J = 9.3, 6.7 Hz, 1H), 3.70 (s, 3H), 3.53 (ddd, J = 10.0, 6.7, 
2.0 Hz, 1H), 3.29-3.10 (m, 5H), 2.29-2.08 (m, 6H), 1.61-1.55 (m, 1H), 1.08 (d, 
J = 6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 204.8, 176.7, 170.7, 66.1, 64.1, 
52.3, 52.1, 46.2, 42.4, 40.5, 38.6, 38.0, 35.6, 29.2, 18.7, 13.9. 
 
 
Alcohol (80):247 Keto acetal 78 (161.0 mg, 0.49 mmol, 1.0 eq.) was dissolved in THF 
(2.8 mL), and formaline (37% aq. solution, 8.3 mL, 112 mmol, 
226 eq.) was added, followed by aq. citrate buffer solution 
(8.3 mL, pH 6.0). The resulting solution was heated up to 40 °C 
and stirred overnight. After cooling to r.t., the reaction mixture was diluted with 
EtOAc and water. The aqueous layer was extracted three times with EtOAc, and the 
combined organic layers were washed with water, dried over Na2SO4, and evaporated 
under reduced pressure. The crude residue was dissolved in a CH2Cl2/MeOH mixture 
(20:1) and filtered through a pad of silica. Purification by flash chromatography 
(CH2Cl2/MeOH 20:1) gave pure product 80 (164.3 mg, 0.46 mmol, 94%) as a white 
solid. 
 
Rf = 0.30 (CH2Cl2/MeOH 20:1). Optical rotation: [α]D = –23.5 (c = 0.30, CHCl3). 
FTIR: ν = 3467, 2957, 2923, 2854, 1766, 1728, 1702, 1465, 1437, 1382, 1300, 1223, 
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1174, 1137, 1096, 1017, 952, 881, 860, 826, 751, 713 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 4.87 (dd, J = 5.8, 3.5 Hz, 1H), 4.34 (d, J = 9.8 Hz, 1H), 4.13 (d, 
J = 9.8 Hz, 1H), 4.00-3.91 (m, 3H), 3.88-3.79 (m, 2H), 3.71 (s, 3H), 3.60 (d, 
J = 10.8 Hz, 1H), 3.02-2.93 (m, 1H), 2.38-2.19 (m, 3H), 2.05 (ddd, J = 12.9, 11.5, 
2.3 Hz, 1H), 1.98-1.84 (m, 1H), 1.79-1.64 (m, 2H), 1.12 (d, J = 6.8 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 208.5, 177.5, 171.4, 103.7, 70.9, 67.0, 65.0, 64.8, 
63.3, 56.6, 42.8, 35.8, 33.8, 30.5, 28.9, 20.8, 17.0. HRMS ESI calc. for C17H25O8 
[M-H]+: 357.1544, found: 357.1552. 
 
 
Chloride (81): To the hydroxymethylated ketoaldehyde 80 (169.0 mg, 0.47 mmol, 
1.0 eq.) was added triphenylphosphine (176.0 mg, 0.66 mmol, 
1.4 eq.), followed by dry acetonitrile (6 mL) and freshly distilled 
trichloroacetonitrile (166 µL, 0.24 mmol, 3.5 eq.). The resulting 
mixture was refluxed at 85 °C overnight. The reaction mixture was then cooled to r.t. 
and treated with a saturated NaHCO3 solution, followed by extraction twice with 
EtOAc. The combined organic layers were dried over Na2SO4, filtered, and 
evaporated under reduced pressure. The crude material was subjected to flash 
chromatography on silica (EtOAc/pentane 1:3) and concentrated to give pure 81 
(146.0 mg, 0.39 mmol, 82%) as colourless oil. 
 
Rf = 0.26 (pentane/EtOAc 3:1). Optical rotation: [α]D = +0.6 (c = 0.30, CHCl3). 
FTIR: ν = 2960, 2882, 2361, 1767, 1705, 1588, 1437, 1413, 1382, 1293, 1221, 1175, 
1128, 1080, 1018, 954, 891, 856, 819, 791, 758, 700 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 4.86 (dd, J = 5.7, 3.7 Hz, 1H), 4.39 (d, J = 10.3 Hz, 1H), 4.22 (d, 
J = 11.0 Hz, 1H), 4.03 (d, J = 10.3 Hz, 1H), 4.00-3.88 (m, 2H), 3.88-3.79 (m, 2H), 
3.73 (s, 3H), 3.43 (d, J = 11.0 Hz, 1H), 3.27-3.17 (m, 1H), 2.45-2.36 (m, 1H), 
2.37-2.27 (m, 2H), 2.09-1.96 (m, 1H), 1.80 (dd, J = 11.0, 2.1 Hz, 1H), 1.68-1.50 (m, 
2H), 1.09 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 204.4, 176.4, 171.3, 
103.5, 71.5, 65.1, 64.8, 63.7, 56.4, 53.0, 48.1, 43.4, 36.2, 35.8, 28.1, 21.1, 17.4. 
HRMS ESI calc. for C17H24O7Cl [M-H]+: 375.1205, found: 375.1213. 
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Acetal (82): Iodide 83 (401.0 mg, 0.86 mmol, 1.0 eq.) was dissolved in dry and 
degassed benzene (30 mL) under argon atmosphere. Tri-n-butyltin 
hydride (348 µL, 1.29 mmol, 1.5 eq.) and AIBN (42.0 mg, 
0.26 mmol, 0.3 eq.) were added and the mixture was stirred for 3 h 
at 85 °C. The solvent was removed in vacuo and the residue was purified by flash 
column chromatography (pentane/EtOAc 2:1) to give the protected aldehyde 82 
(242.0 mg, 0.72 mmol, 84%) as a colourless oil the ring expended side product 84 
(51.0 mg, 0.14 mmol, 16%). 
 
Rf = 0.18 (pentane/EtOAc 2:1). Optical rotation: [α]D = –68.5 (c = 0.49, MeOH). 
FTIR ν = 2955, 2887, 1776, 1733, 1709, 1457, 1364, 1297, 1230, 1148, 1020, 963, 
823, 733 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.85 (t, J = 4.8 Hz, 1H), 4.47 (d, 
J = 9.3 Hz, 1H), 3.95-3.84 (m, 3H), 3.83-3.75 (m, 2H), 3.64 (s, 3H), 2.61 (dd, 
J = 10.3, 6.1 Hz, 1H), 2.43-2.32 (m, 1H), 2.26-2.11 (m, 2H), 2.03-1.86 (m, 2H), 
1.59-1.53 (m, 2H), 1.33 (s, 3H), 1.03 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 207.7, 177.5, 171.1, 103.5, 74.6, 65.0, 64.7, 63.3, 52.6, 50.9, 46.3, 36.1, 
34.8, 27.7, 24.3, 19.5, 16.8. HRMS ESI calc. for C17H25O7 [M-H]+: 341.1595, 
found: 341.1591. 
 
Rf = 0.14 (pentane/EtOAc 2:1). Optical rotation: [α]D = +15.9 
(c = 0.41, CHCl3). FTIR: ν = 2982, 2960, 2932, 2883, 1737, 
1696, 1468, 1445, 1396, 1355, 1323, 1256, 1236, 1214, 1202, 
1181, 1138, 1117, 1081, 1029, 1014, 987, 963, 934, 880, 851, 797, 769, 706 cm-1. 
1H NMR (400 MHz, CDCl3) δ = 4.96 (dd, J = 5.7, 4.2 Hz, 1H), 4.42 (dd, J = 9.4, 
7.1 Hz, 1H), 4.02-3.94 (m, 3H), 3.90-3.84 (m, 2H), 3.76 (s, 3H), 2.90-2.78 (m, 1H), 
2.70 (ddd, J = 8.7, 6.4, 2.8 Hz, 2H), 2.56 (dd, J = 11.8, 4.4 Hz, 1H), 2.46-2.33 (m, 
2H), 2.10-1.94 (m, 2H), 1.76 (ddd, J = 13.9, 5.7, 1.7 Hz, 1H), 1.68 (ddd, J = 15.1, 9.4, 
2.4 Hz, 1H), 1.45 (ddd, J = 14.1, 10.3, 4.2 Hz, 1H), 1.07 (d, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ = 204.3, 177.9, 171.8, 104.0, 71.4, 67.3, 65.0, 64.7, 
52.5, 43.6, 42.5, 37.4, 35.8, 33.3, 29.3, 22.9, 15.7. HRMS ESI calc. for C17H25O7 
[M-H]+: 341.1595, found: 341.1591. X-ray crystal structure is given in the 
appendix. 
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Iodide (83): Alcohol 80 (408 mg, 1.14 mmol, 1.0 eq.), triphenylphosphine (600 mg, 
2.29 mmol, 2.0 eq.) and imidazole (311 mg, 4.57 mmol, 
4.0 eq.) were dissolved in dry benzene (30 mL) under argon 
atmosphere. Iodine (580 mg, 2.29 mmol, 2.0 eq.) was added at r.t. 
and the resulting mixture was stirred for 12 hours at that temperature. The reaction 
was quenched with a 1:1 mixture of saturated NaHCO3 and Na2S2O3 solution and 
extracted three times with EtOAc. Combined organic layers were dried over Na2SO4, 
filtered and evaporated under reduced pressure. The residue was purified by flash 
chromatography on silica (pentane/EtOAc 5:2) giving iodide 83 (401.2 mg, 
0.86 mmol, 75%) as a colourless oil. 
 
Rf = 0.23 (pentane/EtOAc 3:1). Optical rotation: [α]D = +17.9° (c = 0.48, CHCl3). 
FTIR: ν = 2954, 2886, 2360, 1781, 1731, 1710, 1436, 1366, 1225, 1162, 1030, 947, 
824, 732 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.87 (dd, J = 5.8, 3.7 Hz, 1H), 4.39 
(d, J = 10.2 Hz, 1H), 4.01 (d, J = 10.2 Hz, 1H), 3.98-3.87 (m, 3H), 3.86-3.78 (m, 2H), 
3.72 (s, 3H), 3.15 (d, J = 10.3 Hz, 1H), 3.14-3.08 (m, 1H), 2.49-2.38 (m, 1H), 
2.33-2.24 (m, 2H), 2.08-1.98 (m, 1H), 1.86 (tdd, J = 13.3, 8.3, 2.3 Hz, 1H), 1.72-1.55 
(m, 2H), 1.11 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 203.7, 176.2, 
171.1, 103.5, 72.9, 65.1, 64.8, 63.5, 55.3, 53.0, 46.9, 36.4, 35.6, 27.5, 20.8, 17.4, 11.3. 
HRMS ESI calc. for C17H24IO7 [M-H]+: 467.0561, found: 467.0557. 
 
 
Aldehyde (85): The protected aldehyde 82 (227.0 mg, 0.67 mmol, 1.0 eq.) was 
dissolved in acetone (10 mL) before a 1 M aq. HCl solution (5 mL) 
was added. The resulting mixture was stirred overnight at r.t. The 
reaction was quenched by addition of a saturated aq. NaHCO3 
solution and extracted 3 times with EtOAc. The combined organic layers were dried 
over Na2SO4, filtered and evaporated under reduced pressure to yield already pure 85 
(195.8 mg, 0.66 mmol, 99%) as colourless oil. 
 
Rf = 0.56 (pentane/EtOAc 1:1). Optical rotation: [α]D = –87.8 (c = 0.42, CHCl3). 
FTIR: ν = 2956, 2360, 2339, 1776, 1717, 1457, 1385, 1295, 1234, 1155, 1022, 991, 
787 cm-1. 1H NMR (400 MHz, CDCl3) δ = 9.72 (d, J = 1.7 Hz, 1H), 4.60 (d, 
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J = 9.4 Hz, 1H), 3.90 (d, J = 9.4 Hz, 1H), 3.68 (s, 3H), 2.94 (dqd, J = 9.8, 6.8, 3.0 Hz, 
1H), 2.69 (t, J = 7.4 Hz, 1H), 2.67-2.60 (m, 1H), 2.52-2.43 (m, 1H), 2.31-2.19 (m, 
2H), 2.08-1.94 (m, 2H), 1.36 (s, 3H), 1.00 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 208.1, 200.7, 177.3, 170.8, 74.7, 62.3, 52.8, 51.2, 46.8, 46.2, 31.3, 27.2, 
24.5, 18.9, 16.6. HRMS ESI calc. for C15H21O6 [M-H]+: 297.1333 found: 297.1328. 
 
 
Alcohol (87): Aldehyde 85 (78.1 mg, 0.264 mmol, 1.0 eq.) was dissolved in 
HFIP (1 mL). Borane 88256  (1 mol/L in THF, 790 µL, 0.791 mmol, 
3.0 eq.) was added at r.t. under nitrogen atmosphere and stirred 
overnight. The reaction was quenched by addition of saturated 
NH4Cl solution and extracted three times with EtOAc. Combined organic layers were 
dried over Na2SO4, filtered and evaporated under reduced pressure. The crude was 
purified by flash chromatography (pentane/EtOAc 2:3) giving alcohol 87 (66.9 mg, 
0.224 mmol, 85%) as colourless oil. 
 
Rf = 0.26 (EtOAc/pentane 3:2). Optical rotation: [α]D = –79.9 (c = 0.18, MeOH). 
FTIR: ν = 3529, 3407, 2955, 2884, 1775, 1731, 1708, 1456, 1385, 1364, 1293, 1231, 
1187, 1154, 1055, 1021, 989, 916, 848, 732, 681 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 4.48 (d, J = 9.3 Hz, 1H), 3.94 (d, J = 9.3 Hz, 1H), 3.74 (ddd, J = 11.0, 8.8, 5.5 Hz, 
1H), 3.69 (s, 3H), 3.67-3.58 (m, 1H), 2.64 (t, J = 8.4 Hz, 1H), 2.45-2.34 (m, 1H), 2.28 
(dt, J = 9.3, 4.4 Hz, 1H), 2.25-2.17 (m, 1H), 2.07-1.92 (m, 2H), 1.69-1.52 (m, 2H), 
1.39-1.33 (m, 1H), 1.37 (d, J = 2.9 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 208.1, 177.5, 171.3, 74.6, 63.2, 61.0, 52.8, 51.0, 46.5, 35.3, 
34.8, 27.4, 24.4, 19.8, 16.1. HRMS ESI calc. for C15H22NaO6 [M-Na]+: 321.1309, 
found: 321.1308. 
 
 
Iodide (89): Alcohol 87 (26.0 mg, 0.087 mmol, 1.0 eq.) was dissolved in dry benzene  
(5 mL) under nitrogen atmosphere. Triphenylphosphine (45.7 mg, 
0.174 mmol, 2.0 eq.), imidazole (23.7 mg, 0.0349 mmol, 4.0 eq.), 
and iodine (44.2 mg, 0.174 mmol, 2.0 eq.) were added at r.t. and the 
resulting mixture was stirred overnight. The crude mixture was filtered, washed with 
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benzene and evaporated under reduced pressure. The crude oil was purified by flash 
chromatography (pentane/EtOAc 2:1) giving iodide 89 (33.8 mg, 0.083 mmol, 95%) 
as a white solid. 
 
Rf = 0.44 (pentane/EtOAc 2:1). Optical rotation: [α]D = –9.8 (c = 0.58, CHCl3). 
FTIR: ν = 3245, 2971, 2927, 2860, 2171, 1762, 1728, 1700, 1591, 1532, 1489, 1439, 
1385, 1368, 1287, 1230, 1207, 1173, 1119, 1069, 1012, 977, 961, 922, 905, 852, 773, 
764, 722, 692 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.48 (d, J = 9.3 Hz, 1H), 3.93 (d, 
J = 9.3 Hz, 1H), 3.71 (s, 3H), 3.33 (ddd, J = 9.8, 7.7, 4.3 Hz, 1H), 3.07 (td, J = 9.5, 
7.1 Hz, 1H), 2.68-2.60 (m, 1H), 2.37-2.14 (m, 3H), 2.05-1.91 (m, 2H), 1.89-1.78 (m, 
1H), 1.71-1.60 (m, 1H), 1.37 (s, 3H), 0.97 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 207.7, 177.4, 171.0, 74.6, 63.1, 52.9, 51.0, 46.4, 39.5, 35.6, 27.6, 24.5, 
19.7, 15.1, 4.4. HRMS ESI calc. for C15H22IO5 [M-H]+: 409.0506, found: 409.0508. 
X-ray crystal structure is given in the appendix. 
 
 
Samarium(II) iodide: Samarium (151 mg, 1.0 mmol, 1.0 eq.) was activated by hot 
stirring with a heat gun in vacuo. After cooling, 1,2-diiodoethane (prewashed by 
extraction with saturated aqueous Na2S2O3 solution, 141 mg, 0.5 mmol, 1.0 eq.) was 
added under argon atmosphere. THF (dried over sodium, 2 mL) was added and the 
mixture was stirred for 5 min at room temperature. After that time, more THF (3 mL) 
was added and the solution was stirred until it turned dark blue and SmI2 was obtained 
as a 0.1 M solution in THF and was used as such. Procedure was and observations are 
in agreement with literature. 
 
Literature: M. Szostak, M. Spain, D. J. Procter, J. Org. Chem. 2012, 77, 3049. 
 
 
Lactone (57): Iodide 89 (118.0 mg, 0.289 mmol, 1.0 eq.) was dissolved in 
hexamethylphosphoramide (500 µL, 2.890 mmol, 10.0 eq.) under 
nitrogen atmosphere and cooled down to 0 °C. A freshly prepared SmI2 
solution (0.1 M in THF, 7.22 mL, 0.722 mmol, 2.5 eq.) was added and 
the resulting mixture was slowly heated up to r.t. and stirred for 1 hour. The reaction 
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was quenched by addition of a saturated aqueous Rochelle's salt solution and stirred at 
that temperature for 20 min. Extraction was performed three times with EtOAc. 
Combined organic layers were dried over Na2SO4, filtered and evaporated under 
reduced pressure. The crude was purified by flash chromatography on silica 
(pentane/EtOAc 4:1, CAM dip) giving the tricyclic product 57 (61.5 mg, 0.218 mmol, 
76%) as the side-product 86 (5.8 mg, 0.026 mmol, 9%) as white solids. 
 
Rf = 0.41 (pentane/EtOAc 4:1). Optical rotation: [α]D = –17.6 (c = 0.29, MeOH). 
FTIR: ν = 3495, 2959, 2900, 2877, 1770, 1708, 1454, 1435, 1384, 1354, 1325, 1291, 
1270, 1239, 1181, 1148, 1102, 1076, 1058, 1040, 1009, 988, 966, 920, 896, 845, 768, 
739, 714, 681 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.17 (d, J = 2.1 Hz, 1H), 4.44 (d, 
J = 9.5 Hz, 1H), 3.97 (d, J = 9.5 Hz, 1H), 3.79 (s, 3H), 2.40-2.32 (m, 1H), 2.24-2.16 
(m, 1H), 2.14-2.00 (m, 2H), 1.96-1.86 (m, 2H), 1.82-1.71 (m, 1H), 1.66-1.58 (m, 1H), 
1.43 (td, J = 13.9, 2.6 Hz, 1H), 1.35-1.29 (m, 1H), 1.23 (s, 3H), 1.00 (d, J = 6.9 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ = 178.8, 178.5, 85.4, 74.6, 58.0, 52.6, 48.1, 46.8, 
45.1, 36.9, 33.8, 29.4, 23.1, 22.4, 21.2. HRMS ESI calc. for C15H22NaO5 [M-Na]+: 
305.1359, found: 305.1359. 
 
Rf = 0.30 (pentane/EtOAc 4:1). Optical rotation: [α]D = –164.9 
(c = 0.58, CHCl3). FTIR: ν = 2957, 2920, 2852, 2364, 1786, 1656, 
1614, 1459, 1440, 1357, 1342, 1285, 1231, 1216, 1147, 1111, 1071, 
1037, 1011, 949, 827, 760, 734, 701 cm-1. 1H NMR (400 MHz, CDCl3) δ = 12.25 (s, 
1H), 4.52 (d, J = 9.2 Hz, 1H), 3.86 (d, J = 9.2 Hz, 1H), 3.66 (s, 3H), 2.49 (t, 
J = 4.5 Hz, 1H), 2.27-2.13 (m, 2H), 2.01 (ddd, J = 17.5, 8.5, 4.8 Hz, 1H), 1.65 (dddd, 
J = 14.0, 10.0, 6.9, 4.4 Hz, 1H), 1.34 (s, 3H), 1.19-1.12 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ = 177.3, 172.7, 170.0, 99.5, 75.2, 52.1, 46.2, 43.9, 22.1, 19.4, 
18.2. HRMS ESI calc. for C11H15O5 [M-H]+: 227.0914, found: 227.0916. 
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Chloride (91): Deprotected aldehyde 81 (6.3 mg, 0.019 mmol, 1.0 eq.) was dissolved 
in EtOH/CH2Cl2 (1:4, 5 mL) and cooled down to –78 °C. Sodium 
borohydride (7.4 mg, 0.190 mmol, 10.0 eq.) was added and the 
reaction was stirred at this temperature for 2.5 h. The reaction was 
quenched with saturated NH4Cl solution and extracted three times with EtOAc. 
Combined organic layers were dried over Na2SO4, filtered and evaporated under 
reduced pressure. The residue was purified by flash chromatography (pentane/EtOAc 
2:3) giving chloride 91 (4.6 mg, 0.014 mmol, 73%) as colourless oil. 
 
Rf = 0.27 (pentane/EtOAc 2:3). 1H NMR (400 MHz, CDCl3) δ = 4.36 (d, J = 10.3 Hz, 
1H), 4.24 (d, J = 11.0 Hz, 1H), 4.03 (d, J = 10.3 Hz, 1H), 3.74 (s, 3H), 3.64-3.56 (m, 
1H), 3.44 (d, J = 11.0 Hz, 1H), 3.23 (dd, J = 11.3, 7.2 Hz, 1H), 2.42-2.27 (m, 3H), 
2.08-1.96 (m, 1H), 1.88-1.74 (m, 1H), 1.69-1.52 (m, 2H), 1.40-1.29 (m, 2H), 1.02 (d, 
J = 6.8 Hz, 3H). 
 
 
Iodide (90): Alcohol 91 (13.1 mg, 0.0394 mmol, 1.0 eq.) was dissolved in dry 
benzene  (5 mL) under argon atmosphere. Triphenylphosphine 
(20.7 mg, 0.0787 mmol, 2.0 eq.), imidazole (10.7 mg, 0.157 mmol, 
4.0 eq.) and iodine (20.0 mg, 0.078 mmol, 2 eq.) were added at r.t. 
and the resulting mixture was stirred for 2 hours at that temperature. 
The reaction was quenched with a 1:1 mixture of saturated NaHCO3 and Na2S2O3 
solution and subsequently extracted twice with EtOAc. Combined organic layers were 
dried over Na2SO4, filtered and evaporated under reduced pressure. The crude residue 
was purified by flash chromatography (pentane/EtOAc 4:1) giving iodide 90 (2.0 mg, 
0.0045 mmol, 12%) as colourless oil. 
 
Rf = 0.20 (pentane/EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ = 4.36 (d, J = 10.3 Hz, 
1H), 4.25 (d, J = 11.0 Hz, 1H), 4.02 (d, J = 10.3 Hz, 1H), 3.76 (s, 3H), 3.42 (d, 
J = 11.0 Hz, 1H), 3.33 (ddd, J = 9.9, 7.2, 4.2 Hz, 1H), 3.22 (dd, J = 11.6, 7.3 Hz, 1H), 
3.05 (td, J = 9.8, 6.5 Hz, 1H), 2.39-2.26 (m, 3H), 1.90-1.73 (m, 2H), 1.68-1.59 (m, 
1H), 1.01 (d, J = 6.8 Hz, 3H). 
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Aldehyde (92): In a dry round bottomed flask under argon atmosphere was dissolved 
ester 57 (19.7 mg, 0.070 mmol, 1.0 eq.) in dry THF (2 mL) and cooled 
down to 0°C. Borane-methyl sulfide complex (2 M in THF, 70 µL, 
0.140 mmol, 2.0 eq.) was added, the resulting mixture was stirred for 
15 min at 0°C and subsequently at 45 °C for 5.5 h. The mixture was allowed to cool 
down to r.t. for 10 min before ethanol was added until bubbling (exothermic) ceased. 
The solution was evaporated giving a colourless oil. Purification was performed by 
flash chromatography (pentane/EtOAc 3:2) giving aldehyde 92 (11.6 mg, 
0.0460 mmol, 66%) as a white solid.  
 
Rf = 0.32 (pentane/EtOAc 3:2, CAM dip). Optical rotation: [α]D = –13.7 (c = 0.19, 
MeOH). 1H NMR (400 MHz, CDCl3) δ = 9.84 (s, 1H), 4.23 (d, J = 0.8 Hz, 1H), 3.95 
(d, J = 9.6 Hz, 1H), 3.51 (s, 1H), 2.29-2.18 (m, 2H), 2.12 (dddd, J = 14.4, 10.4, 9.1, 
2.2 Hz, 2H), 1.98-1.84 (m, 2H), 1.82-1.72 (m, 1H), 1.72-1.60 (m, 1H), 1.51-1.41 (m, 
1H), 1.41-1.32 (m, 1H), 1.22 (d, J = 0.8 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 210.1, 178.9, 86.4, 75.0, 59.8, 47.5, 46.4, 44.6, 37.8, 31.5, 
30.5, 22.5, 22.3, 19.8. 
 
 
Lactone (93): In a dry round bottomed flask under argon atmosphere was dissolved 
ester 57 (31.8 mg, 0.113 mmol, 1.0 eq.) in dry THF (3 mL) and cooled 
down to 0°C. Borane-methyl sulfide complex (2 M in THF, 113 µL, 
0.225 mmol, 2.0 eq.) was added, the resulting mixture was stirred for 
15 min at 0°C and subsequently at 45 °C for 7 h. The mixture was 
allowed to cool down to r.t. for 10 min before ethanol was added until bubbling 
(exothermic) ceased. The solution was evaporated giving a colourless oil. Crude 
aldehyde 92 was dissolved in THF/water (1:1, 4 mL) and potassium cyanide 
(25.8 mg, 0.396 mmol, 3.5 eq.) was added. The mixture was stirred for 2 d before 
EtOAc was added and the mixture was stirred for a further day. The phases were 
separated and the aqueous layer was extraction with EtOAc for a further day. 
Extractions were performed until no more product was observed in the organic layer. 
Combined organic layers were dried over Na2SO4, filtered and evaporated under 
reduced pressure. The crude was purified by flash chromatography (EtOAc/pentane 
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3:2) giving lactone 93 (20.0 mg, 0.0713 mmol, 63%) as a white solid. 
 
Rf = 0.33 (EtOAc/pentane 1:1). Optical rotation: [α]D = –41.9 (c = 0.16, MeOH). 
FTIR ν = 3421, 2965, 2888, 1774, 1758, 1678, 1462, 1379, 1254, 1196, 1159, 1132, 
1091, 1026, 974, 944, 876, 820, 753, 716 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.40 
(d, J = 9.6 Hz, 1H), 4.35 (d, J = 2.8 Hz, 1H), 3.92 (d, J = 9.6 Hz, 1H), 2.69 (d, 
J = 2.9 Hz, 1H), 2.47 (dt, J = 8.3, 4.2 Hz, 1H), 2.29-2.19 (m, 1H), 2.12-2.00 (m, 3H), 
1.90-1.78 (m, 2H), 1.75-1.65 (m, 1H), 1.35 (s, 3H), 1.08 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ = 179.7, 176.8, 98.1, 75.7, 68.7, 53.5, 44.7, 44.3, 
43.0, 34.5, 30.2, 25.3, 22.3, 20.2, 14.5. HRMS ESI calc. for C15H21O5 
[M-H]+: 281.1384, found: 281.1380. 
 
 
Ketone (94): Alcohol 93 (3.7 mg, 0.0128 mmol, 1.0 eq.) was dissolved in dry CH2Cl2 
(2 mL) under nitrogen atmosphere. Dess-Martin periodinane (10.9 mg, 
0.0257 mmol, 2.0 eq.) was added and the mixture was stirred for 2 h at 
r.t. The reaction was quenched by addition of saturated NaHCO3 
solution and extracted three times with EtOAc. Combined organic layers 
were dried over Na2SO4, filtered and evaporated under reduced pressure. The crude 
product was purified by flash chromatography (pentane/EtOAc 1:1) giving ketone 94 
(3.6 mg, 0.0128 mmol, quant.) as a white solid. 
 
Rf = 0.37 (pentane/EtOAc 1:1). 1H NMR (400 MHz, CDCl3) δ = 3.97 (d, J = 9.9 Hz, 
1H), 3.51 (dd, J = 9.9, 0.6 Hz, 1H), 2.48-2.44 (m, 1H), 2.40 (dd, J = 14.1, 5.7 Hz, 
1H), 2.33-2.19 (m, 1H), 2.11-2.00 (m, 2H), 2.00-1.86 (m, 2H), 1.76 (td, J = 13.7, 
6.4 Hz, 1H), 1.61 (dd, J = 14.7, 2.7 Hz, 1H), 1.46 (d, J = 0.6 Hz, 3H), 1.35 (ddd, 
J = 26.5, 13.3, 5.8 Hz, 1H), 1.00 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 198.2, 178.9, 159.8, 97.2, 75.9, 56.6, 46.8, 46.2, 43.9, 37.0, 31.3, 27.4, 24.2, 21.5, 
15.0. 
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Lactone (95): Lactone 38 (23.0 mg, 0.087 mmol, 1.0 eq.) and a catalytic amount of 
Rh/C (5%, 17.9 mg, 0.009 mmol, 10 mol%) were dissolved in dry 
EtOH (4 mL). The mixture was hydrogenated with 60 bar H2 
atmosphere overnight and subsequently filtered through silica and celite 
and washed with EtOAc. The solvent was removed under reduced 
pressure. The crude material was purified by flash chromatography 
(EtOAc/cyclohexane 1:1) giving the reduced product 95 (23.2 mg, 0.087 mmol, 
quant.) as colourless crystals. 
 
Rf = 0.20 (EtOAc/cyclohexane 1:1, CAM dip). Optical rotation: [α]D = –50.7 
(c = 0.31, MeOH). FTIR ν = 3467, 2961, 2891, 1775, 1747, 1454, 1384, 1234, 1189, 
1150, 1106, 1081, 989, 949, 886, 818, 755, 725 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 4.52 (dd, J = 9.7, 1.6 Hz, 1H), 4.45 (dd, J = 9.7, 7.3 Hz, 1H), 4.31 (s, 1H), 2.90 
(dd, J = 19.7, 9.9 Hz, 1H), 2.60-2.53 (m, 1H), 2.45 (ddd, J = 13.9, 4.2, 2.8 Hz, 1H), 
2.21-2.10 (m, 2H), 1.89-1.79 (m, 3H), 1.57-1.50 (m, 1H), 1.36-1.27 (m, 2H), 1.09 (d, 
J = 6.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 178.4, 177.0, 93.9, 67.8, 67.6, 
54.7, 43.9, 42.0, 36.8, 36.8, 30.6, 24.7, 18.7, 14.0. HRMS ESI calc. for C14H19O5 
[M-H]+: 267.1227, found: 267.1225. X-ray crystal structure is given in the 
appendices section. 
 
 
Ketone (96): Alcohol 95 (4.7 mg, 0.0176 mmol, 1.0 eq.) was dissolved in dry CH2Cl2 
(2 mL) under nitrogen atmosphere. Dess-Martin periodinane (8.3 mg, 
0.0194 mmol, 1.1 eq.) was added and the mixture was stirred for 2 h at 
r.t. The reaction was quenched by addition of saturated NaHCO3 
solution and extracted three times with EtOAc. Combined organic layers 
were dried over Na2SO4, filtered and evaporated under reduced pressure. The crude 
was purified by flash chromatography (EtOAc/pentane 1:1) giving ketone 96 (4.7 mg, 
0.0176 mmol, quant.) as a white solid.  
 
Rf = 0.11 (pentane/EtOAc 1:1). Optical rotation: [α]D = –43.1 (c = 0.29, CHCl3). 
FTIR ν = 2968, 2928, 2873, 2361, 1775, 1756, 1478, 1382, 1337, 1277, 1257, 1210, 
1190, 1164, 1147, 1064, 1030, 984, 966, 935, 897, 870, 831, 802, 731 cm-1. 1H NMR 
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(400 MHz, CDCl3) δ = 4.49 (dd, J = 10.0, 8.4 Hz, 1H), 4.04 (dd, J = 10.0, 6.3 Hz, 
1H), 3.16 (ddd, J = 10.1, 8.4, 6.3 Hz, 1H), 2.98-2.87 (m, 1H), 2.41 (dd, J = 13.9, 
6.3 Hz, 1H), 2.20-2.09 (m, 1H), 2.01-1.84 (m, 3H), 1.74-1.53 (m, 3H), 1.37-1.28 (m, 
1H), 1.06 (d, J = 7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 199.1, 178.1, 159.2, 
93.6, 68.1, 56.3, 47.2, 40.7, 39.4, 36.9, 31.5, 28.6, 19.9, 14.4. HRMS ESI calc. for 
C14H17O5 [M-H]+: 265.1071, found: 265.1069.  
 
 
TES ether (97): Lactone 41 (10.0 mg, 0.0264 mmol, 1.0 eq.) and a catalytic amount 
of Pd(OH)2/C  (20%, 1.85 mg, 0.00264 mmol, 0.1 eq.) were dissolved 
in dry EtOH (1 mL) and hydrogenated under 70 bar H2 pressure 
overnight. The reaction mixture was filtered through silica and celite 
and washed with EtOAc. The solvent was evaporated under reduced 
pressure to give the reduced product 97 (10.0 mg, 0.0264 mmol, quant.) as a white 
solid. 
 
Rf = 0.21 (EtOAc/pentane 1:4). Optical rotation: [α]D = –32.6 (c = 0.40, MeOH). 
FTIR ν = 2954, 2922, 2875, 1777, 1758, 1457, 1381, 1236, 1193, 1162, 1147, 1088, 
1062, 1038, 1003, 968, 945, 891, 835, 807, 741, 719 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 4.49 (dd, J = 9.6, 2.3 Hz, 1H), 4.42 (dd, J = 9.6, 7.6 Hz, 1H), 4.33 (s, 1H), 
2.87 (dd, J = 19.0, 10.0 Hz, 1H), 2.59 (ddd, J = 10.0, 7.6, 2.3 Hz, 1H), 2.41 (ddd, 
J = 13.7, 5.2, 2.7 Hz, 1H), 2.17-2.05 (m, 2H), 1.89-1.70 (m, 3H), 1.52-1.31 (m, 2H), 
1.25 (dt, J = 7.0, 6.6 Hz, 1H), 1.04 (d, J = 6.5 Hz, 3H), 1.00-0.92 (m, 9H), 0.82-0.61 
(m, 6H). 13C NMR (101 MHz, CDCl3) δ = 178.7, 175.4, 92.7, 69.0, 67.8, 54.3, 44.0, 
41.8, 37.3, 37.0, 25.3, 18.8, 14.2, 7.0, 5.4. HRMS ESI calc. for C20H26NO5Si 
[M-NH4]+: 398.2357, found: 398.2352.  
 
 
Alcohol (98): To a solution of the protected lactone 97 (7.0 mg, 0.0184 mmol, 1 eq.) 
in dry THF (3 mL) at –78 °C was added LiHMDS (1 M in THF, 28 µL, 
0.0276 mmol, 1.5 eq.) drop wise. After stirring for 30 min triphenyl 
phosphite (8.8 mg, 0.0276 mmol, 1.5 eq.) was added. Oxygen was then 
passed through the reaction until TLC showed near disappearance of 
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starting material. The reaction was then quenched by the addition of 1 M HCl solution 
at –78 °C. The resulting mixture was slowly heated up to r.t. overnight and extracted 
three times with EtOAc. Combined organic layers were washed with brine, dried over 
Na2SO4, filtered and evaporated under reduced pressure. The crude residue was 
purified by flash chromatography (pentane/EtOAc 2:1) to yield the hydroxylated 
product 98 (3.4 mg, 0.0184 mmol, 47%) as a white solid. 
 
Rf = 0.29 (pentane/EtOAc 2:1). 1H NMR (400 MHz, CDCl3) δ = 4.53 (dd, J = 9.5, 
8.8 Hz, 1H), 4.40 (dd, J = 9.6, 5.7 Hz, 1H), 4.33 (s, 1H), 2.75 (dd, J = 8.7, 5.7 Hz, 
1H), 2.55 (dd, J = 14.3, 7.2 Hz, 1H), 2.22 (ddd, J = 14.2, 8.0, 3.3 Hz, 1H), 2.14-1.99 
(m, 2H), 1.94-1.76 (m, 4H), 1.42-1.29 (m, 2H), 1.06 (d, J = 6.9 Hz, 3H), 1.00-0.92 
(m, 9H), 0.80-0.62 (m, 6H). 13C NMR (101 MHz, CDCl3) δ = 178.8, 175.2, 93.5, 
73.9, 70.0, 67.3, 53.3, 48.5, 46.2, 43.6, 38.1, 30.9, 29.5, 23.0, 14.7, 6.9, 5.1. 
 
 
Lactone (99): Alcohol 93 (2.5 mg, 0.0089 mmol, 1.0 eq.) was dissolved in dry 
THF (1 mL) under nitrogen atmosphere and cooled down to –78 °C. 
LDA (0.28 M in THF, 96 µL, 0.0268 mmol, 3.0 eq.) was added at          
–78 °C and the mixture was stirred for 1 h. Phenylselenyl bromide 
(4.2 mg, 0.0178 mmol, 2.0 eq.) was dissolved in THF (0.15 mL) and 
added at –78 °C. The resulting mixture was stirred for 1 h at that temperature and 
subsequently heated up to 0 °C and stirred for further 30 min. The reaction mixture 
was diluted with a saturated NH4Cl solution and EtOAc. The layers were separated 
and the aqueous layer was extracted two times with EtOAc. Combined organic layers 
were dried over Na2SO4, filtered and evaporated under reduced pressure. The residue 
was dissolved in THF (1 mL) and cooled down to 0 °C. One drop of AcOH and H2O2 
(35% in H2O) were added and the mixture was stirred for 2 h before a saturated 
NaHCO3 solution was added and stirred 1 h at r.t. Extraction with performed three 
times with EtOAc. Combined organic layers were dried over Na2SO4, filtered and 
evaporated under reduced pressure. Purification was performed by flash 
chromatography to yield the desired product 99 (1.2 mg, 0.00431 mmol, 48%) as a 
crystalline solid. 
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Rf = 0.21 (pentane/EtOAc 1:4). Optical rotation: [α]D = –68.4 (c = 0.29, MeOH). 
FTIR: ν = 3357, 2923, 2853, 1762, 1662, 1467, 1378, 1263, 1208, 1159, 1095, 1022, 
962, 930, 902, 795, 748 cm-1. 1H NMR (400 MHz, d4-MeOD) δ = 4.75 (t, J = 5.7 Hz, 
1H), 4.65 (d, J = 9.3 Hz, 1H), 4.01 (s, 1H), 3.87 (d, J = 9.3 Hz, 1H), 3.07 (d, 
J = 5.2 Hz, 1H), 2.31-2.21 (m, 2H), 2.09-1.94 (m, 4H), 1.36 (s, 3H), 1.27-1.15 (m, 
1H), 1.08 (d, J = 7.0 Hz, 3H). 13C NMR (101 MHz, d4-MeOD) δ = 177.7, 174.9, 
101.9, 78.7, 75.6, 75.5, 60.4, 55.4, 44.7, 39.0, 35.4, 34.0, 32.8, 27.3, 15.8. 
HRMS ESI calc. for C15H19O5 [M-H]+: 279.1227, found: 279.1223. X-ray crystal 
structure is given in the appendix. 
 
 
Silyl ether (100): Lactone 99 (1.1 mg, 0.004 mmol, 1.0 eq.) was dissolved in dry 
THF (1 mL) under argon atmosphere and cooled down to –78 °C and 
1 drop of lithium bis(trimethylsilyl)amide (1 M in THF)  was added and 
the mixture was stirred for 1 h at that temperature. After that time, 
1 drop of trimethylchlorosilane was added and the mixture was stirred 
30 min at –78 °C. The mixture was heated up to 0 °C and stirred for 30 min before it 
was quenched by addition a saturated NaHCO3 solution. The mixture was diluted with 
EtOAc, dried over Na2SO4 and filtered over a pad of silica. The organic layer was 
evaporated under reduced pressure. The crude 1H-NMR showed already quite pure 
product. Yield was not determined due to the low amount used for the reaction. 
 
1H NMR (400 MHz, d4-MeOD) δ = 7.02 (dd, J = 7.9, 3.1 Hz, 1H), 4.65 (d, 
J = 9.1 Hz, 1H), 4.46 (s, 1H), 4.16 (d, J = 9.1 Hz, 1H), 3.19 (dd, J = 16.7, 7.9 Hz, 
1H), 2.27 (ddd, J = 15.0, 10.9, 8.5 Hz, 1H), 2.14-2.00 (m, 1H), 2.05 (dd, J = 16.7, 
3.1 Hz, 2H), 1.95 (ddd, J = 20.2, 13.6, 8.0 Hz, 2H), 1.76-1.63 (m, 1H), 1.33 (s, 3H), 
1.07 (d, J = 6.7 Hz, 3H), 0.22 (s, 9H).  
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Silyl ether (101): Lactone 99 (1.1 mg, 0.004 mmol, 1.0 eq.) was dissolved in dry 
THF  (1 mL) under argon atmosphere and cooled down to –78 °C and 
1 drop of lithium bis(trimethylsilyl)amide (1 M in THF) was added and 
the mixture was stirred for 1 h at that temperature. After that time, 
1 drop of trimethylchlorosilane was added and the mixture was stirred 
30 min at –78 °C. The mixture was heated up to 0 °C and stirred for 30 min before it 
was quenched by addition a saturated NaHCO3 solution. The mixture was diluted with 
EtOAc, dried over Na2SO4 and filtered over a pad of silica. The organic layer was 
evaporated under reduced pressure. Purification was performed by flash 
chromatography (pentane/EtOAc 1:1) to yield the desired product 101 along with 
some remaining reagents. Yield was not determined due to low amount used for the 
reaction. 
 
Rf = 0.66 (pentane/EtOAc 1:1). 1H NMR (400 MHz, d4-MeOD) δ = 7.02 (dd, J = 7.9, 
3.2, 1H), 4.66 (d, J = 9.2, 1H), 4.44 (s, 1H), 4.16 (d, J = 9.1, 1H), 3.22 (dd, J = 16.6, 
7.9, 1H), 2.27 (ddd, J = 15.0, 11.2, 8.5, 1H), 2.15-2.03 (m, 2H), 2.00-1.88 (m, 2H), 
1.72-1.59 (m, 1H), 1.34 (s, 3H), 1.09 (d, J = 6.7, 3H), 1.03-0.98 (m, 9H), 0.84-0.65 
(m, 6H). 
 
 
10-Deoxy-jiadifenolide (102): TMS-protected alcohol 100 (1.4 mg, 0.0039 mmol) 
was dissolved in a MeOH/THF mixture (4 mL, 3:1) and cooled down to 
0 °C. One drop of hydrogen peroxide (35% in water) and one drop of an 
aqueous 1 M NaOH solution were added and the resulting mixture was 
stirred for 1 h at 0 °C and subsequently for 15 h at r.t. EtOAc was added 
and the mixture was dried over Na2SO4 and filtered over a pad with silica. The filtrate 
was evaporated under reduced pressure. Purification was performed by flash 
chromatography (EtOAc/pentane 4:1) and the desired product was obtained as a white 
solid. Yield was not determined due to low amount used for the reaction. 
 
Rf = 0.25 (CH2Cl2/MeoH 20:1). 1H NMR (500 MHz, d4-MeOD) δ = 4.63 (d, 
J = 9.4 Hz, 1H), 4.39 (d, J = 5.8 Hz, 1H), 3.97 (s, 1H), 3.82 (d, J = 9.4 Hz, 1H), 
2.30-2.18 (m, 3H), 2.12 (d, J = 13.0 Hz, 1H), 2.09-2.05 (m, 2H), 1.99 (dtd, J = 8.4, 
4.7, 1.9 Hz, 1H), 1.22 (s, 3H), 1.07 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
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d4-MeOD) δ = 177.9, 174.6, 100.5, 81.2, 78.4, 78.3, 74.5, 60.4, 47.6, 38.6, 34.3, 33.0, 
32.5, 19.3, 15.3. HRMS ESI calc. for C15H18NaO6 [M-Na]+: 317.0996, found: 
317.0994. 
 
 
Olefin (103): Lactone 99 (1.3 mg, 0.005 mmol, 1.0 eq.) was dissolved in dry THF  
(1 mL) under argon atmosphere and cooled down to -78 °C and 1 drop 
of lithium bis(trimethylsilyl)amide (1 M in THF) was added and the 
mixture was stirred for 1 h at that temperature. Dess-Martin periodinane 
(5.9 mg, 0.014 mmol, 3.0 eq.) was added and the resulting mixture was 
stirred 30 min at the same temperature and subsequently heated up to r.t. for 1 h. 
Reaction was quenched by addition a saturated NaHCO3 solution. The mixture was 
diluted with EtOAc, dried over Na2SO4, filtered over a pad of silica and washed with 
EtOAc. The filtrate was evaporated under reduced pressure. The crude product was 
used for further reactions without additional purification. Yield was not determined 
due to low amount used for the reaction. 
 
1H NMR (400 MHz, d4-MeOD) δ = 7.04 (dd, J = 7.9, 3.1, 1H), 4.65 (dd, J = 9.1, 0.5, 
1H), 4.38 (s, 1H), 4.16 (d, J = 9.1, 1H), 3.22 (dd, J = 16.9, 7.9, 1H), 2.29 (ddd, 
J = 15.1, 10.9, 8.7, 1H), 2.14-2.00 (m, 2H), 2.00-1.88 (m, 2H), 1.76-1.63 (m, 1H), 
1.33 (s, 3H), 1.09 (d, J = 6.7, 3H). 
 
 
Keto lactone (104): Alcohol 103 (0.5 mg, 0.0018 mmol, 1.0 eq.) was dissolved in dry 
CH2Cl2 (2 mL) and Dess-Martin periodinane (1.5 mg, 0.0036 mmol, 
2.0 eq.) was added. The resulting mixture was stirred overnight at room 
temperature. The reaction was quenched by addition of an aqueous 
saturated NaHCO3 solution. Extraction was performed three times with 
EtOAc and combined organic layers were dried over Na2SO4, filtered and evaporated 
under reduced pressure. Product 104 was obtained along with some traces of the 
starting material and was used for further reactions without additional purification. 
Yield was not determined due to low amount used for the reaction. 
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1H NMR (400 MHz, d4-MeOD) δ = 6.95 (dd, J = 7.7, 3.2, 1H), 4.26 (d, J = 9.4, 1H), 
3.04 (dd, J = 16.6, 7.7, 1H), 2.54 (dd, J = 16.6, 3.2, 1H), 2.45 (ddd, J = 14.6, 12.8, 
6.7, 1H), 2.28-2.18 (m, 1H), 2.14 (dd, J = 14.5, 6.1, 1H), 2.09-1.98 (m, 2H), 1.40 (d, 
J = 0.6, 3H), 1.08 (d, J = 6.9, 3H). One of the C-13 protons is hidden under the water 
peak between 4.89 and 4.85 ppm. 
 
 
Mesylate (105): Lactone 99 (2.9 mg, 0.0104 mmol, 1.0 eq.) was dissolved in dry 
THF (1.5 mL) under argon atmosphere and cooled down to –78 °C. One 
drop of lithium bis(trimethylsilyl)amide (1 M in THF) was added and 
the mixture was stirred for 40 min at that temperature before one drop 
of methanesulfonyl chloride was added. The resulting mixture was 
stirred for 1.5 h at –78 °C, heated up to 0 °C and stirred for a further hour. Finally, the 
solution was warmed up to room temperature and quenched with an aqueous saturated 
NHCl4 solution after 20 min. The mixture was diluted with EtOAc, dried over Na2SO4 
and filtered over a pad of silica. The organic layer was evaporated under reduced 
pressure. The crude product was used for further reactions without additional 
purification. Yield was not determined due to low amount used for the reaction and 
impurities present in the crude product. 
 
1H NMR (400 MHz, d4-MeOD) δ = 7.07 (dd, J = 7.8, 3.3, 1H), 5.45 (s, 1H), 4.66 (dd, 
J = 9.3, 0.4, 1H), 4.19 (d, J = 9.3, 1H), 3.35 (s, 3H), 3.08 (dd, J = 17.7, 7.1, 1H), 
2.36-2.23 (m, 2H), 2.20-2.09 (m, 1H), 2.06-1.94 (m, 2H), 1.82-1.69 (m, 1H), 1.36 (s, 
3H), 1.17 (d, J = 6.8, 3H).  
 
 
Alcohol (106): Crude mesylate 105 was dissolved in a water/ethanol mixture (0.9 mL, 
1:2) and some drops of an aqueous 1 M NaOH solution were added. The 
resulting mixture was stirred for 1 h at room temperature. Solution was 
diluted with EtOAc, dried over Na2SO4, filtered over a pad of silica and 
dried in vacuo. The crude product was used for further reactions without 
additional purification. Yield was not determined due to low amount used for the 
reaction and impurities present in the crude product. 
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1H NMR (500 MHz, d4-MeOD) δ = 6.92 (dd, J = 7.8, 2.7, 1H), 4.73 (s, 1H), 4.57 (dd, 
J = 8.5, 0.5, 1H), 4.05 (d, J = 8.5, 1H), 2.89 (dd, J=17.3, 7.8, 1H), 2.14-2.08 (m, 1H), 
2.09 (dd, J = 17.4, 2.8, 1H), 2.02-1.95 (m, 2H), 1.95-1.86 (m, 1H), 1.76 (d, J = 7.7, 
1H), 1.10 (s, 3H), 1.09 (d, J = 7.1, 3H). 13C NMR (125 MHz, CDCl3) δ = 174.3, 
171.1, 138.9, 135.53, 98.1, 75.8, 74.0, 58.5, 46.9, 43.4, 33.7, 32.4, 28.6, 21.7, 12.3.  
 
 
Lactone (108): Ester 57 (4.5 mg, 0.0159 mmol, 1.0 eq.) was dissolved in dry 
THF (1 mL) under nitrogen atmosphere and cooled down to –78 °C. 
LDA (0.28 M in THF, 171 µL, 0.0478 mmol, 3.0 eq.) was added at        
–78 °C and the mixture was stirred for 1 h. Phenylselenyl bromide 
(7.5 mg, 0.0319 mmol, 2.0 eq.) was dissolved in THF (0.25 mL) and added at –78 °C. 
The resulting mixture was stirred for 1 h at that temperature and subsequently heated 
up to 0 °C and stirred for further 30 min. The reaction mixture was diluted with a 
saturated NH4Cl solution and EtOAc. The layers were separated and the aqueous 
layer was extracted two times with EtOAc. Combined organic layers were dried over 
Na2SO4, filtered and evaporated under reduced pressure. The residue was dissolved in 
THF (1 mL) and cooled down to 0 °C. One drop of AcOH and H2O2 (35% in H2O) 
were added and the mixture was stirred for 2 h before a saturated NaHCO3 solution 
was added and stirred 1 h at r.t. Extraction with performed three times with EtOAc. 
Combined organic layers were dried over Na2SO4, filtered and evaporated under 
reduced pressure. Purification was performed by flash chromatography 
(pentane/EtOAc 4:1 to 3:1) to yield the desired product 108 (2.4 mg, 0.0086 mmol, 
54%) as a white solid and unreacted starting material (1.5 mg, 0.0053 mmol, 81% 
brsm). 
 
Rf = 0.23 (pentane/EtOAc 3:1). Optical rotation: [α]D = +11.4 (c = 0.48, CHCl3). 
FTIR: ν = 3478, 2944, 2921, 2891, 1729, 1683, 1467, 1374, 1343, 1327, 1270, 1250, 
1236, 1193, 1168, 1132, 1109, 1080, 1043, 1027, 997, 975, 897, 851, 791, 763, 
749 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.80 (dd, J = 7.5, 2.9 Hz, 1H), 4.54 (d, 
J = 1.5 Hz, 1H), 4.51 (dd, J = 8.5, 0.8 Hz, 1H), 4.00 (d, J = 8.5 Hz, 1H), 3.70 (s, 3H), 
3.04 (dd, J = 17.1, 7.6 Hz, 1H), 2.23-2.13 (m, 2H), 2.12-1.94 (m, 4H), 1.79 (ddt, 
J = 12.0, 6.8, 3.4 Hz, 1H), 1.29 (d, J = 0.8 Hz, 3H), 1.02 (d, J = 7.0 Hz, 3H). 
O
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13C NMR (101 MHz, CDCl3) δ = 176.1, 169.3, 138.6, 132.7, 87.3, 76.0, 61.3, 52.4, 
48.1, 43.8, 35.8, 34.3, 30.7, 22.4, 19.5. HRMS ESI calc. for C15H21O5 [M-H]+: 
281.1384, found: 281.1383. 
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8 APPENDICES 
8.1 Crystal Structures 
Table 14: Crystal data for 25. 
 
 
 
Formula                             C9H12O3 
Formula weight                     168.19 g · Mol-1 
Z, calculated density              4, 1.341 Mg · m-3 
F(000)                              360 
Description and size of crystal    colourless, 0.060 · 0.140 · 0.270 mm3 
Absorption coefficient             0.100 mm-1 
Min/max transmission               0.99 / 0.99 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   6.0219(6) Å 
b                                   10.7615(11) Å 
c                                   12.8590(12) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   833.32(14) Å3 
Min/max Θ                          2.468° / 33.721° 
Number of collected reflections    21946 
Number of independent reflections  1926 (merging r = 0.041) 
Number of observed reflections     1606 (I>2.0σ(I)) 
Number of refined parameters       109 
r                                   0.0286 
rW                                  0.0408 
Goodness of fit                    1.0898 
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Table 15: Crystal data for 33. 
 
 
 
Formula                             C14H18O5 
Formula weight                     266.29 g · Mol-1 
Z, calculated density              2, 1.372 Mg · m-3 
F(000)                              284 
Description and size of crystal    colourless, 0.020 · 0.070 · 0.340 mm3 
Absorption coefficient             0.104 mm-1 
Min/max transmission               0.99 / 1.00 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   8.2257(4) Å 
b                                   8.6177(4) Å 
c                                   9.4412(4) Å 
α                                   90° 
β                                   105.591(3)° 
γ                                   90° 
V                                   644.63(5) Å3 
Min/max Θ                          2.240° / 33.031° 
Number of collected reflections    15153 
Number of independent reflections  2573 (merging r = 0.046) 
Number of observed reflections     2011 (I>2.0σ(I)) 
Number of refined parameters       172 
r                                   0.0360 
rW                                  0.0476 
Goodness of fit                    1.1258 
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Table 16: Crystal data for 35. 
 
 
 
Formula                             C14H19N2O5 
Formula weight                     294.31 g · Mol-1 
Z, calculated density              4, 1.277 Mg · m-3 
F(000)                              572 
Description and size of crystal    colourless, ? · ? · ? mm3 
Absorption coefficient             0.072 mm-1 
Min/max transmission               1.0000 / 1.0000 
Temperature                        293K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21  
a                                   34.202(14) Å 
b                                   6.366(3) Å 
c                                   6.432(2) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   1400.5(10) Å3 
Min/max Θ                          2.382° / 26.425° 
Number of collected reflections    8620 
Number of independent reflections  1702 (merging r = 0.180) 
Number of observed reflections     865 (I>2.0σ(I)) 
Number of refined parameters       68 
r                                   0.2266 
rW                                  0.3259 
Goodness of fit                    0.8879 
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Table 17: Crystal data for 38. 
 
 
 
Formula                             C14H16O5 
Formula weight                     264.28 g · Mol-1 
Z, calculated density              4, 1.403 Mg · m-3 
F(000)                              560 
Description and size of crystal    colourless, 0.030 · 0.150 · 0.330 mm3 
Absorption coefficient             0.107 mm-1 
Min/max transmission               0.98 / 1.00 
Temperature                        173K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   7.7488(2) Å 
b                                   11.5545(3) Å 
c                                   13.9686(4) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   1250.66(6) Å3 
Min/max Θ                          2.287° / 35.631° 
Number of collected reflections    40767 
Number of independent reflections  3247 (merging r = 0.033) 
Number of observed reflections     2704 (I>2.0σ(I)) 
Number of refined parameters       172 
r                                   0.0308 
rW                                  0.0469 
Goodness of fit                    1.0627 
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Table 18: Crystal data for 39. 
 
 
 
Formula                             C14H14O5 
Formula weight                     262.26 g · Mol-1 
Z, calculated density              8, 1.418 Mg · m-3 
F(000)                              1104 
Description and size of crystal    colourless, 0.030 · 0.090 · 0.230 mm3 
Absorption coefficient             0.108 mm-1 
Min/max transmission               0.99 / 1.00 
Temperature                        173K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   7.1075(2) Å 
b                                   13.8782(4) Å 
c                                   24.9039(7) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   2456.50(12) Å3 
Min/max Θ                          1.635° / 32.583° 
Number of collected reflections    61046 
Number of independent reflections  5007 (merging r = 0.048) 
Number of observed reflections     3825 (I>2.0σ(I)) 
Number of refined parameters       343 
r                                   0.0437 
rW                                  0.0731 
Goodness of fit                    1.0932 
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Table 19: Crystal data for 45. 
 
 
 
Formula                             C14H16O4 
Formula weight                     248.28 g · Mol-1 
Z, calculated density              2, 1.355 Mg · m-3 
F(000)                              264 
Description and size of crystal    colourless, 0.020 · 0.160 · 0.210 mm3 
Absorption coefficient             0.099 mm-1 
Min/max transmission               0.98 / 1.00 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   6.4095(17) Å 
b                                   13.267(3) Å 
c                                   7.6203(19) Å 
α                                   90° 
β                                   110.130(12)° 
γ                                   90° 
V                                   608.4(3) Å3 
Min/max Θ                          2.847° / 31.582° 
Number of collected reflections    12794 
Number of independent reflections  2109 (merging r = 0.068) 
Number of observed reflections     1737 (I>2.0σ(I)) 
Number of refined parameters       163 
r                                   0.0537 
rW                                  0.0751 
Goodness of fit                    1.1043 
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Table 20: Crystal data for 51. 
 
 
 
Formula                             C15H20O5 
Formula weight                     280.32 g · Mol-1 
Z, calculated density              4, 1.314 Mg · m-3 
F(000)                              600 
Description and size of crystal    colourless, 0.030 · 0.080 · 0.310 mm3 
Absorption coefficient             0.098 mm-1 
Min/max transmission               0.99 / 1.00 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   12.9173(5) Å 
b                                   7.3710(3) Å 
c                                   15.3483(6) Å 
α                                   90° 
β                                   104.086(2)° 
γ                                   90° 
V                                   1417.42(10) Å3 
Min/max Θ                          1.852° / 30.032° 
Number of collected reflections    18394 
Number of independent reflections  4442 (merging r = 0.034) 
Number of observed reflections     3663 (I>2.0σ(I)) 
Number of refined parameters       361 
r                                   0.0339 
rW                                  0.0466 
Goodness of fit                    1.1259 
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Table 21: Crystal data for 60. 
 
 
 
Formula                             C14H16O5 
Formula weight                     264.28 g · Mol-1 
Z, calculated density              4, 1.377 Mg · m-3 
F(000)                              560 
Description and size of crystal    colourless, 0.040 · 0.170 · 0.230 mm3 
Absorption coefficient             0.105 mm-1 
Min/max transmission               0.98 / 1.00 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   9.9581(4) Å 
b                                   9.1172(4) Å 
c                                   14.0670(6) Å 
α                                   90° 
β                                   93.587(2)° 
γ                                   90° 
V                                   1274.64(9) Å3 
Min/max Θ                          2.584° / 32.580° 
Number of collected reflections    35267 
Number of independent reflections  4892 (merging r = 0.029) 
Number of observed reflections     4161 (I>2.0σ(I)) 
Number of refined parameters       343 
r                                   0.0302 
rW                                  0.0435 
Goodness of fit                    1.1028 
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Table 22: Crystal data for 63. 
 
 
 
Formula                             C17H22O6 
Formula weight                     322.36 g · Mol-1 
Z, calculated density              2, 1.314 Mg · m-3 
F(000)                              344 
Description and size of crystal    colourless, 0.010 · 0.070 · 0.220 mm3 
Absorption coefficient             0.099 mm-1 
Min/max transmission               0.99 / 1.00 
Temperature                        173K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   9.3651(9) Å 
b                                   10.4682(10) Å 
c                                   9.3907(10) Å 
α                                   90° 
β                                   117.748(4)° 
γ                                   90° 
V                                   814.76(14) Å3 
Min/max Θ                          2.451° / 25.030° 
Number of collected reflections    7520 
Number of independent reflections  1523 (merging r = 0.126) 
Number of observed reflections     1219 (I>2.0σ(I)) 
Number of refined parameters       208 
r                                   0.0599 
rW                                  0.1075 
Goodness of fit                    1.0557 
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Table 23: Crystal data for 75. 
 
 
 
Formula                             C14H20O6 
Formula weight                     284.31 g · Mol-1 
Z, calculated density              4, 1.391 Mg · m-3 
F(000)                              608 
Description and size of crystal    colourless, 0.020 · 0.110 · 0.280 mm3 
Absorption coefficient             0.109 mm-1 
Min/max transmission               0.99 / 1.00 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   8.7432(5) Å 
b                                   12.2122(7) Å 
c                                   12.7131(8) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   1357.42(14) Å3 
Min/max Θ                          3.283° / 39.394° 
Number of collected reflections    48036 
Number of independent reflections  4479 (merging r = 0.037) 
Number of observed reflections     3516 (I>2.0σ(I)) 
Number of refined parameters       181 
r                                   0.0314 
rW                                  0.0524 
Goodness of fit                    1.0609 
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Table 24: Crystal data for 84. 
 
 
 
Formula                             C17H24O7 
Formula weight                     340.37 g · Mol-1 
Z, calculated density              2, 1.382 Mg · m-3 
F(000)                              364 
Description and size of crystal    colourless, 0.020 · 0.170 · 0.190 mm3 
Absorption coefficient             0.898 mm-1 
Min/max transmission               0.86 / 0.98 
Temperature                        123K 
Radiation (wavelength)              Cu Kα (λ = 1.54178 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   10.7060(13) Å 
b                                   6.2176(8) Å 
c                                   12.2984(19) Å 
α                                   90° 
β                                   92.267(10)° 
γ                                   90° 
V                                   818.01(19) Å3 
Min/max Θ                          3.597° / 68.402° 
Number of collected reflections    5437 
Number of independent reflections  2714 (merging r = 0.059) 
Number of observed reflections     2270 (I>2.0σ(I)) 
Number of refined parameters       219 
r                                   0.0953 
rW                                  0.1148 
Goodness of fit                    1.0534 
 
 
 
 
CHAPTER 8 
 
228 
Table 25: Crystal data for 89. 
 
 
 
Formula                             C15H21I1O5 
Formula weight                     408.23 g · Mol-1 
Z, calculated density              4, 1.711 Mg · m-3 
F(000)                              816 
Description and size of crystal    colourless, 0.010 · 0.020 · 0.230 mm3 
Absorption coefficient             2.039 mm-1 
Min/max transmission               0.96 / 0.98 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   6.2741(8) Å 
b                                   13.1986(16) Å 
c                                   19.138(2) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   1584.8(3) Å3 
Min/max Θ                          1.874° / 27.480° 
Number of collected reflections    17159 
Number of independent reflections  3612 (merging r = 0.117) 
Number of observed reflections     2203 (I>2.0σ(I)) 
Number of refined parameters       191 
r                                   0.0603 
rW                                  0.0628 
Goodness of fit                    1.0854 
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Table 26: Crystal data for 95. 
 
 
 
Formula                             C14H18O5 
Formula weight                     266.29 g · Mol-1 
Z, calculated density              4, 1.401 Mg · m-3 
F(000)                              568 
Description and size of crystal    colourless, 0.050 · 0.120 · 0.210 mm3 
Absorption coefficient             0.106 mm-1 
Min/max transmission               0.99 / 0.99 
Temperature                        123K 
Radiation (wavelength)              Mo Kα (λ = 0.71073 Å) 
Crystal system, space group        orthorhombic, P 21 21 21 
a                                   8.3912(4) Å 
b                                   10.4988(5) Å 
c                                   14.3311(7) Å 
α                                   90° 
β                                   90° 
γ                                   90° 
V                                   1262.53(11) Å3 
Min/max Θ                          2.405° / 39.412° 
Number of collected reflections    49860 
Number of independent reflections  4197 (merging r = 0.038) 
Number of observed reflections     3448 (I>2.0σ(I)) 
Number of refined parameters       172 
r                                   0.0290 
rW                                  0.0428 
Goodness of fit                    1.0609 
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Table 27: Crystal data for 99. 
 
 
 
Formula                             C15H18O5 
Formula weight                     278.30 g · Mol-1 
Z, calculated density              2, 1.347 Mg · m-3 
F(000)                              296 
Description and size of crystal    colourless, 0.060 · 0.130 · 0.210 mm3 
Absorption coefficient             0.840 mm-1 
Min/max transmission               0.90 / 0.95 
Temperature                        293K 
Radiation (wavelength)              Cu Kα (λ = 1.54178 Å) 
Crystal system, space group        monoclinic, P 21 
a                                   7.3214(4) Å 
b                                   9.0142(6) Å 
c                                   10.4450(6) Å 
α                                   90° 
β                                   95.474(3)° 
γ                                   90° 
V                                   686.19(7) Å3 
Min/max Θ                          6.072° / 67.672° 
Number of collected reflections    6473 
Number of independent reflections  2329 (merging r = 0.034) 
Number of observed reflections     2232 (I>2.0σ(I)) 
Number of refined parameters       182 
r                                   0.0341 
rW                                  0.0375 
Goodness of fit                    1.1221 
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8.2 1H and 13C NMR Spectra 
1H and 13C NMR Spectra for the all characterized compounds can be found on the 
enclosed CD to this PhD thesis. 
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